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Abstract 
Although it is evident that physiological ageing is accompanied by marked alterations in the 
function of innate immune cells, little is known regarding the underlying mechanism(s). 
Furthermore, the effect of age on many novel aspects of innate immunity is unknown. This 
thesis has identified the mechanism(s) behind the well-documented age-related decline in 
natural killer (NK) cytotoxicity (NKCC) and demonstrated for the first time that human 
ageing is accompanied by a significant reduction in the generation of neutrophil extracellular 
traps (NETs). 
Following target cell recognition, it was found that NK cells from older adults secreted into 
the immunological synapse (IS) significantly lower levels of perforin, a pore-forming protein 
that plays a non-redundant role in NKCC. This impairment led to reduced perforin binding to 
the target cell surface, an event that correlated strongly with NKCC. Underlying the reduction 
in perforin secretion was defective polarisation of lytic granules to the IS, which was 
associated with delayed activation of extracellular signal-regulated kinase 1/2. 
Whilst no age-related difference was observed in NET production triggered by phorbol             
12-myristate 13-acetate (PMA), neutrophils from older adults generated significantly fewer 
NETs when challenged with interleukin-8 or lipopolysaccharide, which was accompanied by 
a reduction in reactive oxygen species generation. As PMA activates cells independent of 
membrane receptors, aberrant intracellular signalling proximal to the neutrophil membrane 
may underlie the age-related impairment in NET production.     
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1.0 Introduction  
1.1 Population ageing and the “healthy ageing phenotype” 
Recent advancements in medical care and public health policies, as well as improvements in 
socio-economic status mean we are now living longer than ever before. Couple this increase 
in lifespan to the decline in birth rate that has occurred over the last fifty years [1], and it is 
not surprising that we are in the midst of a “demographic transition”.  
Based on current mortality rates, it is estimated that the proportion of individuals aged sixty 
years and over, who accounted for eight and ten percent of the global population in 1950 and 
2000 respectively, will constitute twenty-one percent of the total world’s population by 2050, 
a figure, which according to current projections will equate to approximately two billion 
people [2]. Should this forecast become a reality then in 2050 older adults will outnumber 
individuals aged 15 years and under for the first time in history [2]. This change in population 
demographics will be most evident in developed countries. As early as 2015, subjects aged  
65 years and over will account for approximately fourteen percent of the population residing 
in Canada, Australia and Japan [3], whilst by 2030, twenty percent of the total population of 
the United States will fall into this age category [3]. Closer to home, recent estimates from 
the Office for National Statistics suggest that in 2033, twenty-three percent of the UK 
population will be represented by individuals aged 65 years and over, exceeding those aged 
≤16 years by five percent [4].  
The fact that we are living longer can on one hand be perceived as positive news, a testament 
to the improvements made in amongst other things hygiene, medicine and living conditions. 
However, these “extra years” can only be considered beneficial if they are experienced in 
relatively good health. In a recent UK government report, data was presented which showed 
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that whilst life expectancy (LE) over the last twenty years had increased at a fast rate, 
“healthy life expectancy” had not kept pace [5]. Of concern is the fact that the difference 
between these two measures widened during this period. Earlier detection and improved 
management of chronic diseases, together with health becoming a more sensitive issue are 
two possible reasons why people are now living longer whilst experiencing ill-health [5].  
Healthy ageing is a concept that encompasses a broad range of factors, and can be viewed 
from a physiological, psychological, medical or sociological perspective. Thus, what aspects 
of life are considered integral for healthy ageing varies significantly between the different 
fields of gerontology. For instance, whilst psychologists and sociologists view mental 
stability, social interaction and autonomy as key components of healthy ageing, physiologists 
consider physical conditioning, nutritional status and lifestyle to be more important [6]. In 
contrast, the medical profession views the absence of and ability to overcome illness as the 
defining feature of healthy ageing [6].  
Given the differences that exist in what people consider to be the main attributes of healthy 
ageing, establishing a universally accepted definition for this phenomenon has proven 
difficult, and hampered the attempts of gerontologists to fully understand how differences in 
LE and health can arise. Indeed, in a recent article reviewing the findings of studies in which 
twenty-nine different definitions of healthy ageing had been used, Depp and co-workers 
noted the percentage of subjects who considered themselves to have aged healthily ranged 
from 0.4% to 95%, variation that was attributed in part to the lack of a single and concise 
definition of healthy/successful ageing [7]. In an attempt to tackle this issue, specialists 
within the ageing field have recently devised the “healthy ageing phenotype” (HAP). Defined 
as “the condition of being alive, while having highly preserved functioning metabolic, 
hormonal and neuro-endocrine control systems at the organ, tissue and molecular levels” 
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and further characterised by “biological resilience to environmental stressors and the 
maintenance of cognitive and physical function” [8], the HAP brings together concepts from 
all fields of ageing research, and currently represents the most comprehensive definition of 
healthy ageing.  
1.2 Ageing and infection 
Rather than developing strategies that will further extend human lifespan, the current goal of 
ageing research is to improve the health status of older adults by increasing the duration of 
healthy ageing. To achieve this aim, a greater understanding of what factors drive unhealthy 
ageing and how they arise is required.  
Infectious diseases are a common occurrence in the elderly population. Compared to younger 
adults, individuals aged 65 years and over report increased incidences of influenza infection 
[9], community-acquired pneumonia [10;11], and urinary tract infections [12;13], whilst age 
is a major risk factor for the development of nosocomial infections [12;14]. As well as being 
more frequent, infections in the elderly are more severe. For example, mortality arising from 
community-acquired pneumonia has been reported to be as high as thirty percent in 
hospitalised older adults [10;15], whilst ninety percent of influenza-related deaths occur in 
people aged ≥65 years [16]. Strikingly, in the United States, both these infectious diseases 
rank in the top ten leading causes of death for people aged 65 years and over [17], 
highlighting the serious clinical consequences that can arise from infection in older adults. 
However, the severity of infection should not be judged solely in the context of mortality, as 
elderly individuals who survive infectious episodes experience greater rates of morbidity. For 
instance, Fein et al reported the incidence of hospital admissions for community-acquired 
pneumonia rose from <2/1000 for people aged ≤60 years to 12/1000 in subjects aged ≥65 
years [18]. Similarly, hospitalisation rates and the number of days spent in hospital are 
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markedly higher for individuals aged 65 years and over who succumb to influenza infection 
[19;20].  
In addition to reporting increased incidences of infection caused by novel pathogens, older 
adults experience more frequent episodes of latent virus reactivation. In a randomised 
population based retrospective study, Horsburgh and colleagues found age to be the strongest 
risk factor for the reactivation of latent tuberculosis amongst human-immunodeficiency virus 
negative subjects [21]. Similarly, outbreaks of shingles, caused by reactivation of varicella-
zoster virus (VZV) occur more frequently with increasing age [22;23].       
1.3 Immunesenescence 
Multiple factors are thought to underlie the increased incidence and severity of infection in 
older adults. These include but are not limited to: malnutrition, social environment, use of 
immunosuppressive medicines, co-morbidities and age-associated alterations in immune 
function [24]. Collectively referred to as immunesenescence, age-related changes in host 
immunity are observed as early as one year post birth [25], and include alterations in the 
architecture and mechanics of innate barriers, as well as changes in leukocyte number, 
phenotype and function [26-28]. From an evolutionary standpoint, these changes were 
unlikely to have been of significance when average life expectancy was short (~40 years). 
However, the dramatic increase that has occurred in human life span now means the immune 
system has to protect individuals for significantly longer periods of time. Consequently, 
immunesenescence is considered by many to be the major factor that predisposes older adults 
to infection-related morbidity and mortality.  
Given the interest that exists in immunesenescence, the field of immune gerontology is vast, 
and as a result conflicting observations are frequently reported. Contributing to these 
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differences is variation in study protocol. As well as differing in subject inclusion criteria, 
studies often vary in methodological approach, particularly with respect to cell status          
(e.g. primed Vs. unprimed), culture conditions (e.g. cells may be cultured in presence or 
absence of exogenous stimuli), incubation times and assay technique. Thus, when comparing 
the findings of immunogerontological studies, it is important to consider the effect that 
differences in experimental set-up may have had on their outcome.   
1.3.1 Adaptive immunesenescence 
Comprised of highly specialised antigen specific B and T lymphocytes, the adaptive arm of 
the immune system performs two important roles in host protection. In addition to assisting in 
the elimination of pathogen-infected cells, adaptive immunity confers lifelong protection 
against re-infection with the same antigen through the generation of immunological memory. 
Thus, the more frequent episodes of latent virus reactivation reported by elderly subjects        
[21-23], coupled to the age-associated decline in vaccine efficacy [29;30] suggests that the 
protective nature of adaptive immunity wanes with age.  
1.3.1.1 Age-associated changes in the composition and phenotype of the circulating                    
lymphocyte pool 
T lymphocytes 
One of the most notable features of adaptive immunesenescence is involution of the thymus 
gland. Characterised by expansion of the thymic perivascular space, and the gradual 
replacement of functional epithelial cells with fat and fibrous tissue [31;32], thymic 
involution begins as early as one year post birth, and is complete by around the seventh 
decade of life, by which time thymopoietic space constitutes less than 10% of the thymus 
[25;31]. 
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As the thymus is the primary site of T cell development, its involution leads to a marked 
decline in naïve T cell output [33]. However, in spite of a fall in naïve T cell numbers, the 
overall size of the peripheral T cell pool is maintained with age. This is because the age-
related reduction in the generation of naïve T cells is offset by expansion of the memory                 
T cell pool. Driving this inflation is homeostatic proliferation of pre-existing memory T cells 
and infection with latent viruses, such as cytomegalovirus (CMV) and Epstein-Barr virus 
(EBV), whose persistent stimulation of the immune system leads to the generation and 
accumulation of antigen specific memory T cell clones [34-36]. This combination of reduced 
thymic output and an increased number of antigen experienced T cells has a profound impact 
upon the diversity of the circulating T cell receptor (TCR) repertoire, which undergoes a 
marked age-associated contraction [37] that is thought to underlie the inadequate immune 
response elicited by older adults towards novel antigens [38;39]. 
Physiological ageing is accompanied by distinct changes in T cell phenotype. For instance, 
when compared to younger subjects, a greater proportion of circulating T cells in older adults 
exhibit a surface phenotype that is characterised by the absence of the co-stimulatory 
molecules CD27 and CD28, and increased expression of the terminally sulphated glycan 
carbohydrate CD57 and the inhibitory receptor Killer cell lectin-like receptor subfamily G 
member 1 (KLRG1) [40-42]. This phenotype, which is observed primarily on CD8
+
 T cells, 
is commonly associated with T cells that have undergone terminal differentiation, and their 
age-related accumulation is thought to be borne in part from the continued efforts of the 
immune system to control persistent viral infections such as CMV.  T cells from older adults 
also express receptors more commonly observed on the surface of natural killer (NK) cells. 
These include the activatory receptors NKG2D and CD16, as well inhibitory members of the 
killer cell immunoglobulin like receptor (KIR) and C-type lectin family [41;42]. Expression 
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of these “NK cell associated receptors” has been proposed as a means by which aged T cells 
not only compensate for their reduced TCR diversity but also their impaired functionality 
[43].  
B lymphocytes 
B cell generation by the bone marrow (BM) wanes with age. Underlying this reduced 
productivity are alterations in the BM microenvironment and changes in the number and 
differentiation potential of B cell precursors. For instance, ageing is associated with impaired 
release of interleukin (IL)-7 by BM resident stromal cells [44] and a reduced commitment of 
haematopoietic stem cells to lymphopoiesis [45], which together lead to a decline in the 
number of BM residing B cell progenitors [46;47].  
The effect of age on the size of the peripheral B cell pool is unclear, with some groups 
suggesting it is reduced with age [48-50], and others reporting it to be unchanged despite the 
aforementioned reduction in B cell lymphopoiesis [51], a paradox that is explained by an 
apparent increase in B cell longevity with age [52;53]. Whether the composition of the 
circulating B cell pool is altered with age is also an area of debate. For example, studies can 
be found that have shown the percentage and/or numbers of naïve [48;54;55], IgM memory 
[48;56], switched memory [48;55] and late memory [48] B cells are increased [48;55], 
decreased [48;54-56] or unchanged [48] with age. 
1.3.1.2 Age-associated changes in lymphocyte function 
T lymphocytes 
Several studies have demonstrated that when compared to T cells of young controls, those 
obtained from aged subjects exhibit reduced proliferation [57-60], cytotoxicity [60-62] and 
cytokine production [57;62;63] following in vitro or in vivo stimulation. This decrease in         
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T cell function has been attributed in part to: (i) the aforementioned changes in the 
composition of the circulating T cell pool, (ii) functional defects in aged dendritic cells 
[60;64] and (iii) aberrant intracellular signalling. Regarding this latter point, Larbi and                 
co-workers showed the recruitment of lipid rafts, areas of the cell membrane that serve as 
platforms for the localisation and interaction of signalling molecules, to an engaged TCR was 
impaired in T cells from aged donors [65]. This defect, which was linked to an age-related 
decline in membrane fluidity, may explain in part why early signalling events critical for T 
cell activation, such as calcium mobilisation, phosphatidylinositol metabolism and the 
activation of proximal kinases are impaired in stimulated T cells from old donors [59;66;67]. 
It is currently unclear as to whether the function of T regulatory cells (Tregs), a T cell subset 
that promotes peripheral self-tolerance by suppressing the activity, proliferation and cytokine 
production of effector T cells, is altered with age. For instance, results from in vitro studies 
that have employed murine [68;69] or human [70-72] Tregs suggest the suppressive nature of 
this T cell subset is increased [68;70], decreased [69;72] or maintained [69-71] with age. 
Similar inconsistencies have also been reported in the small number of studies that have 
examined age-associated changes in Treg function in vivo [68;69;73;74]. For example, whilst 
Sun and colleagues demonstrated a reduced ability of aged Tregs to regulate IL-17
+
 T cells in 
a murine model of chronic autoimmune colitis [74], a defect they proposed may contribute to 
the increased incidence of autoimmunity in the elderly, Lages et al [68] reported an                      
age-related increase in Treg activity in a model of Leishmania major infection, which they 
proposed may contribute some part to the increased reactivation rates of latent viruses with 
age.        
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B lymphocytes 
Compared to that elicited by younger adults, the vaccination response of elderly individuals is 
characterised by decreased antibody concentrations, delayed peak antibody titres and lower 
seroprotection [29;30;75], features that suggest the humoral immune response wanes with 
age. Indeed, studies employing murine and human B lymphocytes have shown the 
proliferative nature of these cells, as well as their ability to differentiate into antibody 
secreting plasma cells is reduced with age [56;76;77]. Furthermore, the antibodies produced 
by aged B cells are weaker and of lower affinity when compared to those of younger subjects 
[78;79]. 
Critical events in the generation of a robust humoral immune response include: (i) isotype 
switching and somatic hypermutation (SHM), which are essential for the production of high 
affinity class-switched antibodies, and (ii) B cell interaction with T lymphocytes and 
follicular dendritic cells (FDCs), which is important for antigen recognition as well as B cell 
proliferation, selection and survival. With age, aberrations in both these pathways have been 
reported, suggesting the weak humoral immune response of elderly individuals is the result of 
both B cell intrinsic and extrinsic defects. Indeed, the levels of activation-induced cytidine 
deaminase and the transcription factor E47, which are both essential for the induction of 
SHM are markedly lower in stimulated B cells from aged individuals [55;80;81], whilst 
FDCs from aged mice fail to trap and present immune complexes as efficiently as those from 
young mice [82;83]. In terms of T cell dysfunction, Eaton and colleagues found that 
transferring aged CD4
+
 T cells into young mice led to reduced levels of antigen-specific IgG 
antibodies post vaccination, whereas young CD4
+
 T cells transferred into aged mice fully 
supported B cell expansion and IgG production [83]. An age-related decrease in the 
expression of CD40 ligand on the surface of activated T cells, as well as the aforementioned 
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accumulation of CD57
+
 and CD28
-
 T cells in old individuals are two possible explanations 
for this reduced helper activity of aged T cells [83-86]. 
 1.3.2 Innate immunesenescence 
The innate immune system is the body’s first line of defence against infection. Consisting of 
anatomical barriers and a humoral and cellular arm, the innate immune response provides 
immediate non-specific protection against invading pathogens.  
Only a small number of groups have examined the effect of age on barrier function, with the 
majority reporting its protective capacity to be reduced with age. Compared to younger 
adults, old individuals exhibit reduced nasal mucociliary clearance, and struggle to expel 
inhaled particles trapped within small airways of the lungs, defects that have been attributed 
to age-associated changes in the structure and beat frequency of the ciliated cells that line the 
respiratory tract [87-90]. 
The humoral arm of innate immunity consists of a wide array of fluid-phase proteins that 
belong to different molecular families, which include pentraxins, collectins, complement and 
ficolins [91]. Of these, it is the complement system that has received the most attention from 
immune gerontologists. However, the impact of age on this arm of innate immune defence is 
unclear. For instance, with the exception of C1q, whose serum levels have consistently been 
reported to increase with age [92;93], the circulating levels of other key complement proteins 
such as C3 and C4 have reported to be either increased [92;94] or unaltered [94;95] with age. 
Similarly, contradictory data exists with regards to the lytic capacity of the complement 
system, with some groups suggesting this function is decreased with age [96] and others 
reporting no difference [95].   
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The cellular arm of innate immunity is represented by a diverse group of cells that includes 
monocytes, macrophages, dendritic cells, neutrophils, NK cells and NKT cells. In addition to 
mediating direct cytotoxicity, these cells via their ability to secrete immunoregulatory 
cytokines and chemokines influence the developmental stages of an adaptive immune 
response. Thus, a change in the function of innate immune cells with age has the potential to 
impact not only upon a host’s immediate response to infection but also their ability to 
establish long-lasting immunity. 
1.3.2.1 Monocytes and macrophages 
Monocytes constitute approximately ten percent of the circulating leukocyte pool and 
perform two important roles in host defence. In addition to mediating direct cytotoxicity, 
which they accomplish in part through phagocytosis and the production of toxic radicals, 
monocytes serve as precursors to macrophages. Following extravasation into lymphoid and 
non-lymphoid organs, monocytes respond to local environmental signals by differentiating 
into macrophages, who by generating immunoregulatory cytokines and presenting antigens in 
the context of major histocompatibility complex (MHC) find themselves at the interface of 
innate and adaptive immunity.  
The majority of studies that have compared the percentage [97;98] or absolute number 
[99;100] of monocytes in the peripheral blood of young and old individuals have reported no 
age-related differences. However, when the monocyte pool is split into its two major subsets: 
the CD14
+
 CD16
-
 classical subset and the CD14
+
 CD16
+
 non-classical subset, a differential 
effect for age has been described. Whilst both the frequency and total number of non-
classical monocytes increase with age [99;101], the proportions and absolute counts of 
classical monocytes are significantly lower in old individuals [101], suggesting that the 
composition of the monocyte pool changes with age.  
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Due to the difficulty in obtaining macrophages from human tissue, only two studies to our 
knowledge have investigated the effect of human ageing on macrophage number. In both 
instances, an age-related reduction in the frequency of alveolar [102] and BM resident [103] 
macrophages was observed, although only the former reached statistical significance.  
Whether the recruitment of monocytes/macrophages to inflammatory sites is altered with age 
is currently unclear. Whilst Swift et al [104] and Smallwood and colleagues [105] reported an 
age-related increase in macrophage infiltration at sites of thermal injury and foreign challenge 
respectively, results from in vitro experiments [106;107] and a single in vivo human study 
[108] suggest the chemotactic response of aged monocytes/macrophages is markedly 
impaired. Interestingly, Ashcroft et al, who performed cutaneous punch biopsies to assess 
monocyte migration in vivo [108], reported an age-related delay in the appearance of 
adhesion molecules on the endothelial cell surface as well as a reduction in their staining 
intensity, suggesting the impaired migration they observed was due to age-associated changes 
in the endothelium rather than an intrinsic cell defect. 
Monocytes and macrophages eliminate invading microbes primarily through phagocytosis 
and the production of toxic radicals. Macrophages obtained from aged mice have been 
reported to perform phagocytosis at a level that is higher [109;110], lower [104;111] or 
comparable [112] to that of their younger counterparts, making it difficult to determine 
whether the phagocytic capacity of macrophages is altered with age. In contrast, the majority 
of studies that have examined the generation of toxic radicals have shown this function to be 
markedly impaired with age. When stimulated with phorbol 12-myristate 13-acetate (PMA) 
[113-116], interferon-gamma (IFN-γ) [113], lipopolysaccharide (LPS) [117] or opsonised 
pathogens [113], monocytes from aged humans [115;117] and macrophages from long-lived 
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mice [113;114;116] have been shown to generate significantly lower levels of superoxide 
[114-116], hydrogen peroxide [113;117] and reactive nitrogen intermediates [113;117].  
After pathogen engulfment, macrophages assist in the development of an adaptive immune 
response by presenting antigen-derived peptides to T lymphocytes. Following IFN-γ 
stimulation, Herrero et al [118] found macrophages from aged mice expressed significantly 
lower levels of MHC class II molecules on their surface when compared to macrophages 
from younger littermates, a reduction borne from an age-associated impairment in 
transcription of the MHC class II gene. In addition, activated macrophages from aged mice 
express lower levels of CD80 and CD86 [119], two co-stimulatory molecules whose presence 
is critical for optimal activation of T cells. Thus, taken together, these data suggest the 
capacity of macrophages to present antigens and stimulate T cells is impaired with age.  
The effect of age on cytokine and chemokine production by monocytes and macrophages is 
not entirely clear. Whilst some studies have shown the production of tumor necrosis factor-
alpha (TNF-α) [120-122], IL-6 [120-123], IL1-β [123], and IL-8 [124] to be markedly 
reduced with age, others have reported the generation of these pro-inflammatory mediators to 
be increased [125;126] or unchanged [124;127]. This marked variation in study outcome may 
be attributable in part to the maturity of the cell type used. For instance, when one focuses 
upon the results of studies that have used fully differentiated tissue resident macrophages 
rather than immature monocytes from peripheral blood, it is evident that pro-inflammatory 
cytokine production is reduced with age [120-123].   
The majority of studies that have investigated age-associated changes in cytokine production 
by macrophages have stimulated these cells with ligands for Toll-like receptors (TLR), a 
family of pattern recognition receptors that recognise structurally conserved molecules shared 
by viruses, bacteria and fungi [128]. Although it is currently unclear as to whether expression 
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of TLR on the surface of macrophages is altered with age [120-122;129], a number of studies 
have reported impaired signal transduction post TLR ligation, suggesting that the reduction in 
cytokine production that accompanies physiological ageing is borne from defective 
intracellular signalling. For example, in two separate studies, Boehmer and colleagues 
[121;122] investigated mitogen-activated protein kinase (MAPK) activation in                        
LPS-stimulated macrophages and found the levels of phosphorylated p38 and c-Jun                       
N-terminal kinase (JNK) to be markedly lower in macrophages from aged mice. Furthermore, 
following LPS stimulation, aged macrophages fail to up-regulate key components of the TLR 
pathway as efficiently as those from young controls [129].  
1.3.2.2 Dendritic cells 
Dendritic cells (DCs) can be categorised into two distinct subsets, those of myeloid origin, 
which include Langerhan cells (LCs) in the skin and conventional DCs (cDCs) in the blood, 
and those of lymphoid descent, which are represented by circulating plasmacytoid DCs 
(pDCs). Whilst pDCs contribute to a host’s anti-viral response by secreting copious amounts 
of interferon (IFN)-α, LCs and other tissue-resident DCs play an important role in the 
initiation of an adaptive immune response by influencing T cell priming and differentiation.  
Studies that have investigated the impact of human ageing on DC number have focused 
primarily upon those subsets present in peripheral blood: cDCs and pDCs. Whilst age appears 
to have no effect upon the frequency of cDCs [130-132], its impact on pDCs is unclear, with 
some groups demonstrating a marked reduction in the percentage and/or absolute number of 
this DC subset with age [131-134], and others reporting no significant difference between 
young and old donors [130;135].  
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pDCs 
Several groups have shown that following engagement of TLR7, 8 or 9, pDCs from young 
individuals generate significantly more IFN-α, TNF-α and IL-6 than pDCs obtained from 
older adults [98;131;132;134;136]. This age-related reduction in TLR-induced cytokine 
production has been attributed to a decline in TLR expression and aberrant intracellular 
signalling [136]. Indeed, although not observed by all groups [137], ageing appears to be 
associated with a reduction in the expression of TLR7 and TLR9 [131;132], whilst impaired 
up-regulation of phosphoinositide 3-kinase (PI3-K) and the transcription factor IFN 
regulatory factor-7 has been described in TLR9-stimulated pDCs from aged donors [138].  
Through the production of IFN-α, pDCs augment a host’s anti-viral response by enhancing 
the cytotoxic activity of NK and CD8
+
 T cells. Thus, reduced secretion of IFN-α may 
contribute to the increased incidence of viral infection with age. In support of this theory, 
Panda et al reported TLR-induced production of IFN-α to be positively associated with the 
generation of a protective antibody response following influenza vaccination [132], whilst 
Sridharan and colleagues found that through reduced production of IFN-α, pDCs from aged 
donors were unable to enhance the cytotoxicity of resting CD8
+
 T cells [137]. 
Myeloid DCs (mDCs)  
Found at such sites as the skin, mucosa and airways, tissue-resident DCs continually survey 
and sample their local environment for invading microbes. Upon pathogen recognition, DCs 
capture and process the antigen, triggering their maturation, which is characterised by 
phenotypic changes, cytokine secretion and DC migration to secondary lymphoid organs 
(SLO), where upon arrival they help drive an adaptive immune response by presenting 
processed Ag to naïve T cells. 
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Based on current data, it appears that antigen uptake by DCs is not affected by the ageing 
process [139-142]. Whether this is also true for DC migration however is unclear as whilst 
some studies have shown this feature of DCs to be comparable between young and old 
subjects [143-145], others have reported a significant reduction with age [130;141;142]. For 
example, whereas Sprecher et al reported the capacity of LCs to deliver antigen to draining 
lymph nodes (DLNs) was comparable between young and old mice [144], Zhao and 
colleagues observed a marked and progressive age-related decline in both the frequency and 
number of DCs migrating to DLNs in response to respiratory virus infection, a defect they 
attributed to elevated levels of prostaglandin D2 in the lungs of aged mice [142]. 
Increasing experimental evidence suggests that the stimulatory capacity of mDCs wanes with 
age. Compared to those isolated from young controls, aged mDCs have been shown to be less 
effective at inducing T cell proliferation [136;141;146;147], IFN-γ secretion [139;147] and T 
cell cytotoxicity [139;141]. Together, these defects would be expected to lead to a diminished 
T cell-mediated immune response. Indeed, in an in vivo model of tumour growth, Grolleau-
Julius et al [141] demonstrated young tumour bearing mice immunised with aged DCs 
presented with tumours that were significantly larger in size at 7 day follow up than those 
mice who had received DCs from young mice, suggesting that the weakened T cell response 
elicited by aged DCs impacts upon the hosts immune response [141]. However, whether 
these defects in T cell behaviour are the direct result of impaired DC function is unclear. For 
example, although some studies have found DCs from old people to be impaired in antigen 
presentation [140], and to express lower levels of the co-stimulatory markers CD80/86 
following stimulation [147;148], the majority that have investigated these features of DC 
biology have shown them to be comparable between young and old donors 
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[139;141;149;150]. Thus, the weakened T cell response of aged individuals may result from 
intrinsic T cell defects rather than impaired DC function [150].  
Whether ageing is associated with alterations in pro-inflammatory cytokine production by 
mDCs is an area of debate within the literature with studies reporting increased [130], 
decreased [132;135;146;149] or comparable [131;140;150] generation of TNF-α, IL-6 and 
IL-12 by aged mDCs in response to TLR stimulation when compared to that secreted by 
young mDCs. Studies that have reported a decline in cytokine production have attributed it to 
an age-related reduction in TLR expression [132], impaired intracellular signalling [149] and 
an age-associated increase in basal cytokine levels [132]. In the latter case, Panda et al 
compared cytokine expression in mDCs from young and old donors in the absence of 
stimulation and found those from older adults exhibited elevated levels of TNF-α and IL-6 
[132]. High expression at baseline would therefore mean a smaller net-fold increase in 
cytokine production upon TLR stimulation.  
1.3.2.3 Invariant NKT cell function with age  
Comprising 0.5-1% of the circulating T lymphocyte pool, invariant NKT (iNKT) cells are 
innate lymphocytes defined by the expression of a semi invariant TCR (Vα24/Vβ11 in 
humans) that recognises glycolipid antigens presented by the MHC class I-like molecule 
CD1d [151]. Upon recognition of ligands, which include bacterial glycolipids [152], the               
self-lipid β-D-glucopyranosylceramide [153] and the pharmacological agent                                          
α–galactosylceramide (α-GalCer) [154], iNKT cells secrete IL-4, IL-13 and IFN-γ, and via 
the expression of perforin, granzyme B and death receptor ligands exhibit direct cytotoxicity 
towards tumour cells [151]. 
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Physiological ageing in humans is accompanied by a marked decline in the frequency of 
iNKT cells. Whether defined as Vα24+ [155] or Vα24+/Vβ11+ [156-158], the proportion 
[155;156;158] or absolute number [157] of iNKT cells in the peripheral blood of older adults 
has been shown to be significantly lower when compared to that of younger adults. Murine 
studies that have investigated numerical changes in iNKT cells with age have reported a 
significant increase in the proportion [159;160] and absolute number [159] of these cells in 
the lymph nodes, liver and spleen of aged mice. Thus, the age-related decrease in human 
iNKT frequency in peripheral blood may reflect a re-distribution of these cells to other organs 
[161]. 
Ageing is also associated with alterations in the composition of the circulating iNKT pool. 
Based on the presence or absence of CD4 and CD8, iNKT cells can be divided into three 
distinct subsets (CD4
+
 CD8
-
, CD8
+
 CD4
-
 and CD4
-
 CD8
-
). With age, a significant increase in 
the percentage of Va24
+
 CD8
+ 
CD4
-
 iNKT cells has been reported [155], as has an increase in 
the percentage of CD4
+
 CD8
- Vα24+/Vβ11+ cells, the latter being accompanied by a marked 
reduction in the proportion of  CD4
-
 CD8
-
 Vα24+/Vβ11+ iNKT cells [156].  
The effect of age on the function of iNKT cells is not entirely clear, due in part to the small 
number of studies that have investigated this issue. For example, the proliferation of iNKT 
cells in response to α-GalCer stimulation has been reported to be significantly reduced [158] 
or unaffected [156] with age. More consistent findings have however been reported for 
cytokine production, where two independent groups have shown a marked age-dependent 
decrease in IFN-γ secretion by iNKT cells following α-GalCer treatment [156;157].  
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1.3.2.4 Inflammageing 
Alongside the aforementioned changes in immune cell number and function, ageing is 
associated with a low-grade systemic up-regulation in circulating inflammatory mediators. 
Termed inflammageing, this inflammatory state is characterised by elevated levels of             
pro-inflammatory cytokines (e.g. IL-6 and TNF) and acute phase proteins (e.g. C reactive 
protein (CRP)), as well as reduced levels of the anti-inflammatory cytokine IL-10                            
[162-165]. 
Results of longitudinal based studies suggest inflammageing is deleterious to human health. 
Studies in elderly cohorts have shown the low-grade increase in the circulating levels of 
TNF-α [166;167], IL-6 [167-169] and CRP [169;170] are associated with both all-cause         
[166-169] and cause-specific [168;170] mortality. In addition, inflammageing is a predictor 
of frailty [171], has been associated with functional disability [172], and is considered a 
major factor in the development of several age-related pathologies, such as atherosclerosis 
[173], Alzheimer’s disease [165] and sarcopenia [174]. 
Life-long infection with the persistent herpes virus CMV is thought by many to be the major 
driver of inflammageing. Indeed, associations have been reported between CMV 
seropositivity and high circulating levels of CRP [175], whilst in vitro, CMV infection of 
monocytes has been shown to increase their production of both IL-6 and TNF-α [176]. 
However, a recent longitudinal study has challenged this long-standing belief by 
demonstrating that over time, circulating levels of TNF-α and IL-6 increase and IL-10 
decrease in elderly subjects who are CMV negative [177]. Thus, based on this data it would 
appear that factors other than CMV infection drive the gradual increase in systemic 
inflammation that accompanies physiological ageing. These may include the age-related            
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re-distribution of and increase in fat tissue [163], an individuals genetic background [178] 
and the age-associated decline in sex steroid synthesis [179]. 
1.4 Clinical relevance of immunesenescence  
As the primary role of the immune system is to recognise and eliminate pathogen-infected 
cells, immunesenescence is often cited as a major factor underlying the increased incidence 
and severity of infection in older adults. However, this assumption is based primarily on the 
findings of cross-sectional studies, which often fail to control for external factors that 
influence immune function independent of the ageing process (e.g. environment, genetics, 
previous pathogen exposure and nutritional status). In an attempt to overcome this issue and 
establish whether immunesenescence is of clinical significance, a small number of groups 
have performed longitudinal based studies on older adults. 
Focusing on a population of free-living seniors aged 85 years and over, Wikby and 
colleagues identified a set of immune parameters that were associated with future mortality 
[180-183]. The group found that subjects, who at baseline presented with poor T cell mitogen 
responses, low numbers of CD4
+
 T cells and CD19
+
 B cells, an inverted CD4/CD8 ratio and 
an increased number of CD8
+
 CD28
-
 T cells, a phenotype they termed the immune risk 
profile (IRP), exhibited reduced survival rates at follow-up  [180]. In one particular study, it 
was reported that 100% of aged individuals who presented with an IRP at baseline were 
deceased at six-year follow-up, whilst 80% of individuals who developed the IRP during the 
study were also deceased at follow-up [184]. Other studies have focused on specific features 
of the IRP and have shown that an inverted CD4/CD8 ratio and increased circulating 
inflammatory activity (e.g. high IL-6 and CRP levels) are themselves predictors of mortality 
[182].  
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Away from the IRP, it has been shown that thymic function failure at baseline can predict 
mortality at 2-year follow-up [185], whilst an impaired inflammatory response by peripheral 
blood mononuclear cells (PBMCs) following LPS challenge was reported to be associated 
with a 2-fold increase in mortality risk [186].   
Despite demonstrating that features of immunesenescence can predict mortality, the 
associations made in the aforementioned studies were between immune function and                     
all-cause mortality. To date, few groups have investigated in a longitudinal setting whether 
immunesenescence is associated with an increased risk of infection and/or death due to 
infection in older adults [187-190]. In one particular study, Plonquet and co-workers assessed 
the prevalence of nosocomial infections in a cohort of 252 aged individuals and found a 
greater proportion of those who fulfilled the IRP criteria at baseline went on to contract 
pneumonia [190].  
1.5 Natural Killer cells 
Comprising 10-15% of the circulating lymphocyte pool, as well as residing in such peripheral 
tissues as the liver, lungs and peritoneal cavity, natural killer (NK) cells are critical effector 
cells of the innate immune system renowned for their ability to recognise and eliminate 
virally-infected and tumorigenic cells [191]. The importance of NK cells in host protection is 
illustrated by studies that have shown the selective absence of these cells or an impairment in 
their function results in increased episodes of viral infection [192-194] and a reduced ability 
to control the development of certain tumours [195;196]. However, the role of NK cells in 
host immunity appears to extend beyond eliminating virally-infected and malignant cells as 
recent in vivo and in vitro studies have shown NK cells also elicit direct cytotoxicity towards 
bacteria [197], fungi [198] and parasites [199].    
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1.5.1 NK cell effector functions 
NK cells directly eliminate malignant and pathogen-infected cells through two contact- 
dependent mechanisms: granule exocytosis and death receptor ligation (Figure 1.1).  
1.5.1.1 Granule exocytosis 
Granule exocytosis is the predominant mechanism by which NK cells eliminate transformed 
cells [200;201]. Following target cell recognition and formation of an activating 
immunological synapse, NK cells release an array of cytolytic proteins that induce target cell 
death through the induction of apoptosis. Of the many proteins released, it is the membrane-
disrupting protein perforin and a family of serine proteases termed granzymes that are the 
critical effector molecules.  
Mature human perforin is a 534 amino acid protein consisting of three domains: an                      
N-terminal membrane attack complex/perforin domain, an epidermal growth factor like 
domain and a C-terminal calcium binding C2 domain [202]. Following its release from 
secretory lysosomes, perforin binds in a calcium dependent manner to phospholipid 
components of the target cell membrane where it facilitates the entry of apoptosis-inducing 
serine proteases into the target cell cytosol. Mice rendered perforin deficient or humans that 
carry mutations in their perforin gene fail to clear viral infections and eliminate developing 
tumours as efficiently as their controls [203-205]. As well as demonstrating the importance of 
granule exocytosis in host defence, this data illustrates the non-redundant role of perforin in 
this form of NK cell cytotoxicity (NKCC). 
Although the role of perforin in NKCC is firmly established, how it delivers granzymes into 
the cytosol of target cells is still not fully understood (Figure 1.2). Based on its structural 
similarity to the complement protein C9, perforin was originally proposed to function solely 
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Figure 1.1 NK cell cytotoxicity (NKCC). NK cells directly eliminate transformed cells 
through one of two contact-dependent mechanisms. (1) Granule exocytosis: Upon interaction 
with its cellular target, NK cells secrete a range of lytic effector molecules. These include the 
pore-forming protein, perforin, and a number of serine proteases (granzymes). Following 
entry into the cytoplasm of target cells, granzymes activate the apoptotic cascade in either a 
caspase-dependent or independent manner. (2) Death receptor engagement: In response to 
direct cell contact and/or cytokine stimulation, NK cells express on their surface Fas ligand 
(FASL) and TNF-related apoptotic inducing ligand (TRAIL), two members of the TNF 
family, which upon interaction with their cognate receptors (Fas and TRAIL-R respectively), 
promote cell death through the direct activation of cellular caspases.                                        
Figure taken directly from review article by Smyth et al [206]. 
 
 
1 2 
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               (A)          (B)     (C) 
Figure 1.2. Proposed models for how perforin mediates granzyme entry into the target 
cell cytosol. (A) The classic model, which suggests that after binding to the plasma 
membrane of target cells, perforin undergoes oligomerisation, forming channels through 
which granzymes passively diffuse. (B) The endosomolysin model proposes granzymes enter 
the target cell independently of perforin (possibly through interaction with a receptor on the 
target cell surface) and reside in endosomes. Perforin then acts upon the endosomal 
membrane to release granzymes into the cytoplasm. (C) Derived predominantly from the 
work of Theiry et al [207;208], the hybrid model suggests perforin acts on both plasma and 
endosomal membranes. By forming pores in the plasma membrane, perforin induces a 
cellular wound healing response, which results in the co-endocytosis of perforin and 
granzymes into endosomes. Perforin then acts upon the endosomal membrane, allowing 
granzymes to enter the target cell cytosol, where they trigger caspase-dependent and 
independent cell death. In the figure, black lines represent the plasma membrane, endosomal 
membranes are green and lysosomal membranes are blue.                                                               
Figure taken directly from review article by Pipkin et al [209]. 
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at the plasma membrane of its target cell, where following oligomerisation it acted as a 
conduit through which granzymes passively diffused [210;211] (Figure 1.2A). Whilst 
accepted at first, this model was questioned when it was demonstrated that granzymes could 
enter target cells independently of perforin [212-215], possibly via direct interaction with the 
cell surface receptor mannose 6-phosphate [215]. However, granzyme entry alone did not 
induce target cell death, which was observed only when perforin was added to targets that 
had been pre-exposed to granzymes [212], suggesting that it was the endosomal membrane 
and not the plasma membrane that was the site of perforin action (Figure 1.2B). Supporting 
this idea were experiments that substituted perforin with replication-deficient adenovirus or 
bacterial proteins (e.g. streptolysin O or listeriolysin), agents that disrupt endosomal 
membrane integrity, and found granzyme B dependent apoptosis still occurred in the absence 
of cell membrane damage [212;214;216]. However, in spite of this evidence, this model has 
not gained total acceptance within the field, with one particular group suggesting its basic 
principles are borne from methodological error. Rather than binding to specific receptors, Shi 
et al [217], found granzyme B bound to cells mainly by charge and that the washing 
procedure used in the aforementioned studies did not remove it from the cell surface. Using 
an approach that completely removed granzyme B from the target cell membrane, Shi and co-
workers showed the addition of perforin to target cells did not trigger target cell apoptosis 
[217], suggesting that rather than releasing endocytosed granzyme B, perforin was in fact 
delivering surface bound granzyme B into the cytosol. Indeed, only when perforin and 
granzyme B were added to target cells together did the group observe granzyme B release 
from endosomes [217]. Based on this and more recent observations [207;208;218], 
Lieberman and colleagues have proposed the “hybrid model”, which they believe explains 
more convincingly the mechanism by which perforin delivers granzymes into the target cell 
cytosol (Figure 1.2C). Taking ideas from both the traditional pore theory and the 
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endosomolysin model, the group have hypothesised that upon binding to the target cell 
surface, perforin, via forming transmembrane pores, triggers a membrane-repair response that 
results in the co-endocytosis of perforin and granzymes. Perforin then mediates granzyme 
release into the target cell cytosol by undergoing oligomerisation in the endosomal membrane 
[208]. 
Granzymes are a family of structurally-related serine proteases, which following perforin-
mediated entry trigger caspase-dependent and independent target cell death. Human NK cells 
express five granzymes, namely A, B, H, K and M, which possess various substrate 
specificities and exhibit a level of functional redundancy [206;219-221]. Whilst little is 
known regarding the role of granzymes H, K and M in granule-dependent killing [222;223], 
great progress has been made in elucidating the mechanisms by which granzymes A and B 
induce target cell death.    
As an aspase, granzyme B cleaves its substrates after aspartic acid residues. Unsurprisingly 
therefore, several members of the caspase family, including caspases 3, 7, 8 and 10 are direct 
targets of this protease [224;225]. As caspases 3 and 7 target numerous proteins for 
degradation, many of which are involved in deoxyribonucleic acid (DNA) preservation, their 
direct activation by granzyme B underlies the rapid induction of target cell death mediated by 
the granule exocytosis pathway [226]. Indeed, in the absence of granzyme B, target cell death 
mediated by cytotoxic lymphocytes is markedly delayed [220]. In addition to direct 
activation, granzyme B can activate caspases indirectly by driving mitochondrial 
permeabilisation. This is mediated in part through granzyme B cleaving the BH-3 family 
protein BH3-interacting domain death agonist, which in its truncated form drives activation 
of caspase 9 by facilitating the release of pro-apoptotic proteins from the mitochondria into 
the target cell cytosol [227].  
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Caspase activation, whether direct or indirect, is not the only mechanism through which 
granzyme B triggers apoptosis, as pharmacological inhibition of these proteases does not 
prevent granzyme B from inducing target cell death [228;229]. Other routes through which 
this serine protease triggers apoptosis include directly cleaving proteins involved in DNA 
repair (e.g. poly (ADPribose) polymerase (PARP)) [230;231], and preservation [232] as well 
as proteins important for maintaining the integrity of the nuclear membrane such as lamin B  
[233]. 
Granzyme A induces a cell death program that is independent of caspase activation. 
Following entry into the target cell cytosol, granzyme A travels to both the mitochondrial 
matrix and nucleus. Within the mitochondria, granzyme A cleaves NDUFS3, a complex I 
protein, whose degradation results in the generation of reactive oxygen species (ROS) 
[234;235]. An increase in cellular ROS levels triggers the translocation of the SET complex, 
an endoplasmic reticulum-associated oxidative stress response complex, to the nucleus, 
where upon arrival, several of its components, which include: Ape1 (a base excision repair 
enzyme), HMGB2 (a protein that recognises damaged DNA) and SET (an inhibitor of the 
exonuclease NM23-H1) are cleaved by nuclear residing granzyme A [236-238]. Degradation 
of these proteins results in the activation of NM23-H1 and TREX-1, nucleases, which 
mediate the single-stranded DNA damage that is characteristic of granzyme A-induced target 
cell death [236;239]. The SET complex however is not the only target of granzyme A, as it 
also cleaves a range of proteins that are involved in maintaining the integrity of cellular 
DNA. These include but are not limited to nuclear lamins, core histones and PARP 
[233;240;241]. 
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1.5.1.2 Death receptor ligation  
In addition to granule exocytosis, NK cells directly eliminate transformed cells through death 
receptor engagement (Figure 1.1). In response to cytokine stimulation [242;243] or following 
ligation of activatory receptors [244;245], NK cells express on their surface Fas ligand (FasL) 
and TNF-related apoptosis-inducing ligand (TRAIL). Through binding their cognate receptor 
on the target cell surface, FasL and TRAIL induce the formation of a death induced signalling 
complex, which by promoting activation of caspase 8 triggers a signalling cascade that 
culminates in the activation of caspases 3 and 7, and the induction of target cell apoptosis 
[246].  
In resting NK cells, FasL is pre-formed and resides in the same lytic granules as perforin and 
granzymes [247;248], meaning target cells are exposed to these effector molecules 
simultaneously following NK cell degranulation. In contrast, NK cells must drive 
transcription of the TRAIL gene to express this death receptor ligand on its surface [242], a 
prerequisite that maybe responsible for the slower kinetics reported for death receptor-
mediated apoptosis when compared to target cell death induced by granule exocytosis  
[242;245]. 
1.5.1.3 NK cell immunological synapse (NKIS) 
A critical event that precedes the induction of NKCC is the formation of an activating 
immunological synapse (IS). Formed at the NK-target cell interface, the NKIS is 
characterised by “the orderly rearrangement of NK signalling molecules into micrometer-
scale three-dimensional domains” [249;250], and is the site at which ligand recognition, 
signal amplification and granule exocytosis occurs. Through the formation of an IS, NK cells 
deliver cytotoxic effector molecules directly onto the target cell surface. Thus, as well as 
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ensuring the rapid elimination of transformed cells, the creation of an NKIS protects 
neighbouring healthy cells from bystander damage. 
Formation of an NKIS begins with NK-target cell interaction. Mediated by such adhesion 
molecules as CD2, lymphocyte function-associated antigen 1 and macrophage receptor 1, 
close cell-cell contact enables NK activatory receptors to recognise and bind their cognate 
ligands expressed on the target cell surface [251]. NK cell activation leads to the recruitment 
of a number of signalling elements to the NK-target cell interface. These include the protein 
tyrosine kinases Src, Lck, Fyn and Syk, the guanine nucleotide exchange factor Vav1, and 
PI3-Kinase [250], which together drive the next stage of NKIS formation: actin 
polymerisation and reorganisation. 
The recruitment and activation of Vav1 at the NK-target cell interface leads to the formation 
of a multi-subunit protein complex consisting of the Rho family GTPase cell-division control 
protein 42 (Cdc42), Wiskott-Aldrich syndrome protein (WASp) and Arp2/3 [252]. By 
inducing actin nucleation and branching, this complex mediates re-organisation of the actin 
cytoskeleton, a step that is characterised by the segregation of signalling elements into two 
distinct zones: an outer zone, referred to as the peripheral supramolecular activation cluster, 
where adhesion receptors localise, and an inner ring, known as the central SMAC (cSMAC), 
where molecules critical for NK cell signalling reside [251]. As well as augmenting NK cell 
activation by inducing activatory receptor clustering and lipid raft aggregation [249;253], this 
rearrangement of the actin cytoskeleton acts as a trigger for the polarisation of the 
microtubule organising centre (MTOC) towards the developing NKIS. 
MTOC polarisation is co-ordinated with re-organisation of the actin cytoskeleton through the 
actions of Cdc42 interacting protein 4 (CIP4) and the multi-domain protein IQGAP1 
[254;255]. Functioning downstream of Cdc42, CIP4 interacts with WASP and the 
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microtubule component α-tubulin [256-258], and is important not only for the directed 
movement of the MTOC towards the NKIS but also its stabilisation. Indeed, NK cells 
depleted of CIP4 exhibit impaired MTOC polarisation following target cell interaction [254]. 
Similarly, silencing of IQGAP1, which interacts with both Filamentous actin (F-actin) and 
microtubules (MTs), has been shown to markedly reduce MTOC polarisation during NKIS 
formation [255]. In addition to CIP4 and IQGAP1, MAPK signalling is essential for                   
re-orientation of the MTOC. Studies have shown phosphorylation of extracellular signal-
regulated kinase 1/2 (ERK 1/2), JNK and p38 occurs in NK cells following target cell contact 
[259-262], and that these signalling molecules drive MTOC polarisation, lytic granule 
mobilisation and ultimately NKCC. Indeed, selective MAPK inhibition greatly reduces 
MTOC movement to the NK-target cell interface and is associated with impaired NK lytic 
activity [259;260;263].  
Following MTOC polarisation, secretory lysosomes are delivered to the NK-target cell 
interface. Alongside the aforementioned MAPKs, the actin motor proteins dynein and 
kinensin, and the regulatory protein Wasp-interacting protein (WIP), which assist in secretory 
lysosome movement along MTs and lytic granule polarisation respectively [264-266] play an 
important role in this phase of NKIS formation. Upon arrival at the cSMAC, secretory 
lysosomes dock to the plasma membrane, a step that requires the action of the small GTPase 
Rab27a [267]. Once tethered to the membrane, granules are primed for fusion by Munc13-4, 
a binding partner of Rab27a [268]. Lysosomal priming is thought to allow soluble N-
ethylmaleimide-sensitive protein attachment protein receptor (SNARE) proteins, which 
include syntaxin-11, VAMP4 and VAMP7, to interact with each other, and drive the fusion 
of lytic granule membranes with the plasma membrane, resulting in the release of perforin 
and granzyme onto the target cell surface [269;270]. Interestingly, two recent studies reported 
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the novel finding that F-actin is present in the cSMAC [271;272]. As lytic granules express 
the actin binding protein myosin IIA on their surface [273], lysosomes may detach from MTs 
when in the vicinity of the NKIS and associate with F-actin prior to degranulation. In support 
of this claim, Andzelm et al [274] found that inhibition of myosin IIA activity had no effect 
upon actin accumulation or lytic granule polarisation to the NKIS but was associated with a 
marked reduction in lytic granule fusion with the NK cell membrane. 
1.5.1.4 Production of immunoregulatory cytokines and chemokines 
As well as mediating direct cytotoxicity, NK cells are a rich source of immunoregulatory 
cytokines and chemokines. Studies have shown that following cytokine or target cell 
stimulation, NK cells are capable of secreting a range of pro and anti-inflammatory 
mediators, which include TNF-α, IFN-γ, IL-10, macrophage inflammatory protein-1-alpha 
(MIP-1α), MIP-1β and IL-8 [275-278]. 
Primarily through the production of IFN-γ and the aforementioned chemokines, NK cells 
influence the activity of bystander cells at sites of developing inflammation, and thereby 
amplify on-going immune responses. For example, in addition to enhancing the antigen 
presenting capacity of macrophages by up-regulating surface expression of MHC class II 
molecules, NK cell-derived IFN-γ increases both the microbicidal and tumoricidal activity of 
these tissue-resident cells [279;280]. Furthermore, by secreting MIP-1α/β and IL-8, NK cells 
would not only induce the migration of immune cells to the site of antigenic challenge, but 
would enhance the cytolytic activity of surrounding NK cells, as exposure to MIP-1α and 
MIP-1β has been shown to trigger both calcium mobilisation and granule exocytosis in 
resting NK cells [281;282].  
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Although thought of as separate entities, the innate and adaptive arms of the immune system 
undergo considerable cross-talk and reciprocal interaction. Through their production of            
IFN-γ and TNF-α, NK cells place themselves at the interface of this bi-directional 
relationship by influencing DC maturation and T cell differentiation. In co-culture with 
resting [283] or IL-2 activated [284] NK cells, immature DC’s (iDC’s) undergo maturation, 
as evidenced by their increased expression of CD83, CD86 and HLA-DR, and their ability to 
induce proliferation of naïve CD4
+
 T cells [283;284]. This maturation was shown to be 
attributable in part to NK cell-derived IFN-γ and TNF-α, as neutralising antibodies against 
both these cytokines markedly reduced the maturation of iDCs [285]. With regards to NK 
cells and T cell differentiation, Martin-Fontecha et al [286] showed in an elegant study that 
following subcutaneous injection of LPS-matured DC’s, peripheral NK cells travel to the DC 
draining lymph node, where through the production of IFN-γ they help drive T helper 1 cell 
polarisation [286].     
1.5.2 Regulation of NKCC  
Given the direct toxic nature of NK cells and their ability to potentiate ongoing immune 
responses via the production of pro-inflammatory cytokines and chemokines, NK cell 
activation is tightly regulated. Mechanisms controlling the induction of NK cell activity are 
present both in the BM, where only NK cells capable of recognising self MHC class I 
molecules have functional competence bestowed upon them, a phenomenon referred to as 
NK cell “licensing”, and in the periphery where NK cell activation is governed by priming 
signals and an array of germline-encoded activatory and inhibitory receptors.  
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1.5.2.1 NK cell licensing 
In 2005, Yokoyama and colleagues reported that NK cells isolated from MHC class I
-/- 
mice 
not only failed to generate IFN-γ when stimulated with antibodies against activating 
receptors, but exhibited reduced cytotoxicity towards tumour targets when compared to NK 
cells from wild type controls [287]. This aberration in NK cell function was attributed to an 
intrinsic defect borne from the inability of developing NK cells to interact with self MHC 
class I molecules, an association that the group suggested was critical for the generation of 
functionally competent effector cells [287]. Subsequent studies supported this claim by 
confirming that NK cells isolated from MHC class I
-/- 
mice [288;289] and humans [290;291]  
were hyporesponsive to stimulatory signals, a trait that is shared by NK cells that do not 
express the surface receptors that recognise self MHC class I molecules [288;292].  
To date, several models have been proposed to explain how developing NK cells have 
functional competence bestowed upon them by MHC class I molecules, a process referred to 
as NK cell “licensing”. Whilst sharing some common features, these models, whose concepts 
are outlined below, differ in how they believe licensing signals are delivered to and 
interpreted by NK cells. 
(i) Arming model – According to the arming model, recognition of self-MHC class I 
molecules by cell surface inhibitory receptors delivers positive signals to developing NK cells 
which promote their functional maturation. In the absence of such signals, NK cells remain 
hyporesponsive to activatory stimuli.  
(ii) Disarming model – The disarming model proposes that NK cells develop in a functional 
responsive state. Without interaction between inhibitory receptors and MHC class I 
molecules, NK cells are “disarmed” to prevent potentially self-reactive cells entering the 
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peripheral NK pool. Recognition of MHC class I molecules by inhibitory receptors prevents 
this process, allowing for the generation of functionally competent NK cells.     
(iii) Cis-interaction model – The cis-interaction model of NK cell “licensing” proposes that 
functional competence can be acquired by developing NK cells without the need for 
inhibitory receptor engagement by MHC class I molecules. Rather, this theory, which is 
based on the work of Chalifour et al, who found unengaged MHC class I receptors could 
deliver inhibitory signals to NK cells [293], suggests that by associating with inhibitory 
receptors in the same cell membrane, MHC class I molecules render NK cells functionally 
mature by preventing the localisation of unengaged inhibitory receptors to the immunological 
synapse, who upon arrival would otherwise dampen the response of NK cells to activatory 
stimuli.  
(iv) Rheostat model – A feature that distinguishes the rheostat theory from those described 
above is that rather than viewing NK cell “licensing” as an event with a binary outcome, i.e. 
developing NK cells are either “licensed” or “unlicensed”, it considers it to be a quantitative 
phenomenon. The model postulates that the functional responsiveness of peripheral NK cells 
is related to the strength of signal they receive through surface expressed inhibitory receptors 
during their development in the BM [294;295]. Thus, assuming that the host possesses the 
cognate MHC class I ligands, the more inhibitory receptors an NK cell expresses, the greater 
its functional response upon stimulation.  
For many years, NK cell “licensing” was considered a fixed event restricted to the BM. 
However, the findings of two recent studies have challenged both these concepts by showing 
that changes in peripheral MHC class I expression can influence the functional competence 
of mature circulating NK cells. In an elegant study, Elliott and co-workers demonstrated that 
when hyporesponsive unlicensed NK cells from MHC class I
-/-
 mice were transferred into 
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wild type hosts, these cells acquired functional competence, producing cytokines and 
exhibiting cytotoxicity at a level that was comparable to that of NK cells from their wild type 
littermates [296]. Conversely, when functionally responsive NK cells from wild type mice 
were transferred into MHC class I
-/-
 hosts, these cells became hyporesponsive to activatory 
receptor stimulation [296;297]. Thus, in addition to suggesting that continual exposure to 
self-MHC class I molecules is needed for mature circulating NK cells to retain their 
functional competence, it is apparent from both these studies that NK cell “licensing” is not 
solely a developmentally associated process.    
According to the “licensing” hypothesis, NK cells are functionally defective if they do not 
receive signals from self-MHC class I molecules. However, the recent work of Orr and 
colleagues suggests that under certain circumstances, “unlicensed” NK cells are more 
efficient than their “licensed” counterparts at eliminating transformed cells [298]. The group 
showed using a model of murine CMV (MCMV) infection that depleting mice of 
“unlicensed” NK cells resulted in viral titres that were comparable to those in mice that had 
been depleted of all NK cells, and significantly greater than those in wild type controls. In 
contrast, no difference in viral titre was observed between control mice and mice lacking 
“licensed” NK cells, suggesting that it was “unlicensed” NK cells that conferred host 
protection [298]. Indeed, in an adoptive transfer model, only recipients of “unlicensed” NK 
cells were able to survive infection with MCMV [298]. As exposure to inflammatory 
cytokines enhances the responsiveness of “unlicensed” NK cells [287], current thinking is 
that the activation of these effector cells is driven by the pro-inflammatory environment 
created in times of infection [299].  
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1.5.2.2 NK cell priming 
For many years, NK cells were thought to eliminate transformed cells in a manner that was 
independent of prior sensitisation. However, it is now apparent from the findings of recent 
murine [300] and human [301-303] studies that NK cells must be “primed” before they can 
initiate an effective cytotoxic response. 
Tumour cells and cytokines have both been shown to provide NK cells with priming signals. 
In two separate studies, Lowdell and colleagues [302;303] found that by binding to the NK 
cell adhesion molecule CD2, a protein associated with CD15 on the surface of NK-resistant 
tumour cells could deliver to resting NK cells priming signals, which enabled these 
lymphocytes to lyse in subsequent cytotoxicity assays target cells that normally display 
resistance to NK-mediated killing. Detailed examination of the priming process revealed it to 
be associated with a marked up-regulation of CD69 on the NK surface and to occur in the 
presence and absence of signals that negatively regulate the induction of NKCC [302;303]. 
With respect to cytokine-mediated priming, Bryceson et al [301] demonstrated in a series of 
re-directed lytic assays that, with the exception of ligation of the Fc receptor CD16,                  
pre-treatment with the activating cytokine IL-2 was required for resting NK cells to eliminate 
targets cells that expressed ligands for only a single NK cell activating receptor [301]. In a 
similar manner, Hart and colleagues reported that exposure to IL-12 was needed for resting 
NK cells to mediate cytotoxicity or produce IFN-γ upon engagement of TLR7 and TLR8 
[304]. Data showing that cytokine-induced priming enhances intracellular perforin levels and 
NK cell degranulation upon target cell contact [305] provides a possible mechanism for the 
more robust cytotoxicity mediated by cytokine-primed NK cells.  
In the absence of priming signals, NK cells exhibit minimal cytotoxic activity. This was 
demonstrated elegantly in an in vivo model of infection by Lucas et al [300], who found that 
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by trans-presenting IL-15 to NK cells in times of pathogenic challenge, lymph node resident 
CD11c
high
 dendritic cells bestowed upon resting NK cells the ability to perform cytotoxicity 
at a level significantly greater than that of NK cells from mice deficient in CD11c
high
 
dendritic cells [300]. In line with the aforementioned in vitro data, the enhanced cytotoxicity 
of “primed” NK cells was associated with an increase in intracellular granzyme B levels and 
surface CD69 expression [300]. Thus, it appears that priming enhances the cytotoxicity of 
resting NK cells by increasing their cytotoxic armoury and lowering their activatory 
threshold. 
1.5.2.3 NK cell receptors 
Although derived from the same progenitor cell as B and T lymphocytes, NK cell activity is 
not regulated by signals transmitted through one dominant receptor. Rather, NK cell 
activation is governed by the balance of signals received through a multitude of surface 
expressed germline-encoded activatory and inhibitory receptors [306].   
1.5.2.3.1 Inhibitory receptors 
Based on an in vivo experiment that found NK cells could reject tumour cells that had lost 
MHC class I expression but could not prevent tumour development by MHC class I positive 
cells, Karre and colleagues formulated the “missing-self” hypothesis, which put forward the 
idea that the loss of self MHC class I molecules rendered cells susceptible to NK cell-
mediated lysis [307;308]. To explain this concept, it was proposed that NK cells possessed on 
their surface a receptor specific for self-MHC class I molecules, which upon ligand 
recognition prevented NK cell activation by transmitting inhibitory signals [309]. Whilst at 
first this theory was difficult to believe, it is now established that NK cells express on their 
surface an array of inhibitory receptors, that after binding to either MHC class I or non MHC 
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class I molecules negatively regulate NK cell activity (Table 1.1) [306]. Common to all 
inhibitory receptors is the presence in their cytoplasmic domain of an immunoreceptor 
tyrosine-based inhibitory motif (ITIM), which serves as the focal point through which 
inhibition of NK cell activity is mediated. Upon ligand recognition, tyrosine residues present 
within ITIMs are phosphorylated by Src family kinases [310]. Once phosphorylated, these 
residues are bound by the Src homology 2 (SH2) domains of the protein tyrosine 
phosphatases: Src homology region 2-containing protein tyrosine phosphatase-1 (SHP-1), 
SHP-2 or SH2-domain-containing inositol polyphosphate 5-phosphatase (SHIP)-1 [311-313], 
who by targeting an array of intracellular signalling molecules promote NK cell inhibition by 
interfering with numerous steps involved in the induction of NKCC (Table1.2).  
SHP-1 has been proposed to negatively regulate NK cell activity by dephosphorylating an 
array of intracellular signalling molecules. These include the adaptor proteins SH2 domain-
containing leukocyte protein of 76 kDa (SLP-76) and linker for activation of T cells (LAT) 
[314;315], the guanine nucleotide exchange factor Vav [316], the Src family kinase Lck 
[317] and the Syk family kinases Zeta-chain-associated protein kinase 70 (ZAP70) and Syk 
[310;318]. Whether the dephosphorylation of these proteins is mediated directly or indirectly 
is currently unclear [314;316]. Nevertheless, by targeting LAT, SHP-1 has been shown to 
disrupt its association with phospholipase C-γ (PLC-γ) [315], which may underlie the 
decrease in inositol 1,4,5-triphosphate (IP3) release and calcium mobilisation that occurs in 
NK cells following recognition of MHC class I molecules [319]. Moreover, through 
interfering with the rearrangement of the actin cytoskeleton by dephosphorylating Vav [316], 
SHP-1 could be involved in inhibitory receptor-mediated blocking of activatory receptor 
clustering and lipid raft aggregation [320]. 
By hydrolysing the PI3-kinase product phosphatidylinositol-3,4,5-triphosphate (PI-3,4,5-P3) 
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Table 1.1 Inhibitory receptors expressed on the surface of NK cells 
  
Name 
 
Ligand 
 
Signalling Motif 
 
 
 
MHC Class I 
specific 
receptors 
 
KIR2DL 
 
HLA-C 
 
ITIM 
 
KIR3DL 
 
HLA-A,B 
 
ITIM 
 
LILR1/2 
 
HLA Class I molecules 
 
ITIM 
 
CD94/NKG2A/B 
 
HLA-E 
 
ITIM 
 
 
 
Receptors for 
non MHC Class 
I molecules 
 
LAIR 
 
Collagen 
 
ITIM 
 
Siglec 7,9 
 
Sialic Acid 
 
ITIM 
 
KLRG1 
 
Cadherin 
 
ITIM 
 
NKR-P1 
 
Lectin-like transcript 1 
 
ITIM 
Abbreviations; HLA, Human leukocyte antigen; ITIM, Immunoreceptor tyrosine based 
inhibitory motif; KIR, Killer cell immunoglobulin-like receptor; KLRG1, Killer cell lectin-
like receptor G1; LAIR, Leukocyte associated immunoglobulin-like receptor; LILR, 
Leukocyte immunoglobulin-like receptor; NKR-P1, Inhibitory NK cell receptor protein 1; 
Siglec, Sialic acid binding immunoglobulin-like lectins. 
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Table 2.2. Steps in NKCC that are targeted by NK cell inhibitory receptor signalling 
Abbreviations: KIR, Killer-cell immunoglobulin-like receptor; PLCγ, Phospholipase Cγ;            
SHP, Src homology phosphatase-1; SLP-76, Src homology 2 domain-containing leukocyte 
protein of 76 kDa; Syk, Spleen tyrosine kinase. 
Site of action Description Reference(s) 
Conjugate 
formation 
Ligation of KIR2DL1 disrupts NK cell adhesion to its 
target by recruiting SHP-1 to the NK–target cell 
interface. 
[321] 
 
 
Activation receptor 
clustering 
 
KIR2DL1 ligation hampers NKG2D mediated NK 
cell activation by reducing NKG2D translocation to 
lipid rafts. 
KIR2DL1 and KIR2DL2 signalling suppresses 
activation receptor clustering at the immunological 
synapse by disrupting the recruitment of actin binding 
proteins. 
 
[320] 
 
[252;322] 
 
 
 
 
Proximal signalling 
events 
Activatory receptors – KIR2DL1 or CD94/NKG2 
ligation prevents phosphorylation of tyrosine motifs 
within the co-stimulatory receptor CD244. 
Adapter molecules – The transmembrane adapter 
molecules SLP-76 and LAT are thought to be direct 
substrates of SHP-1. 
Phosphorylated proteins – Inhibitory receptor 
ligation interferes with the phosphorylation status of 
molecules that propagate activatory receptor 
signalling. These include Syk family kinases, PLC 
and Vav. Inhibiting PLC activity prevents inositol 
phosphate turnover and calcium mobilisation 
[323] 
 
[314;315] 
 
 
[316;319;324] 
 
 
Polarisation 
 
Overexpression of the phosphatase SHP-2 in NK cell 
lines suppressed polarisation of the microtubule 
organising centre. 
KIR or CD94/NKG2 ligation inhibits LFA-1 or 
NKG2D induced granule polarisation. 
 
[325] 
 
[326] 
 
Degranulation 
 
Degranulation induced by CD16 was reduced upon   
co-ligation of the inhibitory receptor CD94/NKG2A 
 
[327] 
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into phosphatidylinositol-3,4-bisphosphate (PI-3,4-P2) [328], SHIP-1 is a negative regulator 
of PI3-kinase dependent signalling, and therefore influences many aspects of NK cell 
biology. For example, SHIP-1 mediated breakdown of PI-3,4,5-P3 has been shown to reduce 
IFN-γ production by monokine-stimulated NK cells [329] and to negatively regulate antibody 
dependent cell cytotoxicity (ADCC) induced by the engagement of the activating receptor 
CD16 [330]. Furthermore, by reducing PI-3,4,5-P3 levels, SHIP-1 would also affect the 
recruitment into the developing IS of such pleckstrin homology-domain containing activatory 
proteins as protein kinase B, pyruvate dehydrogenase kinase 1 and PLC- γ.  
1.5.2.3.2 Activatory receptors  
If, according to the missing-self hypothesis, NK cell activity can be induced simply by the 
“absence or reduced expression of self molecules” [308], then why don’t NK cells elicit 
cytotoxicity towards self cells with low or no MHC class I expression? One reason is that, 
with the odd exception [331;332], the induction of NKCC requires not only the absence of 
inhibitory signals but also the ligation of activatory receptors [333]. 
NK cell activatory receptors belong in the main to one of two families: (i) the 
immunoglobulin superfamily, members of which include the low affinity IgG Fc receptor 
CD16 (FcγRIII), the natural cytotoxicity receptors (NCRs) NKp30, NKp44 and NKp46, and 
the activatory KIRs, KIR2DS and KIR3DS or (ii) the C-type lectin family, to which the 
receptors CD94/NKG2C, CD94/NKG2E and NKG2D belong [333]. Through the expression 
of these receptors, NK cells recognise a range of targets, which include IgG coated cells that 
are detected by CD16 and transformed cells, whose expression of the stress-inducible 
glycoproteins MHC class I-chain-related protein A (MICA) and MICB is recognised by 
NKG2D [331]. Moreover, by possessing the NCRs NKp44 and NKp46, whose ligands 
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include viral haemagglutinin [334;335] and bacterial surface proteins [336], NK cells can 
recognise directly the presence of invading pathogens.   
All of the NK cell activatory receptors mentioned above possess short cytoplasmic tails, and 
therefore possess no intrinsic signalling activity. Thus, in order to transmit information, these 
receptors, with the exception of NKG2D, associate with signalling polypeptides that contain 
immunoreceptor tyrosine based activatory motifs (ITAMs). These adaptor molecules include 
CD3ζ and FCRγ, which associate with CD16, NKp30 and NKp46, and DNAX-activation 
protein-12 (DAP12), which couples to NKp44, the activatory KIRs as well as CD94/NKG2C 
and CD94/NKG2E [337]. Following ligand recognition, tyrosine residues within ITAMs are 
phosphorylated by Src-family kinases (e.g. Lck and Fyn), which leads to the recruitment and 
subsequent activation of the Syk family kinases Syk and ZAP70. Once activated, these 
kinases phosphorylate various transmembrane adaptor molecules, including LAT and              
SLP-76, which propagate activatory receptor signalling by serving as docking sites for 
downstream SH2 domain containing signalling molecules (e.g. PI3-kinase, PLC-γ1) and 
adaptor proteins (e.g. Son of Sevenless and Vav) (Figure 1.3). Interestingly, whilst activatory 
receptors differ in proximal signalling modules, activatory signals converge on common 
distal signalling molecules to induce NKCC and cytokine production (Figure 1.3). For 
example, Chen and colleagues recently demonstrated that despite utilising different proximal 
signalling molecules, ligation of NKp30, NKp46 or CD94/NKG2C resulted in the 
phosphorylation of the MAPK family members ERK2 and JNK1, whose activation was 
crucial for lytic granule polarisation and NKCC [338].  
As mentioned above, unlike the majority of activatory receptors, NKG2D does not interact 
with an ITAM containing adaptor. Instead, it associates with DAP10, a transmembrane 
adaptor that possesses a YINM motif in its cytoplasmic tail [339]. Phosphorylation of 
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Figure 1.3 Signalling pathways emanating from ITAM-associated NK activatory 
receptors. Figure taken directly from review article by Vivier et al [337]. 
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tyrosine residues within this domain leads to the recruitment of PI3-kinase and growth factor 
receptor-bound protein 2 [340;341], who initiate signalling pathways that ultimately feed into 
those utilised by ITAM-associated receptors (Figure 1.3). For instance, NK cells activated 
through NKG2D exhibit strong MAPK signalling and PLC-γ1 activation [260]. In contrast to 
other activatory receptors, signals transmitted to NK cells through NKG2D can override 
those delivered by inhibitory receptors, allowing NK cells to eliminate MHC class I positive 
targets [331;332]. This phenomenon, which appears to be unique to NKG2D, may reflect the 
fact that this receptor resides permanently in lipid rafts, membrane domains renowned for 
eliciting and sustaining signalling activity [320]. 
1.5.3 NK cell subsets 
Human NK cells are phenotypically characterised by the surface expression of CD56,                
an isoform of the human Neural Cell Adhesion Molecule, and the absence of CD3. However, 
they are not a homogenous population, as based on the differential surface expression of 
CD56 and the low affinity IgG Fc receptor CD16, NK cells can be categorised into one of 
five distinct subsets: (1) CD56
DIM 
CD16
BRIGHT
, (2) CD56
DIM
 CD16
-
, (3) CD56
BRIGHT
 
CD16
DIM
, (4) CD56
BRIGHT
 CD16
-
 and (5) CD56
-
 CD16
BRIGHT
. Numerically, the dominating 
subsets within peripheral blood are CD56
DIM
 CD16
BRIGHT
 and CD56
BRIGHT
 CD16
DIM/-
, which 
differ markedly in both phenotype and function (Figure 1.4). 
1.5.3.1 CD56
BRIGHT
 NK cells  
Via the expression of the chemokine receptors CCR7 and CXCR3, as well as the adhesion 
molecule CD62L, peripheral CD56
BRIGHT
 NK cells possess a surface phenotype that allows 
them access to SLO [342]. Indeed, whilst amounting to only around 5-10% of the circulating 
NK cell pool, CD56
BRIGHT
 NK cells constitute 15% of the total NK cell population present 
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Figure 1.4 NK cell subsets. Schematic representation of the surface phenotype and functional properties of CD56
DIM
 
CD16
+
 and CD56
BRIGHT
 CD16
-
 NK cells, the two predominant subsets of NK cells within human peripheral blood. 
Figure taken directly from review article by Hanna et al [343]. 
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within the spleen and 75-95% of the NK cells resident in the lymph nodes and tonsils 
[276;344]. Interestingly, SLO resident CD56
BRIGHT
 NK cells do not express CCR7 or CD62L 
[276], suggesting that the surface phenotype of this NK subset differs depending upon its 
location. Indeed, compared to their peripheral counterparts, CD56
BRIGHT
 NK cells in SLO are 
NKp30
-
 and show reduced expression of NKp46 and CD94/NKG2A [276]. In addition to 
location, the activation status of CD56
BRIGHT
 NK cells also influences their surface 
phenotype, as exposure to IL-2 has been shown to not only increase surface NKp46 levels but 
induce expression of NKp30, NKp44, CD16 and KIR [14734722]. 
Irrespective of anatomical location and activation status, CD56
BRIGHT
 NK cells express 
receptors for a range of cytokines including IL-1, IL-2, IL-10, IL-12, IL-15 and IL-18 [345]. 
The IL-2 receptor is expressed constitutively in both its intermediate (IL-2Rβγ) and high 
affinity (IL-2Rαβγ) conformations, enabling CD56BRIGHT NK cells to respond to picomolar 
concentrations of this cytokine [344;346].
 
Classically, CD56
BRIGHT
 NK cells are viewed as the predominant source of the NK cell-
derived immunoregulatory cytokines and chemokines described in section 1.5.1.2. However, 
recent evidence suggests that this is dependent upon the type of stimulation. For example, 
CD56
BRIGHT
 NK cells secrete significantly more IFN-γ, GM-CSF, IL-10 and IL-13 than 
CD56
DIM
 NK cells following stimulation with IL-2, IL-12 or IL-15 [275;276;292;344], but 
their production of both cytokines (TNF-α and IFN-γ) and chemokines (e.g. MIP-1α and 
MIP-1β) is negligible following target cell stimulation [277;292], suggesting that CD56BRIGHT 
NK cells are a “cytokine responsive” subset [292;347].  
In keeping with their preference to respond to cytokines, resting CD56
BRIGHT
 NK cells show 
little cytotoxic activity against tumour targets, which is attributable in part to their low 
perforin content and weak capacity to form conjugates [348;349]. However, following 
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stimulation with IL-2, CD56
BRIGHT
 NK cells exhibit a level of NKCC that is comparable to 
that of the cytotoxic CD56
DIM
 NK cell subset, an enhancement borne in part from an IL-2 
induced increase in NCR and NKG2D expression [276;350].  
1.5.3.2 CD56
DIM
 NK cells  
CD56
DIM
 NK cells comprise approximately 90% of the circulating NK cell pool, and are 
therefore the most abundant NK cell subset in human peripheral blood [276]. Through the 
expression of the chemokine receptors CX3CR1 and CXCR1, CD56
DIM
 NK cells are attracted 
to sources of IL-8 and fractalkine [342]. By responding strongly to such signals, CD56
DIM
 
NK cells home to sites of inflammation, where due to their high expression of both perforin 
and granzyme A, and a strong capacity to form conjugates, they mediate potent cytotoxicity 
[348;349]. The induction of NKCC is tightly controlled through the expression of several 
inhibitory and activatory receptors, which include KIR family members, NKG2D, NKp30, 
NKp46, CD94 and CD16 [351;352]. Thus, CD56
DIM
 NK cells can respond directly to 
pathogens through NKp46, recognise transformed cells via NKG2D and mediate ADCC 
through CD16. 
For many years, the role of CD56
DIM
 NK cells in host protection was thought to be restricted 
to the removal of transformed cells through direct cytotoxicity. However, a series of recent 
studies have shown that following target cell recognition or crosslinking of activating 
receptors, CD56
DIM
 NK cells secrete substantial levels of IFN-γ, TNF-α, MIP-1α and MIP-1β 
[277;278;353], suggesting that in addition to mediating NKCC, CD56
DIM
 NK cells are an 
important early source of immunoregulatory cytokines and chemokines. Interestingly, the 
generation of these soluble mediators is marginal when this subset is subjected to cytokine 
stimulation, suggesting that CD56
DIM
 NK cells are a “target responsive” subset [347]. 
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1.5.4 Age associated changes in NK cell function and phenotype  
1.5.4.1 NK cell proportions and absolute number 
A significant increase in the percentage and/or absolute number of CD3
-
 CD56
+
 NK cells 
within the peripheral lymphocyte pool is the general finding reported by studies that have 
investigated the effect of age on NK cell frequency [354-357]. When the composition of the 
circulating NK cell pool has been studied, age has been shown to have a differential effect on 
the two main circulating subsets. Whilst the proportions and/or number of CD56
DIM
 NK cells 
increase with age [351;354], old subjects possess significantly fewer CD56
BRIGHT
 NK cells 
[351;354;355], resulting in a marked age-related increase in the circulating 
CD56
DIM
:CD56
BRIGHT
 ratio [352;358]. As physiological ageing is accompanied by a 
reduction in both NK cell production and proliferation, the increase in NK cells that occurs 
with age has been proposed to result from an accumulation of long-lived NK cells in older 
adults [359].       
1.5.4.2 NK cell phenotype 
Flow cytometric analysis of peripheral blood NK cells has shown physiological ageing to be 
accompanied by changes in surface phenotype. It has been reported by a number of groups 
that CD3
-
 56
+
 57
+
 cells constitute a greater proportion of the circulating NK pool in old 
individuals when compared to younger adults [355;356;360], whilst CD56
DIM
 NK cells 
isolated from old donors express higher levels of the antigenic determinant HLA-DR and the 
death receptor Fas, but lower levels of the activatory marker CD69 when compared to 
CD56
DIM
 NK cells from their young counterparts [361]. As CD57 expression is considered to 
be a sign of NK cell maturity, the increased percentage of CD57 positive NK cells in the 
periphery of old subjects suggests ageing is accompanied by a shift in the maturity status of 
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the circulating NK pool.  
The effect of age on the expression levels of certain NK cell activatory receptors is 
controversial. For example, whilst some studies have reported a decline with age in the 
percentage of NK cells expressing NKp30 or NKp46 [351;362], which in the case of NKp30 
is accompanied by a reduction in its surface density [362], other studies have demonstrated 
similar proportions of NK cells bearing these receptors in young and old donors [355]. More 
consistent findings have however been reported for NKG2D, CD16 and the co-activatory 
receptor CD2 whose levels are all maintained with age [352;355;356].   
With regards to human ageing and NK cell inhibitory receptors, expression of KIR on the 
surface of NK cells from old subjects has been shown to be either increased or comparable to 
the levels present on NK cells isolated from young donors [351;354;356], whilst marked age-
associated reductions in KLRG-1 and NKG2A have been documented [352;354;356], as has 
a decline in CD94, the binding partner of NKG2A [351;352;356]. 
Inter-study differences in experimental protocol is the reason most frequently cited to explain 
the contrasting effects that human ageing has been proposed to have on the expression of 
activatory and inhibitory receptors. However, it is now being recognised that in a manner 
similar to that reported for T lymphocytes, infection with CMV can influence NK cell 
receptor expression. Studies have shown that the percentage of NK cells expressing KLRG-1, 
NKp30 or NKp46 is markedly reduced in CMV seropositive individuals when compared to 
their seronegative counterparts [363;364]. Conversely, CD57
+
 NK cells have been reported to 
form a greater proportion of the circulating NK cell pool in subjects positive for CMV [364]. 
Interestingly, this ability of CMV to modify NK cell receptor expression has been described 
by studies performed solely on young adults, suggesting CMV can induce a surface 
phenotype that is reminiscent of NK cells isolated from aged subjects. Thus, rather than being 
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a consequence of the ageing process, the alterations reported in NK surface phenotype 
between young and old subjects may simply reflect cohort differences in the number of CMV 
positive subjects [364].  
1.5.4.3 NK cell function 
1.5.4.3.1 NKCC and ADCC 
Groups that have investigated the effect of age on the natural cytotoxicity of resting NK cells 
have focused exclusively upon target cell death induced by the granule exocytosis pathway. 
Whilst some studies have demonstrated a marked age-related decline in NKCC [42;357;365], 
others have reported the lytic activity of NK cells to be increased [366-368] or unchanged 
[351;365;369] with age. Underlying these contrasting observations are marked inter-study 
differences in experimental design. For example, whilst some groups performed NKCC 
assays with PBMCs [351;365;367;369], others used peripheral blood lymphocytes (PBL) 
[357;368] or purified NK cells [42;365] as their effector population. Furthermore, studies 
differed in the length of time they cultured NK cells with their targets before assessing 
NKCC, the significance of which was illustrated in the work of Rukavina and colleagues, 
who found NKCC exhibited an age-related impairment in short-term (2 hours) assays, but 
after prolonged co-culture (18 hours) NK lytic activity was comparable between young and 
old donors [370].  
In spite of these conflicting findings, the general belief within the NK cell field is that at the 
single cell level, NKCC is reduced with age. Indeed, an age-related increase in the 
proportions and/or absolute numbers of circulating NK cells was reported by many of the 
studies that found NKCC to be comparable between young and old donors when PBMCs 
were used as effector cells [351;365;371]. Moreover, an age-associated decrease in lytic 
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activity has been reported by the majority of groups that have used purified NK cells at fixed 
concentrations in their cytolytic assays [42;365;371]. 
In an attempt to unearth the mechanism(s) responsible for the age-related decline in NKCC at 
the single cell level, a number of groups have examined the effect of age on the expression of 
NK cell receptors and cytotoxic proteins, as well as key events in the process of NKCC. An 
observation that has been reported by several groups is that NK cells from older adults 
recognise and bind to tumour targets as effectively as those from younger subjects, 
suggesting the age-related impairment in NKCC is the result of a post-binding defect  
[365;372-374]. However, based on current data it is not entirely clear where this defect lies. 
For example, whilst some groups have reported perforin expression is markedly reduced with 
age [370], others have shown the levels of this pore-forming protein, as well as its 
mobilisation and utilisation in response to target cell contact to be comparable between NK 
cells from young and old donors [375]. Likewise, whilst some studies have reported reduced 
expression of the activatory receptor NKp30 on the surface of NK cells from aged subjects, 
and proposed that this would have an adverse effect upon NK cell killing [351;362], other 
groups that have studied this receptor have reported no age-related difference in its 
expression [355]. Thus, despite the general acceptance that NKCC is impaired at the single 
cell level with age, the mechanism(s) responsible are currently unknown.  
In contrast to natural cytotoxicity, ADCC is unaffected by the ageing process. Studies have 
shown no difference in the surface expression of the Fc receptor CD16 with age [352] or in 
the ability of NK cells from old donors to induce lysis of antibody-coated target cells when 
compared to their younger counterparts [356;376;377].  
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1.5.4.3.2 Response to and production of immunoregulatory cytokines and chemokines 
Whilst resting NK cells efficiently lyse MHC class I deficient K562 tumour cells, they 
exhibit little cytotoxicity against Daudi tumour cells due to the absence of NK cell priming 
signals on the surface of the latter cell line [303]. The resistance of Daudi cells to NKCC is 
overcome by pre-treating NK cells with pro-inflammatory cytokines, a procedure that 
generates lymphokine activated killer (LAK) cells. Ageing appears to have no effect upon the 
ability to make LAK cells, as a number of studies have shown NK cells from old donors 
treated with IFN-α [358] IFN-γ [358], IL-2 [378;379] or IL-12 [379] exhibit greater 
cytotoxicity against Daudi targets than their untreated counterparts. However, whether ageing 
impacts upon the cytotoxic capacity of LAK cells is currently unclear, with some groups 
demonstrating comparable LAK activity between young and old subjects [358;378;380], and 
others reporting a marked age-associated reduction in LAK-mediated cytotoxicity following 
IFN-α, IFN-γ or IL-2 treatment of resting NK cells [367;379]. 
Although NK cells isolated from old individuals are capable of up-regulating their production 
of cytokines (e.g. IFN-γ) and chemokines (e.g. MIP-1α, IL-8 and regulated on activation 
normal T cells expressed and secreted (RANTES)) in response to cytokine stimulation 
[358;378;380;381], the levels generated are often significantly lower than those produced by 
NK cells from younger subjects [378;380-382]. The aforementioned age-related decline in 
the frequency and absolute number of cytokine-responsive CD56
BRIGHT
 NK cells 
[351;354;355] is likely to be one mechanism contributing to this impaired functional 
response.  
 
 
Page | 53  
 
1.5.5 Clinical significance of age-associated changes in NK cell number and function 
The recurrent viral episodes experienced by individuals with selective NK cell deficiency 
[192-194] highlights the in vivo importance of NK cells in host protection. However, what 
impact do the aforementioned age-related changes in NK cell number and function have on 
human health, and are they clinically relevant? 
Having observed in a small-scale retrospective study that low NK cell activity in elderly 
people was associated with a past history of severe infection [188], Ogata and colleagues 
undertook a prospective study to confirm a relationship between low NK activity and an 
increased susceptibility to infection. Supporting their previous work, they noted low NKCC 
at baseline was associated not only with an increased risk of developing infection but with a 
reduced probability of surviving infectious episodes [189], a finding in line with an earlier 
longitudinal study that had shown persistently low NK cell activity to be a predictor of 
infectious morbidity in old individuals [187]. In a five-month follow-up study investigating 
the immunomodulatory effect of influenza vaccination in aged subjects, Mysliwska et al  
[383] found NKCC post vaccination to be significantly higher in those individuals who 
attained protective antibody titres, whilst those with low vaccination-induced NK cell activity 
exhibited an increased frequency of respiratory tract infection [383]. Failure to counteract the 
age-associated reduction in NKCC by increasing the circulating number of NK cells also 
appears to be detrimental to health. A three-fold increase in mortality risk was reported in the 
first 2 years of follow-up for elderly individuals with low NK cell numbers when compared 
to those with high NK cell numbers [384].     
Further evidence, albeit indirect, highlighting the importance of NK cells in healthy ageing is 
the results of studies that have been performed on centenarians. Given their extended 
longevity and avoidance of major age-associated diseases, immune gerontologists consider 
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centenarians to be a model of successful human ageing. NK cells isolated from these 
individuals have been shown to exhibit a level of cytotoxicity that is comparable to that of 
young adults, and significantly greater than that of middle-aged subjects [385;386], 
suggesting that preservation of NKCC is important for healthy ageing. 
1.6 Neutrophils 
As the first immune cell recruited to a site of infection, neutrophils are a hosts front-line 
defence against invading pathogens. Unsurprisingly therefore, these cells are equipped with 
an array of anti-microbicidal mechanisms, which enable them to contain and directly 
eliminate foreign antigens. Pathogens are contained via phagocytic uptake and entrapment 
within recently described neutrophil extracellular traps (see section 1.6.2), and eliminated by 
exposure to free radicals and proteolytic enzymes and peptides [387]. However, it has 
become increasingly apparent over recent years that the role of neutrophils in host defence 
extends beyond simply containing and eliminating foreign pathogens. Although terminally 
differentiated, neutrophils secrete a plethora of immunoregulatory chemokines such as               
MIP-1α, MIP-1β, IL-8 and growth-related oncogene-α [388-390], and although contested by 
some groups [388;391] also appear to be an early source of pro-inflammatory cytokines     
[392-394]. Through the secretion of these soluble mediators, neutrophils are able to 
orchestrate immune responses by regulating the recruitment and activity of bystander 
immune cells. Furthermore, it is now evident that neutrophils influence the initial stages of an 
adaptive immune response, with studies demonstrating neutrophils are able to drive DC 
maturation [395], transport antigens to secondary lymphoid tissue [396;397], serve as antigen 
presenting cells [398;399] and modulate both T helper cell differentiation and CD8
+
 immune 
responses [399;400]. 
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1.6.1 Effect of age on neutrophil biology 
1.6.1.1 Neutrophil production 
Produced by the bone marrow at a rate of 1-2x10
11
 per day, neutrophils are the most abundant 
leukocyte in human circulation. With age the proliferative response of neutrophil precursor 
cells to granulocyte colony stimulating factor (G-CSF) deteriorates [401], whilst the response 
to granulocyte macrophage colony stimulating factor (GM-CSF) and IL-3 stimulation is 
maintained [401]. Despite a reduced sensitivity to G-CSF, studies have shown that in both the 
steady-state [402] and in times of acute infection [403], circulating numbers of neutrophils 
are comparable between young and old individuals, suggesting that the process of 
granulopoiesis is unaltered with age.  
1.6.1.2 Neutrophil adherence and chemotaxis 
To arrive at sites of antigenic challenge, neutrophils must first adhere to activated 
endothelium, a step that requires interactions between an array of endothelial ligands and 
their cognate receptors on the neutrophil surface. Studies that have examined the effect of age 
on neutrophil receptors have reported no differences in the levels of CD15 [404] or in the 
expression of the integrins CD11a and CD11b [404-406], which mediate rolling adhesion and 
firm adhesion respectively, suggesting aged neutrophils would be capable of binding the 
activated endothelium. Indeed, several in vitro studies have shown the binding of stimulated 
neutrophils obtained from aged donors to gelatin [407], fibronectin [408], nylon fibres [409] 
and endothelial monolayers [407] is comparable or even increased when compared to that of 
neutrophils isolated from younger adults. 
Once across the vascular endothelium, neutrophils migrate to the site of antigenic challenge 
along chemotactic gradients comprised of complement factors (e.g. complement component 
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5a (C5a)), chemokines (IL-8, MIP-1α) and bacterial products (e.g. formyl-methionine-
leucine-phenyalanine (fMLP)). Based on the findings of in vitro studies it would appear that 
neutrophil migration is impaired with age, as numerous studies have reported defects in the 
chemotactic response of aged neutrophils to fMLP [409-412] and GM-CSF [412]. However, 
these findings are not supported by in vivo data. With the exception of a single study, which 
reported an age-associated reduction in the arrival of neutrophils to sites of damaged skin 
[413], both murine [104;414] and human [415] studies that have investigated in vivo 
neutrophil migration have shown this function to be comparable between young and old 
subjects. 
1.6.1.3 Anti-microbial defence 
Neutrophils express on their surface a multitude of receptors that enable them to detect and 
attach to infecting microbes. These include complement receptors (e.g.CD35, CD18/CD11b), 
TLRs (e.g.TLR4) and the Fc receptor CD16. Neutrophil activation induced by ligation of 
these receptors can trigger pathogen uptake, a crucial first step in neutrophil-mediated 
defence. 
Whilst neutrophils from aged individuals are as efficient as those from young donors at 
ingesting non-opsonised particles [416], their phagocytic activity towards opsonised 
pathogens is markedly reduced [404;405;409;417;418]. Studies have shown that 
physiological ageing is associated with a decline in both the percentage of neutrophils 
capable of phagocytosing opsonised microbes [404;405;409;418], and in the number of 
microbes ingested per cell [405;409;418], two defects that together result in a reduced 
phagocytic efficiency. From current data, it would appear that the age-related decline in the 
uptake of complement coated microbes is the result of an intrinsic signalling defect since 
expression of complement receptors are unaltered with age [419], and serum from aged 
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individuals opsonises pathogens as effectively as that obtained from young subjects [405]. In 
contrast, the reduced efficiency by which aged neutrophils ingest antibody-coated microbes 
has been attributed to an age-associated loss of CD16 from the neutrophil surface, although 
this view is not shared by all groups [405;419]. 
Pathogens engulfed by neutrophils are exposed to a harsh microbicidal environment. Playing 
an important role in the creation of this environment is nicotinamide adenine dinucleotide 
phosphate-oxidase (NADPH oxidase), a membrane bound multi-subunit enzyme whose 
reduction of NADPH generates superoxide (0
2-
). When challenged with Candida albicans 
(C.albicans), zymosan or Escherichia coli (E.coli), aged neutrophils generate 0
2-
 levels that 
are comparable to those produced by neutrophils from young subjects [418;420;421]. 
However, their production of 0
2-
 following stimulation with fMLP, GM-CSF or opsonised 
Staphylococcus aureus (S. aureus) is markedly lower [408;412;415;418;420;421]. Since the 
surface expression of fMLP and GM-CSF receptors is unaltered with age [422-424], the 
impaired response elicited by aged neutrophils towards these stimuli may be borne from 
abnormalities in the neutrophil cell membrane and/or defects in proximal intracellular 
signalling. In support of this idea, no study to date has reported an age-related difference in 
0
2-
 production following stimulation with PMA [408;425;426], a pharmacological agent that 
bypasses the cell membrane to activate NADPH oxidase. Furthermore, when analysing the 
lipid composition of peritoneal neutrophil membranes from young and old rats, Alvarez and 
colleagues discovered a significant age-related decrease in cholesterol content as well as a 
marked increase in phospholipids, changes that were associated with increased membrane 
fluidity and reduced 0
2- 
production upon fMLP stimulation [425].  
Through the process of degranulation, neutrophils are able to eliminate pathogens 
extracellularly. Based on the work of two independent studies, which found that when 
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compared to fMLP-stimulated neutrophils from young controls, those isolated from old 
donors released significantly fewer proteases into the extracellular environment [410;427], it 
seems that this form of neutrophil defence also wanes with age. 
 1.6.1.4 Priming and apoptosis 
Circulating neutrophils are short-lived cells, possessing an estimated half-life of 7-10 hours. 
At sites of infection and inflammation, neutrophil lifespan is increased, primarily as a result 
of exposure to pro-inflammatory cytokines (e.g. GM-CSF, G-CSF) and microbial products 
(e.g. LPS). Indeed, when treated in vitro with these pro-inflammatory mediators, neutrophils 
are rescued from apoptosis. However, GM-CSF and LPS are not as efficient at prolonging the 
lifespan of neutrophils from elderly donors when compared to those of young individuals 
[423;428-431], suggesting that the sensitivity of neutrophils to these survival signals declines 
with age.  
GM-CSF promotes neutrophil survival by increasing the expression of the anti-apoptotic 
protein induced myeloid leukaemia cell differentiation protein (Mcl-1), and reducing the 
expression of the pro-apoptotic protein Bax. However, in aged neutrophils, the levels of both 
proteins are unchanged following GM-CSF treatment [428]. This inability to respond to GM-
CSF has been attributed to defective intracellular signalling. For instance, whilst stimulation 
of neutrophils from young donors with GM-CSF is associated with a significant decline in the 
activity of the tyrosine phosphatase SHP-1, a negative regulator of GM-CSF signalling, no 
reduction in SHP-1 activity is observed in aged neutrophils [429]. Consequently, the activity 
of signalling pathways that promote neutrophil survival in response to GM-CSF, such as the 
Janus kinase/signal transducer and activator of transcription pathway as well as ERK and 
AKT signalling is significantly lower in neutrophils from aged donors when compared to 
those from their younger counterparts [422;423;432].  
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As well as a survival factor, GM-CSF is a priming agent needed for the optimal activation of 
neutrophils. Thus, the age-related decline in neutrophil sensitivity to GM-CSF impacts not 
only upon their lifespan but also their microbicidal capacity. Indeed, two independent studies 
have shown GM-CSF primed neutrophils from young donors generate significantly more 0
2-
following fMLP stimulation than those from older individuals [412;433]. When these 
findings are considered alongside those regarding neutrophil apoptosis, it is reasonable to 
suggest that in vivo, neutrophils from elderly donors would respond less effectively to 
stimulation and die more rapidly, which would adversely affect their ability to eradicate 
foreign pathogens.  
1.6.1.5 Clinical relevance of age-associated changes in neutrophil function 
Neutrophils isolated from elderly subjects exhibit reduced phagocytic killing of bacteria and 
fungi when compared to neutrophils from younger individuals [418;419;434], illustrating that 
the age-related changes described above do impact upon the protective nature of these cells. 
However, are these in vitro observations of clinical significance? To our knowledge, only one 
study to date has addressed this issue. In this study, in which a cohort of elderly individuals 
were followed over seven years, Niwa and colleagues found that when compared to those 
who survived to the end of the study, “non-survivors” presented with significantly impaired 
neutrophil chemotaxis at baseline [411]. Importantly, defective neutrophil migration was 
observed in all subjects in whom infection was the cause of death, suggesting that aberrant 
neutrophil function may contribute some part to the increased incidence and severity of 
infection amongst the elderly population. 
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1.6.2 Neutrophil extracellular traps (NETs) 
In a seminal paper published in 2004, Brinkmann and colleagues described that upon 
stimulation with pro-inflammatory cytokines and whole pathogens, neutrophils released into 
the extracellular environment their nuclear DNA coated with granule-derived peptides and 
enzymes [435]. Termed neutrophil extracellular traps (NETs), these structures are ejected 
from dying neutrophils, and as such are seen as the “last resort” in neutrophil-mediated 
protection, where they play an important role in pathogen containment. As an unusual form 
of cell defence, NETs have received considerable attention from a number of groups, 
meaning that over the last eight years our understanding of how these structures are formed, 
their function, and their relevance in vivo has grown considerably. 
1.6.2.1 Structure and function of NETs 
Consisting of a DNA backbone decorated with a multitude of anti-microbial peptides and 
enzymes, NETs are mesh-like structures approximately 100 nm in diameter. With the 
exception of histones, the anti-microbial proteins present on NETs are derived almost 
exclusively from neutrophil granules and include: myeloperoxidase (MPO), lactoferrin, 
bacterial permeability increasing protein, neutrophil elastase (NE), and cathepsin G 
[435;436]. By binding these proteins, NETs prevent their dissemination, and thus protect 
surrounding tissue from collateral damage. 
As would be predicted from their name, NETs act as physical barriers, trapping a range of 
microbes, which include both gram positive and gram negative bacteria [435;437;438], the 
fungal pathogen C. albicans [439], and the parasites Leishmania amazonensis and 
Plasmodium falciparum [440;441]. Microbial attachment to NETs is mediated predominantly 
by ionic forces between the negatively charged pathogen surface and the positively charged 
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anti-microbial proteins that coat NETs. However, other factors can influence pathogen 
entrapment, and include surfactant protein D, a member of the collectin family that has 
recently been shown to augment pathogen trapping by binding simultaneously to NET fibres 
and carbohydrate ligands present on the surface of bacteria [438]. 
Numerous studies have reported reduced survival rates for pathogens cultured with 
neutrophils that have been pre-treated with NET-inducing stimuli [439;440;442;443]. As 
anti-microbial peptides present on NETs retain their functionality [444-446], this reduction in 
pathogen viability has been assigned to direct microbial killing by NETs. Indeed, treating 
neutrophils with deoxyribonucleases (DNase) to digest NETs prior to or in conjunction with 
the addition of micro-organisms markedly increases pathogen survival [435;439;440;447]. 
However, as pathogen viability is often determined by enumerating colony forming units, 
could it be that pathogens are simply trapped in NETs but still alive? Recent data from two 
independent groups [445;447], who dismantled NETs with DNase prior to measuring 
pathogen viability, suggest that this is the case. In both instances, NET degradation resulted 
in a greater recovery of viable bacteria, suggesting that pathogens trapped in NETs remain 
alive. On this evidence it has been proposed NETs lack microbicidal activity, and that these 
structures are important only for pathogen containment [445;447;448].  
Whilst NETs may not eliminate pathogens directly, they may contribute to the clearance of 
infectious organisms by modulating innate and adaptive immune responses. For instance, 
activation of the contact system, a branch of humoral innate immunity, occurs on NET fibres 
and would result in the generation of pro-inflammatory and anti-microbial peptides [449]. In 
addition, pentraxin 3, a soluble pathogen recognition receptor that binds the complement 
component C1q, is present in NETs, where it could activate this innate form of host defence 
[450]. With regards to adaptive immunity, Tillack and colleagues found that by priming T 
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cells, NETs lower the activatory threshold of these cells allowing them to elicit functional 
responses to suboptimal stimuli [451].  
1.6.2.2 Molecular mechanisms underlying the formation of NETs 
Three distinct pathways have been described for how neutrophils generate and release 
extracellular traps. The first is an oxidant dependent process defined by (i) degradation of the 
nuclear envelope, (ii) disintegration of granule membranes and (iii) cell lysis [443]. These 
steps are triggered by a range of stimuli (e.g. PMA and bacteria), and are complete within 3-4 
hours of neutrophil activation. The second pathway, which is oxidant independent, generates 
NETs within 30-60 minutes, and is characterised by the fusion of nuclear membrane derived 
vesicles with the plasma cell membrane [452]. The third pathway of NET generation stands 
alone in as much as it drives neutrophils to expel DNA that is of mitochondrial rather than 
nuclear origin [453]. Throughout the remainder of this introduction, only NET formation that 
occurs through the first pathway outlined above will be discussed.   
Pro-inflammatory cytokines (e.g. IL-8, TNF-α), pharmacological agents (e.g. PMA), bacteria, 
fungi and protozoa are stimuli that trigger NET release [454], a multi-step process that 
culminates in neutrophil death. Termed “NETosis”, this form of cell death is distinct from 
both apoptosis and necrosis [443], and is defined by unique changes in neutrophil 
morphology. For example, NET release is preceded by homogenisation of eu- and 
heterochromatin, chromatin decondensation and disintegration of both the nuclear envelope 
and granule membranes [443]. These changes allow for the mixing of NET components 
before NETs are released concurrent to rupture of the cell membrane, an event for which a 
functional actin cytoskeleton is crucial [443;455]. 
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Two non-redundant processes that underpin these morphological changes and thus NET 
formation are: histone hypercitrullination and the generation of ROS (Figure 1.5).  
1.6.2.2.1 Histone citrullination 
Neutrophils that lack peptidylarginine deiminase 4 (PAD4), a calcium dependent enzyme that 
catalyses the citrullination of histones H2A, H3, and H4 [456;457], fail to generate NETs, 
suggesting that citrullination of histones is important for NET formation [458]. Indeed, all 
NET-inducing stimuli examined to date, such as IL-8, TNF-α, LPS and the bacteria Shigella 
flexneri increase histone citrullination by activating PAD4 [455;458;459]. 
Histone citrullination is critical for chromatin decondensation, an early event in NET 
formation and a defining feature of NETosis. Studies have shown regions of highly 
decondensed chromatin, which form the backbone of NETs, stain positive for citrullinated 
histones [459], whilst pharmacological inhibition of PAD4 prevents the chromatin 
decondensation normally observed in neutrophils following treatment with NET-inducing 
stimuli [459]. Unsurprisingly therefore, PAD4 inhibition prevents NET formation [459]. 
1.6.2.2.2 Generation of reactive oxygen species 
Pre-treating neutrophils with the NADPH oxidase inhibitor diphenylene iodonium or the anti-
oxidant enzyme catalase prevents NET formation to a wide array of stimuli [443;460], 
suggesting that NET production is dependent upon the generation of ROS. Indeed, when 
challenged with PMA or pathogens, neutrophils isolated from patients with chronic 
granulomatous disease (CGD), an inherited disorder in which subunits of NADPH oxidase 
are either absent or dysfunctional [461], fail to generate NETs and show no signs of the 
aforementioned morphological changes that accompany NET formation [443;462-464].  
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Figure 1.5. Schematic representation of the molecular processes involved in the 
formation of neutrophil extracellular traps (NETs). Ligation of cell surface receptors (A) 
triggers via the serine/threonine protein kinase, protein kinase C (PKC), activation of the 
ROS generating enzyme phagocytic oxidase (PHOX) (B). Production of ROS has been 
proposed to trigger the translocation of neutrophil elastase (NE) and myeloperoxidase (MPO) 
from azurophilic granules (depicted as red circles) to the nucleus, where upon arrival they 
work together to drive degradation of histones (C). Furthermore, ROS have been suggested to 
prolong the activity of peptidyl arginine deiminase 4 (PAD4), an enzyme that drives 
chromatin decondensation by promoting histone hypercitrullination (C). These molecular 
processes lead to the disintegration of both nuclear and granule membranes, allowing for the 
intracellular mixing of NET components prior to rupture of the cell membrane and NET 
release (D). Figure taken directly from review article by Brinkmann et al [465]. 
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However, the cells do produce NETs when treated with exogenous hydrogen peroxide (H2O2) 
[443]. H2O2 however is not the active oxygen species that triggers NET generation. Instead, 
this function has been attributed to its downstream products hypochlorous acid and singlet 
oxygen [443;460;462;464]. Indeed, neutrophils devoid of MPO, a lysosomal protein whose 
enzymatic activity is critical for the generation of these two oxygen species, fail to release 
NETs in response to PMA and fungal challenge [443;466]. 
If the generation of ROS is critical for NET formation then what role do they play in this 
process? Currently the answer to this question is not known, although two roles have been 
proposed (Figure 1.5). Based on data showing elevated calcium levels induce NET formation 
[467],  Remijsen and co-workers have suggested ROS may increase intracellular calcium 
levels by damaging mitochondria and/or the endoplasmic reticulum, and that this would 
promote NET production by sustaining the activity of PAD4 [468]. The second hypothesis 
that has been put forward proposes that ROS generation serves as a trigger for the 
translocation of NE from azurophilic granules to the nucleus, where upon arrival it would 
drive chromatin decondensation by degrading histone H4 [469].     
Although clearly essential for NET production, ROS alone are not sufficient to trigger it, 
suggesting other cellular processes are required. This thinking is based on several lines of 
evidence, which include the inability of fMLP, a potent activator of NADPH oxidase, to 
induce NET formation [470], and the fact that despite generating ROS levels comparable to 
those of young adults, neutrophils isolated from neonates generate significantly fewer NETs 
following LPS stimulation [471]. 
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1.6.2.3 Relevance of NETs in vivo 
Despite a significant number of studies demonstrating that NETs are generated in vivo in 
times of infection [435;440;441;472-476], few groups have examined the contribution of 
NET-mediated immunity to a hosts overall immune response [472;473;477-479]. Given that 
no specific inhibitor of NET formation currently exists, this issue has been tackled either by 
administering DNase to pathogen-infected mice in order to digest pre-formed NETs 
[478;479], or infecting mice with bacterial strains that through expression of DNases can 
escape from NETs [472;473;477].  
In a murine model of polymicrobial sepsis, Meng and colleagues administered DNase to 
evaluate the effect of NETs on bacterial spreading and host survival [478]. They found mice 
treated with DNase exhibited enhanced bacterial dissemination and increased mortality rates 
24 hours post infection when compared to their untreated counterparts, although no 
difference in overall survival rates was observed between the two groups [478]. In other 
murine models of infection, it has been shown that bacterial isolates that express DNases and 
escape from NETs in vitro, are more virulent in vivo [472;473;477]. For instance, nuclease 
expressing bacteria are not cleared as effectively from host tissue as isolates devoid of 
DNases, and induce significantly higher rates of mortality [477]. 
Based on their findings, these groups have proposed that NETs make a significant 
contribution to the innate immune response. In light of the aforementioned studies by Parker 
et al [445] and Menegazzi and colleagues [447] that showed NETs do not directly kill 
pathogens (see section 1.6.2.1), it is likely that NETs confer protection by preventing 
microbial dissemination and degrading pathogen associated virulence factors [435].  
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1.6.2.4 Pathological consequences of NET formation 
Via their ability to capture, contain and possibly eliminate invading micro-organisms, NETs 
may seem at first glance a useful addition to the defensive armoury of neutrophils. However, 
recent findings suggest their production may lead to some unwanted side effects. Firstly, in 
vitro studies have shown NET-resident histones and MPO directly induce epithelial and 
endothelial cell death [446;474;480]. Secondly, NET production in the absence of microbial 
stimulation, or an impaired ability to remove NETs from inflammatory sites has been linked 
to the development and/or pathology of a number of autoimmune diseases and pathological 
conditions such as small vessel vasculitis [481;482], cystic fibrosis [483;484], atherosclerosis 
[485], pre-eclampsia [486] and systemic lupus erythematosus (SLE) [480;487-490]. Of these, 
it is the potential association between NETs and the development of SLE that has been the 
subject of considerable attention.  
Chronically activated pDCs secreting copious amounts of IFN-α are heavily implicated in the 
pathogenesis of SLE. As self DNA activates pDCs from SLE patients [491;492], NETs have 
been proposed to play a role in the propagation of this autoimmune disease, a claim based in 
part on data showing: (i) increased NET production by resting neutrophils from SLE patients 
[480], (ii) impaired degradation of NETs by lupus serum [489;490] and (iii) the presence of 
immune complexes consisting of self DNA and the NET-associated anti-microbial peptide 
LL37 in the sera of SLE patients but not healthy controls, which in vitro trigger pDC 
activation and IFN-α secretion [487;488]. When these data are viewed alongside experiments 
showing IFN-α induces LL37 expression on the surface of circulating neutrophils, whose 
recognition by autoantibodies triggers NET production [487], one can envisage the existence 
of a viscous cycle in SLE patients, in which NETs are the main protagonist.     
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Taken together, this data suggests that NET production is a double-edged sword. On the one 
hand, these structures appear useful for the immediate capture and containment of invading 
pathogens, but if produced in excess or their clearance impaired, NETs are a source of self-
antigen that may drive the development of autoimmune disease as well as exacerbate ongoing 
pro-inflammatory responses.  
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1.7 Summary and thesis aims 
When compared to younger subjects, older adults report an increased incidence of infection. 
As well as being more frequent, infectious episodes in the elderly are longer lasting, more 
severe and are associated with greater morbidity and mortality rates. Whilst numerous factors 
contribute to the increased susceptibility of older adults to infection, many consider age-
associated changes in immune function to be primarily responsible. Despite the importance of 
innate immunity in preventing infections, only in the last decade have we begun to 
understand the impact ageing has on its function, with numerous studies reporting 
considerable age-related modification. However, these studies have mainly been 
observational, with very few identifying the mechanisms responsible for the functional 
changes they describe. Furthermore, the effect of age on many novel aspects of the innate 
immune response such as NET formation has not yet been examined.  
Thus, the aims of this thesis were to: 
1. Identify the mechanism(s) responsible for the age-related decline in NKCC at the 
single cell level. 
2. Determine the effect of age on the generation of neutrophil extracellular traps.  
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CHAPTER 2 
Materials and Methods 
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2.1 Materials and Methods 
2.1.1 Subjects and blood sample collection 
In total, 95 young (mean age 27.2±0.5 years; range 20-35 years; 41 males, 54 females) and            
167 old (mean age 71.7±0.5 years; range 60-91 years; 74 males, 93 females) volunteers were 
enrolled into this study, which was approved by the local research ethics committee. Blood 
samples were collected after obtaining written informed consent from donors, who at the time 
of participation were in good health, free of immunological illness and significant                           
co-morbidity, and were not taking any medication known to interfere with immunity. 
2.1.2 Tissue culture 
For cell culture and cell suspensions, the standard media (unless otherwise stated) was RPMI-
1640 (Sigma-Aldrich, Dorset, UK) supplemented with 10% (volume/volume (v/v)) heat-
inactivated (HI) fetal calf serum (FCS; Sera Laboratories International, Sussex, UK),                          
2 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin (GPS; all purchased 
from Sigma-Aldrich), hereafter referred to as complete media (CM). To prepare HI-FCS, 
FCS was incubated for 30 minutes in a waterbath at 56
0
C. Phosphate buffered saline (PBS) 
was prepared by dissolving one PBS tablet (Sigma-Aldrich) in 200 ml distilled water and was 
autoclaved prior to use.  
2.1.3 Flow Cytometry 
Flow cytometry was performed using a CyAnADP
TM
 bench top cytometer (Dako, 
Cambridgeshire, UK). Excitation of the flurochromes Fluorescein Isothiocyanate (FITC), 
Phycoerythrin (PE) and PE-Cy-7 (PE-CY7) was achieved using an argon laser at 488 nm, and 
emission recorded through specific band pass filters: 530 nm for FITC (FL1), 575 nm for PE 
(FL2) and 750 nm for PE-CY7 (FL5). Pacific Blue (PcB)-conjugated antibodies were excited 
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using a blue-violet laser at 405 nm with emission recorded using a band pass filter at 450 nm 
(FL6). When multi-colour flow cytometry was performed, spectral overlap of flurochromes 
was compensated for by running individual cell populations stained with each dye.    
Flow cytometry data was analysed using Summit v4.3 software (Dako, Colorado, USA). Data 
relating to antigen expression was recorded as both staining intensity and percentage of 
antigen positive cells. Staining intensity was measured as mean fluorescent intensity (MFI) or 
median fluorescent intensity (MedFI) and is presented after subtracting the values of samples 
stained with irrelevant isotype controls.  
2.1.4 Immune cell purification  
2.1.4.1 Isolation of peripheral blood mononuclear cells (PBMCs) 
Venous blood was collected into heparinised tubes and diluted 1:1 with RPMI-1640 media 
supplemented with GPS. This mixture was layered gently over 6 ml of Ficoll-Paque™ PLUS 
(GE Healthcare, Uppsala, Sweden) and centrifuged at 1200 revolutions per minute (rpm) for 
30 minutes at 20
0
C in a bench top centrifuge with no brake (JOUAN CR3i, DJB Labcare 
Limited, Buckinghamshire, UK). Post centrifugation, mononuclear cells were transferred into 
a universal tube (Sarstedt, Leicester, UK), and washed twice (1200 rpm for 10 minutes at 
20
0
C) in magnetic assisted cell sorting buffer (MACS
®
; PBS, 2 mM Ethylenediamine-
Tetraacetic Acid (EDTA), 0.5% bovine serum albumin (BSA) and 0.09% azide; Miltenyi 
Biotec, Gladbach, Germany). PBMC numbers were then determined and cells resuspended in 
CM at a concentration of 1-2x10
6 
/ml for functional and phenotypic analysis or in MACS
® 
buffer for NK cell isolation. 
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2.1.4.2 NK cell isolation 
NK cells were obtained from PBMC samples by negative selection using MACS
®
 technology 
(Human NK cell isolation kit; Miltenyi Biotec). Briefly, freshly isolated PBMCs that had 
been resuspended in MACS
®
 buffer (see section 2.1.4.1) were spun at 300 x g for 10 minutes 
at 4
0
C (JOUAN MR22i), and the subsequent pellet re-constituted in 40 µl of MACS
®
 buffer 
per 10
7 
cells. To this suspension, 10 µl of NK cell biotin-antibody cocktail per 10
7
 cells was 
added and the sample incubated for 15 minutes at 4
0
C with occasional mixing. Post 
incubation, 30 µl of MACS
®
 buffer and 20 µl of NK cell microbead cocktail per 10
7 
cells was 
added and the sample incubated for a further 15 minutes at 4
0
C, after which cells were 
washed in MACS
®
 buffer (2 ml per 10
7 
cells; 300 x g for 10 minutes at 4
0
C) and the pellet 
prepared for magnetic separation by resuspension in 500 µl of MACS
®
 buffer.  
For magnetic separation, an LS column (Miltenyi Biotec) was prepared by placing the 
column in the magnetic field of a QuadroMACS (midi) separator (Miltenyi Biotec) and 
washing with 3 ml of MACS
®
 buffer. The PBMC suspension was applied to the column, 
followed by 9 ml of MACS
®
 buffer, and the elute, which represented the purified NK cell 
population collected. Cells were pelleted by centrifugation (300 x g for 10 minutes at 4
0
C) 
and resuspended to a final concentration of 1, 2 or 5x10
6 
/ml in CM. 
To determine the percentage of NK cells within the isolated cell population, 100 µl aliquots 
of the cell suspension were dispensed into a 96-well flexi plate (BD Falcon™, New Jersey, 
USA) and the plate spun at 250 x g for 5 minutes at 4
0
C (JOUAN MR22i). Post 
centrifugation, supernatants were decanted and pellets resuspended in 100 µl of PBS/1%BSA 
that contained either 1 µg/ml of a FITC-conjugated mouse anti-human CD3 (Dako, 
Cambridgeshire, UK; Clone UCHT1) and 0.3 µg/ml of a PE-conjugated mouse anti-human 
CD56 (Dako; Clone C5.9) or their concentration-matched isotype controls (mouse IgG1-
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FITC (Dako; Code X0927) and mouse IgG2b-PE (Dako; Code X0951)). After a 20-minute 
incubation on ice, cells were washed once in PBS (250 x g for 5 minutes at 4
0
C), transferred 
to polypropylene tubes (Becton Dickinson Labware Europe, Meylan Cedex, France) and 
analysed by flow cytometry, where 15,000 cells were collected and the number that fell 
within a CD56
+
 CD3
-
 gate recorded. On a routine basis, this population comprised ≥97% of 
the isolated sample.    
2.1.4.3 Isolation of peripheral blood neutrophils 
Peripheral blood was collected by venepuncture and transferred to sterile 50 ml Falcon™ 
tubes (Becton Dickinson) containing the anti-coagulant EDTA (3 mg/ml blood; Sigma-
Aldrich). To this, 2% (w/v) dextran (reconstituted in 0.9% saline; Amersham Biosciences, 
Uppsala, Sweden) was added (1 ml per 6 ml of blood) and samples incubated at room 
temperature (RT) to sediment red blood cells. After 30 minutes, leukocyte-rich plasma was 
carefully layered onto a Percoll
®
 density gradient consisting of 80% Percoll
®
 (2.5 ml) and 
56% Percoll
®
 (5 ml) in a sterile 15 ml Falcon™ tube. To prepare gradients, a working stock 
of Percoll
®
 was made by mixing 45 ml of Percoll
®
 (Sigma-Aldrich) with 5 ml of 9% (w/v) 
sodium chloride (NaCl; Sigma-Aldrich). From here, 80% Percoll
®
 was prepared by diluting 
40 ml of the Percoll
®
 stock with 10 ml 0.9% (w/v) NaCl, whilst 56% Percoll
®
 comprised of 
28 ml of the working Percoll
®
 stock and 22 ml of 0.9% (w/v) NaCl. Gradients were then 
prepared by carefully layering 5 ml of 56% Percoll
®
 on top of 2.5 ml 80% Percoll
®
.  
Once loaded with leukocyte-rich plasma, gradients were spun for 20 minutes at 1100 rpm in a 
freestanding centrifuge with no brake at 20°C (JOUAN, MR211i). Post centrifugation, 
neutrophils, which resided at the 80-56% interface were removed, placed into a sterile 50 ml 
Falcon™ tube and washed once at 1600 rpm for 10 minutes in RPMI-1640 media 
supplemented with GPS. Post centrifugation, the supernatant was discarded and cells 
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resuspended in RPMI-1640 media supplemented with GPS or Hank’s balanced salt solution 
(HBSS) supplemented with calcium and magnesium (Gibco
®
, Invitrogen, Paisley, UK) to a 
final concentration of 1x10
6
 /ml. 
Purity of neutrophil preparations was determined by cytospin and differential staining using a 
commercially available Giemsa stain (Diff-Qik; Gentaur Europe, Brussels, Belgium). 
Routinely, neutrophils comprised ≥98% of the cell population. 
2.1.5 Phenotypic analysis  
2.1.5.1 Determination of lymphocyte proportions, absolute numbers and surface      
            phenotype 
200 µl aliquots of isolated PBMCs (1x10
6 
/ml in CM) were dispensed into wells of a 96-well 
flexi-plate and pelleted by centrifugation at 250 x g for 5 minutes at 4
0
C. Post centrifugation, 
supernatants were decanted and cells resuspended in 100 µl PBS/1%BSA containing surface 
specific antibodies (Table 2.1) or their concentration-matched isotype controls (Table 2.2). 
Following a 20-minute incubation on ice, cells were washed once in PBS (250 x g, 5 minutes, 
4
0
C) and transferred to polypropylene tubes for flow cytometric testing. 
To determine lymphocyte proportions, 15,000 lymphocytes were gated on a forward scatter 
(FS)/ sideward scatter (SS) flow cytometry plot and the percentage displaying a CD3
+
, CD3
-
 
CD56
+
, CD3
-
 CD56
+
 CD16
+/- 
or CD3
-
 CD56
-
 CD16
+ 
surface phenotype recorded (Figure 
2.1A-B). Using this data and readings of total lymphocytes, which were obtained from a full 
blood count on EDTA-treated whole blood using a fully automated Coulter ACT
diff
 
haematology analyser (Beckman-Coulter, High Wycombe, UK), the absolute number of 
circulating T and NK cells were calculated. NK cell receptor expression was studied on 5000 
CD3
-
 CD56
DIM
 NK cells, where both the percentage of positive cells and the MedFI values 
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Table 2.1 Anti-human primary antibodies 
Antigen Label Isotype Stock 
concentration 
Dilution Clone Source 
CD3 PcB IgG1κ 0.2 mg/ml 1:100 UCHT1 BD Biosciences 
CD3 FITC IgG1κ 100 mg/L 1:100 UCHT1 Dako 
CD16 FITC IgG1κ 100 mg/L 1:25 DJ130c Dako 
CD56 PE IgG2bκ 30 mg/L 1:100 C5.9 Dako 
CD57 FITC IgMκ 25 µg/ml 1:25 HCD57 BioLegend UK 
CD94 FITC IgG1κ 25 µg/ml 1:5 DX22 eBioscience 
NKp46 PcB IgG1κ 0.5 mg/ml 1:100 9E2 BioLegend UK 
NKG2D PECy7 IgG1κ 50 µg/ml 1:5 1D11 BioLegend UK 
 
Table 2.2 Isotype controls 
 Label Stock 
concentration 
Clone Source 
IgG1κ PcB 0.2 mg/L MOPC-21 BD Biosciences 
IgG1κ PcB 0.5 mg/L MOPC-21 BioLegend UK 
IgG1κ FITC 100 mg/L DAK-GO1 Dako 
IgG1κ PECy7 Lot specific 15H6 Southern 
Biotech 
IgG2bκ PE 200 mg/L DAK-GO9 Dako 
IgMκ FITC 0.5 mg/ml MM-30 BioLegend UK 
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(A) 
 
 
 
 
 
 
(B) 
 
 
 
 
 
 
Figure 2.1. Gating strategy used to identify NK cell subsets within the peripheral 
lymphocyte pool. (A) NK cells within peripheral lymphocytes were defined by the surface 
phenotype CD3
-
 CD56
+
 (Region 7), and based on the differential surface expression of 
CD56, were categorised as either CD56
DIM
 (Region 11) or CD56
BRIGHT
 (Region 12).                  
(B) Gating on NK cells and examining their expression of the low affinity Fc receptor CD16 
allowed for the identification of 4 distinct NK cells subsets: CD56
BRIGHT
 CD16
-
 (Region 13), 
CD56
BRIGHT
 CD16
+
 (Region 14), CD56
DIM
 CD16
-
 (Region 15) and CD56
DIM
 CD16
+
            
(Region 16).  
CD56 
CD3 
CD56 
CD16 
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were recorded. 
2.1.5.2 NKp30 staining on isolated NK cells 
100 µl aliquots of NK cells (1x10
6
 /ml in CM) were dispensed into a 96-well flexi plate and 
pelleted by centrifugation (250 x g for 5 minutes at 4
0
C). After decanting the supernatant, 
cells were resuspended in PBS/1%BSA containing 5 µg/ml of purified mouse anti-human 
NKp30 antibody (BioLegend UK, Cambridge, UK; Clone P30-15) or its concentration-
matched isotype control (BioLegend UK; Clone MOPC-21) and incubated on ice for 20 
minutes. After a single wash in PBS (250 x g, 5 minutes, 4
0
C), cells were resuspended in          
50 µl of 20% (v/v) goat serum (Sigma-Aldrich) in PBS/1%BSA and incubated for 20 minutes 
on ice, after which, samples were washed in PBS (250 x g, 5 minutes, 4
0
C) and pellets 
resuspended in PBS/1%BSA containing 10 µg/ml of FITC goat anti-mouse IgG (BioLegend 
UK; Clone Poly4053). Following a 20-minute incubation on ice, cells were washed in PBS 
(250 x g, 5 minutes, 4
0
C), transferred to polypropylene tubes and analysed by flow 
cytometry, where 10,000 NK cells were counted and the percentage of receptor positive cells 
and their MedFI value recorded. 
2.1.5.3 Measurement of perforin and granzyme B expression in isolated NK cells 
100 µl aliquots of NK cells (1x10
6 
/ml in CM) were transferred into wells of a 96-well flexi 
plate and washed once in PBS at 250 x g for 5 minutes at 4
0
C. Post centrifugation, cells were 
subjected to a 30-minute incubation at RT in the presence of 50 µl fixation medium                     
(Life Technologies, Paisley, UK), after which samples were washed in PBS (250 x g, 5 
minutes, 4
0
C). After decanting the supernatant, cell pellets were resuspended in 50 µl of 
permeabilisation medium (Life Technologies), to which either 10 µg/ml of a PE-conjugated 
monoclonal antibody against human perforin (Ancell, Minnesota, USA; Clone δG9), 5 µg/ml 
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of a FITC-labelled mouse monoclonal antibody against human perforin (BioLegend; Clone 
δG9), 20 µg/ml of a FITC-conjugated mouse anti-human granzyme B (Biolegend UK; Clone 
GB11) antibody or their concentration-matched isotype controls (mouse IgG2b-PE, IgG1-
FITC (both from Dako) or mouse IgG1-FITC (Biolegend UK; Clone MOPC-21)) were 
added. Following a 30-minute incubation at RT in the dark, cells were washed once in PBS 
(250 x g, 5 mins, 4
0
C) and analysed by flow cytometry, where the percentage of positive cells 
and MFI values of 5000-10,000 NK cells were recorded. The absolute number of perforin 
positive NK cells was calculated from cell percentages and total NK cell numbers, which 
were obtained by haematological analysis of whole blood samples (see section 2.1.5.1).  
2.1.6 Analysis of NK cell function 
2.1.6.1 Assessment of NKCC and conjugate formation  
Cytotoxicity of resting NK cells against the human erythroleukaemic cell line K562 was 
assessed by two-colour flow cytometry using an adapted version of the protocol described by 
Godoy-Ramirez and colleagues [493]. The MHC class I deficient NK-sensitive cell line K562 
was used as the target population. Obtained from the American Type Culture Collection 
(ATCC, Middlesex, UK), K562 cells (ATCC number CCL-243) were maintained in CM in 
75 cm
2
 cell culture flasks (Sarstedt) at 37
0
C in a humidified 5% C02 atmosphere. Cells were 
split 1 in 3 on the day preceding experimentation and washed once (1600 rpm, 8 minutes, 
20
0
C) in PBS prior to use. Cultures of K562 cells were replaced on a monthly basis. 
2.1.6.1.1 Cytotoxicity assay 
To determine resting NKCC, 200 µl of NK cells (1x10
6 
/ml in CM) were dispensed into wells 
of a 96-well round bottomed plate (Sarstedt) and serially diluted in CM. To each well, 100 µl 
of K562 cells (1x10
5
 /ml in CM) were added to give effector (E) to target (T) cell ratios of 
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10:1, 5:1 and 2.5:1. E:T cell contact was increased by centrifugation at 50 x g for 1 minute at 
20
0
C, and samples incubated at 37
0
C in a humidified 5% C02 atmosphere for 4 or 16 hours. 
To account for the spontaneous lysis of target cells during this period, 100 µl of K562 cells 
were incubated in the absence of effector cells.  
Post incubation, cells were pelleted (250 x g, 5 minutes, 4
0
C), supernatants removed, and 
samples resuspended in 100 µl PBS/1%BSA containing 0.3 µg/ml PE-conjugated mouse                   
anti-human CD56. After 20 minutes of labelling on ice, cells were washed once in PBS                       
(250 x g, 5 minutes, 4
0
C) and the subsequent pellet resuspended in 90 µl PBS. To detect cell 
death, 10 µl of SYTOX
®
 Blue dead cell stain (pre-diluted 1:800 in PBS; Life Technologies) 
was added to each well and the plate incubated in the dark for 5 minutes at 4
0
C. Post 
incubation, cells were transferred to polypropylene tubes and analysed by flow cytometry. 
2.1.6.1.2 Data acquisition 
To assess the percentage of lysed target cells within samples, NK and K562 cells were 
distinguished from one another by gating on a PE log comp Vs. side scatter flow cytometry 
plot (Figure 2.2A). From here, the number of K562 cells (within a total cell population of 
2000) with perturbed membranes was examined on a Violet 1 log comp flow cytometry plot 
(Figure 2.2B) and percentage specific lysis calculated using the following equation:  
% Specific lysis =  
(N
o
 of SYTOX
®
 +ve cells in test sample – 
N
o
 of SYTOX
®
 +ve cells in spontaneous sample) 
2000 
 
X 100 
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(A)  
                               
 
 
 
 
 
(B)                                                                     
 
 
 
 
 
Figure 2.2. Two-colour flow cytometric analysis of NK cell cytotoxicity and conjugate 
formation. (A) Immunostaining of effector and target cell co-cultures with PE-conjugated 
anti-CD56 allowed for the identification of three distinct cell populations: (1) free K562 cells 
(Region 3), (2) conjugates formed between NK and K562 cells (Region 4) and (3) free NK 
cells (Region 5). (B) By the addition of the cell impermeable DNA binding dye SYTOX
®
 
Blue to NK and K562 co-cultures, the percentage of dead K562 cells was determined by 
examining the number of SYTOX
®
 positive cells (Region 8).  
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For the assessment of conjugate formation, conjugates were defined on a PE log comp Vs. 
side scatter flow cytometry plot as K562 cells positive for PE staining (Figure 2.2A) and the 
percentage within 2000 K562 cells recorded. 
2.1.6.2 Assessment of the cytotoxicity of MIP-1α-treated NK cells 
4-hour NKCC assays were performed as described in section 2.1.6.1 with the only difference 
being that at the start of the incubation period, MIP-1α (R and D Systems Europe Limited, 
Oxford, UK) at a final concentration of 1, 2, 5 and 10 ng/ml or its vehicle control (PBS) was 
added to the NK-K562 co-cultures.  
2.1.6.3. Assessment of the role of perforin and death receptor ligands in NKCC 
To determine the sensitivity of K562 cells to perforin-induced death, 4-hour NKCC assays at 
an E:T ratio of 10:1 were carried out as described in section 2.1.6.1 with the sole 
modification that prior to K562 exposure, NK cells were treated for 2 hours (37
0
C, 5% C02) 
with 10-500 nM of the vacuolar type H
+
-ATPase inhibitor concanamycin A (CMA; Sigma-
Aldrich) [494] or vehicle control. By raising the pH of lytic granules, CMA reduces perforin 
activity by promoting its degradation and/or interfering with the cleavage of pro-perforin into 
its mature active form [495]. 
To assess whether death of K562 cells could be induced through death receptor signalling, 
200 µl aliquots of K562 cells (1x10
6
 /ml in CM) were dispensed into a 96-well flat bottomed 
plate (Sarstedt) and incubated for 4 hours in the presence or absence of sFasL                                 
(10-100  ng/ml), sTRAIL (1-10 ng/ml) (both reagents were a gift from Dr. E. Humphreys, 
University of Birmingham, UK) or TNF-α (1-100 ng/ml; Sigma-Aldrich). Post incubation, 
cells were spun at 250 x g for 5 minutes at 4
0
C and the pellet resuspended in 90 µl of PBS. 
To this, 10 µl of SYTOX
®
 Blue dead cell stain (pre-diluted 1:800 in PBS) was added, and 
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samples transferred to polypropylene tubes. For flow cytometric analysis, the number of 
SYTOX
®
 positive cells within a population of 2000 was studied on a Violet 1 log flow 
cytometry plot and percentage lysis calculated using the equation described in section 
2.1.6.1.2. 
2.1.6.4 CD107a assay  
PBMC’s were isolated as described in section 2.1.4.1 and resuspended in CM to a final 
concentration of 2x10
6
 /ml. 100 µl aliquots were then dispensed into polypropylene tubes, to 
which 100 µl of CM or K562 cells (2x10
5
 /ml or 2x10
6
 /ml in CM) was added. Alongside 
these stimuli, 1.25 µg/ml of a FITC-conjugated mouse anti-human CD107a monoclonal 
antibody (eBiosciences, Hatfield, Ireland, UK; Clone eBioH4A3) or its concentration-
matched isotype control (mouse IgG1-FITC (Dako; Code X0927) was added, and samples 
incubated for 1 hour at 37
o
C in a humidified 5% C02 atmosphere. Post incubation, 6 µg/ml of 
monensin (diluted in 100% ethanol; Sigma-Aldrich) was added to all samples, which were 
then incubated for a further 2 or 5 hours at 37
o
C to give total incubation times of 3 and 6 
hours respectively.  
Post incubation, samples were subjected to centrifugation (1600 rpm, 10 minutes, 4
o
C) and 
cells stained with 100 µl PBS/1%BSA that contained 1 µg/ml of PcB-conjugated mouse anti-
human CD3 (BD Biosciences, Oxford, UK) and 0.3 µg/ml PE-conjugated mouse anti-human 
CD56. After a 20-minute incubation on ice, samples were washed once in PBS (1600 rpm,  
10 minutes, 4
o
C) and CD107a levels measured by flow cytometry.  
For cytometric analysis, the percentage of CD107a positive NK cells was recorded along with 
the MFI value. CD107a expression was measured by gating on CD3
-
 CD56
+
 cells within a 
total lymphocyte population of 50,000 (Figure 2.3A-B). CD107a expression on NK cells  
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(A) 
 
                                           
 
 
 
 
 
 
 
 
(B)  
        
 
                  
 
                              
 
 
 
 
Figure 2.3. Gating strategy for CD107a expression assay. (A) PBMC samples were 
stained with anti-CD56 PE and anti-CD3 PcB to identify NK cells, which are depicted in 
region 5. (B) CD107a expression on unstimulated NK cells (left panel) and on NK cells 
following a 6-hour co-culture with K562 cells at an E:T ratio of 1:1 (right panel). 
 
CD56 
CD56 
CD3 
CD107a 
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cultured with RPMI alone was considered background and the value subtracted from each 
test sample. 
2.1.6.4.1 CD107a assay using isolated NK cells 
100 µl aliquots of NK cells (1x10
6 
/ml in CM) were added to wells of a 96-well round 
bottomed plate that contained 100 µl of CM or K562 cells (1x10
5
 /ml or 1x10
6
 /ml), and 
either 1.25 µg/ml of a FITC-conjugated mouse anti-human CD107a monoclonal antibody or 
its concentration-matched isotype control. After gentle resuspension, E:T cell contact was 
increased by centrifugation (50 x g, 1 minute, 20
0
C), and samples incubated at 37
0
C in a 
humidified 5% C02 atmosphere for 1 hour. Post incubation, samples were treated with                 
6 µg/ml of monensin (diluted in 100% ethanol) and incubated for an additional 3 hours at 
37
o
C.  
Post incubation, samples were subjected to centrifugation (250 x g, 5 minutes, 4
0
C), and 
pellets resuspended in 100 µl PBS/1%BSA containing  0.3 µg/ml of a PE-conjugated mouse 
anti-human CD56 monoclonal antibody. After a 20-minute incubation on ice, cells were 
washed once in PBS (250 x g, 5 minutes, 4
0
C) and analysed by flow cytometry, where 10,000 
NK cells were gated and the percentage exhibiting a CD56
+
 CD107a
+
 phenotype recorded 
along with the accompanying MFI value. CD107a expression on NK cells cultured with 
RPMI alone was considered background and therefore the value was subtracted from all test 
samples. 
2.1.6.5 CD69 staining 
100 µl of freshly isolated NK cells (1x10
6 
/ml in CM) were dispensed into wells of a 96-well 
round bottomed plate, to which 100 µl of K562 cells (1x10
5
 /ml in CM) or CM was added. 
Following centrifugation at 50 x g for 1 minute at 20
0
C to increase E:T cell contact, samples 
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were incubated for 4 hours at 37
o
C in a humidified 5% C02 atmosphere. Post incubation, cells 
were pelleted (250 x g, 5 minutes, 4
o
C), supernatants discarded and samples resuspended in 
PBS/1% BSA containing 0.3 µg/ml PE-conjugated mouse anti-human CD56 and either        
10 µg/ml FITC-conjugated mouse anti-human CD69 (BD Biosciences; Clone L78) or its 
concentration-matched isotype control (mouse IgG1-FITC). After a 20-minute incubation on 
ice, cells were washed once in PBS (250 x g, 5 minutes, 4
o
C) and analysed by flow 
cytometry, where 15,000 NK cells were counted and the percentage expressing CD69 
recorded along with the corresponding MFI value. 
2.1.6.6 Detection of perforin on the surface of K562 cells 
Binding of perforin to the surface of K562 cells was assessed through the use of a FITC-
conjugated anti-perforin antibody using a protocol adapted from the work of Lehmann and 
colleagues [496;497]. Briefly, following a 4-hour co-culture of NK and K562 cells at an E:T 
ratio of 10:1, samples were subjected to centrifugation (250 x g, 5 minutes, 4
o
C) and pellets 
resuspended in PBS/1% BSA that contained 0.3 µg/ml of a PE-conjugated mouse anti-human 
CD56 monoclonal antibody along with either 5 µg/ml of a FITC-labelled mouse monoclonal 
antibody against human perforin or its concentration-matched isotype control (mouse IgG1-
FITC). Following a 20-minute incubation on ice, cells were washed once in PBS                                 
(250 x g, 5 minutes, 4
o
C), and analysed by flow cytometry.  
To determine the percentage of K562 cells to which perforin had bound, NK and K562 cells 
were distinguished from one another by gating on unlabelled K562 cells on a PE log comp 
Vs. side scatter FACS plot, and recording the number within a total population of 2000 that 
displayed positive FITC fluorescence. 
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2.1.6.7 Analysis of perforin concentration in NK-K562 cell co-culture supernatants 
Following a 4-hour co-culture of NK and K562 cells at an E:T ratio of 10:1, samples were 
transferred to 0.5 ml eppendorf tubes and pelleted by centrifugation (3000 rpm for 5 minutes 
at RT) in a bench top microcentrifuge (MSE, London, UK). Cell-free supernatants were then 
harvested, snap-frozen in liquid nitrogen and stored at -80
o
C until use. 
Perforin concentrations were determined using a commercially available solid phase 
sandwich Enzyme Linked-Immuno-Sorbent Assay (ELISA) according to manufacturer’s 
instructions (Abcam, Cambridge, UK). Briefly, after thawing samples on ice, 100 µl aliquots 
were dispensed into wells of a microtiter plate pre-coated with a monoclonal antibody 
specific for human perforin. After a 1-hour incubation at RT, liquid was aspirated and wells 
washed 3 times with 300 µl of wash solution. 50 µl of biotinylated anti-perforin antibody was 
then added to each well and the plate incubated for 1 hour at RT. After liquid aspiration and  
3 washes with 300 µl wash buffer, 100 µl of streptavidin horseradish peroxidise (HRP) 
solution was added to all wells and the plate incubated at RT for 20 minutes. After emptying 
the wells and washing 3 times with 300 µl wash buffer to remove any unbound enzyme, 100 
µl of 3,3’,5,5’-tetramethylbenzidine (TMB) substrate solution was dispensed into all wells. 
Following a 10-minute incubation in the dark at RT, colour development was quenched by 
the addition of 100µl sulphuric acid (H2SO4). Absorbance of all wells was measured within     
5 minutes of adding H2SO4 using a spectrophotometer with a primary wavelength of 420 nm 
and a reference wavelength of 620 nm (BioTek
®
 Synergy HT, Northstar Scientific Limited, 
Leeds, UK). Perforin concentrations within test samples were extrapolated from values 
obtained from a standard curve that was created from standards of known perforin 
concentration using GraphPad Prism
®
 software (GraphPad Software Limited, California, 
USA).             
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2.1.6.8 Measurement of perforin release from NK cells 
Freshly isolated resting NK cells (1x10
6 
/ml in CM) were treated for 4 hours at 37
o
C with 
CM, K562 target cells (E:T 10-1) or PMA (2.5 µg/ml; Sigma-Aldrich) and ionomycin                      
(0.5 µg/ml; Sigma-Aldrich). Post incubation, samples were pelleted (250 x g, 5 minutes, 4
0
C) 
and resuspended in PBS/1% BSA containing 0.3 µg/ml PE-conjugated mouse anti-human 
CD56. After a 20-minute incubation on ice, cells were washed in PBS (250 x g, 5 minutes, 
4
0
C) and resuspended in 50 µl fixation medium. Following a 30-minute incubation at RT, 
samples were washed in PBS (250 x g, 5 minutes, 4
0
C) and resuspended in 50 µl of 
permeabilisation medium, to which either 5 µg/ml of a FITC-labelled mouse monoclonal 
antibody against human perforin or its concentration-matched isotype control (mouse IgG1-
FITC) was added. After a 30-minute incubation in the dark at RT, samples were washed in 
PBS (250 x g, 5 minutes, 4
0
C), and analysed by flow cytometry, where 5000 NK cells were 
counted and the percentage of perforin positive NK cells recorded along with the 
corresponding MFI value. 
2.1.6.9 Immunofluorescence microscopy 
2.1.6.9.1 Staining to determine perforin localisation 
100 µl of freshly isolated NK cells (1x10
6
 /ml in CM) were cultured for 30 minutes               
(37
o
C/5% C02) in wells of a 96-well round bottomed plate with 100 µl of either K562 cells     
(1.5x10
5
 /ml in CM) or CM. Post incubation, samples were cytospun onto microscope slides 
(300 rpm for 5 minutes at RT; Shandon Cytospin 2), and cells fixed in cold acetone (Fisher 
Scientific, Leicester, UK) for 20 minutes at 4
0
C. After air-drying the slides for                        
5 minutes, cells were re-hydrated in PBS and permeabilised by exposure to 0.1% Triton         
x-100 (Sigma-Aldrich) in PBS for 3 minutes at RT. After 3 x 5 minute washes in PBS, cells 
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were treated in a humidified chamber for 10 minutes at RT with 10% (v/v) goat serum in 
PBS/2% BSA, after which slides were subjected to a single 5 minute wash in PBS. Cells were 
then stained in a humidified chamber for 1-hour at RT with 100 µl of PBS/1%BSA 
containing 2.5 µg/ml of a FITC-labelled mouse monoclonal antibody against human perforin 
or its concentration-matched isotype control (mouse IgG1-FITC).  Post incubation, slides 
were washed three times in PBS (5 minutes per wash) before being treated for 30 minutes at 
RT in a humidified chamber with 100 µl of an anti-FITC goat IgG fraction Alexa Fluor
®
 488 
conjugate (Life Technologies) that had been pre-diluted 1:100 from stock in PBS. Following 
3 x 5 minute washes in PBS, samples were stained with 104 ng/ml of DAPI nucleic acid stain 
(Life technologies) for 2 minutes at RT. After a single wash in PBS, 22x22 mm coverslips 
(VWR International, Leicestershire, UK) were adhered to slides with fluoromount medium 
(Sigma-Aldrich), and cells visualised using a LEICA DMI 6000 B microscope (Leica 
microsystems, Milton Keynes, UK) at X40 and X63 objective.  
To determine the percentage of NK cells in which perforin had localised to the NK-target cell 
interface, three individuals blinded to donor age counted fifty NK-K562 cell conjugates on 
slides prepared from three young and three old subjects. 
2.1.6.9.2 F-actin staining  
NK-K562 cell co-cultures were set up as described in section 2.1.6.9.1. Post incubation, 
samples were cytospun onto microscope slides (300 rpm for 5 minutes at RT), and fixed in 
4% paraformaldehyde (Sigma-Aldrich) for 10 minutes at RT. After 3 x 5 minute washes in 
PBS, cells were treated at RT for 3 minutes with 0.2% Triton x-100, which was followed by   
3 x 5 minute washes in PBS, and a 30-minute incubation at RT with PBS/1%BSA. After a 
single wash in PBS, slides were stained in a humidified chamber for 1-hour at RT with            
5 µg/ml FITC-conjugated phalloidin (Sigma-Aldrich). Post incubation slides were washed     
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3 times in PBS and stained with 104 ng/ml of DAPI nucleic acid stain for 2 minutes at RT. 
Following a single wash in PBS, 22x22 mm coverslips were mounted onto slides using 
fluoromount medium and cells visualised using a LEICA DMI 6000 B microscope at X40 
and X63 objective.   
2.1.6.10 Assessment of target cell-induced NK cell apoptosis by Annexin V staining  
100 µl aliquots of NK cells (1x10
6 
/ml in CM) were dispensed into wells of a 96-well round 
bottomed plate, to which 100 µl of K562 cells (1x10
5
 /ml) or CM was added. Following 
centrifugation (50 x g, 1 minute, 20
0
C), samples were incubated for 4 hours at 37
o
C in a 
humidified 5% C02 atmosphere. Post incubation, cells were subjected to centrifugation     
(250 x g, 5 minutes, 4
0
C), and resuspended in PBS/1% BSA that contained 0.3 µg/ml                  
PE-conjugated mouse anti-human CD56. After a 20-minute incubation on ice, cells were 
washed once in PBS (250 x g, 5 minutes, 4
0
C) and pellets resuspended in 98 µl of 1X 
Annexin V binding buffer (0.1 M Hepes (pH 7.4), 1.4 M NaCl, 25 mM CaCl2), to which 2 µl 
of Annexin V FITC (BD Biosciences) was added. Following a 10-minute incubation on ice, 
samples were transferred to polypropylene tubes for flow cytometric analysis.  
To determine the percentage of Annexin V positive NK cells, 10,000 unconjugated NK cells 
were gated on a FS/SS flow cytometry plot and the number exhibiting positive FITC 
fluorescence recorded. The number of Annexin V positive NK cells in samples cultured in 
CM was considered to represent spontaneous apoptosis and therefore this value was 
subtracted from all test samples. 
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2.1.6.11 Analysis of cell signalling by Western blotting 
2.1.6.11.1 Preparation of K562 cell lysates 
K562 cells were washed in PBS (1600 rpm for 8 minutes at 20
0
C) and resuspended at a 
concentration of 1x10
6 
/ml in CM. 100 µl aliquots were then dispensed into 1.5 ml eppendorf 
tubes and cells pelleted by centrifugation (200 x g, 5 minutes, 4
0
C). After discarding 
supernatants, cell lysates were prepared by the addition of 20 µl of sodium dodecyl sulphate 
(SDS) sample buffer (4% SDS (v/v); Geneflow Limited, Staffordshire, UK),                                 
0.1M dithiothreitol (Sigma-Aldrich), 20% glycerol (v/v; BDH Limited, Poole, UK), 0.0625 
M Tris-HCL (pH 6.8), 0.004% bromophenol blue (w/v; Sigma-Aldrich)) and boiled for                 
10 minutes at 100°C. 
2.1.6.11.2 MAPK signalling in antibody-stimulated NK cells 
To study MAPK signalling in activated NK cells, the stimulation protocol outlined in the 
recent article by Al-Hubeshy et al [498] was used. Briefly, 96-well flat-bottomed ELISA 
NUNC plates (Fisher Scientific) were coated with 5 µg/ml of mouse monoclonal antibodies 
directed against the activatory receptors NKG2D (R and D Systems Europe Limited; Clone 
149810) and NKp30 (R and D Systems Europe Limited; Clone 210847). Following overnight 
incubation at 4
0
C, plates were washed 3 times with 200 µl PBS, after which 100 µl aliquots 
of PBS/10%HIFCS (v/v) were dispensed into wells and the plate incubated at RT for                     
30 minutes. Post incubation, blocking solution was decanted and the plates washed 3 times 
with 200 µl PBS. 
Once plates were prepared for use, 20 µl aliquots of freshly isolated NK cells (5x10
6
 /ml in 
CM) were added to wells, and samples incubated for 2, 5, 10, 30, 60 and 90 minutes at  37
o
C 
in a humidified 5% C02 atmosphere. Post stimulation, 20 µl of 2X SDS sample buffer was 
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added to wells, after which lysates were transferred into 0.5 ml eppendorf tubes and boiled 
for 10 minutes at 100°C. Data corresponding to minute 0 reflects NK cells that were lysed 
prior to their addition to antibody-coated wells.   
2.1.6.11.3 PMA and ionomycin stimulated NK cells 
20 µl of freshly isolated NK cells (5x10
6
 /ml in CM) were treated in 96-well flat-bottomed 
plates (BD Falcon) for 2, 5, 10, 30, 60 and 90 minutes with 2.5 µg/ml PMA and 0.5 µg/ml 
ionomycin at 37
o
C in a humidified 5% C02 atmosphere. Post stimulation, cell lysates were 
prepared by the addition of 20 µl of 2X SDS sample buffer, after which samples were 
transferred into 0.5 ml eppendorf tubes and boiled for 10 minutes at 100°C. Data 
corresponding to minute 0 relates to untreated NK cells. 
2.1.6.11.4 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting 
After centrifugation at 13,000 rpm for 2 minutes to pellet cell debris, lysates were loaded 
onto a 10% SDS-polyacrylamide gel (constituents listed in table 2.3) and run for 3 hours at 
200 volts with appropriate pre-stained markers (Bio-Rad, Hertfordshire, UK). Proteins were 
then transferred to methanol-activated 0.45 micron polyvinylidene difluoride membranes 
(Scientific Laboratory Supplies, Yorkshire, UK) using Bio-Rad turbo transfer technology 
(Bio-Rad). Once blotted, membranes were incubated on an orbital shaker (Medline Scientific 
Ltd, Oxford, UK) in 5% BSA/Tris buffered saline (TBS) containing 0.1%  tween-20 (Sigma-
Aldrich) for 1-hour at RT, after which blots were probed overnight at 4°C with either a rabbit 
anti-human Phospho-p44/42 or Phospho-p38 antibody (both purchased from Cell Signalling 
Technology, Hertfordshire, UK; both antibodies were pre-diluted 1:1000 from stock in TBS-
0.1% tween-20 containing 2.5% BSA). Post incubation, blots were subjected to 3 x 15 minute 
washes in TBS-0.1% tween-20 before being probed for 1-hour at RT with a HRP-linked anti- 
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Table 2.3 Constituents of a 10% SDS-polyacrylamide gel 
  
Protogel 
 
H20 
 
1.5M Tris 
pH 8.8 
 
0.5M Tris 
pH 6.5 
 
10% 
SDS 
 
10% 
APS 
 
Temed 
 
Resolving 
gel 
 
10.0 ml 
 
12.5 ml 
 
7.5 ml 
 
n/a 
 
300 µl 
 
150 µl 
 
30 µl 
 
Stacking 
gel 
 
2.6 ml 
 
12.2 ml 
 
n/a 
 
5 ml 
 
200 µl 
 
100 µl 
 
20 µl 
Abbreviations: APS, Ammonium persulfate; H20, Water; SDS, Sodium dodecyl sulphate.   
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rabbit IgG antibody (GE Healthcare, Buckinghamshire, UK; antibody was pre-diluted 1:4000 
from stock in TBS-0.1% tween-20). Following 3 washes in TBS-0.1% tween-20 (15 minutes 
each wash), blots were incubated for 5 minutes at RT in enhanced chemiluminescence 
solution (Geneflow, Staffordshire, UK), after which proteins were visualised using either 
autoradiography against X-ray film (GE Healthcare) or Bio-Rad chemi-doc technology               
(Bio-Rad).  
To confirm equal loading of proteins, primary and secondary antibodies were first removed 
from blots with mild stripping buffer (15 g glycine (Sigma-Aldrich), 1 g SDS (Sigma- 
Aldrich), 10 ml Tween 20 (Sigma-Aldrich) in 1 L ultrapure water; pH 2.2).  For this, blots 
were subjected to 2X 10-minute incubations in stripping buffer at RT, followed by 2X                 
10-minute washes in PBS. After a further 2X 5-minute incubations at RT in TBS-0.1%       
tween-20, blots were blocked in 5% BSA/TBS-0.1% tween-20 for 1-hour at RT, before being 
probed overnight at 4
o
C with an Erk 1/2 or p38 antibody (diluted 1:2000 from stock in                
TBS-0.1% tween-20 containing 1% BSA; Cell Signalling Technology). Post incubation, blots 
were washed 3 times (15 minutes each wash) in TBS-0.1% tween-20 and probed with a     
HRP-linked anti-rabbit IgG antibody (pre-diluted 1:4000 from stock in TBS-0.1% tween-20) 
for 1-hour at RT. Blots were then washed 3 times in TBS-0.1% tween-20 (15 minutes each 
wash) and proteins visualised as described above. Densitometry was performed using the 
National Institute of Health ImageJ software package (http://rsbweb.nih.gov/ij/). 
2.1.6.12 Determination of cytokine and chemokine secretion 
100 µl aliquots of freshly isolated NK cells (1x10
6 
/ml in CM) were dispensed into wells of a 
96-well round bottomed plate containing 100 µl of either K562 cells (1x10
6
 /ml in CM; E:T 
1:1) or CM. Following centrifugation at 50 x g for 1 minute at 20
0
C, samples were incubated 
for 6 hours at 37
o
C in a humidified 5% C02 atmosphere. Post incubation, samples were 
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transferred to 0.5 ml eppendorf tubes and cells pelleted by centrifugation (3000 rpm for                   
5 minutes at RT) in a bench top microcentrifuge. Supernatants were then harvested,                   
snap-frozen in liquid nitrogen and stored at -80
o
C prior to analysis.  
To determine cytokine and chemokine concentrations, multiplex technology was performed 
according to manufacturer’s instructions (Life Technologies). Briefly, after pre-wetting wells 
of a 96-well filter plate with wash solution, 25 µl of a 1X antibody bead stock for the 
cytokines IFN-γ and TNF-α, and the chemokines IL-8 and MIP-1α was added to each well. 
After a 30-second incubation at RT, the plate was washed once with wash solution and 50 µl 
of incubation buffer added to all wells. 100 µl of standard solution or tissue culture 
supernatant was then added to relevant wells and the plate incubated in the dark for 2 hours at 
RT on an orbital shaker (speed 500-600 rpm; Grant Instruments Limited, Cambridge, UK). 
Post incubation, the plate was washed twice with wash buffer and 100 µl of a 1X biotinylated 
antibody stock added to all wells. Following a 1-hour incubation in the dark at RT on an 
orbital shaker (speed 500-600 rpm), the plate was washed twice and 100 µl of                                   
1X streptavidin-RPE added to all wells. After a further 30-minute incubation in the dark on 
an orbital shaker (speed 500-600 rpm), the plate was washed 3 times and 100 µl of wash 
solution added to all wells. Cytokine and chemokine concentrations were then analysed using 
a Luminex
®
 100™ instrument (Luminex® Corporation, Austin, Texas, USA). 
2.1.7 Analysis of neutrophil function 
2.1.7.1 Quantification of NET formation  
For the analysis of NET formation by unprimed neutrophils, 100 µl aliquots of neutrophils 
(1x10
6
 /ml in RPMI-1640 media supplemented with GPS, hereafter referred to as assay 
media) were dispensed into wells of a 96-well flat bottomed plate (Becton Dickinson) 
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containing 75 µl of assay media. Cells were then stimulated by the addition of 25 µl of either 
PMA (0.25-25 nM; Sigma-Aldrich), IL-8 (10 ng/ml; R&D Systems, Abingdon, UK) or LPS 
(100 ng/ml; Sigma-Aldrich) and incubated for 3 hours at 37
o
C in a humidified 5% C02 
atmosphere. All stimuli were prepared from stock solutions in assay media, which alone 
served as a negative control. 
Post incubation, samples were treated with 1 U/ml of micrococcal nuclease (MNase; Sigma-
Aldrich) and 1 µM of the cell-impermeable DNA binding dye SYTOX
® 
Green                            
(Life Technologies) in order to digest and stain extracellular DNA respectively. After 
incubation at RT for 10 minutes, samples were transferred to 0.5 ml eppendorf tubes 
(Sarstedt) and pelleted at 5000 rpm for 10 minutes. The DNA content of supernatants was 
then assessed by transferring 170 µl to a flat-bottomed 96-well black plate (Corning, New 
York, USA) and measuring fluorescence in a Fluoroskan Ascent fluorometric plate reader 
(Labsystems Affinity sensors, Cambridge, UK) that was equipped with a filter setting of                
485 nm (excitation) and 530 nm (emission). Experiments were performed in quadruplicate 
and background fluorescence values of unstimulated controls subtracted from test samples.    
For the assessment of NET formation by primed neutrophils, isolated neutrophils (1x10
6
 /ml 
in assay media) were treated with 10 ng/ml TNF-α (Sigma-Aldrich) or vehicle control for              
15 minutes at 37
o
C in a humidified 5% C02 atmosphere. Post incubation, samples were 
washed once (1600 rpm for 10 minutes) and cells re-suspended to 1x10
6
 /ml in assay media. 
NET formation in response to LPS (100 ng/ml) or Il-8 (10 ng/ml) stimulation was then 
examined as described above, with the exception that for the comparison of NET formation 
between young and old donors, fluorescence was measured using a BioTek
®
 Synergy 2 
fluorometric plate reader (NorthStar Scientific Ltd, Leeds, UK) equipped with a filter setting 
of 485 nm (excitation) and 528 nm (emission). 
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2.1.7.2 Visualisation of NETs by fluorescent microscopy 
2x10
5
 neutrophils, resuspended in assay media, were seeded onto 13 mm circular glass 
coverslips (VWR International) and incubated for 30 minutes at 37
o
C in a 5% CO2 
atmosphere to allow for cell adherence. Post incubation, neutrophils were stimulated with 
either PMA (25 nM), IL-8 (10 ng/ml), LPS (100 ng/ml) or assay media for 3 hours (37
o
C, 5% 
CO2), after which cells were fixed by an additional 30-minute incubation at 37
o
C in the 
presence of 4% paraformaldehyde. Once fixed, neutrophils were subjected to the following 
staining protocol; 
 3X 5-minute washes in PBS at RT 
 1X 1-minute incubation at RT in 0.1% triton x-100  
 1X 5-minute wash in PBS at RT 
 1X 5-minute incubation at RT with 1 µM SYTOX® Green 
 1X 5-minute wash in PBS at RT 
Once stained, specimens were mounted in fluoromount medium and visualised using a 
LEICA DMI 6000 B microscope at X10, X20 or X63 objective. 
2.1.7.3 Measurement of ROS generation 
ROS generation was assessed by luminol-amplified chemiluminescence, a technique that 
detects both extracellular and intracellular free radicals [499]. 
To assess ROS generation in unprimed neutrophils, 100 µl aliquots of neutrophils (1x10
6
 /ml 
in HBSS supplemented with calcium and magnesium) were dispensed into wells of a 96-well 
white-bottomed flat plate (Corning) containing 25 µl of luminol (working concentration 
1µM; pH 7.3; Sigma-Aldrich) and 50 µl of calcium and magnesium containing HBSS. Cells 
were then treated with either LPS (100 ng/ml), PMA (25 nM), IL-8 (10 ng/ml) or vehicle 
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control, and ROS generation assessed at 1-minute intervals for 60 minutes using a Berthold 
Centro LB 960 luminometer (Berthold Technologies, Hertfordshire, UK). Experiments were 
performed in quadruplicate, with ROS production calculated as area under the curve (AUC). 
To measure ROS production by primed neutrophils, isolated neutrophils (1x10
6
 /ml in HBSS 
supplemented with calcium and magnesium) were treated with 10 ng/ml TNF-α or vehicle 
control for 15 minutes at 37
o
C in a humidified 5% C02 atmosphere. ROS production in 
response to LPS (100 ng/ml) and IL-8 (10 ng/ml) stimulation was then measured as described 
above. 
2.1.7.4 Simvastatin treatment of primed neutrophils 
Freshly isolated neutrophils resuspended at 1x10
6
 /ml in either assay media or HBSS 
supplemented with calcium and magnesium were treated for 40 minutes at 37
o
C with 1 nM 
simvastatin (Sigma-Aldrich) or vehicle control. During the last 15 minutes of treatment, 
TNF-α (10 ng/ml) was added to prime cells.  
2.1.8 Detection of serum immunoglobulin-G (IgG) antibodies to CMV 
The presence of serum IgG antibodies to CMV was determined using an in-house pre-
validated ELISA (a gift from the laboratory of P. A.H. Moss, School of Cancer Sciences, 
University of Birmingham, Birmingham, UK). Briefly, wells of a 96-well flat-bottomed 
ELISA NUNC plate were coated overnight at 4
0
C with 50 µl of viral or mock lysate that had 
been pre-diluted 1:4000 from stock in carbonate-bicarbonate coating buffer (Sigma-Aldrich). 
Stocks of viral lysate were generated from the supernatants of MRC-5 fibroblasts that had 
been infected for 4 hours at 37
o
C with the AD169 or Townel125 human CMV strains at a 
multiplicity of infection of 4:1. Mock infections were performed simultaneously to produce 
lysates that acted as controls for non-specific IgG binding. Once coated, ELISA NUNC plates 
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were washed 3 times in wash buffer (PBS/0.05% Tween; 200 µl per wash), after which 25 µl 
of donor serum samples (pre-diluted 1:150 in dilution buffer (PBS/0.05% Tween/1% BSA)) 
were added in duplicate to both viral and mock lysate wells alongside 75 µl of dilution buffer. 
Following a 1-hour incubation at RT, plates were washed 3 times in wash buffer, after which 
samples were treated for an additional 1-hour at RT with 100 µl of goat anti-human-IgG-HRP 
conjugated secondary antibody (pre-diluted 1:8000 in dilution buffer; Southern Biotech, 
Alabama, USA). After 3 washes with wash buffer, 100 µl of TMB substrate solution (Sigma-
Aldrich) was dispensed into all wells and the plate incubated for 10 minutes at RT in the 
dark. Reactions were stopped by the addition of 100µl 2N H2SO4 (Sigma-Aldrich), and 
absorbance recorded using a spectrophotometer with a primary wavelength of 420 nm and a 
reference wavelength of 620 nm.  
For analysis, average readings of mock lysate wells were subtracted from the values obtained 
in viral lysate wells. Using these figures, CMV titres were calculated from a standard curve 
of known CMV titres in GraphPad Prism
®
 software. Values greater than 10 were considered 
to be CMV positive.   
2.1.9 Data handling and statistical analysis 
Statistical analyses were performed using GraphPad Prism
®
 software or PASW statistics 
software version 18.0 (Chicago, Illinois, USA). To test if data came from a Gaussian 
distribution, the Kolmogorov-Smirnov test was used. For data that followed a normal 
distribution, unpaired and paired student T-tests were performed to assess differences 
between two independent groups or matched paired samples respectively. A one-way analysis 
of variance (ANOVA) with either a Dunnett’s or Tukey post hoc test was used to study 
differences between more than two groups, whilst a repeated measures ANOVA with either a 
Dunnett’s or Tukey post hoc test was used to compare more than two matched observations. 
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A linear regression was performed to assess the relationship between two variables. For              
non-normally distributed data, the non-parametric Mann-Whitney U test, a Wilcoxon 
matched-pairs signed rank test or Kruskal-Wallis test with Dunn’s multiple comparison post 
hoc test were used. The effect of age and CMV status on immune parameters was assessed by 
a two-way ANOVA, where age and CMV were inserted as dependent variables. When a 
significant effect for CMV was observed, Bonferroni post hoc analysis was performed to 
determine its location. 
Where data is presented in box and whisker plot format, the middle line depicts the median 
value and the whiskers represent the minimum and maximum data points. Data presented in 
histogram format is summarised as mean ± standard error of the mean (SEM). In all 
instances, the minimum level of confidence at which results were considered significant was 
p ≤ 0.05. 
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CHAPTER 3 
 
Studies to identify the mechanism(s) underlying the 
age-associated reduction in NK cell cytotoxicity 
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3.1 Introduction 
A number of studies have shown that physiological ageing is accompanied by a marked 
reduction in NKCC at the single cell level [42;365;371]. As a key form of frontline defence 
against virally-infected cells, this age-related decline in NK cell lytic activity is often cited as 
a factor that contributes to the increased incidence and severity of viral infection reported 
amongst older adults [9]. In support of this claim, Ogata and co-workers demonstrated in two 
separate studies that low NKCC was associated with both the development of infection and 
death due to infection in a cohort of immunologically normal older adults [188;189], findings 
that were in agreement with an earlier longitudinal study that had shown persistently low NK 
cell activity to be a predictor of infectious morbidity in old individuals [187].  
Despite the significance that the age-related decline in NK cell lytic activity has on human 
health, no study to date has identified the mechanism(s) responsible. With the exception of a 
small number of studies that have reported no age-related impairment in NK-target cell 
interaction [365;372;374], the NK cell literature is riddled with contradictory data concerning 
the effect of age on key features of the NKCC process. For instance, whereas some groups 
have suggested perforin levels decline with age [370], others have shown the expression of 
this pore-forming protein, along with its mobilisation and utilisation in response to target cell 
contact is comparable between NK cells from young and old donors [375]. Similarly, whilst 
some studies have reported reduced expression of activatory receptors on the surface of NK 
cells from aged subjects, and proposed that these changes would have a negative impact upon 
NK cell killing [351;362], other groups that have studied the same receptors have reported no 
effect for age on their expression [355]. However, it may be that signalling downstream of 
activatory receptors is impaired with age since when compared to NK cells from younger 
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adults, those from older subjects have been shown to produce significantly lower levels of the 
calcium-mobilising second messenger IP3 in response to target cell contact [373].  
Given that despite numerous attempts, no study to date had fully established why the lytic 
activity of NK cells declines with age, the aim of this chapter was to elucidate the underlying 
cause(s) of this phenomenon. To do this, NK cells were isolated from healthy young                          
(≤35 years) and old (≥60 years) donors, and the effect of age on each of the events 
fundamental to the process of NKCC was examined. 
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3.2 Results 
3.2.1. Effect of age on the proportions and absolute numbers of circulating NK cells 
Immunostaining and multi-colour flow cytometric analysis of PBMC samples isolated from 
young and old donors was performed to assess the effect of age on the composition of the 
circulating lymphocyte pool (Table 3.1). A greater proportion of both CD3
-
 56
+
 and CD3
-
56
+
57
+
 NK cells was found amongst the lymphocyte pool of old individuals when compared 
to young adult controls, changes which were accompanied by an age-related reduction in the 
percentage of CD3
+
 lymphocytes (Table 3.1). 
Based on the differential surface expression of CD56, NK cells can be divided into two major 
subsets, CD56
DIM
 and CD56
BRIGHT
 [345]. When analysed according to this criteria, a 
differential effect of age was observed, with older adults possessing a significantly higher 
percentage of CD56
DIM
 cells amongst their lymphocyte pool but a significantly lower 
proportion of CD56
BRIGHT
 cells, which culminated in an increased CD56
DIM
 to CD56
BRIGHT
 
ratio (Table 3.1). Further analysis based on the co-expression of CD56 and the low affinity Fc 
receptor CD16 revealed the accumulation of CD56
DIM
 cells to be the result of an increased 
proportion of CD3
-
16
+
56
DIM
 NK cells, whilst a significant decline in the percentage of CD3
-
16
-
56
BRIGHT
 cells accounted for the reduction in the CD56
BRIGHT
 subset (Table 3.1) [500]. In 
addition to CD56
DIM
 and CD56
BRIGHT
 subsets, the frequency of CD3
-
56
-
16
+
 NK cells was 
assessed and an age-related reduction observed (Table 3.1). 
In a smaller cohort of individuals, full blood counts were performed in addition to flow 
cytometry in order to examine the effect of age on the absolute number of circulating 
lymphocytes (Table 3.2).  Compared to their younger counterparts, old individuals presented  
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Table 3.1. Age-associated changes in the circulating lymphocyte pool 
 Young 
(n = 21) 
Old 
(n = 21) 
p Value 
CD3
+
56
-
 64.44±1.8 58.40±1.8 0.02 
CD3
-
56
+
 10.60±0.9 17.21±1.2 0.0001 
CD3
-
56
+
57
+ ¥
 55.62±2.9 66.10±2.1 0.03 
CD56
DIM
 10.40±0.9 16.75±1.2 <0.0001 
CD56
BRIGHT
 0.56±0.1 0.40±0.04 0.03 
CD3
-
16
+
56
DIM ¥
 85.7±1.5 91.8±1.0 0.001 
CD3
-
16
-
56
DIM ¥
 3.8±0.5 3.8±0.8 0.537 
CD3
-
16
+
56
BRIGHT ¥
 1.6±0.2 1.5±0.3 0.392 
CD3
-
16
-
56
BRIGHT ¥
 8.3±1.1 2.6±0.4 <0.0001 
DIM:BRIGHT 
 
CD3
-
56
-
16
+ ∞
 
23:1±3.5 
 
3.5±0.6 
51:1±5.7 
 
7.8±1.0 
0.0001 
 
0.001 
 
 
Values are presented as mean ± SEM. 
¥
Data for CD16 and CD57 expression reflects the 
proportion of antigen positive cells within the NK cell pool. 
∞
The frequency of CD3
-
56
-
16
+
 
NK cells is presented as a percentage of CD3
-
56
-
 lymphocytes. All other data relates to the 
percentage of positive cells within the lymphocyte pool. Differences between groups were 
assessed by an unpaired student T test or Mann-Whitney U test. Significant differences are 
indicated in bold font.  
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Table 3.2. Effect of age on the absolute number (x10
6
/L) of circulating lymphocytes 
 Young 
(n = 11) 
Old 
(n = 15) 
p Value 
 
Lymphocytes 
 
CD3
+
56
-
 
 
2036±119.30 
 
1429±78.74 
 
1520±120.00 
 
1077±101.80 
 
0.004 
 
0.005 
CD3
-
56
+
 231±23.82 176±21.07 0.058 
CD56
DIM
 217±23.20 170±21.01 0.161 
CD56
BRIGHT
 14±2.10 6±0.65 0.0003 
CD3
-
16
+
56
DIM ¥
 206±22.68 165±20.83 0.206 
CD3
-
16
-
56
DIM ¥
 7±1.45 4±0.47 0.083 
CD3
-
16
+
56
BRIGHT ¥
 4±0.69 2±0.40 0.001 
CD3
-
16
-
56
BRIGHT ¥
 14±2.70 5±0.62 <0.0001 
    
 
Values are presented as mean ± SEM. 
¥
Data for CD16 expression relates to the number of 
antigen positive cells within the CD3
-
56
+ 
NK cell pool. Differences between groups were 
assessed by an unpaired student T test or Mann-Whitney U test. Significant differences are 
indicated in bold font. 
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with significantly lower numbers of total lymphocytes and CD3
+
56
-
 T cells, whilst a trend 
was observed for an age-related reduction in the circulating numbers of CD3
-
 56
+
 NK cells 
(Table 3.2). When NK cells were analysed by subset, no differences were found between 
young and old subjects in the absolute number of circulating CD56
DIM
, CD56
DIM 
16
+
 or 
CD56
DIM
 16
- 
subsets. In contrast, a marked age-related decline was observed in the total 
number of CD56
BRIGHT
 NK cells, which was attributable to a significant reduction in both the 
CD56
BRIGHT
 16
+
 and CD56
BRIGHT
 16
-
 subsets (Table 3.2). 
3.2.2. Effect of age on NKCC  
In line with the work of previous groups, who had reported a marked age-related decline in 
NKCC at the single cell level [42;365;371], preliminary studies revealed that at a range of 
effector:target (E:T) ratios, NK cells isolated from old donors exhibited reduced cytotoxicity 
towards the MHC class I deficient K562 cell line when compared to those obtained from 
younger controls (Figure 3.1). As maximal killing and the greatest age-related difference in 
lytic activity was observed at 10:1, additional killing assays were performed at this E:T ratio 
in a larger cohort. Confirming our preliminary data, the cytotoxicity of resting NK cells from 
old donors against K562 target cells was markedly lower than that of NK cells from their 
younger counterparts following a 4-hour co-culture (percentage target cell lysis,                           
Young = 41±3.1% Vs. Old = 21±2.4%, P = <0.0001; Figure 3.2 A-B), an impairment that 
was still observed when NK-K562 cell co-cultures were extended to 16 hours                                             
(Figure 3.3A-B). 
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(A) 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. NKCC at the single cell level is reduced with age across a range of 
effector:target cell ratios. Cytotoxicity of resting NK cells purified from 5 young and 5 old 
donors towards the MHC class I deficient K562 tumour cell line was measured at a range of 
effector:target (E:T) cell ratios by two-colour flow cytometry following a 4-hour co-culture. 
Data is expressed as mean ± SEM with differences between the two groups at each E:T ratio 
assessed by an unpaired student T test. ** indicates p ≤0.005, * indicates p ≤0.05. 
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(A)  
 
 
 
 
 
 
 
 
 
(B)          
                                                           
 
 
  
 
 
 
 
 
Figure 3.2. Age-related decline in NK cell lytic activity in short-term cytotoxicity assays. 
(A) Cytotoxicity of resting NK cells isolated from 12 young and 12 old donors against the 
MHC class I deficient K562 tumour cell line at an E:T of 10:1 was assessed by two-colour 
flow cytometry following a 4-hour co-culture. Data is expressed as mean ± SEM, with 
differences between the two groups assessed by an unpaired student T test.                                  
(B) Representative flow cytometry histograms for 2 young and 2 old donors highlighting the 
age-related decline in NKCC. Open histograms depict K562 cells cultured in the absence of 
NK cells, filled histograms represent SYTOX
®
 positive target cells. 
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(A)  
 
 
 
 
 
 
 
 
 
(B)  
 
 
 
 
 
 
 
 
 
Figure 3.3. Age-related decline in NK cell lytic activity in long-term cytotoxicity assays. 
(A) Cytotoxicity of resting NK cells towards the MHC class I deficient K562 cell line                
(E:T, 10:1) was measured after a 16-hour co-culture. Values represent mean ± SEM of 11 
young and 8 old donors with differences between the two groups assessed by an unpaired 
student T test. (B) Representative flow cytometry histograms for 2 young and 2 old donors 
demonstrating the age-associated reduction in NKCC. Open histograms depict K562 cells 
cultured in the absence of NK cells, filled histograms represent SYTOX
®
 positive target cells. 
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To aid in our understanding of the mechanism(s) underlying this age-related impairment in 
NKCC, it was important to determine which of the two contact-dependent pathways utilised 
by NK cells to eliminate their targets (granule exocytosis or death receptor ligation) was 
responsible for inducing K562 cell lysis. Treating NK cells with concanamycin A (CMA), a 
potent inhibitor of perforin activity [495], significantly reduced K562 cell lysis (Figure 3.4). 
In contrast, no target cell lysis was observed when K562 cells were treated with soluble 
ligands for the death receptors Fas (Figure 3.5A), TRAIL (Figure 3.5B) or TNF                         
(Figure 3.5C).  
Together, these data demonstrate that NK cell-mediated lysis of K562 cells is dependent upon 
granule exocytosis, and that a defect in this pathway is responsible for the age-related 
impairment in NKCC.  
3.2.3. Effect of age on the formation of NK-K562 cell conjugates 
To study NKCC, a previously described flow cytometric protocol that involved labelling NK 
cells post K562 co-culture with a PE-conjugated antibody specific for CD56 was used [493]. 
In addition to providing information on NK cell lytic activity, this approach enabled 
assessment of the formation of NK-K562 cell conjugates, which were classified as K562 
target cells exhibiting positive red fluorescence (Figure 3.6A).  
It was found that whilst NKCC exhibited a marked age-related decline, NK cells from old 
donors were as efficient in binding their target cells as those isolated from young adult 
controls (Figure 3.6B), suggesting the impairment in NKCC that accompanies human ageing 
is the result of a post-binding defect.   
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Figure 3.4. NK cells induce lysis of K562 target cells through the granule exocytosis 
pathway. Resting NK cells isolated from 3 young donors were treated for 2 hours with                    
10-500 nM concanamycin A (CMA), a potent inhibitor of perforin based cytotoxicity, after 
which their lytic activity towards K562 target cells was assessed in 4-hour cytotoxicity 
assays. Data are presented as mean ± SEM, with differences between the conditions analysed 
by a one-way ANOVA with Dunnett’s post hoc test versus untreated (UNT) group. 
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(A) 
 
 
 
 
 
 
(B) 
 
 
 
 
 
 
 
(C) 
 
 
 
 
 
Figure 3.5. Death receptor ligation does not induce lysis of K562 tumour cells. K562 
cells (2x10
5
) were treated for 4 hours with increasing concentrations of sFasL (A), sTRAIL 
(B) or TNF-α (C), after which, the percentage of cells with perturbed membranes was 
examined by flow cytometry. Data are presented as the mean ± SEM of three separate 
experiments performed in triplicate. Differences between the groups were assessed by a 
Kruskal-Wallis test with Dunn’s multiple comparison post hoc test. 
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(A) 
 
 
 
 
 
                                         
 
(B)  
 
 
 
 
 
 
 
 
Figure 3.6. No age-associated impairment in the formation of NK-K562 cell conjugates. 
(A)  Flow cytometry dot plot of an NK-K562 cell co-culture. By labelling NK cells with a 
CD56-PE antibody, NK-K562 conjugates were defined as K562 cells exhibiting positive red 
fluorescence (region R9). Free K562 cells are shown in region R5. (B) Percentage of K562 
cells bound to NK cells isolated from young (n = 12) and old (n = 12) donors following              
4-hour co-culture. Data is expressed as mean ± SEM, with differences between the groups 
assessed by an unpaired student T test. 
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3.2.4. Effect of age and CMV serostatus on NK cell receptor expression and activation 
NK cell activity is regulated by signals transmitted through a multitude of germline-encoded 
activatory and inhibitory receptors [306]. When activatory signals dominate NKCC is 
induced. Thus, the possibility that an age-related reduction in activatory receptor expression 
was responsible for the decline observed in NKCC was considered. In particular the impact 
of age on the expression levels of the C-type lectin family member NKG2D and the NCR 
NKp30, whose ligands MICA/B and B7-H6 respectively are expressed on the K562 tumour 
cell line was investigated [260;501].  
Both the percentage of cytotoxic CD56
DIM
 NK cells expressing NKG2D and its staining 
intensity was comparable between young and old subjects (Table 3.3 and Figure 3.7). 
Similarly, no age-related changes were found in the percentage of NKp30
+
 NK cells. 
However, a small but significant difference was noted in the surface intensity of NKp30, with 
NK cells from old individuals presenting with lower levels of this receptor (Table 3.3 and 
Figure 3.7). Other surface receptors examined included the NCR NKp46, where an age-
associated reduction in the percentage of NK cells expressing this receptor was noted, and the 
Fc receptor CD16, whose expression when measured as either the percentage of positive cells 
or staining intensity did not change with age (Table 3.3 and Figure 3.7).    
In addition to activatory receptors, expression of CD57, a marker of NK cell maturity and 
CD94, a molecule required for the surface expression of the C-type lectin family members 
NKG2A/B/C/E/H [502] was measured. The percentage of CD57
+
 NK cells and CD57 surface 
density was shown to be greater in elderly subjects (Table 3.3, Figure 3.7), whilst both the 
frequency of CD94
+
 NK cells and its staining intensity was markedly reduced with age 
(Table 3.3 and Figure 3.7).   
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Table 3.3. Age-related changes in NK cell receptor expression. 
 
 
 
 
 
 
 
 
 
 
 
 
Expression of NKG2D, NKp46, CD16, CD94 and CD57 was studied on the surface of 5000 CD56
DIM
 NK cells isolated from 21 young and 21 
old donors. Expression of NKp30 was examined on 15,000 CD3
-
 CD56
+
 NK cells obtained from 18 young and 18 old subjects. Data are 
presented as the percentage of antigen positive cells and median fluorescent intensity (MedFI) and expressed as mean ± SEM. Differences 
between groups were assessed by an unpaired student T test or Mann-Whitney U test with significant differences indicated in bold font. 
 
 
 
 
 
 
NKG2D 
 
 
NKp30 
 
 
NKp46 
 
 
CD16 
 
 
CD94 
 
 
CD57 
 
 
 Percentage positive  
 
Staining Intensity (MedFI) 
 
 
Young 
 
Old 
 
P 
 
Young 
 
Old 
 
P 
 
92.10±1.50 
 
 
85.17±2.63 
 
 
81.95±1.90 
 
 
96.71±0.44 
 
 
62.29±3.82 
 
 
61.52±2.25 
 
91.71±1.14 
 
 
81.61±3.62 
 
 
67.05±4.60 
 
 
96.76±0.63 
 
 
43.52±2.91 
 
 
70.05±1.92 
 
0.512 
 
 
0.601 
 
 
0.005 
 
 
0.496 
 
 
0.0003 
 
 
0.006 
 
42.86±2.70 
 
 
16.22±1.22 
 
 
10.57±0.73 
 
 
146.30±9.3 
 
 
30.05±5.10 
 
 
137.9±43.74 
 
39.62±2.80 
 
 
12.89±0.96 
 
 
8.52±1.18 
 
 
120.2±11.06 
 
 
14.19±2.39 
 
 
214.0±35.62 
 
0.406 
 
 
0.040 
 
 
0.148 
 
 
0.080 
 
 
0.006 
 
 
0.014 
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Figure 3.7. Age-related changes in NK cell receptor expression. Representative histograms showing the expression levels of NKG2D, 
NKp30, NKp46, CD94, CD16 and CD57 on the surface of resting NK cells isolated from healthy young (blue lines) and old (red lines) subjects. 
Black lines depict isotype controls. 
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Infection with the β-herpes virus CMV is known to influence NK cell receptor expression 
[363;364]. With this in mind, the CMV status of a subset of individuals from the above 
cohort was determined and its effect alongside age on the surface phenotype of circulating 
NK cells examined.  
In this smaller group of subjects, age was associated with a significant reduction in both the 
percentage of CD94
+
 NK cells and the surface density of NKG2D, whilst a trend for an age-
related decline in NKp46
+
 NK cells was also observed (Table 3.4 and Table 3.5). With 
regards to CMV, it was found that infection with this virus had no significant effect upon the 
proportions of circulating NKG2D
+
, CD94
+
, NKp46
+
 or NKp30
+ 
NK cells (Table 3.4), or the 
surface density of these receptors (Table 3.5), with the exception of NKp30, where NK cells 
isolated from young CMV
+ 
donors exhibited significantly lower MedFI readings for this 
activatory receptor when compared to those from CMV
-
 individuals (Table 3.5). For no 
receptor was a significant interaction between CMV and age found.  
In addition to surface receptors, the effects of age and CMV on the expression of CD57 were 
also studied. Whilst a trend for an age-associated increase in the circulating frequency of 
CD56
DIM
 CD57
+
 NK cells was observed (Young, 65.71±2.49 Vs. Old, 73.17±2.74, p = 0.06), 
a significant effect was found for CMV (F (1, 17) = 7.96, p = 0.012, η2 = 0.319), with CMV+ 
individuals possessing a significantly higher proportion of this NK subset in their peripheral 
pool (Figure 3.8A). Post-hoc analysis revealed this effect was confined to our elderly 
population (Figure 3.8B). As well as influencing the frequency of CD57
+
 NK cells, CMV 
elicited a strong effect upon the surface density of CD57 (F (1, 17) = 25.19,                             
p = <0.0001, η2 = 0.597; Figure 3.9A). It was found that NK cells isolated from both young 
and old seropositive donors exhibited increased surface density of CD57 when compared to 
their seronegative counterparts (Figure 3.9B). Interestingly, whilst aged CMV
+
 individuals 
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presented with significantly higher MedFI readings for CD57 when compared to young 
CMV
+
 subjects, no difference was found in CD57 surface density between young and old 
CMV negative donors (Figure 3.10). 
The differences observed in NK cell receptor expression with age (Table 3.3 and Figure 3.7) 
offered no insight into whether NK cells from old donors exhibited impaired activation 
following target cell contact. Thus, to address this issue, the surface expression of CD69, a 
marker of early NK cell activation was measured both at baseline and following a 4-hour co-
culture with K562 tumour cells. CD69 expression on resting NK cells was comparable 
between young and old subjects in terms of both the percentage of positive cells                     
(Figure 3.11A) and surface density (Figure 3.11B), and as expected, target cell recognition 
led to a marked increase in both the proportions of CD69
+
 NK cells (Young,                                   
Pre = 15.00±2.01 Vs. Post = 45.38±3.33, P = <0.0001; Old, Pre = 17.04±1.89 Vs.                           
Post = 50.92±3.02, P = <0.0001) and its staining intensity (Young, Pre = 5.00±0.83 Vs.                 
Post = 10.29±1.57, P = <0.01; Old, Pre = 4.92±0.81 Vs. Post = 9.77±1.13, P = <0.01). 
However, when the up-regulation of CD69 induced by K562 cells was compared between the 
two groups, no statistically significant differences were found (Figure 3.12A and 3.12B). 
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Table 3.4. Effect of age and CMV status on the frequency of receptor positive NK cells 
 
 
 
 
 
 
 
 
 
 
 
Data are expressed as mean ± SEM. Significant differences are indicated in bold font. 
 
 
 
 
 
 
Young 
 
 
Old 
 
Age 
 
CMV 
 
CMV 
negative 
 
CMV  
positive 
 
CMV 
negative 
 
CMV 
positive  
 
F 
 
P 
 
F 
 
P 
 
NKG2D 
(n = 21) 
 
CD94 
(n = 18) 
 
NKp30 
(n = 21) 
 
NKp46 
(n = 22) 
 
 
94.6±1.80 
 
 
65.0±4.10 
 
 
84.7±3.55 
 
 
82.2±2.82 
 
89.8±3.11 
 
 
56.3±3.40 
 
 
77.3±2.94 
 
 
80.3±3.10 
 
89.2±2.02 
 
 
43.4±3.88 
 
 
89.0±3.22 
 
 
61.4±4.72 
 
93.3±2.52 
 
 
38.7±4.74 
 
 
74.3±4.38 
 
 
68.8±5.35 
 
0.132 
 
 
6.122 
 
 
0.014 
 
 
3.628 
 
0.721 
 
 
0.027 
 
 
0.907 
 
 
0.073 
 
0.019 
 
 
0.737 
 
 
3.938 
 
 
0.104 
 
0.893 
 
 
0.405 
 
 
0.060 
 
 
0.751 
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Table 3.5. Effect of age and CMV status on the surface density of NK cell receptors 
 
 
 
 
 
 
 
 
 
 
 
Data are expressed as mean ± SEM and represents MedFI values. Significant differences are indicated in bold font. *Bonferroni post 
hoc analysis revealed the significant effect for CMV resided in the young cohort.   
 
 
 
 
 
 
Young 
 
 
Old 
 
Age 
 
CMV 
 
CMV 
negative 
 
CMV  
positive 
 
CMV 
Negative 
 
CMV 
positive  
 
F 
 
P 
 
F 
 
P 
 
NKG2D 
(n = 21) 
 
CD94 
(n = 18) 
 
NKp30 
(n = 21) 
 
NKp46 
(n = 22) 
 
 
48.3±3.62 
 
 
32.5±4.58 
 
 
17.6±2.25 
 
 
10.5±1.50 
 
40.0±3.56 
 
 
22.0±3.65 
 
 
11.5±1.92 
 
 
10.8±1.82 
 
33.2±2.33 
 
 
12.8±3.18 
 
 
14.6±1.99 
 
 
7.9±2.64 
 
32.7±2.79 
 
 
19.0±4.84 
 
 
11.6±2.10 
 
 
8.8±2.22 
 
5.004 
 
 
1.783 
 
 
0.655 
 
 
1.031 
 
0.039 
 
 
0.703 
 
 
0.427 
 
 
0.323 
 
0.762 
 
 
0.064 
 
 
6.596 
 
 
0.061 
 
0.395 
 
 
0.804 
 
 
0.018* 
 
 
0.808 
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Figure 3.8. Effect of CMV status on the frequency of circulating CD57
+
 NK cells. 
Percentage of CD56
DIM
57
+
 NK cells within the circulating NK cell pool of CMV
+
 (n = 7) 
and CMV
- 
(n = 14) subjects. (A) Effect of CMV status alone on the percentage of 
CD56
DIM
57
+
 NK cells. (B) Effect of CMV status on the percentage of CD56
DIM
57
+
 NK cells 
in young (n = 11, CMV
+
 = 4, CMV
- 
= 7) and old (n = 10, CMV
+
 = 3, CMV
- 
= 7) donors. 
Data are summarised as mean ± SEM and was analysed by a two-way ANOVA with 
Bonferroni post hoc test. 
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(A) 
 
 
 
 
 
 
(B) 
 
 
 
 
 
 
Figure 3.9. Effect of CMV status on the surface expression of CD57 on circulating NK 
cells. CD57 staining intensity on the surface of CD56
DIM
57
+
 NK cells in the circulating NK 
cell pool of CMV
+
 (n = 7) and CMV
- 
(n = 14) subjects. (A) Effect of CMV status alone on 
CD57 staining intensity. (B) Effect of CMV status on CD57 staining intensity in young          
(n = 11, CMV
+
 = 4, CMV
- 
= 7) and old (n = 10, CMV
+
 = 3, CMV
- 
= 7) donors. Data are 
summarised as mean ± SEM and was analysed by a two-way ANOVA with Bonferroni post 
hoc test. 
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Figure 3.10. Exposure to CMV and not age drives the increase in CD57 surface density. 
CD57 staining intensity on the surface of CD56
DIM
57
+
 NK cells in the circulating lymphocyte 
pool of CMV
+
 (young, n = 4, old, n = 3) and CMV
- 
(young, n = 7, old, n = 7) subjects. Data 
are presented as mean ± SEM and was analysed by a two-way ANOVA with Bonferroni post 
hoc test. 
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(A) 
 
 
 
 
 
 
 
 
 
(B) 
 
 
 
 
 
 
 
Figure 3.11. Activation status of resting NK cells. Expression of the early activation 
marker CD69 was examined on the surface of freshly isolated CD56
+
 NK cells from young     
(n = 14) and old (n = 13) donors. The percentage of CD69
+
 NK cells (A) and mean 
fluorescent intensity values (MFI) (B) are shown. Differences between groups were assessed 
by an unpaired student T test or Mann-Whitney U test.  
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(A) 
 
 
 
 
 
 
 
(B) 
 
 
 
 
 
 
 
 
Figure 3.12. Activation status of K562 cell stimulated NK cells. Surface expression of the 
early activation marker CD69 was examined on isolated CD3
-
 CD56
+
 NK cells obtained from 
young (n = 14) and old (n = 13) subjects following a 4-hour co-culture with K562 cells at an 
E:T of 10:1. (A) Fold increase above baseline in the percentage of CD69
+
 NK cells. (B) 
CD69 staining intensity (MFI). Data is presented after subtracting baseline CD69 expression 
values. Differences between groups were assessed by an unpaired student T test or Mann-
Whitney U test. 
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3.2.5. Effect of age on cytotoxic effector expression and secretory lysosome fusion  
In figure 3.4, it was shown that NK cells induce K562 cell lysis via the granule exocytosis 
pathway. Two important effector molecules of this pathway are perforin and granzyme B 
[206]. Thus, the possibility that the age-related decline in NKCC was borne from reduced 
expression of either of these two proteins was investigated. 
No age-associated difference either in the percentage of NK cells positive for perforin or 
granzyme B (Figure 3.13A and Figure 3.13B), or in the staining intensity of these proteins 
(Figure 3.13C and Figure 3.13D) was found, suggesting NK cells from older subjects are 
armed to a similar degree with the key cytotoxic molecules needed to induce target cell lysis. 
Interestingly, when the absolute number of circulating perforin positive NK cells was 
calculated, a significant age-related decline was seen (Young (n = 10) 214.4±21.98 x10
6
/L 
Vs. Old (n = 11) = 147.8±13.85 x10
6
/L, P = 0.02). However, driving this reduction was a 
decreased number of absolute NK cells (Young = 243.9±22.33 x10
6
/L Vs. Old = 166.3±13.84 
x10
6
/L, P = 0.007) rather than a change in perforin expression (% perforin positive NK cells, 
Young = 86.8±2.09 Vs. Old = 88.64±1.91, P = 0.523).  
Since perforin and granzyme B expression was comparable between young and old NK cells, 
it was next investigated whether the reduction in NK cell lytic activity observed with age was 
the result of impaired fusion of perforin and granzyme containing secretory lysosomes with 
the NK cell plasma membrane. To do this, surface CD107a expression was assessed.  
CD107a is a glycosylated protein located on the inner membrane of lytic granules [503]. 
During the process of granule exocytosis, the fusion of lytic granules with the NK membrane 
results in expression of CD107a on the NK cell surface, where it can be detected through the 
use of monoclonal antibodies and its expression measured by flow cytometry [504]. 
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(A)                 (B) 
 
 
 
 
 
 
 
 
(C)          (D) 
 
 
 
 
 
 
 
 
Figure 3.13. No age-related difference in perforin or granzyme B expression in resting 
NK cells. CD3
-
 56
+
 NK cells were obtained from 10 young and 10 old individuals and their 
expression of the cytotoxic effector molecules perforin and granzyme B measured by flow 
cytometry. (A-B) Percentage of NK cells positive for perforin (A) and granzyme B (B) 
staining. (C-D) MFI values for perforin (C) and granzyme B (D). Differences between the 
groups were analysed by an unpaired student T test.  
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As a sensitive marker of secretory lysosome fusion, the CD107a assay has become a popular 
approach for groups interested in studying granule exocytosis. Inevitably therefore,                  
inter-study variation exists in how the assay is performed. For example, whilst some groups 
have measured CD107a expression on NK cells following a 6-hour co-culture of PBMCs and 
K562 target cells at an E:T ratio of 10:1[504], others have studied its expression after a                 
3-hour incubation at an E:T ratio of 1:1 [505]. Therefore, prior to examining the effect of age 
on lytic granule fusion, experiments were performed to determine which of the above 
conditions induced maximal CD107a expression. At both 3 (Figure 3.14A) and                                  
6 (Figure 3.14B) hour time points, surface levels of CD107a were significantly higher on NK 
cells treated with K562 cells at an E:T ratio of 1:1 compared to those treated at a 10:1 ratio. 
In terms of incubation time, CD107a expression was greatest following a 6-hour incubation 
(Figure 3.14C). Thus, CD107a expression on NK cells was measured following a 6-hour 
PBMC-K562 co-culture at an E:T ratio of 1:1. As well as recording the percentage of 
CD107a
+
 NK cells, the MFI of CD107a on the NK surface was determined as it has been 
proposed to provide information on the number of lytic granules that have fused with the NK 
cell membrane during the period of co-culture [506]. 
The results showed both the percentage of CD107a
+
 NK cells (Figure 3.15A) and the 
accompanying MFI values (Figure 3.15B) to be comparable between young and old subjects, 
suggesting no age-associated impairment in secretory lysosome fusion. To rule out the 
possibility that the actions of bystander cells within the PBMC pool were masking an age-
related defect in granule fusion, CD107a expression on the surface of purified NK cell 
populations was measured following a 4-hour co-culture with K562 target cells. These 
experimental conditions mirrored the NKCC assays in which an age-related decline in NK 
lytic activity was seen. Supporting the data obtained with PBMCs, no difference in CD107a  
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expression between young and old donors was found (Figure 3.16A-B). 
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(A)                   (B)  
 
 
 
 
 
 
 
 
(C)  
 
 
 
 
 
 
 
Figure 3.14. Effect of culture time and E:T cell ratio on the surface expression of 
CD107a. To determine optimal conditions for inducing CD107a expression on NK cells, 
PBMCs isolated from 16 young volunteers were incubated for 3 (A) or 6 (B) hours with 
K562 cells at an E:T ratio of 10:1 or 1:1, after which surface CD107a expression was 
measured on CD3
-
 CD56
+
 cells by flow cytometry. (C) CD107a expression on NK cells 
following a 3 and 6-hour co-incubation of PBMCs with K562 target cells at an E:T ratio of 
1:1. Data are presented as mean ± SEM, with statistical significance determined by a paired 
student T test or Wilcoxon matched-pairs signed rank test. 
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Figure 3.15. Effect of age on secretory lysosome fusion. Expression of CD107a on the 
surface of CD3
-
 CD56
+
 NK cells was assessed after a 6-hour co-culture of PBMC’s and K562 
target cells at an E:T ratio of 1:1 (young, n = 16; old, n = 12). Data are presented as the 
percentage of CD107a
+
 NK cells (A) and the MFI of externalised CD107a (B). Differences 
between the two groups were assessed by an unpaired student T test.  
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Figure 3.16. No age-associated difference in CD107a expression on the surface of K562-
stimulated NK cells.  NK cells isolated from young and old donors were cultured for                   
4-hours with K562 tumour cells at an E:T ratio of 10:1 (n = 12 young and 12 old) and 1:1                       
(n = 11 young and 11 old), after which secretory lysosome fusion was assessed by measuring 
surface CD107a expression by flow cytometry. Data are presented as the mean ± SEM of the 
percentage of CD107a
+
 NK cells (A) and the MFI of externalised CD107a (B). Differences 
between the two groups were assessed by an unpaired student T test or Mann-Whitney U test. 
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3.2.6. Effect of age on perforin binding to the target cell surface 
Binding of perforin to the target cell surface is a crucial prerequisite for the induction of 
target cell death mediated by the granule exocytosis pathway [496]. Given the fact that no 
difference was seen in either perforin expression or secretory lysosome fusion with age, it 
was hypothesised that impaired perforin binding to the surface of K562 tumour cells could be 
responsible for the age-associated reduction in NKCC. 
Using a FITC-conjugated anti-perforin antibody, K562 tumour cells were stained after a        
4-hour culture with NK cells at an E:T ratio of 10-1. The results showed both the percentage 
of K562 cells exhibiting positive FITC fluorescence, and the number of perforin molecules 
bound to the K562 cell surface was significantly lower when these cells had been cultured 
with NK cells from older adults (Figure 3.17A-C). Importantly, when perforin binding and 
NKCC assays were performed together, a highly significant positive association between 
perforin binding and target cell lysis was observed (Figure 3.18), suggesting the age-
associated reduction in perforin binding was related to the impairment in NKCC with age. 
3.2.7. Effect of age on perforin secretion in to the immunological synapse (IS) 
Two hypotheses could explain the age-associated decrease in perforin binding to the surface 
of K562 cells. The reduction in binding could be the result of either an age-related alteration 
in the structure and/or binding activity of perforin, or could be due to less perforin being 
released into the IS formed between an aged NK cell and its target. With the former option 
unlikely, the second proposal was tested by collecting supernatants from 4-hour NK-K562 
cell co-cultures and measuring the concentration of perforin using an enzyme linked-
immuno-sorbent assay (ELISA). It was found that the levels of perforin were significantly 
lower in supernatants collected from those co-cultures that had contained NK cells isolated 
from older adults (Figure 3.19).  
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Figure 3.17. Age-associated reduction in perforin binding to the target cell surface. NK 
cells isolated from young (n = 16) and old (n = 16) subjects were co-cultured for 4 hours 
(E:T, 10:1) with K562 cells, after which perforin binding to the target cell surface was 
analysed by flow cytometry. Data are presented as the percentage of perforin positive K562 
cells (A) and perforin staining intensity on the target cell surface (B). Differences between 
the groups were assessed by an unpaired student T test. (C) Representative flow cytometry 
histograms showing the percentage of K562 target cells to which perforin had bound. Empty 
and filled histograms depict isotype and test antibody staining respectively.   
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Figure 3.18. Positive association between perforin binding and NK cell cytotoxicity.               
NK cells isolated from 12 young subjects were co-cultured for 4 hours (E:T, 10:1) with K562 
cells, after which perforin binding to the target cell surface and NKCC were assessed 
simultaneously by flow cytometry.   
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Figure 3.19. Impaired secretion of perforin into the immunological synapse by NK cells 
from old individuals. NK cells obtained from young (n = 13) and old (n = 15) subjects were 
co-cultured with K562 tumour cells for 4 hours at an E:T ratio of 10:1, after which cell-free 
supernatants were harvested and perforin concentration determined by ELISA. Data are 
presented as mean ± SEM, with differences between the two groups assessed by a Mann-
Whitney U test. 
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To confirm the ELISA results, perforin secretion in response to K562 cell stimulation was 
studied in a separate cohort of individuals using a recently described flow cytometric protocol 
[507]. As expected, co-culture with K562 target cells led to a significant decrease in perforin 
staining intensity in NK cells from both young and old donors (Figure 3.20A). However, 
relative to baseline expression, the reduction in staining intensity was significantly lower for 
NK cells obtained from aged donors (Figure 3.20B). In contrast, no age-associated 
impairment in perforin secretion was seen when NK cells were treated with the phorbol ester 
PMA and the calcium mobilising agent ionomycin (Figure 3.20B).    
Taken together, these data suggest that the reduction observed in perforin binding to the 
target cell surface with age was secondary to an age-related impairment in perforin secretion. 
3.2.8 Effect of age on NK cell apoptosis induced by K562 target cell contact 
After delivering a lethal hit, NK cells have been shown to either: (i) detach from their target 
and eliminate additional transformed cells, a phenomenon referred to as NK cell recycling 
[507], (ii) become functionally anergic [508] or (iii) undergo target-cell induced apoptosis 
[509]. Interestingly, in a study examining the effect of age on LAK cell activity, Plett and 
colleagues noted that when compared to those isolated from young controls, NK cells from 
aged mice were more susceptible to target cell-induced apoptosis [510]. By undergoing cell 
death, NK cells would be unable to recycle and induce lysis of other target cells. Thus, the 
possibility that an age-related increase in target cell-induced apoptosis was also true for 
human NK cells was considered with the thinking being that the decline in perforin 
concentrations observed in NK-K562 co-cultures with age could have resulted from a 
reduced ability of NK cells from older adults to kill multiple targets.  
To test this theory, NK cells from young and old donors were cultured with K562 target cells 
for 4 hours, after which NK cell death was studied by staining samples with Annexin V. 
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Figure 3.20. Age-related reduction in perforin secretion by K562-stimulated NK cells. 
(A) A 4-hour culture with K562 target cells resulted in a significant reduction in perforin 
staining intensity in NK cells from young (n = 11) and old (n = 10) subjects. (B) Reduction in 
perforin staining intensity in NK cells following a 4-hour treatment with K562 target cells or 
PMA (2.5 µg/ml) and ionomycin (0.5 µg/ml). For K562 treatment, data relates to the            
mean ± SEM for 11 young and 10 old donors. For PMA and ionomycin, data is mean ± SEM 
collected from 10 young and 10 old subjects. 
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As a protein that exhibits high affinity for phosphatidylserine, a phospholipid expressed on 
the outer membrane of cells undergoing apoptosis, positive Annexin V staining is considered 
a sensitive marker of early cell death [511]. In contrast to the findings of Plett et al [510], no 
age-associated difference in the percentage of annexin V positive NK cells was seen 
following K562 cell co-culture (Figure 3.21). 
3.2.9. Effect of age on polarisation of perforin to the NK cell immunological synapse  
NKCC mediated by the granule exocytosis pathway relies upon the mobilisation and delivery 
of lytic granules to the NK-target cell interface [206]. Having observed an age-related 
reduction in perforin release following target cell contact (Figure 3.19 and Figure 3.20), it 
was hypothesised that the movement of lytic granules to the NKIS was impaired with age. To 
test this idea, NK cells from young and old subjects were cultured either alone or with K562 
tumour cells for 30 minutes, after which cells were fixed, permeabilised and stained with a 
FITC-conjugated monoclonal antibody specific for human perforin. The location of this pore-
forming protein within NK cells was then studied by immunofluorescence microscopy.  
In accordance with previous observations [263], perforin was dispersed throughout the 
cytoplasm of resting NK cells (Figure 3.22A), and as expected, target cell contact prompted 
NK cells from both young and old subjects to deliver perforin to the IS (Figure 3.22B). 
However, the percentage of NK cells from older adults that had polarised perforin to the NK-
target cell interface was markedly lower when compared to NK cells from younger controls 
(Figure 3.23A-B). Whilst target cell binding triggered 63% of NK cells from young donors to 
deliver perforin to the NK-target cell interface, a frequency that is in line with other studies 
that have measured perforin polarisation in healthy young adults [512], only in 35% of NK 
cells from older subjects that had bound to K562 target cells was there evidence of lytic 
granule polarisation (Figure 3.23B). 
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Figure 3.21. Effect of age on NK cell apoptosis induced by target cell contact. NK cells 
were co-cultured with K562 target cells at an E:T ratio of 10-1 for 4 hours, after which the 
percentage of NK cells staining positive for Annexin V was examined by flow cytometry. 
Data was collected from 12 young and 12 old donors, with differences between the groups 
assessed by an unpaired student T test. 
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Figure 3.22. Perforin expression in resting and K562 cell-stimulated NK cells.   
Following a 30-minute culture either alone (A) or in the presence of K562 target cells (B), 
NK cells were stained with a FITC-conjugated antibody against human perforin to examine 
the location of this pore-forming protein. Nuclei were counterstained with DAPI. Images 
were taken at X40 or X63 objective and are representative of experiments performed on                     
3 young and 3 old subjects. Blue arrows point to regions of perforin polarisation to the IS.            
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Figure 3.23. Age-related impairment in perforin polarisation to the NKIS. (A) NK:K562 
cell conjugates prepared from young and old donors were immunostained after a 30-minute 
co-culture to examine perforin localisation (FITC-conjugated antibody). Nuclei were 
counterstained with DAPI. Images were taken at X40 or X63 objective and are representative 
of experiments performed on 3 young and 3 old subjects. Blue arrows point to regions of 
perforin polarisation to the IS, whilst yellow arrows highlight NK cells that have not 
delivered perforin to the NK-target cell interface. (B) Percentage of NK cells bound to K562 
tumour cells that had polarised perforin to the NKIS. Data are presented as mean ± SEM of 
values provided by three individuals, who blinded to donor age, counted 50 NK-K562 cell 
conjugates on slides prepared from 3 young and 3 old donors.   
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3.2.10. Effect of age on F-actin polymerisation and MAPK activation 
So far, the data presented above had revealed a previously unrecognised impairment in the 
function of NK cells from older adults: reduced release of perforin into the IS. Having 
identified defective mobilisation of lytic granules to the NK-target cell interface as a possible 
cause, the next series of experiments set out to determine the mechanism(s) behind the                
age-related impairment in perforin polarisation.  
An early event in the formation of an activating IS is the polymerisation and accumulation of 
F-actin at the NK-target cell interface [513]. When this step is impaired, lytic granules fail to 
polarise efficiently to the NKIS and NKCC is markedly reduced [251;513]. Given that these 
features mirrored the behaviour of NK cells isolated from older adults, it was investigated 
whether this aspect of IS formation was altered with age. To do this, NK cells from young 
and old donors were cultured with K562 cells, and after 30 minutes, samples were stained 
with FITC-conjugated phalloidin. By binding to F-actin with high selectively, phalloidin is a 
tool often used to study the distribution and formation of F-actin networks. In conjugates 
formed between K562 cells and NK cells from both young and old donors, F-actin 
accumulated at the NK-target cell contact point (Figure 3.24), suggesting the process of actin 
polymerisation was not altered with age.  
Actin polymerisation triggers the polarisation of perforin containing secretory lysosomes to 
the NK-target cell interface [514]. Important for this phase of IS formation is the activation of 
the MAPK family. To date, the MAPKs: ERK1/2, JNK and P38 have been proposed to be 
involved in delivering lytic granules to the NK-target cell interface [260;261;263;338]. Thus, 
it was possible that an age-related delay in the activation kinetics of these serine/threonine 
protein kinases was responsible for the impaired polarisation of perforin to the IS. Activation 
of MAPKs occurs via dual phosphorylation of threonine and tyrosine residues present within  
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Figure 3.24. Cellular localisation of F-actin in K562-stimulated NK cells. NK:K562 cell 
conjugates prepared from young and old donors were immunostained after a 30-minute                
co-culture with FITC-conjugated phalloidin to study F-actin distribution. Nuclei were 
counterstained with DAPI. Images were taken at X40 or X63 objective and are representative 
of experiments performed on 3 young and 3 old subjects. Arrows point to regions of F-actin 
accumulation. 
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the activation loop of these kinases [515]. Therefore, using phospho-specific antibodies, 
Western blotting was used to assess the activation status of MAPKs in stimulated NK cells 
from young and old subjects. Due to technical difficulties with antibodies targeted against 
JNK, only the kinetics of ERK1/2 and P38 activation were studied.  
Initial experiments revealed the presence of phosphorylated ERK1/2 and P38 in K562 cells 
(Figure 3.25). Given that Western blotting measures protein expression in cell lysates, this 
finding meant an alternative approach was required to activate NK cells since it would not 
have been possible for us to discriminate between NK and K562 cell-derived phosphorylated 
MAPKs in lysates prepared from E:T cell co-cultures. Thus, MAPK activation kinetics were 
studied in NK cells that had been stimulated for 0, 2, 5, 10, 30, 60 and 90 minutes with 
antibodies against the activatory receptors NKG2D and NKp30. These receptors were 
selected as their ligands have been shown to be present on the surface of K562 cells 
[260;501]. 
Figures 3.26A and 3.27A show the ERK1/2 activation kinetics in antibody stimulated NK 
cells from a young and old donor respectively. To quantify the up-regulation in ERK1/2 
phosphorylation that occurred upon antibody stimulation, densitometry analysis was 
performed on Western blots from 5 young (Figure 3.26B) and 4 old (Figure 3.27B) subjects, 
measuring activation as a ratio of phosphorylated-ERK1/2 to total ERK1/2. For young 
donors, within 10 minutes of stimulation a significant increase in ERK1/2 activation was seen 
when compared to untreated controls (Figure 3.26B).  Activation peaked at 30 minutes, but 
was still significantly higher than unstimulated controls at both 60 and 90 minutes                     
(Figure 3.26B). In contrast, NK cells from older adults required 30 minutes of antibody 
stimulation before ERK1/2 activity was significantly greater than that observed in resting 
cells (Figure 3.27B). This significant increase in activation was also observed at 60 minutes 
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post stimulation but was no longer evident at 90 minutes, where the level of ERK1/2 activity 
was not significantly different from that present in control samples (Figure 3.27B). 
Interestingly, when stimulated with the phorbol ester PMA and the calcium ionophore 
ionomycin, NK cells from young and old donors showed comparable ERK1/2 activation 
kinetics (Figure 3.28 A-B, Figure 3.29 A-B).  
In contrast to ERK1/2, there was no evidence for P38 phosphorylation upon antibody 
stimulation of NK cells from young subjects (Figure 3.30). For this reason, the effect of age 
on the activation kinetics of this MAPK was not studied further. 
Taken together, these data have demonstrated an age-related delay in the activation kinetics 
of ERK1/2 following ligation of activatory receptors. Given the important role of this MAPK 
in lytic granule mobilisation and polarisation [263], this would suggest this impairment may 
underlie the aberrant delivery of perforin to the IS observed with age, which in turn may be 
responsible for the age-related reduction in perforin release.  
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Figure 3.25. Expression of phosphorylated MAPKs in K562 tumour cells. Western 
blotting was performed on cell lysates prepared from 100,000 K562 cells to measure the 
expression of phosphorylated ERK1/2 (p-ERK1/2) and phosphorylated P38 (p-P38), with 
total ERK1/2 and total P38 serving as loading controls respectively. The results displayed are 
representative of four independent experiments performed on two separate K562 cell 
cultures. 
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Figure 3.26. ERK 1/2 activation kinetics in NK cells obtained from young donors 
following NKG2D and NKp30 receptor ligation. Resting NK cells isolated from young 
subjects were stimulated over a 90-minute period with antibodies targeted against the 
activatory receptors NKG2D and NKp30. At the time points indicated, cell lysates were 
prepared and ERK1/2 activation measured by Western blotting using a phospho-specific anti-
ERK1/2 antibody. Total ERK1/2 expression served as a loading control. (A) An example of 
ERK 1/2 phosphorylation kinetics in stimulated NK cells from a young donor.                      
(B) Densitometry analysis of ERK1/2 activation. Data are presented as mean ± SEM of                            
5 independent experiments. For statistical analysis, a repeated measures ANOVA was 
performed with Dunnett’s post hoc test. Time 0 was considered the control value to which all 
other time points were compared. *** indicates p ≤0.0001, * indicates p ≤0.05. 
pERK1/2 
   0     2      5     10    30   60    90 
ERK1/2 
0 2 5 10 30 60 90
0.0
0.5
1.0
1.5
***
***
**
Time (mins)
p
E
R
K
:T
o
ta
l 
E
R
K
Page | 150  
 
(A)  
 
 
 
 
(B) 
 
 
 
 
 
 
 
 
 
Figure 3.27. ERK 1/2 activation kinetics in NK cells isolated from older adults in 
response to NKG2D and NKp30 receptor ligation. Resting NK cells were stimulated over 
a 90-minute period with antibodies targeted against the activatory receptors NKG2D and 
NKp30. At the time points indicated, cell lysates were prepared and ERK1/2 activation 
measured by Western blotting using a phospho-specific anti-ERK1/2 antibody. Total ERK1/2 
expression served as a loading control. (A) An example of ERK 1/2 phosphorylation kinetics 
in stimulated NK cells from an old individual. (B) Densitometry analysis of ERK1/2 
activation. Data are presented as mean ± SEM of 4 independent experiments. For statistical 
analysis, a repeated measures ANOVA was performed with Dunnett’s post hoc test.                     
Time 0 was considered the control value to which all other time points were compared.                   
** indicates p ≤0.005, * indicates p ≤0.05. 
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Figure 3.28. ERK 1/2 activation kinetics in NK cells isolated from young subjects in 
response to PMA and ionomycin stimulation. Resting NK cells were stimulated over a              
90-minute period with 2.5 µg/ml PMA and 0.5 µg/ml ionomycin. At the time points 
indicated, cell lysates were prepared and ERK1/2 activation measured by Western blotting 
using a phospho-specific anti-ERK1/2 antibody. Total ERK1/2 expression served as a loading 
control. (A) An example of ERK 1/2 phosphorylation kinetics in stimulated NK cells from a 
young donor. (B) Densitometry analysis of ERK1/2 activation. Data are presented as mean ± 
SEM of 4 independent experiments. For statistical analysis, a repeated measures ANOVA 
was performed with Dunnett’s post hoc test. Time 0 was considered the control value to 
which all other time points were compared. *** indicates p ≤0.0001. 
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Figure 3.29. ERK 1/2 activation kinetics in NK cells obtained from older adults in 
response to PMA and ionomycin stimulation. Resting NK cells were stimulated over a           
90-minute period with 2.5 µg/ml PMA and 0.5 µg/ml ionomycin. At the time points 
indicated, cell lysates were prepared and ERK1/2 activation measured by Western blotting 
using a phospho-specific anti-ERK1/2 antibody. Total ERK1/2 expression served as a loading 
control. (A) An example of ERK 1/2 phosphorylation kinetics in stimulated NK cells from an 
older adult. (B) Densitometry analysis of ERK1/2 activation. Data are presented as mean ± 
SEM of 3 independent experiments. For statistical analysis, a repeated measures ANOVA 
was performed with Dunnett’s post hoc test. Time 0 was considered the control value to 
which all other time points were compared. *** indicates p ≤0.0001. 
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Figure 3.30. Kinetics of P38 MAPK phosphorylation in NK cells isolated from young 
subjects in response to NKG2D and NKp30 receptor ligation. Resting NK cells were 
stimulated over a 60-minute period with antibodies targeted against the activatory receptors 
NKG2D and NKp30. At the time points indicated, cell lysates were prepared and P38 
activation measured by Western blotting using a phospho-specific anti-P38 antibody. Total 
P38 expression served as a loading control. Results displayed are representative of                             
2 independent experiments performed on NK cells isolated from young adults.   
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3.2.11 Effect of age on target cell-induced cytokine and chemokine production 
As well as mediating direct cytotoxicity, NK cells are a rich early source of 
immunoregulatory cytokines and chemokines. Exposure to pro-inflammatory cytokines and 
interaction with target cells trigger NK cells into secreting significant amounts of these 
soluble mediators [277;292]. Whilst several studies have examined the effect of age on 
cytokine and chemokine production induced by pro-inflammatory cytokine treatment 
[361;378;381;382], no study to date had investigated whether target cell-induced cytokine 
and chemokine production was altered with age. To address this, purified NK cells from 
young and old donors were cultured with K562 target cells for 6 hours, after which, cell-free 
supernatants were harvested, and the concentrations of IFN-γ, TNF-α, IL-8 and MIP1-α 
measured using luminex
®
 technology. 
As expected, NK cells responded to target cell treatment by secreting cytokines and 
chemokines, and in line with previous publications [277], the concentrations of chemokines 
present in supernatants were significantly greater than that of cytokines for both young and 
old donors (Table 3.6). Age comparisons revealed NK cells from old donors generated 
significantly less MIP1-α, IL-8 and IFN-γ following interaction with K562 target cells when 
compared to NK cells from young subjects (Figure 3.31 A-B). In contrast, no age-associated 
difference was observed in TNF-α production (Figure 3.31B). 
In addition to its potent chemoattractant properties, MIP1-α has been shown to increase the 
cytotoxic capacity of NK cells [281]. Thus, in an effort to determine whether the small but 
significant decrease we had observed in MIP1-α secretion with age could be of biological 
relevance, NK-K562 cell co-cultures were supplemented with 1 or 2 ng/ml of MIP1-α, the 
concentrations secreted by old and young NK cells respectively in response to target cell 
contact (Table 3.6), and after 4 hours NKCC was assessed. In both young (Figure 3.32A) and 
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old (Figure 3.32B) cohorts, there was no significant difference in the killing activity between 
MIP1-α and control-treated NK cells. There was also no increase in NKCC when NK cells 
were treated with 5 or 10 ng/ml of MIP1-α, concentrations that have previously been shown 
to enhance NK cell killing [281] (Figure 3.32A-B). 
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Table 3.6. Cytokine and chemokine production by target-cell stimulated NK cells 
  
Chemokine/Cytokine 
Concentration  
(pg/ml) 
 
P Value 
 
 
 
 
 
Young 
(n = 13) 
 
 
 
 
MIP1-α Vs. TNF-α 
 
MIP1-α Vs. IFN-γ 
 
IL-8 Vs. TNF-α 
 
IL-8 Vs. IFN-γ 
 
MIP1-α Vs. IL-8 
 
 
1963±310.00 Vs. 155±62.14 
 
1963±310.00 Vs. 93.0±25.75 
 
1991±252.00 Vs. 155±62.14 
 
1991±252.00 Vs. 93.0±25.75 
 
1963±310.00 Vs. 1991±252.00 
 
<0.0001 
 
<0.0001 
 
<0.0001 
 
<0.0001 
 
n.s. 
 
 
 
 
 
Old 
(n = 15) 
 
 
 
 
 
MIP1-α Vs. TNF-α 
 
MIP1-α Vs. IFN-γ 
 
IL-8 Vs. TNF-α 
 
IL-8 Vs. IFN-γ 
 
MIP1-α Vs. IL-8 
 
1086±185.70 Vs. 51.87±8.41 
 
1086±185.70 Vs. 27.60±4.46 
 
1333±168.80 Vs. 51.87±8.41 
 
1333±168.80 Vs. 27.60±4.46 
 
1086±185.70 Vs. 1333±168.80   
 
<0.0001 
 
<0.0001 
 
<0.0001 
 
<0.0001 
 
n.s. 
 
Values are presented as mean ± SEM. Differences between cytokine and chemokine 
concentrations were analysed by a repeated measures ANOVA. Significant differences are 
indicated in bold font.  
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Figure 3.31. Effect of age on target cell-induced cytokine and chemokine production. 
Concentrations of MIP1-α and IL-8 (A), and IFN-γ and TNF-α (B) in supernatants collected 
from 6-hour co-cultures of resting NK cells and K562 target cells (E:T, 1:1). Values represent 
mean ± SEM of 13 young and 15 old donors, with differences between groups assessed by 
either an unpaired student T test or Mann-Whitney U test. 
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Figure 3.32. Addition of MIP1-α to NK-K562 cell co-cultures does not enhance NKCC. 
NK cells isolated from young (A) or old (B) donors were cultured for 4 hours with K562 
target cells (E:T, 10:1, 5:1 and 2.5:1) in the presence or absence of MIP-1α (1-10 ng/ml). Post 
incubation, NKCC was measured by two-colour flow cytometry. Data from 3 young and 3 
old subjects are summarised as mean ± SEM, with differences between treatment conditions 
assessed by a repeated measures ANOVA. 
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3.3 Discussion 
NK cells are critical effector cells of the innate immune system renowned for their role in 
recognising and eliminating virally-infected and malignant cells. A well-documented feature 
of physiological ageing is a reduction in the cytotoxic capacity of NK cells at the single cell 
level [42;365;371], which is often proposed to contribute to the increased incidence of viral 
infection reported by older adults [9]. To date, only a small number of studies have addressed 
this theory directly [187-189]. Although limited with respect to sample size and follow-up 
time, these studies, which have been performed predominantly in older adults, have shown 
low NKCC to be associated with: (i) a past history of severe infection, (ii) an increased 
susceptibility to infection and (iii) death due to infection [187-189], suggesting that the age-
related deterioration in NKCC is of physiological relevance. Given the significance of these 
data, it is surprising that no study to date has identified the mechanism(s) that underlies the 
reduction in NKCC with age. Thus, in addition to investigating the effect of human ageing on 
the composition of the circulating NK cell pool, the aim of this chapter was to elucidate the 
cause of the age-associated decline in NKCC.  
Confirming the findings of previous studies [42;351;354-356;361;516], compared to younger 
adults, older individuals had a greater proportion of both CD3
-
 56
+
 and CD3
-
56
+
57
+
 NK cells 
within their peripheral lymphocyte pool. Expression of CD57 on the surface of NK cells is 
considered a marker of maturity, and is associated with distinct functional properties. 
Compared to their negative counterparts, CD57
+
 NK cells undergo fewer rounds of cell 
division and produce less IFN-γ in response to both target cell and cytokine stimulation 
[517]. As these features are reminiscent of the behaviour of NK cells isolated from old 
subjects [358;361;380], the accumulation of CD57
+
 NK cells that this report and others 
[42;354] have observed in elderly donors may contribute to the changes reported in NK cell 
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function with age [518]. Interestingly, although impaired in their response to cytokine and 
target cell stimulation, CD57
+
 NK cells exhibit greater lytic activity towards antibody-coated 
cells than CD57
-
 NK cells [517]. Despite possessing a greater proportion of CD57
+
 NK cells 
within their peripheral lymphocyte pool, elderly subjects perform ADCC at a level that is 
comparable to that of younger adults [356;376;377], suggesting that in a manner similar to 
natural cytotoxicity, ADCC may also be reduced with age at the single cell level [500].  
What factors contribute to the accumulation of CD57
+
 NK cells in aged individuals? 
Currently, the answer to this question is unknown but there are two possibilities. Firstly, with 
age, both the production and proliferation rates of NK cells fall [359], yet their circulating 
numbers have been reported to be comparable to [355;519] or higher [351;361;516] than that 
recorded in younger adults, suggesting the existence of a long-lived NK cell subset in elderly 
individuals. Given their highly mature differentiated state, CD57
+
 NK cells may be this long-
lived NK cell population [517]. An alternative explanation is that factors independent of age 
drive the accumulation of CD57
+
 NK cells over time. In a recent study performed entirely on 
samples collected from young volunteers, Bigley and co-workers noted that seropositivity for 
CMV was associated with an increased proportion of circulating KLRG1
-
/CD57
+
 NK cells 
[364]. Based on this observation the group proposed that the elevated levels of CD57
+
 NK 
cells in elderly subjects may not be the result of ageing per se but a consequence of latent 
viral infection [364]. Whilst no effect for CMV on the frequency of CD57
+ 
NK cells in young 
donors was observed in this thesis, it was found that old CMV
+
 individuals possessed a 
greater percentage of this subset in their peripheral pool when compared to their CMV
-
 
counterparts. Therefore, these data suggest that long-term antigen stimulation is needed to 
drive the accumulation of mature NK cells. In line with this proposal, Elpek et al have 
recently shown that the frequency of mature NK cells increases in vivo following sustained 
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but not transient exposure to the potent NK activating cytokine IL-15 [520]. Thus, instead of 
being a by-product of the ageing process, the accumulation of CD57
+
 NK cells in older adults 
may in fact result from life-long exposure to stimuli that drive NK cell activation [364]. On 
this note, it is of interest that when CD57 surface density was assessed, which was 
significantly higher in both young and old CMV
+
 subjects when compared to their negative 
counterparts, no difference in expression levels between young and old seronegative donors 
was seen, a finding that lends support to the idea that factors independent of age are involved 
in re-modelling the circulating NK cell pool.  
Based on the differential surface expression of CD56, NK cells can be divided into two major 
subsets: CD56
DIM
 and CD56
BRIGHT
. Whilst the effect of age on the absolute number of 
circulating CD56
DIM
 NK cells is controversial [351;361;519], an age-related increase in their 
frequency is well documented [351;354;358;361], as is a dramatic reduction in both the 
proportion and total numbers of CD56
BRIGHT
 NK cells [351;354;355;358;519], changes that 
lead to an increased CD56
DIM 
to CD56
BRIGHT
 ratio with age [352;358]. As well as confirming 
these much publicised age-associated changes in NK cell composition, this study performed a 
more detailed phenotypic analysis of NK cell subsets, and found the increased frequency of 
CD56
DIM
 cells with age to be the result of an accumulation of CD56
DIM
CD16
+
 NK cells, 
whilst a significant decline in the percentage of CD56
BRIGHT
CD16
- 
NK cells accounted for the 
reduction in the CD56
BRIGHT
 subset. Alongside these observations, ageing was found to be 
associated with an increase in the percentage of CD56
-
CD16
+
 NK cells, a subset that when 
compared to CD56
DIM 
NK cells exhibits defective natural and antibody dependent 
cytotoxicity [521-523] but comparable chemokine secretion [524;525], suggesting an 
immunoregulatory role for CD56
-
CD16
+
 NK cells in host protection. This finding is not in 
agreement with the recent work of Lutz et al, who reported no effect for age on the 
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percentage of this NK cell subset [354]. However, in that study, samples were obtained 
exclusively from women, whilst the cohort used in this thesis consisted of both males and 
females. Possible gender-related differences in the frequency of CD56
-
CD16
+
 NK cells may 
therefore explain these discordant findings. 
By displaying potent cytotoxic activity in vitro, CD56
DIM 
NK cells are considered to be the 
NK cell subset primarily responsible for the direct elimination of transformed cells, and 
therefore an increased frequency of CD56
DIM 
NK cells within the peripheral lymphocyte pool 
of older adults may represent a compensatory mechanism to counteract the age-related 
decrease in NKCC at the single cell level. In response to cytokine stimulation, CD56
BRIGHT 
NK cells generate an array of immunoregulatory cytokines and chemokines such as IFN-γ, 
TNF-α, IL-8 and MIP-1α/β [275;276;292;344]. Through the production of these mediators, 
CD56
BRIGHT 
NK cells have the capacity to activate monocytes, drive the maturation of iDCs, 
enhance the microbicidal capacity of local phagocytes and recruit bystander immune cells to 
sites of developing inflammation [526;527]. Thus, due to a lower number of blood 
CD56
BRIGHT 
NK cells, the ability of older adults to amplify on-going immune responses may 
be impaired, especially as this decline in number is accompanied by a marked age-associated 
reduction in cytokine and chemokine production by stimulated  CD56
BRIGHT 
NK cells 
[378;380-382].  
Using a two-colour flow cytometric protocol that allowed for the simultaneous assessment of 
NKCC and NK-target cell conjugate formation, it was found that when compared to NK cells 
from young volunteers, those isolated from older adults exhibited reduced lytic activity 
towards K562 tumour cells. This age-related impairment in NKCC was observed in both 4 
and 16-hour NK-K562 co-cultures and was not accompanied by a reduction in conjugate 
formation, suggesting a post-binding defect was responsible. Although the findings of the                 
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4-hour NK-K562 co-cultures confirm the work of previous studies that have shown an age-
associated decline in NKCC at the single level at this time point [42;365;371], the results of 
long-term (16-hour) cytolytic assays are in contrast to those of Rukavina et al who reported 
similar levels of NKCC between young and old subjects following prolonged culture with 
target cells [370]. Differences in experimental design may be responsible for this variation in 
outcome. For instance, whilst Rukavina and co-workers cultured PBL’s with K562 target 
cells for 18 hours before measuring NKCC [370], the 16-hour cytolytic assays presented in 
this thesis were performed with purified NK cells.  
With the odd exception [331;332], the induction of NKCC requires both the absence of MHC 
class I molecules on the target cell surface and the ligation of NK cell activatory receptors. 
Thus, it was conceivable that the reduced lytic activity exhibited by aged NK cells towards 
the MHC class I deficient K562 cell line was the result of an age-associated reduction in 
activatory receptor expression. In accordance with previous studies [351;362], a significant 
age-related decline in the percentage of NKp46
+
 NK cells and the surface density of NKp30 
was observed here. However, these changes in phenotype are unlikely to explain the impaired 
lytic activity elicited by aged NK cells towards K562 cells as this cell line does not express 
ligands for NKp46 [528], and the addition of blocking antibodies against NKp30 and/or 
NKp46 to NK-K562 cell co-cultures does not alter the rate of K562 cell lysis [528;529]. In 
contrast, numerous studies have shown that blocking antibodies against NKG2D, whose 
ligands MICA/B and ULBP2 are expressed on the surface of K562 cells [260;529;530], 
significantly reduces NK-mediated target cell lysis [529;530]. However, in line with the 
published literature [351;355], this study observed no age-related difference in the percentage 
of NKG2D
+
 NK cells or in its surface density. Thus, changes in receptor expression cannot 
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be put forward as an explanation for the reduced lytic activity of aged NK cells towards the 
K562 cell line.  
Influenza virus hemagglutinin is a recently identified ligand for NKp46 [335]. In addition to 
inducing direct NK-mediated lysis of flu-infected cells [335], recognition of HA by NKp46 
enhances IFN-γ production by NK cells, an outcome that has been proposed to aid the early 
developmental phases of an influenza specific adaptive immune response by promoting the 
maturation of influenza-infected DCs [531]. As well as protecting against influenza infection, 
NKp46 is important for the recognition and elimination of monocytes and macrophages 
infected with M. tuberculosis by NK cells [532;533]. Thus, whilst not responsible for the age-
related decline in NKCC towards K562 cells, a reduced frequency of NKp46
+
 NK cells may 
contribute to the increased incidence and severity of influenza infection reported by older 
adults [9;16;19;20], and possibly to the reactivation of latent TB, for which age is a major 
risk factor [21]. Away from infection, Thoren and colleagues have recently shown NK cells 
directly induce neutrophil apoptosis in an NKp46 dependent manner [534]. Given the 
reduced percentage of NKp46
+
 NK cells in older adults, it would be interesting to compare 
the survival rates of neutrophils cultured with purified NK cells from young and old donors. 
An age-related reduction in NK-mediated neutrophil apoptosis could be one factor that 
contributes to the delayed resolution of inflammatory responses in elderly individuals [535].  
In addition to examining to the effect of age on activatory receptor expression, the impact on 
the expression of CD94, a protein that interacts with both activatory (CD94-NKG2C/E/H) 
and inhibitory (CD94-NKG2A/B) receptors of the C-type lectin family [502] was considered. 
Confirming the work of other groups [351;352], an age-associated reduction in the 
percentage of circulating CD94
+
 NK cells was observed, which was accompanied by a 
marked reduction in its staining intensity. It is known that the inhibitory receptor                       
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CD94-NKG2A has a higher binding affinity than its activatory counterpart CD94-NKG2C 
for their shared ligand HLA-E, and can override the activatory signals that emanate from this 
complex [536;537]. Recently, Hayhoe and colleagues [352] speculated that the loss of CD94 
with age may lead to unregulated NK cell lysis, presumably as a result of reduced                   
CD94-NKG2A expression. However, CD94 shows no preference in terms of its binding 
partner. Thus, one would assume that a loss of CD94 would impact upon the expression of 
both activatory and inhibitory complexes, making it difficult to suggest what functional 
consequences if any the decline in CD94 expression with age has on NK cell function. 
Granule exocytosis and death receptor ligation are the two mechanisms through which NK 
cells directly eliminate transformed cells [206]. In cytotoxicity assays that employ K562 cells 
as the target, killing is thought to be mediated exclusively by the granule exocytosis pathway. 
Indeed, it was shown in this report that pre-treating NK cells with CMA, a potent inhibitor of 
perforin-based cytotoxicity [494;495], significantly reduced their lytic activity towards K562 
cells in subsequent 4-hour cytotoxicity assays, whereas culturing K562 cells with death 
receptor ligands had no effect on their viability. Based on these observations it was 
hypothesised that a defect in the granule exocytosis pathway was responsible for the age-
related decline in NKCC and this issue was addressed by examining the effect of age on 
events fundamental to this form of NKCC.  
The pore-forming protein perforin and the serine protease granzyme B are critical effector 
molecules of the granule exocytosis pathway, which work together to induce caspase-
dependent and independent cell death. When both the percentage of perforin and granzyme B 
positive NK cells, as well the staining intensity of these proteins, were compared between 
young and old subjects no age-related differences were seen, suggesting that NK cells from 
older adults are suitably armed with the effector molecules needed to induce target cell lysis. 
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Whilst in agreement with the previous work of Mariani and co-workers [375], these data 
relating to perforin expression contrast with that of Rukavina et al, who reported an age-
related decline in both the percentage of perforin positive NK cells and the number of 
perforin molecules expressed per cell [370]. A possible explanation for these opposing 
observations is inter-study differences in subject inclusion criteria. As well as being small in 
number (n = 7), the elderly cohort studied by Rukavina et al consisted entirely of care home 
residents, who may have been a more frail group when compared to the community dwelling 
elderly subjects that were enrolled into both this study and that performed by Mariani and 
colleagues [370;375]. In a separate group of young and old individuals, full blood counts 
were performed alongside flow cytometric analysis in order to calculate the absolute number 
of perforin positive NK cells, and the results showed a significant age-related decline. 
However, since this was driven by a significant fall in the total number of NK cells rather 
than a reduction in the percentage of perforin positive cells, which was again comparable 
between young and old subjects, this cannot explain the age-associated decline in NKCC 
reported in this thesis since purified NK cells at a fixed concentration were used in cytolytic 
assays. 
Fusion of secretory lysosomes with the NK cell plasma membrane precedes the release of 
perforin and granzymes into the IS. In contrast to the findings of previous murine [538] and 
human [355] studies that had shown this aspect of NKCC to be impaired with age, the data 
here showed lysosome fusion to be comparable between NK cells from young and old 
donors. Using the expression of CD107a on the outer surface of NK cells as a marker of 
lysosome fusion, this study found no significant age-associated difference in the percentage 
of CD107a
+
 cells or its staining intensity when either whole PBMC’s or purified NK cells 
were cultured with K562 cells. In the abovementioned human-based study, the impairment in 
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lysosome fusion was observed only when the response of young donors was compared to 
those subjects considered “very old” (≥80 years, n = 30). Very few individuals within the 
elderly cohort used here met this criterion (n = 8), which may explain why no effect of age on 
lysosome fusion was seen.  
Two major models exist that attempt to explain how perforin delivers granzymes into the 
target cell cytosol. The first suggests that perforin acts entirely at the plasma membrane, 
where it forms channels through which granzymes passively diffuse [211;539]. In the second 
model it is proposed that perforin works first on the plasma membrane to trigger perforin and 
granzyme uptake by the target cell and then on the endosomal membrane to facilitate 
granzyme entry into the cytoplasm [207;208;218]. Whilst it remains to be determined which 
of these models is correct, both agree that interaction of perforin with the target cell surface is 
critical for granzyme-mediated apoptosis. When perforin binding to the surface of K562 cells 
was determined, it was found that the percentage of target cells to which perforin had bound, 
as well as the number of molecules present on the cell surface, was significantly lower when 
these cells had been cultured with NK cells from older adults. Importantly, cytotoxicity 
assays performed alongside perforin binding experiments revealed a strong positive 
association between these two events suggesting that reduced perforin binding contributes to 
the age-related decline in NKCC. Underlying this reduction in perforin binding was reduced 
availability. ELISA analysis of supernatants collected from 4-hour NK-K562 cell co-cultures 
revealed the concentration of perforin was significantly lower in supernatants harvested from 
cultures that had contained NK cells from older individuals. This finding revealed a 
previously undescribed age-related impairment in perforin release into the IS and was 
confirmed at the single cell level when perforin secretion in response to K562 cell contact 
was measured by flow cytometry. Interestingly, when NK cells were stimulated with PMA 
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and ionomycin, no age-associated difference in perforin release was observed. As PMA and 
ionomycin bypass the cell membrane to activate cells, this suggested that either a defect in 
target cell recognition or aberrant intracellular signalling downstream of NK cell receptors 
was responsible for the age-associated decline in perforin secretion. Given the previously 
described similarity observed in conjugate formation, combined with comparable expression 
of the early activation marker CD69 on the surface of young and old NK cells following 
target cell recognition, the latter hypothesis seemed more likely to be correct.    
In the absence of overriding inhibitory signals, target cell recognition leads to the formation 
of an activating IS, which is essential for the directed secretion of cytolytic effector 
molecules onto the target cell surface. An important early step in IS formation is the 
reorganisation of the actin cytoskeleton, for which actin polymerisation is required [513]. 
When NK-K562 cell conjugates were assessed by immunofluorescence, an accumulation of 
F-actin at the interface formed between K562 cells and NK cells was seen with both young 
and old donors, suggesting that signalling events leading to actin polymerisation were not 
impaired with age. Formation of F-actin networks serves as a trigger for the movement of the 
MTOC to the developing IS, which is essential for the delivery of lytic granules to the NK-
target cell interface. To test whether this stage of IS formation was impaired with age, NK 
cells cultured alone or with K562 target cells were assessed for the location of lytic granules 
by staining samples with an antibody against perforin. As expected, lytic granules were 
dispersed throughout the cytoplasm of resting NK cells and polarised to the IS that was 
formed upon target cell recognition. However, from the images it was evident that the 
delivery of lytic granules to the NK-target cell interface was not as efficient in NK cells from 
older adults. Moreover, when the proportion of NK cells that had polarised granules to the IS 
was compared between young and old subjects, a significant age-related reduction was found.  
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Thus, these findings suggest that defective polarisation of lytic granules to the IS underlies 
the reduction in perforin secretion observed with age.  
The mobilisation and delivery of lytic granules to the NK-target interface requires activation 
of the MAPK ERK1/2 [259;540]. Having observed a defect in granule polarisation in NK 
cells of older adults, the kinetics of ERK 1/2 activation was investigated. To do this, NK cells 
were stimulated with antibodies targeted against the activating receptors NKG2D and 
NKp30, and by Western blot analysis the expression of phosphorylated ERK1/2 was 
determined. Within 10 minutes of treatment, a significant increase in the phosphorylation 
status of ERK1/2 within NK cells from young individuals was seen, which was maintained 
for the remainder of the time-course that terminated after 90 minutes. In contrast, only after 
30 minutes did a significant increase in ERK1/2  phosphorylation occur in NK cells isolated 
from older adults, which although maintained at 60 minutes was no longer evident 90 
minutes post stimulation. Thus, it would seem from these data that NK cells from aged 
donors display slower kinetics of ERK1/2 activation and fail to sustain this signalling 
pathway as long as their younger counterparts. However, it must be stressed that whilst the 
ligands for NKG2D and NKp30 are expressed on the surface of K562 cells                          
[260;501;528-530], the antibody stimulation technique used does not reflect the vast array of 
receptor-ligand interactions that occur upon NK-K562 contact. Thus, the subtle age-related 
changes observed in the kinetics of ERK1/2 phosphorylation may not have been evident had 
NK cells been stimulated with K562 cells. Due to difficulties in establishing a method that 
would have allowed us to differentiate between phosphorylated ERK1/2 expressed by 
activated NK cells and that endogenously expressed in K562 cells, it was not possible to 
perform this experiment. However, ERK1/2 activation kinetics in NK cells from young and 
old donors following PMA and ionomycin stimulation were compared and no age-related 
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difference was seen. As these agents bypass the cell membrane, these data suggest that 
aberrant intracellular signalling proximal to the NK cell membrane was responsible for the 
age-associated delay observed in ERK1/2 activation.   
From the data presented in this chapter, it is proposed that reduced perforin secretion 
underlies the reduction in NKCC that accompanies physiological ageing. Furthermore, this 
impaired secretion is attributed to defective polarisation of lytic granules to the IS. However, 
there may be an alternative mechanism by which to explain the age-associated decline in 
perforin release. In a recent study, Herz et al [541] found that despite no difference in 
perforin expression or lytic granule fusion, cytotoxic CD8
+
 T cells from acid 
sphingomyelinase (ASMase) deficient mice released fewer cytolytic effector molecules into 
the IS upon target cell recognition and exhibited reduced perforin dependent cytotoxicity 
when compared to CD8
+
 T cells from their wild type counterparts [541]. Through a series of 
elegant experiments, the group attributed the impaired cytolytic activity of ASMase-deficient 
CD8
+
 T cells to the failure of cytotoxic granules that had fused with plasma membrane to 
contract and expel their contents into the IS [541]. Thus, could it be that the activity of 
ASMase is reduced in NK cells of older adults? Currently, the answer to this question is 
unknown but it is certainly a plausible explanation for the significantly lower perforin 
concentrations we found in supernatants harvested from NK-K562 co-cultures that had 
contained NK cells from older individuals, especially since despite observing a marked age-
associated impairment in perforin polarisation to the IS, no difference in lytic granule fusion 
was found with age. Furthermore, it is known that lytic granule contraction and exocytosis 
are sensitive to the lipid composition of the plasma cell membrane [542].Whilst no study has 
examined the effect of age on the lipid composition of the NK cell membrane, an age-related 
increase in cholesterol content has been reported in the plasma membrane of T cells [65]. 
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Interestingly, Roozemond and colleagues [543] found that decreasing the fluidity of the NK 
cell membrane significantly reduced their lytic activity towards K562 cells, a defect that they 
proposed resulted from reduced secretion of cytotoxic effector molecules [543]. Should 
ageing be associated with an increase in the cholesterol content of the NK cell membrane 
then the resultant increase in membrane rigidity may impede the contraction of lytic granules 
and/or the ejection of their contents into the IS. 
In response to cytokine or target cell stimulation, NK cells secrete an array of 
immunoregulatory cytokines and chemokines, such as TNF-α, IFN-γ, MIP-1α and IL-8 
[275;277;278]. Whilst a number of studies had examined the effect of age on the production 
of these soluble mediators by cytokine-stimulated NK cells [378;380-382], no group had 
investigated whether target cell-induced cytokine and chemokine production was altered with 
age. To address this, purified NK cells from young and old subjects were cultured with K562 
target cells for 6 hours, after which the concentrations of TNF-α, IFN-γ, IL-8 and MIP-1α in 
cell-free supernatants were measured. In line with previous work [277], NK cells from both 
young and old donors secreted significantly greater amounts of chemokines than cytokines 
upon target cell contact, suggesting chemokine production is initiated at a lower activatory 
threshold. Comparison of cytokine and chemokine production between our young and old 
cohort showed a significant age-associated decline in the production of IFN-γ, IL-8 and MIP-
1α, but no difference in TNF-α secretion. Based on these findings and those of other studies 
that have reported an age-related reduction in both cytokine and chemokine production by 
cytokine-stimulated NK cells [378;380-382], it would be tempting to suggest that the 
immunoregulatory capacity of NK cells wanes with age. However, although statistically 
significant, the differences that this study and others have observed in the concentrations of 
cytokines and chemokines secreted by NK cells from young and old donors are small and 
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may not be of biological relevance. To address this issue, it would be useful to compare the 
functional responses of immune cells treated with the concentrations of cytokines and 
chemokines secreted by target cell or cytokine stimulated NK cells from young and old 
subjects. This was attempted in this thesis, where MIP-1α, which had previously been shown 
to augment the lytic activity of NK cells [281], was added to NK-K562                         co-
cultures at the concentrations secreted by young or old NK cells in response to target cell 
stimulation. However, no enhancing effect of this chemokine on NKCC was observed. 
In summary, as well as confirming previously described age-associated alterations in the 
composition of the circulating NK cell pool, studies presented in this chapter have shown for 
the first time that NK cells from older adults exhibited impaired perforin secretion upon 
target cell contact, a defect we propose mediates the reduction in NKCC that accompanies 
physiological ageing. This impairment in perforin secretion is attributed at least in part to 
defective polarisation of lytic granules to the IS. Furthermore, target cell-induced cytokine 
and chemokine production was reduced with age, although the biological relevance of this 
finding remains to be determined. 
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CHAPTER 4 
 
Effect of human ageing on the generation of 
neutrophil extracellular traps (NETs) 
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4.1 Introduction 
Neutrophils are a critical component of the innate immune system, providing frontline 
protection against infection with rapidly dividing bacteria, fungi and yeast. Upon arrival at a 
site of infection, neutrophils unleash an array of anti-microbial mechanisms in an effort to 
directly contain and eliminate the invading pathogen. For many years, these mechanisms 
were thought to be limited to phagocytosis, production of ROS and degranulation [387]. 
However, in 2004, a fourth defensive strategy was discovered: the generation of neutrophil 
extracellular traps (NETs) [435]. Consisting of a DNA backbone decorated with a multitude 
of granule-derived anti-microbial peptides and enzymes, NETs are ejected from dying 
neutrophils and are thought to play an important role in the entrapment of bacteria, parasites 
and fungi [465].   
Compared to younger subjects, older adults report an increased incidence of bacterial and 
fungal infection. As well as being more frequent, these infectious episodes are more severe 
and are associated with increased morbidity and mortality rates [544-547]. As neutrophils 
represent the first line of defence against bacteria and fungi, this data implies that the 
protective capacity of neutrophils wanes with age. Indeed, numerous in vitro studies have 
documented an age-associated reduction in neutrophil phagocytosis [404;409;417], ROS 
production [412;415;420;421] and degranulation [410;427]. However, no study to date had 
examined whether NET formation was altered with age.   
Whilst data are emerging from murine-based studies that suggest NETs play an important 
role in pathogen containment during the early phases of infection [478;479], no direct in vivo 
evidence exists in humans to suggest a role for these structures in conferring host protection. 
However, a role has been proposed based on the results of studies that have examined NET 
production by neutrophils isolated from patients who exhibit an increased risk of infection. 
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For instance, Yost and colleagues showed neutrophils from newborn children, in whom 
bacterial infection is a major cause of death and morbidity [548], failed to generate NETs 
when exposed to inflammatory agonists [471]. Conversely, Bianchi et al restored NET 
formation in a CGD patient via gene therapy, and showed that this coincided with the 
clearance of a pre-existing fungal infection in vivo [463].  
Based on these observations and the increased susceptibility older adults exhibit towards both 
fungal and bacterial infection [544-547], the aim of this chapter was to study the effect of 
human ageing on the generation of NETs. To achieve this, the following objectives were set: 
1. Quantify NET formation in response to PMA stimulation by unprimed neutrophils 
from young and old donors. 
2. Determine the effect of neutrophil priming on NET formation. 
3. Examine the effect of age on NET generation by primed neutrophils in response to      
IL-8 and LPS stimulation. 
4. Study the impact of age on ROS generation: a key event in NET formation.       
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4.2 Results 
4.2.1 Neutrophil isolation by dextran-Percoll
®
 density centrifugation does not result in    
         spontaneous NET production 
Dextran-Percoll
®
 density centrifugation is a common method used to isolate neutrophils from 
whole blood. Recently, it was reported that neutrophils obtained by this procedure generated 
NETs in the absence of additional stimulation, culminating in high background fluorescence 
values in untreated control samples [443]. Given that dextran-Percoll
®
 density centrifugation 
is the routine method by which neutrophils are isolated in this laboratory, it was important to 
investigate this finding. To do this, neutrophils that had been obtained by dextran-Percoll 
density centrifugation and cultured for 3 hours at 37
0
C were stained with the nucleic acid 
binding dye SYTOX
®
 Green and studied by immunofluorescence microscopy.   
In contrast to the aforementioned study [443], no evidence of NET formation was seen in 
cultures of resting neutrophils (Figure 4.1A). The cells retained their distinctive multi-lobed 
nucleus and showed no signs of chromatin decondensation, an early event in NET formation 
(Figure 4.1B).  
4.2.2 Assessment of NET formation  
Two techniques that are commonly used to study NET formation are their visualisation by 
immunofluorescence microscopy and the quantification of extracellular DNA in supernatants 
taken from cultures of stimulated neutrophils. Thus, prior to studying the effect of age on 
NET generation, it was first necessary to establish these methods within the laboratory. To do 
this, neutrophils were stimulated with the phorbol ester PMA, a potent inducer of NET 
formation. 
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Figure 4.1. Neutrophil isolation by dextran-Percoll
®
 density centrifugation does not 
induce spontaneous NET formation. Neutrophils isolated by dextran-Percoll
®
 density 
centrifugation were cultured for 3 hours at 37
0
C. Post incubation, samples were stained with 
the nucleic acid binding dye SYTOX
®
 Green, and their nuclear morphology visualised by 
fluorescence microscopy. Images were taken at X10 (A) and X63 (B) objective and are 
representative of 5 separate experiments. 
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For immunofluorescence microscopy, the protocol recently described by Brinkmann et al 
[549] was used. Following a 3-hour incubation in the presence or absence of 25 nM PMA, 
neutrophils were fixed in 2% paraformaldehyde and stained with SYTOX
® 
Green. As shown 
in figure 4.2A, there was no evidence of NET formation by neutrophils that had been cultured 
in media alone. In contrast, those stimulated with PMA had formed NETs, as shown by the 
presence of extracellular material that stained positive for SYTOX
® 
Green (Figure 4.2B).  
To quantify NET formation, cultures of PMA-stimulated neutrophils were treated with 
SYTOX
® 
Green and micrococcal nuclease, an endo-exonuclease that digests double-stranded 
nucleic acids. Cell-free supernatants were then collected and their DNA content measured by 
fluorometry. Using this approach, the generation of NETs by PMA-treated neutrophils was 
consistently observed (Figure 4.3), which as reported by other groups [443;486] occurred in a 
dose and time-dependent manner (Figure 4.4A-B).  
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4.2. Assessment of NET formation by immunofluorescence microscopy. Neutrophils 
isolated from young adults were cultured for 3 hours in the absence (A) or presence (B) of             
25 nM PMA. Post incubation, samples were stained with the nucleic acid binding dye 
SYTOX
®
 Green, and visualised by fluorescence microscopy. Images are representative of 
two separate experiments performed and were taken at X20 and X63 objective.  
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Figure 4.3. PMA is a potent inducer of NET formation.  Neutrophils isolated from young 
donors (n = 10) were stimulated for 3 hours with 25 nM PMA, after which the DNA content 
of cell-free supernatants was assessed by fluorometry. Data are presented as mean ± SEM of 
experiments performed in quadruplicate after subtracting the background fluorescence of 
untreated controls. AFU, Arbitrary fluorescence units. 
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(A) 
 
 
 
 
 
 
 
 
(B)  
 
 
 
 
 
 
 
 
 
Figure 4.4. NET formation induced by PMA is dose and time-dependent. (A) Neutrophils 
isolated from 5 young donors were cultured with the indicated doses of PMA for 3 hours, 
after which the DNA content of cell-free supernatants was assessed by fluorometry.                       
(B) Neutrophils obtained from 5 young subjects were treated for 1, 2 and 3 hours with 25 nM 
PMA, after which the DNA content of cell-free supernatants was measured by fluorometry. 
For both figures, data are presented as mean ± SEM after subtracting the background 
fluorescence of untreated controls. Differences between treatment conditions were assessed 
using a repeated measures ANOVA with Tukey’s multiple comparison post hoc test.                 
AFU, Arbitrary fluorescence units. 
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4.2.3 Effect of age on PMA-induced NET formation   
To date, the majority of studies that have examined NET production by human neutrophils 
have used PMA as their stimulating agent. Having confirmed that PMA was a potent inducer 
of NET formation, it was investigated whether the generation of NETs triggered by PMA was 
altered with age. Quantification of extracellular DNA in cell-free supernatants (Figure 4.5A), 
and the visualisation of NETs by immunofluorescence microscopy (Figure 4.5B) revealed no 
age-associated difference in PMA-induced NET formation. 
A prerequisite for the generation of NETs is the production of ROS. As expected, given that 
no age-associated difference in NET formation was seen, ROS production in response to 
PMA stimulation was also found to be comparable between neutrophils obtained from young 
and old donors (Figure 4.6).  
4.2.4 Neutrophil priming enhances NET formation  
Although PMA is a potent inducer of NET formation, it is a pharmacological agent with no 
physiological relevance. Therefore, the next set of experiments focused on NET production 
by neutrophils treated with the pro-inflammatory cytokine IL-8 and the bacterial product 
LPS.  
Whether IL-8 and LPS trigger NET formation is an area of debate within the literature, with 
those who fail to report their production suggesting it to reflect the inability of these 
inflammatory agonists to activate NADPH oxidase [468]. To determine whether IL-8 or LPS 
could induce NET production, neutrophils were treated with 100 ng/ml LPS or 10 ng/ml IL-8, 
and after 3 hours the DNA content of cell-free supernatants was measured. With the 
exception of two individuals who failed to generate NETs following treatment with IL-8, all 
subjects produced NETs in response to both stimuli (Figure 4.7A-B).  
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Figure 4.5. Effect of age on PMA-induced NET formation. (A) NET formation by 
neutrophils following 3-hour stimulation with 25 nM PMA. Data are presented as arbitrary 
fluorescence units (AFU) after subtracting the background fluorescence of untreated controls, 
and represents the mean ± SEM of 10 and 8 experiments performed on neutrophils from 
young and old donors respectively. (B) Immunofluorescence images of NET production by 
neutrophils from young and old donors in response to 3-hour stimulation with 25 nM PMA. 
Images were taken at X63 objective and are representative of 2 separate experiments. 
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Figure 4.6. Effect of age on ROS generation by PMA treated neutrophils. ROS 
generation by freshly isolated neutrophils in response to stimulation with 25 nM PMA was 
measured over a 60-minute period by luminol-amplified chemiluminescence. Data are 
presented as area under the curve (AUC) and represents the mean ± SEM of experiments 
performed on 10 young and 8 old subjects. 
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Figure 4.7. NET generation by unprimed neutrophils in response to LPS and IL-8 
stimulation. Neutrophils isolated from young donors (n = 10) were stimulated for 3 hours 
with 100 ng/ml LPS (A) or 10 ng/ml IL-8 (B), after which the DNA content of cell-free 
supernatants was assessed by fluorometry. Data are presented as arbitrary fluorescence units 
(AFU) after subtracting the background fluorescence of untreated controls, with each column 
representing the mean ± SEM of experiments performed in quadruplicate.  
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Simultaneous assessment of ROS production revealed that both LPS and IL-8 stimulation 
significantly increased the generation of free radicals above the levels produced by untreated 
controls (Figure 4.8A-B). 
Although both IL-8 and LPS were able to drive NET formation, experiments were performed 
on neutrophils that were in a resting state prior to stimulation. En route to sites of infection, 
neutrophils are exposed to pro-inflammatory cytokines such as TNF-α and GM-CSF, which 
through a process referred to as “priming” heighten the sensitivity of neutrophils to 
subsequent stimulation. Thus, in an effort to mimic the conditions that neutrophils are 
subjected to in times of pathogenic challenge, neutrophils were primed with 10 ng/ml TNF-α 
prior to assessing NET formation. The DNA content of cell-free supernatants taken from 
cultures of primed neutrophils following LPS (Figure 4.9A) and IL-8 (Figure 4.10A) 
treatment was significantly higher than that present in supernatants obtained from cultures 
that consisted of unprimed cells, suggesting that priming had enhanced NET production. 
Indeed, when assessing NET formation via immunofluorescence microscopy, it was apparent 
that compared to resting cells, primed neutrophils had extruded a greater amount of DNA into 
the extracellular environment upon LPS (Figure 4.9B) and IL-8 (Figure 4.10B) stimulation. 
Furthermore, it appeared based on nuclear morphology, that a greater proportion of primed 
neutrophils, which had not yet generated NETs, were undergoing the process of NETosis as 
very few of these cells possessed a multi-lobed nucleus (Figures 4.9B and 4.10B). 
As well as augmenting NET formation, priming enhanced the production of free radicals. 
Compared to resting cells, ROS generation by primed neutrophils was significantly greater in 
response to both LPS (Figure 4.11A) and IL-8 (Figure 4.11B) challenge. 
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Figure 4.8. ROS production by unprimed neutrophils in response to LPS and              
IL-8 stimulation. Generation of ROS by freshly isolated neutrophils in response to 
stimulation with 100 ng/ml LPS (A) or 10 ng/ml IL-8 (B) was measured over a 60-minute 
period by luminol-amplified chemiluminescence. Data are presented as area under the curve 
(AUC) and represents the mean ± SEM of 10 experiments performed on neutrophils obtained 
from young subjects. Group differences were assessed using a Wilcoxon matched-pairs 
signed rank test.  
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Figure 4.9. Neutrophil priming significantly enhances LPS-induced NET formation.              
(A) Quantification of extracellular DNA present in supernatants taken from cultures of 
unprimed or TNF-α primed neutrophils following a 3-hour stimulation with 100 ng/ml LPS. 
Data are presented as arbitrary fluorescence units (AFU) after subtracting the background 
fluorescence of untreated controls, and represents the mean ± SEM of experiments performed 
on neutrophils obtained from 5 young donors. Differences between groups were analysed 
using a paired student T test. (B) Immunofluorescence images of NETs generated by 
unprimed and primed neutrophils following a 3-hour stimulation with 100 ng/ml LPS. 
Arrows point to regions of extracellular DNA. Images are representative of 2 independent 
experiments and were taken at X20 objective.  
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Figure 4.10. Neutrophil priming significantly enhances IL-8-induced NET formation. 
(A) Quantification of extracellular DNA present in supernatants taken from cultures of 
unprimed or TNF-α primed neutrophils following a 3-hour stimulation with 10 ng/ml IL-8. 
Data are presented as arbitrary fluorescence units (AFU) after subtracting the background 
fluorescence of untreated controls, and represents the mean ± SEM of experiments performed 
on neutrophils obtained from 5 young donors. Differences between groups were analysed 
using a paired student T test. (B) Immunofluorescence images of NETs generated by 
unprimed and primed neutrophils following a 3-hour stimulation with 100 ng/ml IL-8. 
Arrows point to regions of extracellular DNA. Images are representative of 2 independent 
experiments and were taken at X20 objective. 
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Figure 4.11. Neutrophil priming significantly enhances ROS production. ROS generation 
by unprimed or TNF-α primed neutrophils in response to 100 ng/ml LPS (A) or 10 ng/ml        
IL-8 (B) was measured over a 60-minute period by luminol-amplified chemiluminescence. In 
the left panel, ROS generation is presented as area under the curve (AUC) and represents the 
mean ± SEM of 8 experiments performed on neutrophils from young subjects. In the right 
panel, representative plots of ROS generation are shown. Group differences were assessed 
using a paired student T test. RLU, relative light units.  
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4.2.5 Effect of age on NET production and ROS generation by primed neutrophils   
Having observed that when compared to their resting counterparts, primed neutrophils 
elicited a more robust NET response upon LPS and IL-8 treatment, it was decided that 
primed neutrophils would be used in the assays that set out to determine whether NET 
production induced by these two inflammatory agonists was altered with age.  
Quantification of extracellular DNA in cell-free supernatants revealed a significant age-
associated decline in NET production induced by LPS (Figure 4.12A) and IL-8                     
(Figure 4.13A) stimulation, findings confirmed when NET formation was visualised by 
immunofluorescence microscopy (Figures 4.12B and 4.13B). Accompanying this impairment 
in NET formation was an age-related reduction in the generation of free radicals. After 
priming with TNF-α, neutrophils were challenged with LPS (Figure 4.14A) or IL-8                  
(Figure 4.14B) and neutrophils from older adults generated significantly less ROS when 
compared to the levels produced by neutrophils from younger controls (Figure 4.14A-B). 
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Figure 4.12. Age-related impairment in LPS-induced NET formation. (A) Neutrophils 
obtained from young (n = 8) and old (n = 11) donors were primed with 10 ng/ml TNF-α prior 
to a 3-hour treatment with 100 ng/ml LPS. Post stimulation, the DNA content of cell-free 
supernatants was assessed by fluorometry. Data are presented as arbitrary fluorescence units 
(AFU) after subtracting the background fluorescence of untreated controls, and represents the 
mean ± SEM. (B) Immunofluorescence images of LPS-induced NET production by primed 
neutrophils from young and old donors. Images were taken at X20 objective and are 
representative of 2 independent experiments. Arrows point to regions of extracellular DNA. 
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Figure 4.13. Age-associated reduction in IL-8-induced NET formation by primed 
neutrophils. Neutrophils obtained from young (n = 9) and old (n = 10) donors were primed 
with 10 ng/ml TNF-α prior to a 3-hour treatment with 10 ng/ml IL-8. Post stimulation, the 
DNA content of cell-free supernatants was assessed by fluorometry. Data are presented as 
arbitrary fluorescence units (AFU) after subtracting the background fluorescence of untreated 
controls, and represents the mean ± SEM. Group differences were assessed by a Mann 
Whitney U test. (B) Immunofluorescence images of IL-8-induced NET production by primed 
neutrophils from young and old donors. Images were taken at X20 objective and are 
representative of 2 independent experiments. Arrows point to regions of extracellular DNA. 
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Figure 4.14. Age-related decline in ROS production by primed neutrophils. ROS 
generation by TNF-α primed neutrophils in response to 100 ng/ml LPS (A) or 10 ng/ml IL-8 
(B) was measured over a 60-minute period by luminol-amplified chemiluminescence. In the 
left panel, ROS generation is presented as area under the curve (AUC) and represents the 
mean ± SEM of experiments performed on neutrophils isolated from 8 young and 8 old 
subjects. In the right panel, representative plots of ROS generation are shown. Group 
differences were assessed using an unpaired student T test. RLU, relative light units.  
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4.2.6 Simvastatin increases IL-8 induced ROS production by neutrophils from older  
          adults but has no effect upon NET formation   
It has recently been demonstrated that pre-treating neutrophils with simvastatin, an inhibitor 
of 3-hydroxy 3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme 
in cholesterol biosynthesis, significantly increases NET formation triggered by PMA [550]. 
As the only treatment regimen known to date to enhance NET generation, it was examined 
whether pre-treatment with simvastatin could boost IL-8-induced NET production by primed 
neutrophils from older adults.  
Quantification of extracellular DNA in cell-free supernatants revealed statin pre-treatment 
had no significant effect upon NET generation by IL-8 stimulated neutrophils (Figure 4.15). 
However, simvastatin-treated neutrophils did produce a modest but significant increase in 
ROS following IL-8 challenge when compared to those that had been treated with vehicle 
control (Figure 4.16 A-B). 
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Figure 4.15. Simvastatin treatment does not alter IL-8 induced NET production by 
primed neutrophils from older adults. After a 40-minute treatment with 1 nM simvastatin 
or vehicle control, TNF-α primed neutrophils were stimulated for 3 hours with 10 ng/ml IL-8, 
after which the DNA content of cell-free supernatants was quantified by fluorometry. Data 
are presented as mean ± SEM of 7 independent experiments after subtracting the background 
fluorescence of untreated samples. Differences between conditions were assessed by a paired 
student T test. AFU, Arbitrary fluorescence units. 
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Figure 4.16. Simvastatin enhances IL-8 induced ROS generation by primed neutrophils 
from older adults. Following a 40-minute treatment with 1 nM simvastatin, TNF-α primed 
neutrophils were challenged with 10 ng/ml IL-8 and ROS production measured over a                   
60-minute period by luminol-amplified chemiluminescence. (A) ROS generation presented as 
area under the curve (AUC). Data represents mean ± SEM of 6 experiments performed on 
neutrophils isolated from older adults. Differences between conditions were assessed by a 
paired student T test. (B) Representative plot illustrating the increased ROS generation by 
simvastatin-treated neutrophils. RLU, relative light units. 
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4.3 Discussion 
Consisting of a DNA backbone decorated with granule-derived peptides and enzymes, NETs 
are a recently identified defensive strategy of neutrophils [435;436]. Generated in response to 
bacterial, fungal and parasitic challenge [435;440;472;473;475], NETs, as their name 
suggests, are thought to play an important role in pathogen entrapment [478]. Compared to 
younger individuals, older adults succumb more readily to bacterial and fungal infections, 
which are more severe in nature and associated with greater morbidity and mortality rates 
[544-547]. As neutrophils represent the first-line of defence against these two types of 
pathogen, which are potent inducers of NET formation, the aim of this chapter was to 
determine whether like other forms of neutrophil defence, NET formation was altered with 
age. 
When challenged with PMA, the most potent inducer of NET formation, neutrophils isolated 
from young and old donors generated comparable levels of NETs. As a stimulus that 
bypasses the cell membrane, this observation indicates that downstream of activation of 
protein kinase C (PKC), signalling molecules involved in NET formation are not inherently 
altered by the ageing process. Indeed, ROS generation, which is a prerequisite for NET 
formation was comparable between neutrophils from young and old donors in response to 
PMA stimulation. 
In this thesis, it was shown that upon IL-8 or LPS stimulation, resting neutrophils generated 
NETs. This observation is in agreement with some [435;471;486] but not all [470;551] 
studies that have previously investigated NET production by neutrophils treated with these 
inflammatory agonists. However, although NETs were generated, the response of resting 
neutrophils was weak. In a recent study, Demers and colleagues [552] challenged control and 
G-CSF-treated mice with low-dose LPS and measured levels of plasma DNA, which they 
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considered to be a marker of NET generation in vivo. Whilst an increase in plasma DNA was 
observed in control mice, the levels recorded in G-CSF-treated mice at both 1 and 24-hours 
post challenge were significantly greater, suggesting that G-CSF had sensitised neutrophils 
for NET formation [552].  This finding supported earlier in vitro work that had shown upon 
stimulation with the complement protein C5a, primed neutrophils generated significantly 
more NETs than their resting counterparts [553]. Thus, both sets of data suggest priming 
neutrophils strongly enhances NET production upon secondary stimulation. Indeed, in this 
report it was shown that short-term exposure to TNF-α prior to IL-8 or LPS treatment, 
significantly increased NET formation above the levels generated by their unprimed 
counterparts. What this and other studies have not yet addressed however is the mechanism(s) 
by which this occurs, although it is likely to be the result of two factors, which will now be 
briefly discussed.      
ROS production by neutrophils is dependent upon activation of NADPH oxidase, a 
multicomponent enzyme system that consists of the trans-membrane protein cytochrome b558, 
a cytosolic complex comprising of three proteins, namely p40
phox
, p47
phox
 and p67
phox
, and the 
G protein Rac2 [554]. In resting cells, the distribution of these proteins between the 
membrane and cytosol ensures that NADPH oxidase resides in an inactive state. Through 
inducing partial phosphorylation of the cytosolic proteins p47
phox
 and p67
phox
 [555;556], 
which triggers their translocation to the cell membrane, and increasing the expression of 
cytochrome b558within the plasma membrane [557], priming agents such as TNF-α promote 
assembly of the NADPH oxidase complex at the neutrophil cell membrane, leading to 
enhanced ROS generation when these cells are exposed to a second stimulus. Indeed, when 
compared to their resting counterparts, a 2.2 and 2.1-fold increase in ROS generation by 
TNF-α primed neutrophils following LPS and IL-8 challenge respectively was seen here. As 
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ROS production is a key event in NET generation [443;462;463], this priming-induced 
increase in ROS generation may be one mechanism by which to explain the greater NET 
formation by primed neutrophils. Another possibility is that priming initiates the process of 
NET formation. In a recent paper, Wang and co-workers reported that TNF-α stimulation of 
human neutrophils for 15 minutes, the time-frame we used for neutrophil priming, resulted in 
the hypercitrullination of histone H4, a modification that is thought to drive chromatin 
decondensation [458;459]. Therefore, it would appear that short-term stimulation with TNF-α 
is sufficient to activate PAD4, the enzyme that catalyses histone citrullination and whose 
activity is essential for NET production [458]. Thus, it is reasonable to suggest that the 
process of NET formation may have already been underway in TNF-α primed neutrophils 
prior to their stimulation with LPS or IL-8.   
When the effect of age on NET production by TNF-α primed neutrophils was investigated, 
neutrophils from older adults generated significantly fewer NETs when stimulated with either 
LPS or IL-8 when compared to cells from young donors. Accompanying this defect in NET 
production was an age-associated reduction in the generation of ROS.  Whilst an age-related 
impairment in NET formation is a novel observation, the decline in ROS generation has been 
reported previously. In these studies, it was shown that ROS production by GM-CSF-primed 
neutrophils upon fMLP stimulation was markedly reduced with age [412;433]. Thus, these 
findings along with the observations shown here suggest that neutrophils from elderly 
subjects are not primed as efficiently as those from younger adults.  
As the generation of ROS is fundamental for NET formation [443;462;463], a decline in ROS 
production is a possible mechanism by which to explain the age-related impairment in NET 
generation by TNF-α primed neutrophils. However, although necessary, ROS by themselves 
cannot induce NET formation [458;470]. Therefore, other factors in addition to the decline 
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we observed in ROS production may have contributed to the age-associated impairment in 
NET generation. These include: defective intracellular signalling, aberrant induction of 
autophagy and/or histone citrullination and age-related alterations in the composition of the 
circulating neutrophil pool. Each of these possibilities will now be discussed. 
(i) Defective intracellular signalling  
Although neutrophils from elderly individuals failed to generate NETs as effectively as those 
from young controls in response to IL-8 or LPS treatment, no age-associated difference in 
PMA-induced NET formation was seen. Since PMA activates cells independently of 
membrane receptors via direct activation of PKC, this finding suggests that defective 
intracellular signalling proximal to the neutrophil membrane and upstream of PKC may 
underlie the age-related impairment observed in both ROS and NET production following  
IL-8 and LPS stimulation. 
Neutrophils respond directly to IL-8 and LPS challenge as a result of their expression of the 
G protein coupled receptors CXCR1 and CXCR2, and the pathogen recognition receptor 
TLR4 respectively. Results of a single study have shown no changes with age in either the 
proportion of neutrophils expressing TLR4 or in the surface density of this receptor [412], 
suggesting no age-related impairment in the ability of neutrophils to detect LPS. In contrast, 
studies performed within our group have shown ageing to be accompanied by a significant 
reduction in the percentage of CXCR1
+
 neutrophils, although no change was observed in 
CXCR2 expression (H. Greenwood, unpublished observations). As it is signalling through 
CXCR1 and not CXCR2 that triggers activation of NADPH oxidase [558], this reduced 
frequency of CXCR1
+
 neutrophils may be responsible in part not only for the age-related 
impairment we observed in IL-8-induced ROS generation, but also NET formation given that 
ROS production is necessary for the generation of these structures.  
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The signalling pathway downstream of TLR4 consists of adaptor molecules such as MyD88 
and a number of serine/threonine protein kinases [559]. When studying the response of 
neutrophils from young and old subjects to LPS stimulation, Fulop and colleagues noted that 
the quantity of MyD88 was significantly lower in the membranes of neutrophils that had been 
obtained from older adults [412]. Furthermore, aged neutrophils failed to recruit the protein 
kinase IRAK-1 into lipid rafts, a defect the group assigned to previously described age-
associated alterations in the physicochemical status of the neutrophil membrane [412;425]. 
IRAK-1 is an upstream activator of MAPKs, which have recently been shown to play an 
important role in NET formation [559;560]. Thus, an age-related impairment in MAPK 
signalling resulting from inefficient recruitment of IRAK-1 to lipid rafts could underlie the 
reduction in LPS-induced NET formation with age. That said, it should be noted that               
TLR4-induced activation of MAPK can also occur in a MyD88 and IRAK-1 independent 
manner [559]. Whether this pathway is also altered in neutrophils with age is unknown. 
To date, no group has investigated whether the recruitment and/or activation of signalling 
elements downstream of CXCR1 and/or CXCR2 are also affected by age. However, based on 
the concept of Fulop et al [412], which suggests age-associated changes in the composition of 
the neutrophil membrane would lead to impaired signalling for all surface receptors, then it is 
likely that IL-8 induced signalling pathways would be altered with age.  
(ii) Autophagy and histone hypercitrullination  
Based on their observation that PMA-induced NET formation was preceded by massive 
vacuolization and the generation of vesicles with double membranes, Remijsen et al [470] 
investigated whether autophagy was involved in NET production. Using the PI3-kinase 
inhibitor wortmannin, the group showed autophagy induction was essential for both the 
generation of these vesicles and NET formation [470]. Several forms of autophagy exist, and 
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whilst not stated by the group, the generation of double membrane vesicles suggests it is the 
induction of macroautophagy that is important for NET formation.  
Whilst it is currently unknown as to whether IL-8 can induce autophagy in neutrophils, a 
recent study has shown LPS to be a potent inducer of autophagy in these cells [561]. Thus, 
did an age-related impairment in autophagy induction contribute to the decline in NET 
production observed with age following LPS stimulation? To answer this question it first has 
to be determined whether macroautophagy is required for LPS-induced NET formation since 
Remijsen and co-workers only studied this phenomenon in the context of PMA treatment 
[470]. If it is, then interestingly there is evidence, albeit in non-immune cells, that has shown 
the rate of macroautophagy declines with increasing age [562;563]. Since this thesis found no 
age-related difference in PMA-induced NET production, this would suggest that the 
machinery that drives autophagy is not inherently defective in neutrophils from older adults.  
Therefore, any impairment in autophagy induction with age would most likely be borne from 
aberrant intracellular signalling proximal to the neutrophil membrane. On this note, the 
activation of signalling molecules that regulate macroautophagy such as MAPKs have been 
shown to be impaired in neutrophils from older adults following ligation of cell surface 
receptors [432;564], which suggests the induction of macroautophagy may not be as efficient 
in neutrophils from aged donors when compared to that of their younger counterparts.  
Alongside ROS generation and the induction of autophagy, hypercitrullination of histones H3 
and H4 is a critical event in NET generation. Catalysed by the calcium-dependent enzyme 
PAD4, this post-translational modification of histones is thought to drive chromatin 
decondensation [459]. Several studies have demonstrated that following receptor ligation, 
neutrophils from older adults exhibit impaired calcium mobilisation [418;565], which has 
been attributed to an age-related reduction in the generation of the calcium mobilising second 
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messenger IP3 [424]. Given the importance of calcium in triggering and sustaining PAD4 
activity, it is reasonable to think that a defect in its mobilisation would adversely affect PAD4 
function, a consequence of which would be a reduction in histone citrullination and 
chromatin decondensation. To test this proposal, initial studies could examine by Western 
blotting the degree of histone H3 and H4 citrullination in primed neutrophils from young and 
old subjects following IL-8 and LPS stimulation.    
 (iii) Age-associated alterations in the composition of the circulating neutrophil pool 
Evidence is emerging that suggests neutrophils are a heterogeneous population of cells. For 
instance, in mice, three neutrophil subsets with unique functional and phenotypic 
characteristics have been described [394], whilst in humans, neutrophil heterogeneity based 
on differential surface expression of CD16 has been reported [566]. Interestingly, in vitro 
studies have shown that not all neutrophils generate NETs upon stimulation [443], with one 
group suggesting that as little as 20% are capable of performing this function [567]. Could it 
be that NET production is a feature of a distinct neutrophil subset? Currently, no study has 
attempted to answer this question, but if we assume that it is, then maybe the age-related 
impairment in NET formation was the result of an age-associated reduction in the frequency 
of neutrophils capable of generating NETs. 
Results of two recent studies have challenged the long-standing notion that NETs exhibit 
direct microbicidal activity. Unlike previous groups who cultured micro-organisms with 
resting neutrophils or neutrophils that had been pre-treated with NET-inducing stimuli, and 
assumed that the reduced number of micro-organisms they recovered from the latter culture 
was the result of NET-based killing, both Menegazzi et al [447] and Parker and colleagues 
[445] released micro-organisms that during culture had become entangled within NETs 
before assessing their viability. Using this approach, neither group found evidence of NET-
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mediated killing. Based on these observations, it has been suggested that rather than 
eliminating pathogens directly, NETs serve to merely contain pathogens at the infection foci 
[447;448]. In support of this claim, two independent groups have shown that in vivo depletion 
of NETs via exogenous DNase treatment significantly enhances bacterial dissemination 
[478;479]. Thus, if mirrored in vivo, the age-related decline in NET formation could prevent 
elderly individuals from effectively confining pathogens to the initial site of infection.  
In recent years, evidence has emerged from epidemiological studies that suggests the use of 
statins, a family of HMG-CoA reductase inhibitors widely prescribed for the treatment of 
hyperlipidemia, may be beneficial for the treatment and prevention of bacterial infections. In 
the first study of its kind, Liappis and colleagues investigated retrospectively the association 
between statin therapy and mortality arising from bacteraemia in hospitalised older adults, 
and found increased survival rates amongst those individuals who had received statin 
treatment [568]. That statins reduce infection-associated mortality has since been reported by 
several other groups [569-571], whilst evidence can also be found to suggest that statin use 
reduces the risk of contracting community-acquired pneumonia [572]. From these data it has 
been proposed that alongside their lipid-lowering properties, statins exert immunomodulatory 
effects. Interestingly, in a recent study, Chow et al reported that in vitro statin treatment could 
directly influence the bactericidal capacity of neutrophils by enhancing their generation of 
NETs [550]. Based on this observation it was investigated whether pre-treating neutrophils 
from old donors with simvastatin could increase NET production upon subsequent exposure 
to IL-8. In contrast to the result of Chow et al [550], no difference in NET formation between 
vehicle and simvastatin-treated neutrophils treated with IL-8 was found. Inter-study 
differences in experimental design are likely to be responsible for these contrasting 
observations, the most significant being the dose of simvastatin used. Whilst in this study 
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neutrophils were treated with 1 nM simvastatin, which is akin to the concentrations present in 
the circulation of patients undergoing standard statin therapy (20-40 mg per day; Dr. 
Elizabeth Sapey, personal communication), Chow et al [550] pre-treated cells with 10 µM 
simvastatin, which represents a supraphysiological concentration. Other differences in 
experimental set-up include the length of simvastatin treatment (40 minutes Vs. 1 hour), the 
source of neutrophils (old Vs. young adults) and the stimuli used to trigger NET formation 
(IL-8 Vs. PMA). Another caveat is that due to time constraints, data presented in this thesis 
was collected from a small cohort of only seven donors, meaning it is possible that the study 
was under powered. 
Although this study found statin treatment had no significant effect upon NET production, a 
small but significant increase in ROS production was seen in simvastatin-treated neutrophils 
in response to IL-8 stimulation. As mentioned above, ROS generation by neutrophils is 
dependent upon activation of the multicomponent enzyme system NADPH oxidase, which is 
mediated primarily through phosphorylation of its cytosolic and membrane components 
[554]. One kinase that is known to be involved in NADPH oxidase activation is PKC, whose 
phosphorylation of the trans-membrane protein cytochrome b558 has been shown to be 
important for promoting the assembly of NADPH oxidase at the neutrophil plasma membrane 
[573]. Interestingly, statins have been reported to significantly increase PKC activity [574]. 
Thus, a possible mechanism that could explain how pre-treatment with simvastatin enhanced 
IL-8-induced ROS production is that prior to IL-8 challenge, simvastatin-treated neutrophils 
had already begun to assemble NADPH oxidase at the plasma membrane. 
 
 
Page | 207  
 
 
 
 
 
 
Chapter 5 
General Discussion 
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5.0 General Discussion 
5.1 Mechanism(s) underlying the age-associated reduction in NKCC  
When this project was conceived, it had been known for many years that physiological 
ageing was accompanied by a marked reduction in NK lytic activity at the single cell level 
[42;365;371]. However, no group had identified the underlying cause(s), although from the 
results of a small number of studies it was known that the defect lay downstream of NK-
target cell interaction [365;372;374]. In this thesis, it has been shown that upon target cell 
contact, NK cells from older adults release less perforin into the IS. This defect resulted in 
reduced perforin binding to the target cell surface, an event that was found to correlate 
strongly with target cell lysis. Thus, it is proposed that an age-related impairment in perforin 
secretion into the IS mediates the decline in NKCC that accompanies physiological ageing. 
From the findings presented in this report, the age-related decline in perforin secretion can be 
attributed to defective polarisation of lytic granules to the NK-target cell interface, and the 
data suggest that this results in part from delayed activation of the MAPK, ERK1/2, which 
plays a critical role in the mobilisation and polarisation of secretory lysosomes [263]. 
However, the fact that no age-associated difference was seen in the number of granules that 
had fused with the NK cell plasma membrane despite an impairment in granule polarisation 
in NK cells from older adults, suggests that another mechanism may contribute to the decline 
in perforin secretion. As discussed earlier, an intriguing possibility is that ageing is also 
associated with a reduction in the activity of ASMase, as this enzyme, which catalyses the 
hydrolysis of sphingomyelin to ceramide, has been shown to play a crucial role in the 
secretion of cytolytic effector molecules into the IS [541]. Interestingly, impaired activation 
of both ERK1/2 and ASMase could occur as a result of an age-related defect in a single 
signalling molecule: PKC.  
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PKC is a large family of serine-threonine kinases consisting of 11 isoenzymes that are 
classified into three subfamilies: classical PKCs, which include PKC α, βI, βII and γ, novel 
PKCs, which are represented by PKC δ, ε, η and θ, and the atypical PKCs to which PKC ζ 
and ι belong [575;576]. These subfamilies are distinguished from one another by the co-
factors that regulate their activity. For example, whilst classical PKCs require calcium and 
diacylglycerol (DAG) to function, novel PKCs are regulated entirely by DAG [575;576]. In 
contrast, atypical PKC isoenzymes possess no calcium or DAG binding domains, and instead 
are thought to be regulated through protein-protein interactions and phosphorylation [575]. 
Several studies have demonstrated that upon binding to K562 target cells, NK cells generate 
significant amounts of DAG and the calcium mobilising second messenger IP3[577-580], 
suggesting a role for PKC signalling in natural cytotoxicity. Indeed, the addition of broad-
acting PKC inhibitors to NK-K562 co-cultures significantly reduces target cell lysis [581]. 
Importantly, in the context of the findings presented in this thesis, it seems that PKC is part of 
the signalling cascade that triggers the secretion of cytotoxic molecules by NK cells, since 
PKC inhibition has been shown to dramatically reduce PMA-induced granule exocytosis 
[582]. NK cells express the PKC isoenzymes, PKC α, β, δ, ε, θ and ζ [583-585]. With respect 
to the work presented here, PKCδ is particularly interesting given that it has been shown to 
not only modulate ERK1/2 activity [586] but to also bind, phosphorylate and activate 
ASMase [587;588]. Thus, the delayed kinetics in ERK1/2 phosphorylation that were 
observed in NK cells from older adults following stimulation with plate-bound anti-NKG2D 
and NKp30 antibodies, and the decrease in ASMase activity that is proposed may occur with 
age could both be explained by an age-related reduction in PKCδ activity. Importantly, 
studies have already been performed that have shown signalling events leading to PKC 
activation are impaired in NK cells from older adults. In an elegant study, Mariani and 
colleagues demonstrated a marked age-related decrease in the ability of NK cells to generate 
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IP3 following K562 stimulation, which was borne from a delay in phosphatidylinositol 4,5-
bisphosphate (PIP2) hydrolysis [373]. As DAG is also a product of PIP2 breakdown, one 
would assume that the levels of this second messenger are also lower in K562-stimulated NK 
cells from older adults. As a novel PKC, PKCδ requires binding of DAG to its regulatory 
domain in order to become activated [575;576]. Thus, it is reasonable to suggest that the 
activity of PKCδ may be lower in NK cells from older subjects following K562 stimulation. 
Given that PKCδ lies upstream of ERK1/2 [586], then a reduction in its activity could 
contribute to the age-related impairment we observed in the delivery of lytic granules to the 
NK-target cell interface since ERK signalling is essential for lytic granule mobilisation and 
polarisation [263]. Furthermore, as ASMase is activated by PKCδ–mediated phosphorylation 
[587;588], reduced PKCδ activity would lead to a decline in ASMase activity.  
When NK cells were stimulated with PMA and ionomycin, which mimic the signals provided 
by DAG and IP3 respectively, no age-related difference in either perforin release or in the 
kinetics of ERK1/2 phosphorylation were found. These findings are similar to those of 
Ghoneum and co-workers who reported PMA treatment could correct the defective cytolytic 
activity of NK cells from aged mice [589]. As both PMA and ionomycin bypass cell-surface 
receptors to activate PKC, these two sets of data support the previously described work of 
Mariani et al [373] by suggesting that signalling events that precede PKC activation are 
impaired with age. As reported for other cells types [65;425], age-related alterations in the 
lipid composition of the NK cell plasma membrane may be responsible for these proximal 
signalling defects. Present within the plasma membrane are specialised microdomains called 
lipid rafts. Enriched for sphingolipids and cholesterol, lipid rafts fuse together to form large 
signalling platforms that assist in signal transduction by serving as a site at which signalling 
complexes interact. Interestingly, ceramide, which is generated predominantly by ASMase-
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mediated hydrolysis of sphingomyelin, drives the fusion of lipid rafts into large platforms. 
Since ASMase is a PKCδ activated enzyme [587;588], the decline in PKCδ activity that may 
accompany physiological ageing would lead to impaired activation of ASMase, a 
consequence of which would be reduced production of ceramide at the plasma membrane. 
This would affect the efficiency of lipid raft fusion, leading to impaired signal transduction 
upon ligation of activatory receptors.  
Bringing together the data discussed in the above two paragraphs, it is proposed that impaired 
activation of PKCδ following target cell binding could be responsible for the age-related 
decline in NKCC. The result of delayed PIP2 hydrolysis following ligation of activatory 
receptors, reduced PKCδ activity could explain both the delayed kinetics of ERK1/2 
phosphorylation that were observed in NK cells from older adults following stimulation with 
plate bound antibodies, as well as the age-associated impairment we noted in ERK1/2-
dependent polarisation of lytic granules to the IS, as c-Raf, an upstream activator of ERK1/2 
is a direct target of PKCδ [586]. Furthermore, a reduction in PKCδ activity could explain our 
rather intriguing finding that despite comparable granule fusion and perforin expression, NK 
cells from older subjects released less perforin into the IS when compared to their younger 
controls.  
To provide support for this theory it will be necessary to show that PKCδ activity is reduced 
in stimulated NK cells from older donors. Whilst the PMA and ionomycin data suggest that 
signalling pathways that trigger PKC activation upon target cell binding are impaired with 
age, more direct evidence is needed. As translocation of PKCδ from the cytosol to the plasma 
membrane is a hallmark of its activation, comparing the location of this kinase in stimulated 
NK cells from young and old subjects would be a useful starting point.    
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When the expression of the early activation marker CD69 on the surface of young and old 
NK cells following K562 stimulation was compared, no age-related difference was observed. 
Interestingly, Borrego and co-workers have shown that PKC signalling is heavily involved in 
K562 cell-induced expression of CD69 [590]. Thus, if impaired activation of PKC underlies 
the age-related decline in NKCC, then why was surface CD69 expression not reduced in NK 
cells from older adults? As mentioned earlier, NK cells express classical, novel and atypical 
PKC isoenzymes [583-585], which differ in the co-factors that regulate their activity 
[575;576]. From the work of Mariani et al, which showed an age-related delay in PIP2 
hydrolysis [373], one would assume that the activity of both classical and novel PKCs is 
reduced in K562 stimulated NK cells from older adults since the PIP2 products IP3 and/or 
DAG are required for their activation [575;576]. However, atypical PKC isoenzymes possess 
no calcium or DAG binding domains, and as such their activity may be comparable in young 
and old NK cells. Which PKC isoenzyme is responsible for driving CD69 expression on the 
surface of K562-stimulated NK cells is unknown since Borrego et al used a broad acting PKC 
inhibitor in their experiments [590]. If we assume that PKCζ, the atypical PKC expressed by 
NK cells, is responsible then this may explain why no age-related decline in CD69 expression 
was seen, though this is pure speculation at this point. 
A feature of physiological ageing is the accumulation of senescent cells. These cells, which 
have been detected in such tissues as skin [591], bone [592] and endothelium [593] reside in 
a state of irreversible cell cycle arrest, yet remain metabolically active, secreting an array of 
growth factors, pro-inflammatory cytokines (e.g. IL-6 and IL-8) and proteases (e.g. matrix 
metalloproteinases). In light of these functional properties, the sites at which they reside and 
the fact that they accumulate with age, senescent cells have been suggested to contribute to 
the development of a number of age-related pathologies by compromising tissue homeostasis 
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and function [594]. Recently, Baker and colleagues [595] tested this proposal by using an 
innovative transgenic strategy that enabled them to specifically eliminate senescent cells from 
tissues in which age-associated pathologies develop. In a group of young mice, life-long 
removal of senescent cells was shown to delay the onset of such age-related conditions as 
sarcopenia and cataracts [595]. More striking however was the fact that the elimination of 
senescent cells in older mice, who were already displaying ageing traits, attenuated the 
subsequent age-associated loss of muscle mass and fat tissue that was observed in littermate 
controls [595]. Thus, it seems that senescent cells can be assigned a causative role in the 
development of a number of age-associated pathologies. Interestingly, Sagiv and co-workers 
have recently suggested that via perforin-mediated cytotoxicity, NK cells eliminate senescent 
cells in vivo [596]. In a murine model of liver fibrosis, a setting in which the removal of 
senescent cells is important to limit damage and facilitate repair [597], the group found an 
increased frequency of senescent cells in the livers of perforin deficient mice when compared 
to their wild type counterparts, which was accompanied by greater tissue scarring and 
extracellular matrix deposition [596]. Whilst the use of perforin deficient mice is not the best 
model in which to assign a direct role for NK cells in senescent cell clearance, given that both 
iNKT cells and CD8
+
 T cells also use this form of cytotoxicity, Sagiv et al did show in vitro 
that through the granule exocytosis pathway, primary human NK cells elicit potent 
cytotoxicity towards senescent fibroblasts [596]. Given that this thesis has reported a marked 
age-related decline in this form of NK cell-mediated defence, could it be that this impairment 
contributes to the increased frequency of senescent cells found in aged tissue? A simple study 
that could be undertaken to begin testing this hypothesis would be to perform the in vitro 
cytotoxicity assays described by Sagiv et al [596] using NK cells from young and old donors 
and comparing the efficiency by which senescent cells are lysed. Should an age-related 
impairment be found, it would be of interest to move to their in vivo model of liver fibrosis 
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and compare the rate of senescent cell clearance between cohorts of young RAG1
-/-
 mice into 
which NK cells from young or aged mice had been adoptively transferred. 
In a recent study, Bigley and co-workers showed that infection with CMV has a marked 
impact on the composition of the circulating NK cell pool [364]. When compared to their 
seronegative counterparts, subjects infected with CMV were found to have a lower frequency 
of KLRG1
+
/CD57
-
 NK cells and a higher proportion of KLRG1
-
/CD57
+
 NK cells [364]. 
These observations mirrored previously described age-related changes in NK cell phenotype 
[42;352;354], yet the study was performed entirely on samples from young donors, leading 
the group to propose that the changes in NK cell phenotype that had previously been assigned 
to the ageing process may have in fact been driven by CMV [364]. With this in mind, it was 
investigated whether donor CMV status influenced the novel finding of this thesis: the age-
related decline in perforin release upon K562 cell contact. Whilst statistical analysis revealed 
age to be the main determinant for reduced perforin release [(F1,15) = 8.03, p = 0.013,                     
η2 = 0.349], a trend for CMV positive individuals to release less perforin upon K562 
stimulation was found [(F1,15) = 4.21, p = 0.058, η2 = 0.219] (Figure 5.1). This observation, 
albeit not statistically significant, is in line with previous reports that have shown interaction 
with CMV reduces the cytotoxic capacity of human NK cells [598;599]. However, unlike 
these studies, where NK cells were cultured in vitro with HCMV-infected cells prior to the 
analysis of NKCC, the findings of this thesis were obtained using NK cells whose 
cytotoxicity was examined immediately following isolation, suggesting their lytic nature had 
been altered in vivo.  
An emerging concept within the NK cell field is that in addition to mediating direct lysis of 
transformed cells, NK cells play an important immunoregulatory role in times of viral 
infection. Murine-based studies have shown that via perforin-dependent cytotoxicity, NK  
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Figure 5.1 Effect of age and CMV status on perforin release by NK cells following K562        
               stimulation.  
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cells negatively regulate virus-specific CD8
+
 T cell responses either through directly 
eliminating these cells [600] or by removing immune cells that assist in CD8
+
 T cell 
responses such as DCs and CD4
+
 T cells [601;602]. Although not a view shared by all groups 
[600], it is thought that by limiting T cell immunity, NK cells promote host survival by 
preventing excessive immune-mediated pathology [601]. As a persistent virus that undergoes 
continual low-level replication, CMV requires life-long immunological control. Therefore, 
could it be that in CMV positive individuals, NK cells are having to constantly regulate on-
going CMV-specific T cell responses, a consequence of which could be their functional 
exhaustion? Commonly observed in virus-specific CD8
+
 T cells in settings of chronic viral 
infection, functional exhaustion is characterised by a loss of cell function. Interestingly, 
functionally exhausted CD8
+
 T cells exhibit reduced perforin-mediated cytotoxicity ex vivo 
[603]. Thus, maybe the trend observed here for reduced perforin secretion by NK cells from 
CMV seropositive donors was due to an increased frequency of functionally exhausted NK 
cells within the peripheral pool of these subjects. In T cells, functional exhaustion is 
associated with increased expression of the inhibitory receptors programmed death 1 and       
T-cell immunoglobulin domain and mucin domain 3 [603;604]. Comparing the expression 
levels of these receptors on NK cells isolated from CMV positive and negative donors would 
be a quick and easy approach by which to begin testing whether CMV infection is associated 
with functional exhaustion in NK cells.  
Another mechanism that is worth considering with respect to how CMV may influence 
NKCC is based around the concept of NK cell licensing. This phenomenon dictates that to 
become functionally competent, NK cells must express on their surface inhibitory receptors 
that actively engage self-MHC class I molecules. Indeed, numerous studies have shown NK 
cells isolated from MHC class I deficient hosts are hyporesponsive to stimulatory signals 
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[288-291], a trait shared by NK cells that lack inhibitory receptors specific for self-MHC 
class I molecules [288;292]. For many years, it was thought that NK cells were licensed 
during their development in the BM, and that when released into the periphery their 
functional capacity was fixed. However, the findings of two recent studies suggest that 
changes in the peripheral MHC environment can alter the responsiveness of mature 
circulating NK cells [296;297]. Of particular interest is the work of Joncker and colleagues, 
which demonstrated that, when transferred into MHC class I deficient mice, mature 
responsive NK cells from wild type mice became hyporesponsive, suggesting that NK cells 
must continually sample self-MHC class I molecules in order to retain their reactivity [297]. 
As a persistent virus, CMV possesses several immune evasion strategies, one of which is to 
down-regulate expression of MHC class I molecules from the surface of infected cells 
[605;606]. Thus, it is reasonable to consider the possibility that due to CMV-mediated 
alterations in the MHC class I environment, a greater proportion of circulating NK cells may 
be hyporesponsive in CMV positive donors, which may explain our observation for a trend 
towards reduced perforin secretion by NK cells from CMV positive individuals upon target 
cell stimulation. This proposal may also extend to other persistent viruses such as EBV and 
VZV, which like CMV, reduce cell surface expression of MHC class I molecules [607;608]. 
It must be said however that whilst environmentally-induced alterations in NK cell 
responsiveness can be detected in vitro [296;297], its significance in vivo is unclear given the 
recent work of Orr et al, which revealed that in times of infection, “unlicensed” NK cells play 
a more important role in host protection than their licensed counterparts [298]. 
6.2 Ageing and NET formation 
NETs were discovered in 2004 by Brinkmann and colleagues [435], who noted that when 
challenged with pro-inflammatory cytokines or bacteria, neutrophils released into the 
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extracellular environment chromatin fibres decorated with granule-derived peptides and 
enzymes [435].  Since this seminal paper, our understanding of how NETs are formed, their 
constituents and the stimuli that trigger their generation has grown considerably [465]. 
However, as a relatively novel field, many aspects of NET biology require more in depth 
analysis. For instance, there is a need to: (i) further define the mechanisms that govern NET 
formation, (ii) determine the fate of microbes that become entangled within NETs and                 
(iii) gain a greater understanding of the contribution NETs make to host defence in vivo 
[448].  
When first described, NETs were thought to confer protection through pathogen entrapment 
and direct killing. However, based on the recent observations of Parker et al [445] and 
Menegazzi and colleagues [447], who both found that pathogens entangled within NETs 
remained viable, current opinion within the field is that NETs serve only to contain pathogens 
to the initial site of infection. Thus, could the age-related decrease we observed in NET 
formation contribute to the more invasive infections experienced by older adults? Results of a 
study that came to our attention whilst this discussion was being written suggest that this is a 
possibility. After observing in vitro that in response to S. aureus stimulation, neutrophils from 
aged mice generated significantly fewer NETs than those isolated from younger littermates, 
Tseng et al [609] examined its biological relevance in a murine model of skin infection. 
Staining of infected skin tissue obtained from young mice revealed the presence of NETs at 
the edge of the infection foci, with very few bacteria beyond the initial site of inoculation 
[609]. In contrast, staining of skin tissue obtained from aged mice, who by day three post-
infection exhibited a significantly increased systemic bacterial burden, revealed a 
disorganised and much smaller meshwork of extracellular DNA, which had been penetrated 
by many bacteria [609]. Based on these findings, the group proposed that whilst unlikely to 
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be solely responsible, an age-associated impairment in NET generation contributes to the 
increased incidence of invasive bacterial diseases reported by older adults [609]. Our 
observation, albeit in vitro, that NET formation by neutrophils from elderly humans is also 
reduced provides some support to this claim.  
When concluding their findings, Tseng and colleagues suggested that gaining a greater 
understanding of the mechanisms that underlie the age-related decrease they observed in NET 
formation could lead to the development of therapeutic strategies to enhance NET production 
in aged hosts [609]. Whilst appealing, attempting to enhance NET formation in vivo is a 
strategy fraught with danger. For instance, as well as promoting thrombosis [610] and 
directly inducing epithelial and endothelial cell death [446], NETs have been linked to the 
pathology of several inflammatory disorders [485;611] and proposed to contribute to the 
development of certain autoimmune conditions [480;487;488].This latter association between 
NETs and autoimmunity is particularly pertinent in the context of trying to enhance NET 
formation in older adults, given that ageing has been shown to be accompanied by an increase 
in the circulating levels of auto antibodies against the two major constituents of NETs: DNA 
and histones [612-614].  
Although a characteristic feature of the innate immune response, NET generation has recently 
been reported to influence the activity of adaptive immune cells. In a series of in vitro assays, 
Tillack and colleagues [451] demonstrated that through a contact-dependent mechanism, 
NETs directly prime CD4
+
 T cells, thereby reducing their activation threshold. Indeed, when 
compared to T cells that had been cultured with resting neutrophils, the functional response 
elicited by NET-primed T cells was significantly greater not only in times of antigenic 
specific challenge but also following sub-optimal stimulation [451]. Thus, whilst not directly 
microbicidal, NETs may promote pathogen clearance by increasing the activity of bystander 
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immune cells. Given the age-related reduction in NET generation presented in this thesis and 
by Tseng et al [609], then NET-mediated T cell priming may not be as efficient in older 
adults, further exacerbating the well-documented dysregulation in T cell function that 
accompanies physiological ageing [57;58;61;62]. 
Despite the fact that numerous studies have examined the effect of human ageing on 
neutrophil function, only one group has performed a longitudinal-based study to determine 
the effect that age-associated changes in neutrophil behaviour have on human health [411]. 
Thus, in an effort to establish whether a direct link exists between neutrophil 
immunesenescence and the increased incidence of infection reported by older adults, 
retrospective and prospective studies should be at the forefront of future research. In the 
context of this thesis, in which it was demonstrated for the first time that physiological ageing 
in humans is accompanied by a marked reduction in NET formation, a longitudinal study that 
enrols both young and older adults would be of particular interest as its results would provide 
an insight into whether the increased susceptibility older adults exhibit towards bacterial and 
fungal infection [544-547], two pathogens that are potent inducers of NET formation, is 
attributable in any way to the age-related decline in NET generation we observed in vitro.  
 
 
 
 
 
 
Page | 221  
 
 
 
 
CHAPTER 6 
REFERENCES 
 
 
 
 
 
 
 
 
 
 
Page | 222  
 
6.0 References 
 1.  United Nations Department of Economic and Social Affairs Population Division. 
World Population Ageing:1950-2050. Chapter I. Demographic determinants of 
population ageing.  
Ref Type: Report 
 2.  United Nations Department of Economic and Social Affairs Population Division. 
World Population Ageing 1950-2050 Executive Summary.  
Ref Type: Report 
 3.  Kinsella K, Velkoff VA. U.S. Census Bureau, Series P95/01-1, An Aging World: 
2001. U.S. Government Printing Office.  
Ref Type: Report 
 4.  Office for National Statistics. Ageing, Fastest increase in the "oldest old".  2009.  
Ref Type: Report 
 5.  House of Lords Science and Technology Committee. Ageing: Scientific Aspects.                
1-133. 2005.  
Ref Type: Report 
 6.  Hansen-Kyle L: A concept analysis of healthy aging. Nurs.Forum 2005, 40:45-57. 
 7.  Depp CA, Jeste DV: Definitions and predictors of successful aging: a comprehensive 
review of larger quantitative studies. Am.J.Geriatr.Psychiatry 2006, 14:6-20. 
 8.  Franco OH, Karnik K, Osborne G, Ordovas JM, Catt M, van der Ouderaa F: 
Changing course in ageing research: The healthy ageing phenotype. Maturitas 2009, 
63:13-19. 
 9.  Fleming DM, Elliot AJ: The impact of influenza on the health and health care 
utilisation of elderly people. Vaccine 2005, 23 Suppl 1:S1-S9. 
 10.  Janssens JP, Krause KH: Pneumonia in the very old. Lancet Infect.Dis. 2004, 4:112-
124. 
 11.  Marston BJ, Plouffe JF, File TM, Jr., Hackman BA, Salstrom SJ, Lipman HB, 
Kolczak MS, Breiman RF: Incidence of community-acquired pneumonia requiring 
hospitalization. Results of a population-based active surveillance Study in Ohio. The 
Community-Based Pneumonia Incidence Study Group. Arch.Intern.Med. 1997, 
157:1709-1718. 
 12.  Emori TG, Banerjee SN, Culver DH, Gaynes RP, Horan TC, Edwards JR, Jarvis WR, 
Tolson JS, Henderson TS, Martone WJ, .: Nosocomial infections in elderly patients in 
the United States, 1986-1990. National Nosocomial Infections Surveillance System. 
Am.J.Med. 1991, 91:289S-293S. 
 13.  Magliano E, Grazioli V, Deflorio L, Leuci AI, Mattina R, Romano P, Cocuzza CE: 
Gender and age-dependent etiology of community-acquired urinary tract infections. 
ScientificWorldJournal. 2012, 2012:349597. 
Page | 223  
 
 14.  Hanson LC, Weber DJ, Rutala WA: Risk factors for nosocomial pneumonia in the 
elderly. Am.J.Med. 1992, 92:161-166. 
 15.  Yoshikawa TT: Perspective: aging and infectious diseases: past, present, and future. 
J.Infect.Dis. 1997, 176:1053-1057. 
 16.  Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda 
K: Mortality associated with influenza and respiratory syncytial virus in the United 
States. JAMA 2003, 289:179-186. 
 17.  U.S.Department of Health and Human Services. Trends in Influenza and Pneumonia 
Among Older Persons in the United States.  1-12. 2008.  
Ref Type: Report 
 18.  Fein AM: Pneumonia in the elderly: overview of diagnostic and therapeutic 
approaches. Clin.Infect.Dis. 1999, 28:726-729. 
 19.  Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, 
Weintraub E, Bridges CB: The annual impact of seasonal influenza in the US: 
measuring disease burden and costs. Vaccine 2007, 25:5086-5096. 
 20.  Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda 
K: Influenza-associated hospitalizations in the United States. JAMA 2004, 292:1333-
1340. 
 21.  Horsburgh CR, Jr., O'Donnell M, Chamblee S, Moreland JL, Johnson J, Marsh BJ, 
Narita M, Johnson LS, von Reyn CF: Revisiting rates of reactivation tuberculosis: a 
population-based approach. Am.J.Respir.Crit Care Med. 2010, 182:420-425. 
 22.  Donahue JG, Choo PW, Manson JE, Platt R: The incidence of herpes zoster. 
Arch.Intern.Med. 1995, 155:1605-1609. 
 23.  Ragozzino MW, Melton LJ, III, Kurland LT, Chu CP, Perry HO: Population-based 
study of herpes zoster and its sequelae. Medicine (Baltimore) 1982, 61:310-316. 
 24.  High KP: Infection as a cause of age-related morbidity and mortality. Ageing Res.Rev. 
2004, 3:1-14. 
 25.  Steinmann GG, Klaus B, Muller-Hermelink HK: The involution of the ageing human 
thymic epithelium is independent of puberty. A morphometric study. 
Scand.J.Immunol. 1985, 22:563-575. 
 26.  Aw D, Silva AB, Palmer DB: Immunosenescence: emerging challenges for an ageing 
population. Immunology 2007, 120:435-446. 
 27.  Panda A, Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR, Lord JM, Shaw AC: 
Human innate immunosenescence: causes and consequences for immunity in old age. 
Trends Immunol. 2009, 30:325-333. 
 28.  Shaw AC, Joshi S, Greenwood H, Panda A, Lord JM: Aging of the innate immune 
system. Curr.Opin.Immunol. 2010, 22:507-513. 
Page | 224  
 
 29.  Hannoun C, Megas F, Piercy J: Immunogenicity and protective efficacy of influenza 
vaccination. Virus Res. 2004, 103:133-138. 
 30.  Looney RJ, Hasan MS, Coffin D, Campbell D, Falsey AR, Kolassa J, Agosti JM, 
Abraham GN, Evans TG: Hepatitis B immunization of healthy elderly adults: 
relationship between naive CD4+ T cells and primary immune response and 
evaluation of GM-CSF as an adjuvant. J.Clin.Immunol. 2001, 21:30-36. 
 31.  Flores KG, Li J, Sempowski GD, Haynes BF, Hale LP: Analysis of the human thymic 
perivascular space during aging. J.Clin.Invest 1999, 104:1031-1039. 
 32.  Yang H, Youm YH, Sun Y, Rim JS, Galban CJ, Vandanmagsar B, Dixit VD: Axin 
expression in thymic stromal cells contributes to an age-related increase in thymic 
adiposity and is associated with reduced thymopoiesis independently of ghrelin 
signaling. J.Leukoc.Biol. 2009, 85:928-938. 
 33.  Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, Casti A, 
Franceschi C, Passeri M, Sansoni P: Shortage of circulating naive CD8(+) T cells 
provides new insights on immunodeficiency in aging. Blood 2000, 95:2860-2868. 
 34.  Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, Nayak L, Moss 
PA: Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater 
clonality in healthy elderly individuals. J.Immunol. 2002, 169:1984-1992. 
 35.  Ouyang Q, Wagner WM, Wikby A, Walter S, Aubert G, Dodi AI, Travers P, Pawelec 
G: Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a 
single dominant CMV epitope in the very old. J.Clin.Immunol. 2003, 23:247-257. 
 36.  Ouyang Q, Wagner WM, Walter S, Muller CA, Wikby A, Aubert G, Klatt T, 
Stevanovic S, Dodi T, Pawelec G: An age-related increase in the number of CD8+ T 
cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is 
counteracted by a decreased frequency of their antigen-specific responsiveness. 
Mech.Ageing Dev. 2003, 124:477-485. 
 37.  Naylor K, Li G, Vallejo AN, Lee WW, Koetz K, Bryl E, Witkowski J, Fulbright J, 
Weyand CM, Goronzy JJ: The influence of age on T cell generation and TCR 
diversity. J.Immunol. 2005, 174:7446-7452. 
 38.  Messaoudi I, Lemaoult J, Guevara-Patino JA, Metzner BM, Nikolich-Zugich J: Age-
related CD8 T cell clonal expansions constrict CD8 T cell repertoire and have the 
potential to impair immune defense. J.Exp.Med. 2004, 200:1347-1358. 
 39.  Yager EJ, Ahmed M, Lanzer K, Randall TD, Woodland DL, Blackman MA: Age-
associated decline in T cell repertoire diversity leads to holes in the repertoire and 
impaired immunity to influenza virus. J.Exp.Med. 2008, 205:711-723. 
 40.  Effros RB, Boucher N, Porter V, Zhu X, Spaulding C, Walford RL, Kronenberg M, 
Cohen D, Schachter F: Decline in CD28+ T cells in centenarians and in long-term T 
cell cultures: a possible cause for both in vivo and in vitro immunosenescence. 
Exp.Gerontol. 1994, 29:601-609. 
Page | 225  
 
 41.  McNerlan SE, Rea IM, Alexander HD, Morris TC: Changes in natural killer cells, the 
CD57CD8 subset, and related cytokines in healthy aging. J.Clin.Immunol. 1998, 
18:31-38. 
 42.  Miyaji C, Watanabe H, Minagawa M, Toma H, Kawamura T, Nohara Y, Nozaki H, 
Sato Y, Abo T: Numerical and functional characteristics of lymphocyte subsets in 
centenarians. J.Clin.Immunol. 1997, 17:420-429. 
 43.  Vallejo AN, Mueller RG, Hamel DL, Jr., Way A, Dvergsten JA, Griffin P, Newman 
AB: Expansions of NK-like alphabetaT cells with chronologic aging: novel 
lymphocyte effectors that compensate for functional deficits of conventional NK cells 
and T cells. Ageing Res.Rev. 2011, 10:354-361. 
 44.  Stephan RP, Reilly CR, Witte PL: Impaired ability of bone marrow stromal cells to 
support B-lymphopoiesis with age. Blood 1998, 91:75-88. 
 45.  Rossi DJ, Bryder D, Zahn JM, Ahlenius H, Sonu R, Wagers AJ, Weissman IL: Cell 
intrinsic alterations underlie hematopoietic stem cell aging. Proc.Natl.Acad.Sci.U.S.A 
2005, 102:9194-9199. 
 46.  Miller JP, Allman D: The decline in B lymphopoiesis in aged mice reflects loss of 
very early B-lineage precursors. J.Immunol. 2003, 171:2326-2330. 
 47.  Riley RL, Kruger MG, Elia J: B cell precursors are decreased in senescent BALB/c 
mice, but retain normal mitotic activity in vivo and in vitro. 
Clin.Immunol.Immunopathol. 1991, 59:301-313. 
 48.  Frasca D, Diaz A, Romero M, Landin AM, Blomberg BB: Age effects on B cells and 
humoral immunity in humans. Ageing Res.Rev. 2011, 10:330-335. 
 49.  Paganelli R, Quinti I, Fagiolo U, Cossarizza A, Ortolani C, Guerra E, Sansoni P, 
Pucillo LP, Scala E, Cozzi E, .: Changes in circulating B cells and immunoglobulin 
classes and subclasses in a healthy aged population. Clin.Exp.Immunol. 1992, 90:351-
354. 
 50.  Veneri D, Ortolani R, Franchini M, Tridente G, Pizzolo G, Vella A: Expression of 
CD27 and CD23 on peripheral blood B lymphocytes in humans of different ages. 
Blood Transfus. 2009, 7:29-34. 
 51.  Stephan RP, Sanders VM, Witte PL: Stage-specific alterations in murine B 
lymphopoiesis with age. Int.Immunol. 1996, 8:509-518. 
 52.  Kline GH, Hayden TA, Klinman NR: B cell maintenance in aged mice reflects both 
increased B cell longevity and decreased B cell generation. J.Immunol. 1999, 
162:3342-3349. 
 53.  Miller JP, Cancro MP: B cells and aging: balancing the homeostatic equation. 
Exp.Gerontol. 2007, 42:396-399. 
Page | 226  
 
 54.  Colonna-Romano G, Bulati M, Aquino A, Scialabba G, Candore G, Lio D, Motta M, 
Malaguarnera M, Caruso C: B cells in the aged: CD27, CD5, and CD40 expression. 
Mech.Ageing Dev. 2003, 124:389-393. 
 55.  Frasca D, Landin AM, Lechner SC, Ryan JG, Schwartz R, Riley RL, Blomberg BB: 
Aging down-regulates the transcription factor E2A, activation-induced cytidine 
deaminase, and Ig class switch in human B cells. J.Immunol. 2008, 180:5283-5290. 
 56.  Shi Y, Yamazaki T, Okubo Y, Uehara Y, Sugane K, Agematsu K: Regulation of aged 
humoral immune defense against pneumococcal bacteria by IgM memory B cell. 
J.Immunol. 2005, 175:3262-3267. 
 57.  Deng Y, Jing Y, Campbell AE, Gravenstein S: Age-related impaired type 1 T cell 
responses to influenza: reduced activation ex vivo, decreased expansion in CTL 
culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. 
J.Immunol. 2004, 172:3437-3446. 
 58.  Douziech N, Seres I, Larbi A, Szikszay E, Roy PM, Arcand M, Dupuis G, Fulop T, 
Jr.: Modulation of human lymphocyte proliferative response with aging. 
Exp.Gerontol. 2002, 37:369-387. 
 59.  Fulop T, Jr., Gagne D, Goulet AC, Desgeorges S, Lacombe G, Arcand M, Dupuis G: 
Age-related impairment of p56lck and ZAP-70 activities in human T lymphocytes 
activated through the TcR/CD3 complex. Exp.Gerontol. 1999, 34:197-216. 
 60.  Moretto MM, Lawlor EM, Khan IA: Aging mice exhibit a functional defect in 
mucosal dendritic cell response against an intracellular pathogen. J.Immunol. 2008, 
181:7977-7984. 
 61.  Brien JD, Uhrlaub JL, Hirsch A, Wiley CA, Nikolich-Zugich J: Key role of T cell 
defects in age-related vulnerability to West Nile virus. J.Exp.Med. 2009, 206:2735-
2745. 
 62.  Smithey MJ, Renkema KR, Rudd BD, Nikolich-Zugich J: Increased apoptosis, 
curtailed expansion and incomplete differentiation of CD8+ T cells combine to 
decrease clearance of L. monocytogenes in old mice. Eur.J.Immunol. 2011, 41:1352-
1364. 
 63.  Bernstein ED, Gardner EM, Abrutyn E, Gross P, Murasko DM: Cytokine production 
after influenza vaccination in a healthy elderly population. Vaccine 1998, 16:1722-
1731. 
 64.  Li G, Smithey MJ, Rudd BD, Nikolich-Zugich J: Age-associated alterations in 
CD8alpha+ dendritic cells impair CD8 T-cell expansion in response to an intracellular 
bacterium. Aging Cell 2012. 
 65.  Larbi A, Douziech N, Dupuis G, Khalil A, Pelletier H, Guerard KP, Fulop T, Jr.: Age-
associated alterations in the recruitment of signal-transduction proteins to lipid rafts in 
human T lymphocytes. J.Leukoc.Biol. 2004, 75:373-381. 
Page | 227  
 
 66.  Quadri RA, Plastre O, Phelouzat MA, Arbogast A, Proust JJ: Age-related tyrosine-
specific protein phosphorylation defect in human T lymphocytes activated through 
CD3, CD4, CD8 or the IL-2 receptor. Mech.Ageing Dev. 1996, 88:125-138. 
 67.  Whisler RL, Bagenstose SE, Newhouse YG, Carle KW: Expression and catalytic 
activities of protein tyrosine kinases (PTKs) Fyn and Lck in peripheral blood T cells 
from elderly humans stimulated through the T cell receptor (TCR)/CD3 complex. 
Mech.Ageing Dev. 1997, 98:57-73. 
 68.  Lages CS, Suffia I, Velilla PA, Huang B, Warshaw G, Hildeman DA, Belkaid Y, 
Chougnet C: Functional regulatory T cells accumulate in aged hosts and promote 
chronic infectious disease reactivation. J.Immunol. 2008, 181:1835-1848. 
 69.  Zhao L, Sun L, Wang H, Ma H, Liu G, Zhao Y: Changes of CD4+CD25+Foxp3+ 
regulatory T cells in aged Balb/c mice. J.Leukoc.Biol. 2007, 81:1386-1394. 
 70.  Hwang KA, Kim HR, Kang I: Aging and human CD4(+) regulatory T cells. 
Mech.Ageing Dev. 2009, 130:509-517. 
 71.  Rosenkranz D, Weyer S, Tolosa E, Gaenslen A, Berg D, Leyhe T, Gasser T, Stoltze 
L: Higher frequency of regulatory T cells in the elderly and increased suppressive 
activity in neurodegeneration. J.Neuroimmunol. 2007, 188:117-127. 
 72.  Tsaknaridis L, Spencer L, Culbertson N, Hicks K, LaTocha D, Chou YK, Whitham 
RH, Bakke A, Jones RE, Offner H, Bourdette DN, Vandenbark AA: Functional assay 
for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive 
activity. J.Neurosci.Res. 2003, 74:296-308. 
 73.  Sharma S, Dominguez AL, Lustgarten J: High accumulation of T regulatory cells 
prevents the activation of immune responses in aged animals. J.Immunol. 2006, 
177:8348-8355. 
 74.  Sun L, Hurez VJ, Thibodeaux SR, Kious MJ, Liu A, Lin P, Murthy K, Pandeswara S, 
Shin T, Curiel TJ: Aged regulatory T cells protect from autoimmune inflammation 
despite reduced STAT3 activation and decreased constraint of IL-17 producing T 
cells. Aging Cell 2012, 11:509-519. 
 75.  Wolters B, Junge U, Dziuba S, Roggendorf M: Immunogenicity of combined hepatitis 
A and B vaccine in elderly persons. Vaccine 2003, 21:3623-3628. 
 76.  Frasca D, Nguyen D, Riley RL, Blomberg BB: Effects of aging on proliferation and 
E47 transcription factor activity induced by different stimuli in murine splenic B cells. 
Mech.Ageing Dev. 2003, 124:361-369. 
 77.  Whisler RL, Williams JW, Jr., Newhouse YG: Human B cell proliferative responses 
during aging. Reduced RNA synthesis and DNA replication after signal transduction 
by surface immunoglobulins compared to B cell antigenic determinants CD20 and 
CD40. Mech.Ageing Dev. 1991, 61:209-222. 
Page | 228  
 
 78.  Frasca D, Riley RL, Blomberg BB: Humoral immune response and B-cell functions 
including immunoglobulin class switch are downregulated in aged mice and humans. 
Semin.Immunol. 2005, 17:378-384. 
 79.  Yang X, Stedra J, Cerny J: Relative contribution of T and B cells to hypermutation 
and selection of the antibody repertoire in germinal centers of aged mice. J.Exp.Med. 
1996, 183:959-970. 
 80.  Frasca D, Van der Put E, Landin AM, Gong D, Riley RL, Blomberg BB: RNA 
stability of the E2A-encoded transcription factor E47 is lower in splenic activated B 
cells from aged mice. J.Immunol. 2005, 175:6633-6644. 
 81.  Frasca D, Landin AM, Alvarez JP, Blackshear PJ, Riley RL, Blomberg BB: 
Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and 
is involved in the degradation of E47 mRNA. J.Immunol. 2007, 179:918-927. 
 82.  Aydar Y, Balogh P, Tew JG, Szakal AK: Altered regulation of Fc gamma RII on aged 
follicular dendritic cells correlates with immunoreceptor tyrosine-based inhibition 
motif signaling in B cells and reduced germinal center formation. J.Immunol. 2003, 
171:5975-5987. 
 83.  Eaton SM, Burns EM, Kusser K, Randall TD, Haynes L: Age-related defects in CD4 
T cell cognate helper function lead to reductions in humoral responses. J.Exp.Med. 
2004, 200:1613-1622. 
 84.  Andersson E, Ohlin M, Borrebaeck CA, Carlsson R: CD4+CD57+ T cells derived 
from peripheral blood do not support immunoglobulin production by B cells. Cell 
Immunol. 1995, 163:245-253. 
 85.  Fernandez-Gutierrez B, Jover JA, De MS, Hernandez-Garcia C, Vidan MT, Ribera 
JM, Banares A, Serra JA: Early lymphocyte activation in elderly humans: impaired T 
and T-dependent B cell responses. Exp.Gerontol. 1999, 34:217-229. 
 86.  Weyand CM, Brandes JC, Schmidt D, Fulbright JW, Goronzy JJ: Functional 
properties of CD4+. Mech.Ageing Dev. 1998, 102:131-147. 
 87.  Ho JC, Chan KN, Hu WH, Lam WK, Zheng L, Tipoe GL, Sun J, Leung R, Tsang 
KW: The effect of aging on nasal mucociliary clearance, beat frequency, and 
ultrastructure of respiratory cilia. Am.J.Respir.Crit Care Med. 2001, 163:983-988. 
 88.  Incalzi RA, Maini CL, Fuso L, Giordano A, Carbonin PU, Galli G: Effects of aging 
on mucociliary clearance. Compr.Gerontol.A 1989, 3 Suppl:65-68. 
 89.  Puchelle E, Zahm JM, Bertrand A: Influence of age on bronchial mucociliary 
transport. Scand.J.Respir.Dis. 1979, 60:307-313. 
 90.  Svartengren M, Falk R, Philipson K: Long-term clearance from small airways 
decreases with age. Eur.Respir.J. 2005, 26:609-615. 
 91.  Bottazzi B, Doni A, Garlanda C, Mantovani A: An integrated view of humoral innate 
immunity: pentraxins as a paradigm. Annu.Rev.Immunol. 2010, 28:157-183. 
Page | 229  
 
 92.  Nagaki K, Hiramatsu S, Inai S, Sasaki A: The effect of aging on complement activity 
(CH50) and complement protein levels. J.Clin.Lab Immunol. 1980, 3:45-50. 
 93.  Yonemasu K, Kitajima H, Tanabe S, Ochi T, Shinkai H: Effect of age on C1q and C3 
levels in human serum and their presence in colostrum. Immunology 1978, 35:523-
530. 
 94.  Oyeyinka GO, Salimonu LS: Levels of complement components, immunoglobulins 
and acute phase proteins in plasma during aging in Nigeria. Afr.J.Med.Med.Sci. 1999, 
28:177-180. 
 95.  Bellavia D, Frada G, Di FP, Feo S, Franceschi C, Sansoni P, Brai M: C4, BF, C3 
allele distribution and complement activity in healthy aged people and centenarians. 
J.Gerontol.A Biol.Sci.Med.Sci. 1999, 54:B150-B153. 
 96.  Hazlett LD, Masinick-McClellan SA, Barrett RP: Complement defects in aged mice 
compromise phagocytosis of Pseudomonas aeruginosa. Curr.Eye Res. 1999, 19:26-32. 
 97.  Qian F, Wang X, Zhang L, Chen S, Piecychna M, Allore H, Bockenstedt L, 
Malawista S, Bucala R, Shaw AC, Fikrig E, Montgomery RR: Age-associated 
elevation in TLR5 leads to increased inflammatory responses in the elderly. Aging 
Cell 2012, 11:104-110. 
 98.  Shodell M, Siegal FP: Circulating, interferon-producing plasmacytoid dendritic cells 
decline during human ageing. Scand.J.Immunol. 2002, 56:518-521. 
 99.  Seidler S, Zimmermann HW, Bartneck M, Trautwein C, Tacke F: Age-dependent 
alterations of monocyte subsets and monocyte-related chemokine pathways in healthy 
adults. BMC.Immunol. 2010, 11:30. 
 100.  Takahashi I, Ohmoto E, Aoyama S, Takizawa M, Oda Y, Nonaka K, Nakada H, 
Yorimitsu S, Kimura I: Monocyte chemiluminescence and macrophage precursors in 
the aged. Acta Med.Okayama 1985, 39:447-451. 
 101.  Nyugen J, Agrawal S, Gollapudi S, Gupta S: Impaired functions of peripheral blood 
monocyte subpopulations in aged humans. J.Clin.Immunol. 2010, 30:806-813. 
 102.  Zissel G, Schlaak M, Muller-Quernheim J: Age-related decrease in accessory cell 
function of human alveolar macrophages. J.Investig.Med. 1999, 47:51-56. 
 103.  Ogawa T, Kitagawa M, Hirokawa K: Age-related changes of human bone marrow: a 
histometric estimation of proliferative cells, apoptotic cells, T cells, B cells and 
macrophages. Mech.Ageing Dev. 2000, 117:57-68. 
 104.  Swift ME, Burns AL, Gray KL, DiPietro LA: Age-related alterations in the 
inflammatory response to dermal injury. J.Invest Dermatol. 2001, 117:1027-1035. 
 105.  Smallwood HS, Lopez-Ferrer D, Squier TC: Aging enhances the production of 
reactive oxygen species and bactericidal activity in peritoneal macrophages by 
upregulating classical activation pathways. Biochemistry 2011, 50:9911-9922. 
Page | 230  
 
 106.  Fietta A, Merlini C, De Bernardi PM, Gandola L, Piccioni PD, Grassi C: Non specific 
immunity in aged healthy subjects and in patients with chronic bronchitis. Aging 
(Milano.) 1993, 5:357-361. 
 107.  Ortega E, Garcia JJ, De la Fuente M: Modulation of adherence and chemotaxis of 
macrophages by norepinephrine. Influence of ageing. Mol.Cell Biochem. 2000, 
203:113-117. 
 108.  Ashcroft GS, Horan MA, Ferguson MW: Aging alters the inflammatory and 
endothelial cell adhesion molecule profiles during human cutaneous wound healing. 
Lab Invest 1998, 78:47-58. 
 109.  Hilmer SN, Cogger VC, Le Couteur DG: Basal activity of Kupffer cells increases 
with old age. J.Gerontol.A Biol.Sci.Med.Sci. 2007, 62:973-978. 
 110.  Mancuso P, McNish RW, Peters-Golden M, Brock TG: Evaluation of phagocytosis 
and arachidonate metabolism by alveolar macrophages and recruited neutrophils from 
F344xBN rats of different ages. Mech.Ageing Dev. 2001, 122:1899-1913. 
 111.  Higashimoto Y, Fukuchi Y, Shimada Y, Ishida K, Ohata M, Furuse T, Shu C, 
Teramoto S, Matsuse T, Sudo E, .: The effects of aging on the function of alveolar 
macrophages in mice. Mech.Ageing Dev. 1993, 69:207-217. 
 112.  Esposito AL, Clark CA, Poirier WJ: An assessment of the respiratory burst and 
bactericidal activity of alveolar macrophages from adult and senescent mice. 
J.Leukoc.Biol. 1988, 43:445-454. 
 113.  Ding A, Hwang S, Schwab R: Effect of aging on murine macrophages. Diminished 
response to IFN-gamma for enhanced oxidative metabolism. J.Immunol. 1994, 
153:2146-2152. 
 114.  Hayakawa H, Sato A, Yagi T, Uchiyama H, Ide K, Nakano M: Superoxide generation 
by alveolar macrophages from aged rats: improvement by in vitro treatment with IFN-
gamma. Mech.Ageing Dev. 1995, 80:199-211. 
 115.  Alvarez E, Santa MC: Influence of the age and sex on respiratory burst of human 
monocytes. Mech.Ageing Dev. 1996, 90:157-161. 
 116.  Alvarez E, Santa MC, Machado A: Respiratory burst reaction changes with age in rat 
peritoneal macrophages. Biochim.Biophys.Acta 1993, 1179:247-252. 
 117.  McLachlan JA, Serkin CD, Morrey KM, Bakouche O: Antitumoral properties of aged 
human monocytes. J.Immunol. 1995, 154:832-843. 
 118.  Herrero C, Sebastian C, Marques L, Comalada M, Xaus J, Valledor AF, Lloberas J, 
Celada A: Immunosenescence of macrophages: reduced MHC class II gene 
expression. Exp.Gerontol. 2002, 37:389-394. 
 119.  Plowden J, Renshaw-Hoelscher M, Gangappa S, Engleman C, Katz JM, Sambhara S: 
Impaired antigen-induced CD8+ T cell clonal expansion in aging is due to defects in 
antigen presenting cell function. Cell Immunol. 2004, 229:86-92. 
Page | 231  
 
 120.  Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S: Cutting edge: 
impaired Toll-like receptor expression and function in aging. J.Immunol. 2002, 
169:4697-4701. 
 121.  Boehmer ED, Goral J, Faunce DE, Kovacs EJ: Age-dependent decrease in Toll-like 
receptor 4-mediated proinflammatory cytokine production and mitogen-activated 
protein kinase expression. J.Leukoc.Biol. 2004, 75:342-349. 
 122.  Boehmer ED, Meehan MJ, Cutro BT, Kovacs EJ: Aging negatively skews 
macrophage. Mech.Ageing Dev. 2005, 126:1305-1313. 
 123.  Chelvarajan RL, Collins SM, Van Willigen JM, Bondada S: The unresponsiveness of 
aged mice to polysaccharide antigens is a result of a defect in macrophage function. 
J.Leukoc.Biol. 2005, 77:503-512. 
 124.  van DD, Mohanty S, Thomas V, Ginter S, Montgomery RR, Fikrig E, Allore HG, 
Medzhitov R, Shaw AC: Age-associated defect in human TLR-1/2 function. 
J.Immunol. 2007, 178:970-975. 
 125.  Clark JA, Peterson TC: Cytokine production and aging: overproduction of IL-8 in 
elderly males in response to lipopolysaccharide. Mech.Ageing Dev. 1994, 77:127-139. 
 126.  Rink L, Cakman I, Kirchner H: Altered cytokine production in the elderly. 
Mech.Ageing Dev. 1998, 102:199-209. 
 127.  Ahluwalia N, Mastro AM, Ball R, Miles MP, Rajendra R, Handte G: Cytokine 
production by stimulated mononuclear cells did not change with aging in apparently 
healthy, well-nourished women. Mech.Ageing Dev. 2001, 122:1269-1279. 
 128.  Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu.Rev.Immunol. 2003, 21:335-
376. 
 129.  Chelvarajan RL, Liu Y, Popa D, Getchell ML, Getchell TV, Stromberg AJ, Bondada 
S: Molecular basis of age-associated cytokine dysregulation in LPS-stimulated 
macrophages. J.Leukoc.Biol. 2006, 79:1314-1327. 
 130.  Agrawal A, Agrawal S, Cao JN, Su H, Osann K, Gupta S: Altered innate immune 
functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-
signaling pathway. J.Immunol. 2007, 178:6912-6922. 
 131.  Jing Y, Shaheen E, Drake RR, Chen N, Gravenstein S, Deng Y: Aging is associated 
with a numerical and functional decline in plasmacytoid dendritic cells, whereas 
myeloid dendritic cells are relatively unaltered in human peripheral blood. 
Hum.Immunol. 2009, 70:777-784. 
 132.  Panda A, Qian F, Mohanty S, van DD, Newman FK, Zhang L, Chen S, Towle V, 
Belshe RB, Fikrig E, Allore HG, Montgomery RR, Shaw AC: Age-associated 
decrease in TLR function in primary human dendritic cells predicts influenza vaccine 
response. J.Immunol. 2010, 184:2518-2527. 
Page | 232  
 
 133.  Perez-Cabezas B, Naranjo-Gomez M, Fernandez MA, Grifols JR, Pujol-Borrell R, 
Borras FE: Reduced numbers of plasmacytoid dendritic cells in aged blood donors. 
Exp.Gerontol. 2007, 42:1033-1038. 
 134.  Canaday DH, Amponsah NA, Jones L, Tisch DJ, Hornick TR, Ramachandra L: 
Influenza-induced production of interferon-alpha is defective in geriatric individuals. 
J.Clin.Immunol. 2010, 30:373-383. 
 135.  Della BS, Bierti L, Presicce P, Arienti R, Valenti M, Saresella M, Vergani C, Villa 
ML: Peripheral blood dendritic cells and monocytes are differently regulated in the 
elderly. Clin.Immunol. 2007, 122:220-228. 
 136.  Agrawal A, Gupta S: Impact of aging on dendritic cell functions in humans. Ageing 
Res.Rev. 2011, 10:336-345. 
 137.  Sridharan A, Esposo M, Kaushal K, Tay J, Osann K, Agrawal S, Gupta S, Agrawal A: 
Age-associated impaired plasmacytoid dendritic cell functions lead to decreased CD4 
and CD8 T cell immunity. Age (Dordr.) 2011, 33:363-376. 
 138.  Stout-Delgado HW, Yang X, Walker WE, Tesar BM, Goldstein DR: Aging impairs 
IFN regulatory factor 7 up-regulation in plasmacytoid dendritic cells during TLR9 
activation. J.Immunol. 2008, 181:6747-6756. 
 139.  Donnini A, Argentati K, Mancini R, Smorlesi A, Bartozzi B, Bernardini G, 
Provinciali M: Phenotype, antigen-presenting capacity, and migration of antigen-
presenting cells in young and old age. Exp.Gerontol. 2002, 37:1097-1112. 
 140.  Paula C, Motta A, Schmitz C, Nunes CP, Souza AP, Bonorino C: Alterations in 
dendritic cell function in aged mice: potential implications for immunotherapy design. 
Biogerontology. 2009, 10:13-25. 
 141.  Grolleau-Julius A, Harning EK, Abernathy LM, Yung RL: Impaired dendritic cell 
function in aging leads to defective antitumor immunity. Cancer Res. 2008, 68:6341-
6349. 
 142.  Zhao J, Zhao J, Legge K, Perlman S: Age-related increases in PGD(2) expression 
impair respiratory DC migration, resulting in diminished T cell responses upon 
respiratory virus infection in mice. J.Clin.Invest 2011, 121:4921-4930. 
 143.  Pietschmann P, Hahn P, Kudlacek S, Thomas R, Peterlik M: Surface markers and 
transendothelial migration of dendritic cells from elderly subjects. Exp.Gerontol. 
2000, 35:213-224. 
 144.  Sprecher E, Becker Y, Kraal G, Hall E, Harrison D, Shultz LD: Effect of aging on 
epidermal dendritic cell populations in C57BL/6J mice. J.Invest Dermatol. 1990, 
94:247-253. 
 145.  Ogden S, Dearman RJ, Kimber I, Griffiths CE: The effect of ageing on phenotype and 
function of monocyte-derived Langerhans cells. Br.J.Dermatol. 2011, 165:184-188. 
Page | 233  
 
 146.  Grolleau-Julius A, Garg MR, Mo R, Stoolman LL, Yung RL: Effect of aging on bone 
marrow-derived murine CD11c+CD4-CD8alpha- dendritic cell function. J.Gerontol.A 
Biol.Sci.Med.Sci. 2006, 61:1039-1047. 
 147.  Liu WM, Nahar TE, Jacobi RH, Gijzen K, van BJ, Hak E, Jonges M, Boog CJ, van 
der Zeijst BA, Soethout EC: Impaired production of TNF-alpha by dendritic cells of 
older adults leads to a lower CD8+ T cell response against influenza. Vaccine 2012, 
30:1659-1666. 
 148.  Qian F, Wang X, Zhang L, Lin A, Zhao H, Fikrig E, Montgomery RR: Impaired 
interferon signaling in dendritic cells from older donors infected in vitro with West 
Nile virus. J.Infect.Dis. 2011, 203:1415-1424. 
 149.  Wong CP, Magnusson KR, Ho E: Aging is associated with altered dendritic cells 
subset distribution and impaired proinflammatory cytokine production. Exp.Gerontol. 
2010, 45:163-169. 
 150.  Tesar BM, Walker WE, Unternaehrer J, Joshi NS, Chandele A, Haynes L, Kaech S, 
Goldstein DR: Murine [corrected] myeloid dendritic cell-dependent toll-like receptor 
immunity is preserved with aging. Aging Cell 2006, 5:473-486. 
 151.  Bendelac A, Savage PB, Teyton L: The biology of NKT cells. Annu.Rev.Immunol. 
2007, 25:297-336. 
 152.  Kinjo Y, Illarionov P, Vela JL, Pei B, Girardi E, Li X, Li Y, Imamura M, Kaneko Y, 
Okawara A, Miyazaki Y, Gomez-Velasco A, Rogers P, Dahesh S, Uchiyama S, 
Khurana A, Kawahara K, Yesilkaya H, Andrew PW, Wong CH, Kawakami K, Nizet 
V, Besra GS, Tsuji M, Zajonc DM, Kronenberg M: Invariant natural killer T cells 
recognize glycolipids from pathogenic Gram-positive bacteria. Nat.Immunol. 2011, 
12:966-974. 
 153.  Brennan PJ, Tatituri RV, Brigl M, Kim EY, Tuli A, Sanderson JP, Gadola SD, Hsu 
FF, Besra GS, Brenner MB: Invariant natural killer T cells recognize lipid self antigen 
induced by microbial danger signals. Nat.Immunol. 2011, 12:1202-1211. 
 154.  Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, 
Sato H, Kondo E, Koseki H, Taniguchi M: CD1d-restricted and TCR-mediated 
activation of valpha14 NKT cells by glycosylceramides. Science 1997, 278:1626-
1629. 
 155.  DelaRosa O, Tarazona R, Casado JG, Alonso C, Ostos B, Pena J, Solana R: 
Valpha24+ NKT cells are decreased in elderly humans. Exp.Gerontol. 2002, 37:213-
217. 
 156.  Jing Y, Gravenstein S, Chaganty NR, Chen N, Lyerly KH, Joyce S, Deng Y: Aging is 
associated with a rapid decline in frequency, alterations in subset composition, and 
enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood. 
Exp.Gerontol. 2007, 42:719-732. 
Page | 234  
 
 157.  Molling JW, Kolgen W, van der Vliet HJ, Boomsma MF, Kruizenga H, Smorenburg 
CH, Molenkamp BG, Langendijk JA, Leemans CR, von Blomberg BM, Scheper RJ, 
van den Eertwegh AJ: Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ 
NKT cell numbers are decreased in cancer patients independent of tumor type or 
tumor load. Int.J.Cancer 2005, 116:87-93. 
 158.  Peralbo E, DelaRosa O, Gayoso I, Pita ML, Tarazona R, Solana R: Decreased 
frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T 
(iNKT) cells in healthy elderly. Biogerontology. 2006, 7:483-492. 
 159.  Faunce DE, Palmer JL, Paskowicz KK, Witte PL, Kovacs EJ: CD1d-restricted NKT 
cells contribute to the age-associated decline of T cell immunity. J.Immunol. 2005, 
175:3102-3109. 
 160.  Poynter ME, Mu HH, Chen XP, Daynes RA: Activation of NK1.1+ T cells in vitro 
and their possible role in age-associated changes in inducible IL-4 production. Cell 
Immunol. 1997, 179:22-29. 
 161.  Peralbo E, Alonso C, Solana R: Invariant NKT and NKT-like lymphocytes: two 
different T cell subsets that are differentially affected by ageing. Exp.Gerontol. 2007, 
42:703-708. 
 162.  Hager K, Machein U, Krieger S, Platt D, Seefried G, Bauer J: Interleukin-6 and 
selected plasma proteins in healthy persons of different ages. Neurobiol.Aging 1994, 
15:771-772. 
 163.  Pedersen M, Bruunsgaard H, Weis N, Hendel HW, Andreassen BU, Eldrup E, Dela F, 
Pedersen BK: Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass 
and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. 
Mech.Ageing Dev. 2003, 124:495-502. 
 164.  Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafe M, Cavallone L, 
Franceschi C, Caruso C: Gender-specific association between -1082 IL-10 promoter 
polymorphism and longevity. Genes Immun. 2002, 3:30-33. 
 165.  Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P, Pedersen 
BK: A high plasma concentration of TNF-alpha is associated with dementia in 
centenarians. J.Gerontol.A Biol.Sci.Med.Sci. 1999, 54:M357-M364. 
 166.  Bruunsgaard H, Andersen-Ranberg K, Hjelmborg JB, Pedersen BK, Jeune B: 
Elevated levels of tumor necrosis factor alpha and mortality in centenarians. 
Am.J.Med. 2003, 115:278-283. 
 167.  Bruunsgaard H, Ladelund S, Pedersen AN, Schroll M, Jorgensen T, Pedersen BK: 
Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old 
people. Clin.Exp.Immunol. 2003, 132:24-31. 
 168.  Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH, Jr., 
Heimovitz H, Cohen HJ, Wallace R: Associations of elevated interleukin-6 and C-
reactive protein levels with mortality in the elderly. Am.J.Med. 1999, 106:506-512. 
Page | 235  
 
 169.  Reuben DB, Cheh AI, Harris TB, Ferrucci L, Rowe JW, Tracy RP, Seeman TE: 
Peripheral blood markers of inflammation predict mortality and functional decline in 
high-functioning community-dwelling older persons. J.Am.Geriatr.Soc. 2002, 50:638-
644. 
 170.  Gussekloo J, Schaap MC, Frolich M, Blauw GJ, Westendorp RG: C-reactive protein 
is a strong but nonspecific risk factor of fatal stroke in elderly persons. 
Arterioscler.Thromb.Vasc.Biol. 2000, 20:1047-1051. 
 171.  Baylis D, Bartlett DB, Syddall HE, Ntani G, Gale CR, Cooper C, Lord JM, Sayer AA: 
Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year 
longitudinal study in community-dwelling older people. Age (Dordr.) 2012. 
 172.  Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS: The association of plasma IL-6 
levels with functional disability in community-dwelling elderly. J.Gerontol.A 
Biol.Sci.Med.Sci. 1997, 52:M201-M208. 
 173.  Bruunsgaard H, Skinhoj P, Pedersen AN, Schroll M, Pedersen BK: Ageing, tumour 
necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin.Exp.Immunol. 2000, 
121:255-260. 
 174.  Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, Nevitt 
M, Harris TB: Relationship of interleukin-6 and tumor necrosis factor-alpha with 
muscle mass and muscle strength in elderly men and women: the Health ABC Study. 
J.Gerontol.A Biol.Sci.Med.Sci. 2002, 57:M326-M332. 
 175.  Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, Epstein SE: 
Effects of total pathogen burden on coronary artery disease risk and C-reactive protein 
levels. Am.J.Cardiol. 2000, 85:140-146. 
 176.  Geist LJ, Dai LY: Cytomegalovirus modulates interleukin-6 gene expression. 
Transplantation 1996, 62:653-658. 
 177.  Bartlett DB, Firth CM, Phillips AC, Moss P, Baylis D, Syddall H, Sayer AA, Cooper 
C, Lord JM: The age-related increase in low-grade systemic inflammation 
(Inflammaging) is not driven by cytomegalovirus infection. Aging Cell 2012. 
 178.  Bonafe M, Olivieri F, Cavallone L, Giovagnetti S, Mayegiani F, Cardelli M, Pieri C, 
Marra M, Antonicelli R, Lisa R, Rizzo MR, Paolisso G, Monti D, Franceschi C: A 
gender--dependent genetic predisposition to produce high levels of IL-6 is detrimental 
for longevity. Eur.J.Immunol. 2001, 31:2357-2361. 
 179.  Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R: Up-
regulation of TNF-producing T cells in the bone marrow: a key mechanism by which 
estrogen deficiency induces bone loss in vivo. Proc.Natl.Acad.Sci.U.S.A 2001, 
98:13960-13965. 
 180.  Larbi A, Franceschi C, Mazzatti D, Solana R, Wikby A, Pawelec G: Aging of the 
immune system as a prognostic factor for human longevity. Physiology.(Bethesda.) 
2008, 23:64-74. 
Page | 236  
 
 181.  Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B: Immune parameters in a 
longitudinal study of a very old population of Swedish people: a comparison between 
survivors and nonsurvivors. J.Gerontol.A Biol.Sci.Med.Sci. 1995, 50:B378-B382. 
 182.  Wikby A, Nilsson BO, Forsey R, Thompson J, Strindhall J, Lofgren S, Ernerudh J, 
Pawelec G, Ferguson F, Johansson B: The immune risk phenotype is associated with 
IL-6 in the terminal decline stage: findings from the Swedish NONA immune 
longitudinal study of very late life functioning. Mech.Ageing Dev. 2006, 127:695-704. 
 183.  Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG: Changes in CD8 and CD4 
lymphocyte subsets, T cell proliferation responses and non-survival in the very old: 
the Swedish longitudinal OCTO-immune study. Mech.Ageing Dev. 1998, 102:187-
198. 
 184.  Strindhall J, Nilsson BO, Lofgren S, Ernerudh J, Pawelec G, Johansson B, Wikby A: 
No Immune Risk Profile among individuals who reach 100 years of age: findings 
from the Swedish NONA immune longitudinal study. Exp.Gerontol. 2007, 42:753-
761. 
 185.  Ferrando-Martinez S, Romero-Sanchez MC, Solana R, Delgado J, de la Rosa R, 
Munoz-Fernandez MA, Ruiz-Mateos E, Leal M: Thymic function failure and C-
reactive protein levels are independent predictors of all-cause mortality in healthy 
elderly humans. Age (Dordr.) 2011. 
 186.  van den Biggelaar AH, Huizinga TW, de Craen AJ, Gussekloo J, Heijmans BT, 
Frolich M, Westendorp RG: Impaired innate immunity predicts frailty in old age. The 
Leiden 85-plus study. Exp.Gerontol. 2004, 39:1407-1414. 
 187.  Levy SM, Herberman RB, Lee J, Whiteside T, Beadle M, Heiden L, Simons A: 
Persistently low natural killer cell activity, age, and environmental stress as predictors 
of infectious morbidity. Nat.Immun.Cell Growth Regul. 1991, 10:289-307. 
 188.  Ogata K, Yokose N, Tamura H, An E, Nakamura K, Dan K, Nomura T: Natural killer 
cells in the late decades of human life. Clin.Immunol.Immunopathol. 1997, 84:269-
275. 
 189.  Ogata K, An E, Shioi Y, Nakamura K, Luo S, Yokose N, Minami S, Dan K: 
Association between natural killer cell activity and infection in immunologically 
normal elderly people. Clin.Exp.Immunol. 2001, 124:392-397. 
 190.  Plonquet A, Bastuji-Garin S, Tahmasebi F, Brisacier C, Ledudal K, Farcet J, Paillaud 
E: Immune risk phenotype is associated with nosocomial lung infections in elderly in-
patients. Immun.Ageing 2011, 8:8. 
 191.  Trinchieri G: Biology of natural killer cells. Adv.Immunol. 1989, 47:187-376. 
 192.  Eidenschenk C, Dunne J, Jouanguy E, Fourlinnie C, Gineau L, Bacq D, McMahon C, 
Smith O, Casanova JL, Abel L, Feighery C: A novel primary immunodeficiency with 
specific natural-killer cell deficiency maps to the centromeric region of chromosome 
8. Am.J.Hum.Genet. 2006, 78:721-727. 
Page | 237  
 
 193.  Etzioni A, Eidenschenk C, Katz R, Beck R, Casanova JL, Pollack S: Fatal varicella 
associated with selective natural killer cell deficiency. J.Pediatr. 2005, 146:423-425. 
 194.  Biron CA, Byron KS, Sullivan JL: Severe herpesvirus infections in an adolescent 
without natural killer cells. N.Engl.J.Med. 1989, 320:1731-1735. 
 195.  Ballas ZK, Turner JM, Turner DA, Goetzman EA, Kemp JD: A patient with 
simultaneous absence of "classical" natural killer cells (CD3-, CD16+, and NKH1+) 
and expansion of CD3+, CD4-, CD8-, NKH1+ subset. J.Allergy Clin.Immunol. 1990, 
85:453-459. 
 196.  Yang CM, Yang YH, Lin YT, Lu MY, Chiang BL: Natural killer cell deficiency 
associated with Hodgkin's lymphoma: a case report. J.Formos.Med.Assoc. 2002, 
101:73-75. 
 197.  Small CL, McCormick S, Gill N, Kugathasan K, Santosuosso M, Donaldson N, 
Heinrichs DE, Ashkar A, Xing Z: NK cells play a critical protective role in host 
defense against acute extracellular Staphylococcus aureus bacterial infection in the 
lung. J.Immunol. 2008, 180:5558-5568. 
 198.  Schmidt S, Tramsen L, Hanisch M, Latge JP, Huenecke S, Koehl U, Lehrnbecher T: 
Human natural killer cells exhibit direct activity against Aspergillus fumigatus 
hyphae, but not against resting conidia. J.Infect.Dis. 2011, 203:430-435. 
 199.  Korbel DS, Finney OC, Riley EM: Natural killer cells and innate immunity to 
protozoan pathogens. Int.J.Parasitol. 2004, 34:1517-1528. 
 200.  Smyth MJ, Thia KY, Cretney E, Kelly JM, Snook MB, Forbes CA, Scalzo AA: 
Perforin is a major contributor to NK cell control of tumor metastasis. J.Immunol. 
1999, 162:6658-6662. 
 201.  Sayers TJ, Brooks AD, Lee JK, Fenton RG, Komschlies KL, Wigginton JM, Winkler-
Pickett R, Wiltrout RH: Molecular mechanisms of immune-mediated lysis of murine 
renal cancer: differential contributions of perforin-dependent versus Fas-mediated 
pathways in lysis by NK and T cells. J.Immunol. 1998, 161:3957-3965. 
 202.  Voskoboinik I, Smyth MJ, Trapani JA: Perforin-mediated target-cell death and 
immune homeostasis. Nat.Rev.Immunol. 2006, 6:940-952. 
 203.  van den Broek ME, Kagi D, Ossendorp F, Toes R, Vamvakas S, Lutz WK, Melief CJ, 
Zinkernagel RM, Hengartner H: Decreased tumor surveillance in perforin-deficient 
mice. J.Exp.Med. 1996, 184:1781-1790. 
 204.  Walsh CM, Matloubian M, Liu CC, Ueda R, Kurahara CG, Christensen JL, Huang 
MT, Young JD, Ahmed R, Clark WR: Immune function in mice lacking the perforin 
gene. Proc.Natl.Acad.Sci.U.S.A 1994, 91:10854-10858. 
 205.  Brennan AJ, Chia J, Trapani JA, Voskoboinik I: Perforin deficiency and susceptibility 
to cancer. Cell Death.Differ. 2010, 17:607-615. 
Page | 238  
 
 206.  Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van 
Dommelen SL, Degli-Esposti MA, Hayakawa Y: Activation of NK cell cytotoxicity. 
Mol.Immunol. 2005, 42:501-510. 
 207.  Thiery J, Keefe D, Saffarian S, Martinvalet D, Walch M, Boucrot E, Kirchhausen T, 
Lieberman J: Perforin activates clathrin- and dynamin-dependent endocytosis, which 
is required for plasma membrane repair and delivery of granzyme B for granzyme-
mediated apoptosis. Blood 2010, 115:1582-1593. 
 208.  Thiery J, Keefe D, Boulant S, Boucrot E, Walch M, Martinvalet D, Goping IS, 
Bleackley RC, Kirchhausen T, Lieberman J: Perforin pores in the endosomal 
membrane trigger the release of endocytosed granzyme B into the cytosol of target 
cells. Nat.Immunol. 2011, 12:770-777. 
 209.  Pipkin ME, Lieberman J: Delivering the kiss of death: progress on understanding how 
perforin works. Curr.Opin.Immunol. 2007, 19:301-308. 
 210.  Tschopp J, Masson D, Stanley KK: Structural/functional similarity between proteins 
involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis. Nature 
1986, 322:831-834. 
 211.  Masson D, Tschopp J: Isolation of a lytic, pore-forming protein (perforin) from 
cytolytic T-lymphocytes. J.Biol.Chem. 1985, 260:9069-9072. 
 212.  Froelich CJ, Orth K, Turbov J, Seth P, Gottlieb R, Babior B, Shah GM, Bleackley 
RC, Dixit VM, Hanna W: New paradigm for lymphocyte granule-mediated 
cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic 
agent is necessary for cytosolic delivery and subsequent apoptosis. J.Biol.Chem. 
1996, 271:29073-29079. 
 213.  Shi L, Mai S, Israels S, Browne K, Trapani JA, Greenberg AH: Granzyme B (GraB) 
autonomously crosses the cell membrane and perforin initiates apoptosis and GraB 
nuclear localization. J.Exp.Med. 1997, 185:855-866. 
 214.  Pinkoski MJ, Hobman M, Heibein JA, Tomaselli K, Li F, Seth P, Froelich CJ, 
Bleackley RC: Entry and trafficking of granzyme B in target cells during granzyme 
B-perforin-mediated apoptosis. Blood 1998, 92:1044-1054. 
 215.  Motyka B, Korbutt G, Pinkoski MJ, Heibein JA, Caputo A, Hobman M, Barry M, 
Shostak I, Sawchuk T, Holmes CF, Gauldie J, Bleackley RC: Mannose 6-
phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B 
during cytotoxic T cell-induced apoptosis. Cell 2000, 103:491-500. 
 216.  Browne KA, Blink E, Sutton VR, Froelich CJ, Jans DA, Trapani JA: Cytosolic 
delivery of granzyme B by bacterial toxins: evidence that endosomal disruption, in 
addition to transmembrane pore formation, is an important function of perforin. 
Mol.Cell Biol. 1999, 19:8604-8615. 
Page | 239  
 
 217.  Shi L, Keefe D, Durand E, Feng H, Zhang D, Lieberman J: Granzyme B binds to 
target cells mostly by charge and must be added at the same time as perforin to trigger 
apoptosis. J.Immunol. 2005, 174:5456-5461. 
 218.  Keefe D, Shi L, Feske S, Massol R, Navarro F, Kirchhausen T, Lieberman J: Perforin 
triggers a plasma membrane-repair response that facilitates CTL induction of 
apoptosis. Immunity. 2005, 23:249-262. 
 219.  Ebnet K, Hausmann M, Lehmann-Grube F, Mullbacher A, Kopf M, Lamers M, 
Simon MM: Granzyme A-deficient mice retain potent cell-mediated cytotoxicity. 
EMBO J. 1995, 14:4230-4239. 
 220.  Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ: Cytotoxic 
lymphocytes require granzyme B for the rapid induction of DNA fragmentation and 
apoptosis in allogeneic target cells. Cell 1994, 76:977-987. 
 221.  Pao LI, Sumaria N, Kelly JM, van DS, Cretney E, Wallace ME, Anthony DA, Uldrich 
AP, Godfrey DI, Papadimitriou JM, Mullbacher A, Degli-Esposti MA, Smyth MJ: 
Functional analysis of granzyme M and its role in immunity to infection. J.Immunol. 
2005, 175:3235-3243. 
 222.  Wang S, Xia P, Shi L, Fan Z: FADD cleavage by NK cell granzyme M enhances its 
self-association to facilitate procaspase-8 recruitment for auto-processing leading to 
caspase cascade. Cell Death.Differ. 2012, 19:605-615. 
 223.  Hu D, Liu S, Shi L, Li C, Wu L, Fan Z: Cleavage of survivin by Granzyme M triggers 
degradation of the survivin-X-linked inhibitor of apoptosis protein (XIAP) complex to 
free caspase activity leading to cytolysis of target tumor cells. J.Biol.Chem. 2010, 
285:18326-18335. 
 224.  Darmon AJ, Nicholson DW, Bleackley RC: Activation of the apoptotic protease 
CPP32 by cytotoxic T-cell-derived granzyme B. Nature 1995, 377:446-448. 
 225.  Chinnaiyan AM, Hanna WL, Orth K, Duan H, Poirier GG, Froelich CJ, Dixit VM: 
Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3. 
Curr.Biol. 1996, 6:897-899. 
 226.  Taylor RC, Cullen SP, Martin SJ: Apoptosis: controlled demolition at the cellular 
level. Nat.Rev.Mol.Cell Biol. 2008, 9:231-241. 
 227.  Alimonti JB, Shi L, Baijal PK, Greenberg AH: Granzyme B induces BID-mediated 
cytochrome c release and mitochondrial permeability transition. J.Biol.Chem. 2001, 
276:6974-6982. 
 228.  Sarin A, Williams MS, Alexander-Miller MA, Berzofsky JA, Zacharchuk CM, 
Henkart PA: Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 
family proteases. Immunity. 1997, 6:209-215. 
 229.  Trapani JA, Jans DA, Jans PJ, Smyth MJ, Browne KA, Sutton VR: Efficient nuclear 
targeting of granzyme B and the nuclear consequences of apoptosis induced by 
Page | 240  
 
granzyme B and perforin are caspase-dependent, but cell death is caspase-
independent. J.Biol.Chem. 1998, 273:27934-27938. 
 230.  Andrade F, Roy S, Nicholson D, Thornberry N, Rosen A, Casciola-Rosen L: 
Granzyme B directly and efficiently cleaves several downstream caspase substrates: 
implications for CTL-induced apoptosis. Immunity. 1998, 8:451-460. 
 231.  Froelich CJ, Hanna WL, Poirier GG, Duriez PJ, D'Amours D, Salvesen GS, Alnemri 
ES, Earnshaw WC, Shah GM: Granzyme B/perforin-mediated apoptosis of Jurkat 
cells results in cleavage of poly(ADP-ribose) polymerase to the 89-kDa apoptotic 
fragment and less abundant 64-kDa fragment. Biochem.Biophys.Res.Commun. 1996, 
227:658-665. 
 232.  Thomas DA, Du C, Xu M, Wang X, Ley TJ: DFF45/ICAD can be directly processed 
by granzyme B during the induction of apoptosis. Immunity. 2000, 12:621-632. 
 233.  Zhang D, Beresford PJ, Greenberg AH, Lieberman J: Granzymes A and B directly 
cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis. 
Proc.Natl.Acad.Sci.U.S.A 2001, 98:5746-5751. 
 234.  Martinvalet D, Zhu P, Lieberman J: Granzyme A induces caspase-independent 
mitochondrial damage, a required first step for apoptosis. Immunity. 2005, 22:355-
370. 
 235.  Martinvalet D, Dykxhoorn DM, Ferrini R, Lieberman J: Granzyme A cleaves a 
mitochondrial complex I protein to initiate caspase-independent cell death. Cell 2008, 
133:681-692. 
 236.  Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J: Tumor suppressor NM23-H1 is 
a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome 
assembly protein SET is its inhibitor. Cell 2003, 112:659-672. 
 237.  Fan Z, Beresford PJ, Zhang D, Xu Z, Novina CD, Yoshida A, Pommier Y, Lieberman 
J: Cleaving the oxidative repair protein Ape1 enhances cell death mediated by 
granzyme A. Nat.Immunol. 2003, 4:145-153. 
 238.  Fan Z, Beresford PJ, Zhang D, Lieberman J: HMG2 interacts with the nucleosome 
assembly protein SET and is a target of the cytotoxic T-lymphocyte protease 
granzyme A. Mol.Cell Biol. 2002, 22:2810-2820. 
 239.  Chowdhury D, Beresford PJ, Zhu P, Zhang D, Sung JS, Demple B, Perrino FW, 
Lieberman J: The exonuclease TREX1 is in the SET complex and acts in concert with 
NM23-H1 to degrade DNA during granzyme A-mediated cell death. Mol.Cell 2006, 
23:133-142. 
 240.  Zhang D, Pasternack MS, Beresford PJ, Wagner L, Greenberg AH, Lieberman J: 
Induction of rapid histone degradation by the cytotoxic T lymphocyte protease 
Granzyme A. J.Biol.Chem. 2001, 276:3683-3690. 
Page | 241  
 
 241.  Zhu P, Martinvalet D, Chowdhury D, Zhang D, Schlesinger A, Lieberman J: The 
cytotoxic T lymphocyte protease granzyme A cleaves and inactivates poly(adenosine 
5'-diphosphate-ribose) polymerase-1. Blood 2009, 114:1205-1216. 
 242.  Sato K, Hida S, Takayanagi H, Yokochi T, Kayagaki N, Takeda K, Yagita H, 
Okumura K, Tanaka N, Taniguchi T, Ogasawara K: Antiviral response by natural 
killer cells through TRAIL gene induction by IFN-alpha/beta. Eur.J.Immunol. 2001, 
31:3138-3146. 
 243.  Medvedev AE, Johnsen AC, Haux J, Steinkjer B, Egeberg K, Lynch DH, Sundan A, 
Espevik T: Regulation of Fas and Fas-ligand expression in NK cells by cytokines and 
the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity. Cytokine 1997, 
9:394-404. 
 244.  Chua HL, Serov Y, Brahmi Z: Regulation of FasL expression in natural killer cells. 
Hum.Immunol. 2004, 65:317-327. 
 245.  Wallin RP, Screpanti V, Michaelsson J, Grandien A, Ljunggren HG: Regulation of 
perforin-independent NK cell-mediated cytotoxicity. Eur.J.Immunol. 2003, 33:2727-
2735. 
 246.  Lavrik I, Golks A, Krammer PH: Death receptor signaling. J.Cell Sci. 2005, 118:265-
267. 
 247.  Bossi G, Griffiths GM: Degranulation plays an essential part in regulating cell surface 
expression of Fas ligand in T cells and natural killer cells. Nat.Med. 1999, 5:90-96. 
 248.  Kojima Y, Kawasaki-Koyanagi A, Sueyoshi N, Kanai A, Yagita H, Okumura K: 
Localization of Fas ligand in cytoplasmic granules of CD8+ cytotoxic T lymphocytes 
and natural killer cells: participation of Fas ligand in granule exocytosis model of 
cytotoxicity. Biochem.Biophys.Res.Commun. 2002, 296:328-336. 
 249.  Orange JS: Formation and function of the lytic NK-cell immunological synapse. 
Nat.Rev.Immunol. 2008, 8:713-725. 
 250.  Krzewski K, Strominger JL: The killer's kiss: the many functions of NK cell 
immunological synapses. Curr.Opin.Cell Biol. 2008, 20:597-605. 
 251.  Orange JS, Harris KE, Andzelm MM, Valter MM, Geha RS, Strominger JL: The 
mature activating natural killer cell immunologic synapse is formed in distinct stages. 
Proc.Natl.Acad.Sci.U.S.A 2003, 100:14151-14156. 
 252.  Krzewski K, Chen X, Orange JS, Strominger JL: Formation of a WIP-, WASp-, actin-
, and myosin IIA-containing multiprotein complex in activated NK cells and its 
alteration by KIR inhibitory signaling. J.Cell Biol. 2006, 173:121-132. 
 253.  Masilamani M, Nguyen C, Kabat J, Borrego F, Coligan JE: CD94/NKG2A inhibits 
NK cell activation by disrupting the actin network at the immunological synapse. 
J.Immunol. 2006, 177:3590-3596. 
Page | 242  
 
 254.  Banerjee PP, Pandey R, Zheng R, Suhoski MM, Monaco-Shawver L, Orange JS: 
Cdc42-interacting protein-4 functionally links actin and microtubule networks at the 
cytolytic NK cell immunological synapse. J.Exp.Med. 2007, 204:2305-2320. 
 255.  Kanwar N, Wilkins JA: IQGAP1 involvement in MTOC and granule polarization in 
NK-cell cytotoxicity. Eur.J.Immunol. 2011, 41:2763-2773. 
 256.  Aspenstrom P: A Cdc42 target protein with homology to the non-kinase domain of 
FER has a potential role in regulating the actin cytoskeleton. Curr.Biol. 1997, 7:479-
487. 
 257.  Tian L, Nelson DL, Stewart DM: Cdc42-interacting protein 4 mediates binding of the 
Wiskott-Aldrich syndrome protein to microtubules. J.Biol.Chem. 2000, 275:7854-
7861. 
 258.  Linder S, Hufner K, Wintergerst U, Aepfelbacher M: Microtubule-dependent 
formation of podosomal adhesion structures in primary human macrophages. J.Cell 
Sci. 2000, 113 Pt 23:4165-4176. 
 259.  Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B: 
Dependence of both spontaneous and antibody-dependent, granule exocytosis-
mediated NK cell cytotoxicity on extracellular signal-regulated kinases. J.Immunol. 
1998, 161:6648-6656. 
 260.  Li C, Ge B, Nicotra M, Stern JN, Kopcow HD, Chen X, Strominger JL: JNK MAP 
kinase activation is required for MTOC and granule polarization in NKG2D-mediated 
NK cell cytotoxicity. Proc.Natl.Acad.Sci.U.S.A 2008, 105:3017-3022. 
 261.  Trotta R, Fettucciari K, Azzoni L, Abebe B, Puorro KA, Eisenlohr LC, Perussia B: 
Differential role of p38 and c-Jun N-terminal kinase 1 mitogen-activated protein 
kinases in NK cell cytotoxicity. J.Immunol. 2000, 165:1782-1789. 
 262.  Chini CC, Boos MD, Dick CJ, Schoon RA, Leibson PJ: Regulation of p38 mitogen-
activated protein kinase during NK cell activation. Eur.J.Immunol. 2000, 30:2791-
2798. 
 263.  Wei S, Gamero AM, Liu JH, Daulton AA, Valkov NI, Trapani JA, Larner AC, Weber 
MJ, Djeu JY: Control of lytic function by mitogen-activated protein 
kinase/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: 
identification of perforin and granzyme B mobilization by functional ERK2. 
J.Exp.Med. 1998, 187:1753-1765. 
 264.  Burkhardt JK, McIlvain JM, Jr., Sheetz MP, Argon Y: Lytic granules from cytotoxic 
T cells exhibit kinesin-dependent motility on microtubules in vitro. J.Cell Sci. 1993, 
104 ( Pt 1):151-162. 
 265.  Krzewski K, Chen X, Strominger JL: WIP is essential for lytic granule polarization 
and NK cell cytotoxicity. Proc.Natl.Acad.Sci.U.S.A 2008, 105:2568-2573. 
Page | 243  
 
 266.  Mentlik AN, Sanborn KB, Holzbaur EL, Orange JS: Rapid lytic granule convergence 
to the MTOC in natural killer cells is dependent on dynein but not cytolytic 
commitment. Mol.Biol.Cell 2010, 21:2241-2256. 
 267.  Stinchcombe JC, Barral DC, Mules EH, Booth S, Hume AN, Machesky LM, Seabra 
MC, Griffiths GM: Rab27a is required for regulated secretion in cytotoxic T 
lymphocytes. J.Cell Biol. 2001, 152:825-834. 
 268.  Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, Lambert N, 
Ouachee-Chardin M, Chedeville G, Tamary H, Minard-Colin V, Vilmer E, Blanche S, 
Le DF, Fischer A, de Saint BG: Munc13-4 is essential for cytolytic granules fusion 
and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). 
Cell 2003, 115:461-473. 
 269.  Arneson LN, Brickshawana A, Segovis CM, Schoon RA, Dick CJ, Leibson PJ: 
Cutting edge: syntaxin 11 regulates lymphocyte-mediated secretion and cytotoxicity. 
J.Immunol. 2007, 179:3397-3401. 
 270.  Krzewski K, Gil-Krzewska A, Watts J, Stern JN, Strominger JL: VAMP4- and 
VAMP7-expressing vesicles are both required for cytotoxic granule exocytosis in NK 
cells. Eur.J.Immunol. 2011, 41:3323-3329. 
 271.  Rak GD, Mace EM, Banerjee PP, Svitkina T, Orange JS: Natural killer cell lytic 
granule secretion occurs through a pervasive actin network at the immune synapse. 
PLoS.Biol. 2011, 9:e1001151. 
 272.  Brown AC, Oddos S, Dobbie IM, Alakoskela JM, Parton RM, Eissmann P, Neil MA, 
Dunsby C, French PM, Davis I, Davis DM: Remodelling of cortical actin where lytic 
granules dock at natural killer cell immune synapses revealed by super-resolution 
microscopy. PLoS.Biol. 2011, 9:e1001152. 
 273.  Sanborn KB, Rak GD, Maru SY, Demers K, Difeo A, Martignetti JA, Betts MR, 
Favier R, Banerjee PP, Orange JS: Myosin IIA associates with NK cell lytic granules 
to enable their interaction with F-actin and function at the immunological synapse. 
J.Immunol. 2009, 182:6969-6984. 
 274.  Andzelm MM, Chen X, Krzewski K, Orange JS, Strominger JL: Myosin IIA is 
required for cytolytic granule exocytosis in human NK cells. J.Exp.Med. 2007, 
204:2285-2291. 
 275.  Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, 
Caligiuri MA: Human natural killer cells: a unique innate immunoregulatory role for 
the CD56(bright) subset. Blood 2001, 97:3146-3151. 
 276.  Ferlazzo G, Thomas D, Lin SL, Goodman K, Morandi B, Muller WA, Moretta A, 
Munz C: The abundant NK cells in human secondary lymphoid tissues require 
activation to express killer cell Ig-like receptors and become cytolytic. J.Immunol. 
2004, 172:1455-1462. 
Page | 244  
 
 277.  Fauriat C, Long EO, Ljunggren HG, Bryceson YT: Regulation of human NK-cell 
cytokine and chemokine production by target cell recognition. Blood 2010, 115:2167-
2176. 
 278.  De MA, Bozzano F, Cantoni C, Moretta L: Revisiting human natural killer cell subset 
function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of 
abundant IFN-gamma on activation. Proc.Natl.Acad.Sci.U.S.A 2011, 108:728-732. 
 279.  Bancroft GJ, Sheehan KC, Schreiber RD, Unanue ER: Tumor necrosis factor is 
involved in the T cell-independent pathway of macrophage activation in scid mice. 
J.Immunol. 1989, 143:127-130. 
 280.  Trinchieri G: Natural killer cells wear different hats: effector cells of innate resistance 
and regulatory cells of adaptive immunity and of hematopoiesis. Semin.Immunol. 
1995, 7:83-88. 
 281.  Taub DD, Sayers TJ, Carter CR, Ortaldo JR: Alpha and beta chemokines induce NK 
cell migration and enhance NK-mediated cytolysis. J.Immunol. 1995, 155:3877-3888. 
 282.  Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B: Activation of NK cells 
by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. J.Immunol. 
1996, 156:322-327. 
 283.  Piccioli D, Sbrana S, Melandri E, Valiante NM: Contact-dependent stimulation and 
inhibition of dendritic cells by natural killer cells. J.Exp.Med. 2002, 195:335-341. 
 284.  Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G: 
Reciprocal activating interaction between natural killer cells and dendritic cells. 
J.Exp.Med. 2002, 195:327-333. 
 285.  Vitale M, Della CM, Carlomagno S, Pende D, Arico M, Moretta L, Moretta A: NK-
dependent DC maturation is mediated by TNFalpha and IFNgamma released upon 
engagement of the NKp30 triggering receptor. Blood 2005, 106:566-571. 
 286.  Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, 
Sallusto F: Induced recruitment of NK cells to lymph nodes provides IFN-gamma for 
T(H)1 priming. Nat.Immunol. 2004, 5:1260-1265. 
 287.  Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, French AR, 
Sunwoo JB, Lemieux S, Hansen TH, Yokoyama WM: Licensing of natural killer cells 
by host major histocompatibility complex class I molecules. Nature 2005, 436:709-
713. 
 288.  Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH: A subset 
of natural killer cells achieves self-tolerance without expressing inhibitory receptors 
specific for self-MHC molecules. Blood 2005, 105:4416-4423. 
 289.  Liao NS, Bix M, Zijlstra M, Jaenisch R, Raulet D: MHC class I deficiency: 
susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991, 
253:199-202. 
Page | 245  
 
 290.  Zimmer J, Donato L, Hanau D, Cazenave JP, Tongio MM, Moretta A, de la Salle H: 
Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient 
patients (type I bare lymphocyte syndrome). J.Exp.Med. 1998, 187:117-122. 
 291.  Furukawa H, Yabe T, Watanabe K, Miyamoto R, Miki A, Akaza T, Tadokoro K, 
Tohma S, Inoue T, Yamamoto K, Juji T: Tolerance of NK and LAK activity for HLA 
class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type 
I). Hum.Immunol. 1999, 60:32-40. 
 292.  Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, 
Reviron D, Middleton D, Romagne F, Ugolini S, Vivier E: Human NK cell education 
by inhibitory receptors for MHC class I. Immunity. 2006, 25:331-342. 
 293.  Chalifour A, Scarpellino L, Back J, Brodin P, Devevre E, Gros F, Levy F, Leclercq G, 
Hoglund P, Beermann F, Held W: A Role for cis Interaction between the Inhibitory 
Ly49A receptor and MHC class I for natural killer cell education. Immunity. 2009, 
30:337-347. 
 294.  Brodin P, Lakshmikanth T, Johansson S, Karre K, Hoglund P: The strength of 
inhibitory input during education quantitatively tunes the functional responsiveness of 
individual natural killer cells. Blood 2009, 113:2434-2441. 
 295.  Joncker NT, Fernandez NC, Treiner E, Vivier E, Raulet DH: NK cell responsiveness 
is tuned commensurate with the number of inhibitory receptors for self-MHC class I: 
the rheostat model. J.Immunol. 2009, 182:4572-4580. 
 296.  Elliott JM, Wahle JA, Yokoyama WM: MHC class I-deficient natural killer cells 
acquire a licensed phenotype after transfer into an MHC class I-sufficient 
environment. J.Exp.Med. 2010, 207:2073-2079. 
 297.  Joncker NT, Shifrin N, Delebecque F, Raulet DH: Mature natural killer cells reset 
their responsiveness when exposed to an altered MHC environment. J.Exp.Med. 2010, 
207:2065-2072. 
 298.  Orr MT, Murphy WJ, Lanier LL: 'Unlicensed' natural killer cells dominate the 
response to cytomegalovirus infection. Nat.Immunol. 2010, 11:321-327. 
 299.  Elliott JM, Yokoyama WM: Unifying concepts of MHC-dependent natural killer cell 
education. Trends Immunol. 2011, 32:364-372. 
 300.  Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A: Dendritic cells prime 
natural killer cells by trans-presenting interleukin 15. Immunity. 2007, 26:503-517. 
 301.  Bryceson YT, March ME, Ljunggren HG, Long EO: Synergy among receptors on 
resting NK cells for the activation of natural cytotoxicity and cytokine secretion. 
Blood 2006, 107:159-166. 
 302.  Sabry M, Tsirogianni M, Bakhsh IA, North J, Sivakumaran J, Giannopoulos K, 
Anderson R, Mackinnon S, Lowdell MW: Leukemic priming of resting NK cells is 
killer Ig-like receptor independent but requires CD15-mediated CD2 ligation and 
natural cytotoxicity receptors. J.Immunol. 2011, 187:6227-6234. 
Page | 246  
 
 303.  North J, Bakhsh I, Marden C, Pittman H, Addison E, Navarrete C, Anderson R, 
Lowdell MW: Tumor-primed human natural killer cells lyse NK-resistant tumor 
targets: evidence of a two-stage process in resting NK cell activation. J.Immunol. 
2007, 178:85-94. 
 304.  Hart OM, Athie-Morales V, O'Connor GM, Gardiner CM: TLR7/8-mediated 
activation of human NK cells results in accessory cell-dependent IFN-gamma 
production. J.Immunol. 2005, 175:1636-1642. 
 305.  Strowig T, Chijioke O, Carrega P, Arrey F, Meixlsperger S, Ramer PC, Ferlazzo G, 
Munz C: Human NK cells of mice with reconstituted human immune system 
components require preactivation to acquire functional competence. Blood 2010, 
116:4158-4167. 
 306.  Pegram HJ, Andrews DM, Smyth MJ, Darcy PK, Kershaw MH: Activating and 
inhibitory receptors of natural killer cells. Immunol.Cell Biol. 2011, 89:216-224. 
 307.  Karre K, Ljunggren HG, Piontek G, Kiessling R: Selective rejection of H-2-deficient 
lymphoma variants suggests alternative immune defence strategy. Nature 1986, 
319:675-678. 
 308.  Ljunggren HG, Karre K: In search of the 'missing self': MHC molecules and NK cell 
recognition. Immunol.Today 1990, 11:237-244. 
 309.  Borrego F: The first molecular basis of the "missing self" hypothesis. J.Immunol. 
2006, 177:5759-5760. 
 310.  Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, 
Lanier LL, Kinet JP, Abraham RT, Leibson PJ: Sequential involvement of Lck and 
SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine 
kinase activation. Immunity. 1996, 5:629-638. 
 311.  Olcese L, Lang P, Vely F, Cambiaggi A, Marguet D, Blery M, Hippen KL, Biassoni 
R, Moretta A, Moretta L, Cambier JC, Vivier E: Human and mouse killer-cell 
inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. 
J.Immunol. 1996, 156:4531-4534. 
 312.  Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet 
JP, Long EO: Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor 
receptor. Immunity. 1996, 4:77-85. 
 313.  Tessmer MS, Fugere C, Stevenaert F, Naidenko OV, Chong HJ, Leclercq G, Brossay 
L: KLRG1 binds cadherins and preferentially associates with SHIP-1. Int.Immunol. 
2007, 19:391-400. 
 314.  Binstadt BA, Billadeau DD, Jevremovic D, Williams BL, Fang N, Yi T, Koretzky 
GA, Abraham RT, Leibson PJ: SLP-76 is a direct substrate of SHP-1 recruited to 
killer cell inhibitory receptors. J.Biol.Chem. 1998, 273:27518-27523. 
 315.  Valiante NM, Phillips JH, Lanier LL, Parham P: Killer cell inhibitory receptor 
recognition of human leukocyte antigen (HLA) class I blocks formation of a 
Page | 247  
 
pp36/PLC-gamma signaling complex in human natural killer (NK) cells. J.Exp.Med. 
1996, 184:2243-2250. 
 316.  Stebbins CC, Watzl C, Billadeau DD, Leibson PJ, Burshtyn DN, Long EO: Vav1 
dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition 
of cellular cytotoxicity. Mol.Cell Biol. 2003, 23:6291-6299. 
 317.  Chiang GG, Sefton BM: Specific dephosphorylation of the Lck tyrosine protein 
kinase at Tyr-394 by the SHP-1 protein-tyrosine phosphatase. J.Biol.Chem. 2001, 
276:23173-23178. 
 318.  Brumbaugh KM, Binstadt BA, Billadeau DD, Schoon RA, Dick CJ, Ten RM, Leibson 
PJ: Functional role for Syk tyrosine kinase in natural killer cell-mediated natural 
cytotoxicity. J.Exp.Med. 1997, 186:1965-1974. 
 319.  Kaufman DS, Schoon RA, Robertson MJ, Leibson PJ: Inhibition of selective 
signaling events in natural killer cells recognizing major histocompatibility complex 
class I. Proc.Natl.Acad.Sci.U.S.A 1995, 92:6484-6488. 
 320.  Endt J, McCann FE, Almeida CR, Urlaub D, Leung R, Pende D, Davis DM, Watzl C: 
Inhibitory receptor signals suppress ligation-induced recruitment of NKG2D to GM1-
rich membrane domains at the human NK cell immune synapse. J.Immunol. 2007, 
178:5606-5611. 
 321.  Burshtyn DN, Shin J, Stebbins C, Long EO: Adhesion to target cells is disrupted by 
the killer cell inhibitory receptor. Curr.Biol. 2000, 10:777-780. 
 322.  Abeyweera TP, Merino E, Huse M: Inhibitory signaling blocks activating receptor 
clustering and induces cytoskeletal retraction in natural killer cells. J.Cell Biol. 2011, 
192:675-690. 
 323.  Watzl C, Stebbins CC, Long EO: NK cell inhibitory receptors prevent tyrosine 
phosphorylation of the activation receptor 2B4 (CD244). J.Immunol. 2000, 165:3545-
3548. 
 324.  Palmieri G, Tullio V, Zingoni A, Piccoli M, Frati L, Lopez-Botet M, Santoni A: 
CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular 
regulated kinase activation, leading to cytotoxic function of human NK cells. 
J.Immunol. 1999, 162:7181-7188. 
 325.  Purdy AK, Campbell KS: SHP-2 expression negatively regulates NK cell function. 
J.Immunol. 2009, 183:7234-7243. 
 326.  Das A, Long EO: Lytic granule polarization, rather than degranulation, is the 
preferred target of inhibitory receptors in NK cells. J.Immunol. 2010, 185:4698-4704. 
 327.  Bryceson YT, Ljunggren HG, Long EO: Minimal requirement for induction of natural 
cytotoxicity and intersection of activation signals by inhibitory receptors. Blood 2009, 
114:2657-2666. 
Page | 248  
 
 328.  Damen JE, Liu L, Rosten P, Humphries RK, Jefferson AB, Majerus PW, Krystal G: 
The 145-kDa protein induced to associate with Shc by multiple cytokines is an 
inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. 
Proc.Natl.Acad.Sci.U.S.A 1996, 93:1689-1693. 
 329.  Trotta R, Parihar R, Yu J, Becknell B, Allard J, Wen J, Ding W, Mao H, Tridandapani 
S, Carson WE, Caligiuri MA: Differential expression of SHIP1 in CD56bright and 
CD56dim NK cells provides a molecular basis for distinct functional responses to 
monokine costimulation. Blood 2005, 105:3011-3018. 
 330.  Galandrini R, Tassi I, Mattia G, Lenti L, Piccoli M, Frati L, Santoni A: SH2-
containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and 
modulates CD16-mediated cytotoxicity in human NK cells. Blood 2002, 100:4581-
4589. 
 331.  Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T: Activation of NK 
cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999, 
285:727-729. 
 332.  Cerwenka A, Baron JL, Lanier LL: Ectopic expression of retinoic acid early 
inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC 
class I-bearing tumor in vivo. Proc.Natl.Acad.Sci.U.S.A 2001, 98:11521-11526. 
 333.  Lanier LL: NK cell recognition. Annu.Rev.Immunol. 2005, 23:225-274. 
 334.  Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O: Recognition 
of viral hemagglutinins by NKp44 but not by NKp30. Eur.J.Immunol. 2001, 31:2680-
2689. 
 335.  Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, Davis DM, 
Strominger JL, Yewdell JW, Porgador A: Recognition of haemagglutinins on virus-
infected cells by NKp46 activates lysis by human NK cells. Nature 2001, 409:1055-
1060. 
 336.  Esin S, Batoni G, Counoupas C, Stringaro A, Brancatisano FL, Colone M, Maisetta 
G, Florio W, Arancia G, Campa M: Direct binding of human NK cell natural 
cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria. 
Infect.Immun. 2008, 76:1719-1727. 
 337.  Vivier E, Nunes JA, Vely F: Natural killer cell signaling pathways. Science 2004, 
306:1517-1519. 
 338.  Chen X, Trivedi PP, Ge B, Krzewski K, Strominger JL: Many NK cell receptors 
activate ERK2 and JNK1 to trigger microtubule organizing center and granule 
polarization and cytotoxicity. Proc.Natl.Acad.Sci.U.S.A 2007, 104:6329-6334. 
 339.  Billadeau DD, Upshaw JL, Schoon RA, Dick CJ, Leibson PJ: NKG2D-DAP10 
triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. 
Nat.Immunol. 2003, 4:557-564. 
Page | 249  
 
 340.  Upshaw JL, Arneson LN, Schoon RA, Dick CJ, Billadeau DD, Leibson PJ: NKG2D-
mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and 
phosphatidylinositol-3-kinase in human natural killer cells. Nat.Immunol. 2006, 
7:524-532. 
 341.  Wu J, Song Y, Bakker AB, Bauer S, Spies T, Lanier LL, Phillips JH: An activating 
immunoreceptor complex formed by NKG2D and DAP10. Science 1999, 285:730-
732. 
 342.  Campbell JJ, Qin S, Unutmaz D, Soler D, Murphy KE, Hodge MR, Wu L, Butcher 
EC: Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes 
identified by chemokine receptor expression repertoire. J.Immunol. 2001, 166:6477-
6482. 
 343.  Hanna J, Mandelboim O: When killers become helpers. Trends Immunol. 2007, 
28:201-206. 
 344.  Fehniger TA, Cooper MA, Nuovo GJ, Cella M, Facchetti F, Colonna M, Caligiuri 
MA: CD56bright natural killer cells are present in human lymph nodes and are 
activated by T cell-derived IL-2: a potential new link between adaptive and innate 
immunity. Blood 2003, 101:3052-3057. 
 345.  Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell 
subsets. Trends Immunol. 2001, 22:633-640. 
 346.  Caligiuri MA, Zmuidzinas A, Manley TJ, Levine H, Smith KA, Ritz J: Functional 
consequences of interleukin 2 receptor expression on resting human lymphocytes. 
Identification of a novel natural killer cell subset with high affinity receptors. 
J.Exp.Med. 1990, 171:1509-1526. 
 347.  Zhang X, Yu J: Target recognition-induced NK-cell responses. Blood 2010, 
115:2119-2120. 
 348.  Nagler A, Lanier LL, Cwirla S, Phillips JH: Comparative studies of human FcRIII-
positive and negative natural killer cells. J.Immunol. 1989, 143:3183-3191. 
 349.  Jacobs R, Hintzen G, Kemper A, Beul K, Kempf S, Behrens G, Sykora KW, Schmidt 
RE: CD56bright cells differ in their KIR repertoire and cytotoxic features from 
CD56dim NK cells. Eur.J.Immunol. 2001, 31:3121-3127. 
 350.  Konjevic G, Mirjacic MK, Vuletic A, Radenkovic S: Novel aspects of in vitro IL-2 or 
IFN-alpha enhanced NK cytotoxicity of healthy individuals based on NKG2D and 
CD161 NK cell receptor induction. Biomed.Pharmacother. 2010, 64:663-671. 
 351.  Almeida-Oliveira A, Smith-Carvalho M, Porto LC, Cardoso-Oliveira J, Ribeiro AS, 
Falcao RR, Abdelhay E, Bouzas LF, Thuler LC, Ornellas MH, Diamond HR: Age-
related changes in natural killer cell receptors from childhood through old age. 
Hum.Immunol. 2011, 72:319-329. 
Page | 250  
 
 352.  Hayhoe RP, Henson SM, Akbar AN, Palmer DB: Variation of human natural killer 
cell phenotypes with age: identification of a unique KLRG1-negative subset. 
Hum.Immunol. 2010, 71:676-681. 
 353.  Juelke K, Killig M, Luetke-Eversloh M, Parente E, Gruen J, Morandi B, Ferlazzo G, 
Thiel A, Schmitt-Knosalla I, Romagnani C: CD62L expression identifies a unique 
subset of polyfunctional CD56dim NK cells. Blood 2010, 116:1299-1307. 
 354.  Lutz CT, Karapetyan A, Al-Attar A, Shelton BJ, Holt KJ, Tucker JH, Presnell SR: 
Human NK cells proliferate and die in vivo more rapidly than T cells in healthy 
young and elderly adults. J.Immunol. 2011, 186:4590-4598. 
 355.  Le Garff-Tavernier M, Beziat V, Decocq J, Siguret V, Gandjbakhch F, Pautas E, 
Debre P, Merle-Beral H, Vieillard V: Human NK cells display major phenotypic and 
functional changes over the life span. Aging Cell 2010, 9:527-535. 
 356.  Lutz CT, Moore MB, Bradley S, Shelton BJ, Lutgendorf SK: Reciprocal age related 
change in natural killer cell receptors for MHC class I. Mech.Ageing Dev. 2005, 
126:722-731. 
 357.  Di LG, Balistreri CR, Candore G, Cigna D, Colombo A, Romano GC, Colucci AT, 
Gervasi F, Listi F, Potestio M, Caruso C: Granulocyte and natural killer activity in the 
elderly. Mech.Ageing Dev. 1999, 108:25-38. 
 358.  Krishnaraj R: Senescence and cytokines modulate the NK cell expression. 
Mech.Ageing Dev. 1997, 96:89-101. 
 359.  Zhang Y, Wallace DL, de Lara CM, Ghattas H, Asquith B, Worth A, Griffin GE, 
Taylor GP, Tough DF, Beverley PC, Macallan DC: In vivo kinetics of human natural 
killer cells: the effects of ageing and acute and chronic viral infection. Immunology 
2007, 121:258-265. 
 360.  Simpson RJ, Cosgrove C, Ingram LA, Florida-James GD, Whyte GP, Pircher H, Guy 
K: Senescent T-lymphocytes are mobilised into the peripheral blood compartment in 
young and older humans after exhaustive exercise. Brain Behav.Immun. 2008, 
22:544-551. 
 361.  Borrego F, Alonso MC, Galiani MD, Carracedo J, Ramirez R, Ostos B, Pena J, 
Solana R: NK phenotypic markers and IL2 response in NK cells from elderly people. 
Exp.Gerontol. 1999, 34:253-265. 
 362.  Tarazona R, Gayoso I, Corona A, Luisa Pita M, Peralbo E, Casado JG, Sanchez-
Correa B, Morgado S, Solana R: NK cells in human ageing. In Handbook on 
immunosenescence. 2009:531-544. 
 363.  Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N, Lopez-Botet M: Imprint 
of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004, 
104:3664-3671. 
 364.  Bigley AB, Lowder TW, Spielmann G, Rector JL, Pircher H, Woods JA, Simpson RJ: 
NK-cells have an impaired response to acute exercise and a lower expression of the 
Page | 251  
 
inhibitory receptors KLRG1 and CD158a in humans with latent cytomegalovirus 
infection. Brain Behav.Immun. 2012, 26:177-186. 
 365.  Facchini A, Mariani E, Mariani AR, Papa S, Vitale M, Manzoli FA: Increased number 
of circulating Leu 11+ (CD 16) large granular lymphocytes and decreased NK activity 
during human ageing. Clin.Exp.Immunol. 1987, 68:340-347. 
 366.  Krishnaraj R, Blandford G: Age-associated alterations in human natural killer cells. 1. 
Increased activity as per conventional and kinetic analysis. 
Clin.Immunol.Immunopathol. 1987, 45:268-285. 
 367.  Kutza J, Murasko DM: Effects of aging on natural killer cell activity and activation by 
interleukin-2 and IFN-alpha. Cell Immunol. 1994, 155:195-204. 
 368.  Onsrud M: Age dependent changes in some human lymphocyte sub-populations. 
Changes in natural killer cell activity. Acta Pathol.Microbiol.Scand.C. 1981, 89:55-
62. 
 369.  Nagel JE, Collins GD, Adler WH: Spontaneous or natural killer cytotoxicity of K562 
erythroleukemic cells in normal patients. Cancer Res. 1981, 41:2284-2288. 
 370.  Rukavina D, Laskarin G, Rubesa G, Strbo N, Bedenicki I, Manestar D, Glavas M, 
Christmas SE, Podack ER: Age-related decline of perforin expression in human 
cytotoxic T lymphocytes and natural killer cells. Blood 1998, 92:2410-2420. 
 371.  Mariani E, Roda P, Mariani AR, Vitale M, Degrassi A, Papa S, Facchini A: Age-
associated changes in CD8+ and CD16+ cell reactivity: clonal analysis. 
Clin.Exp.Immunol. 1990, 81:479-484. 
 372.  Ligthart GJ, Schuit HR, Hijmans W: Natural killer cell function is not diminished in 
the healthy aged and is proportional to the number of NK cells in the peripheral blood. 
Immunology 1989, 68:396-402. 
 373.  Mariani E, Mariani AR, Meneghetti A, Tarozzi A, Cocco L, Facchini A: Age-
dependent decreases of NK cell phosphoinositide turnover during spontaneous but not 
Fc-mediated cytolytic activity. Int.Immunol. 1998, 10:981-989. 
 374.  Vitale M, Zamai L, Neri LM, Galanzi A, Facchini A, Rana R, Cataldi A, Papa S: The 
impairment of natural killer function in the healthy aged is due to a postbinding 
deficient mechanism. Cell Immunol. 1992, 145:1-10. 
 375.  Mariani E, Sgobbi S, Meneghetti A, Tadolini M, Tarozzi A, Sinoppi M, Cattini L, 
Facchini A: Perforins in human cytolytic cells: the effect of age. Mech.Ageing Dev. 
1996, 92:195-209. 
 376.  Fernandes G, Gupta S: Natural killing and antibody-dependent cytotoxicity by 
lymphocyte subpopulations in young and aging humans. J.Clin.Immunol. 1981, 
1:141-148. 
 377.  Edwards DL, Avis FP: Antibody-dependent cellular cytotoxicity effector cell 
capability among normal individuals. J.Immunol. 1979, 123:1887-1893. 
Page | 252  
 
 378.  Mariani E, Pulsatelli L, Meneghetti A, Dolzani P, Mazzetti I, Neri S, Ravaglia G, 
Forti P, Facchini A: Different IL-8 production by T and NK lymphocytes in elderly 
subjects. Mech.Ageing Dev. 2001, 122:1383-1395. 
 379.  Kutza J, Murasko DM: Age-associated decline in IL-2 and IL-12 induction of LAK 
cell activity of human PBMC samples. Mech.Ageing Dev. 1996, 90:209-222. 
 380.  Krishnaraj R, Bhooma T: Cytokine sensitivity of human NK cells during 
immunosenescence. 2. IL2-induced interferon gamma secretion. Immunol.Lett. 1996, 
50:59-63. 
 381.  Mariani E, Pulsatelli L, Neri S, Dolzani P, Meneghetti A, Silvestri T, Ravaglia G, 
Forti P, Cattini L, Facchini A: RANTES and MIP-1alpha production by T 
lymphocytes, monocytes and NK cells from nonagenarian subjects. Exp.Gerontol. 
2002, 37:219-226. 
 382.  Mariani E, Meneghetti A, Neri S, Ravaglia G, Forti P, Cattini L, Facchini A: 
Chemokine production by natural killer cells from nonagenarians. Eur.J.Immunol. 
2002, 32:1524-1529. 
 383.  Mysliwska J, Trzonkowski P, Szmit E, Brydak LB, Machala M, Mysliwski A: 
Immunomodulating effect of influenza vaccination in the elderly differing in health 
status. Exp.Gerontol. 2004, 39:1447-1458. 
 384.  Pawelec G, Solana R, Remarque E, Mariani E: Impact of aging on innate immunity. 
J.Leukoc.Biol. 1998, 64:703-712. 
 385.  Cossarizza A, Ortolani C, Monti D, Franceschi C: Cytometric analysis of 
immunosenescence. Cytometry 1997, 27:297-313. 
 386.  Sansoni P, Cossarizza A, Brianti V, Fagnoni F, Snelli G, Monti D, Marcato A, Passeri 
G, Ortolani C, Forti E, .: Lymphocyte subsets and natural killer cell activity in healthy 
old people and centenarians. Blood 1993, 82:2767-2773. 
 387.  Segal AW: How neutrophils kill microbes. Annu.Rev.Immunol. 2005, 23:197-223. 
 388.  Schroder AK, von der OM, Kolling U, Altstaedt J, Uciechowski P, Fleischer D, 
Dalhoff K, Ju X, Zenke M, Heussen N, Rink L: Polymorphonuclear leucocytes 
selectively produce anti-inflammatory interleukin-1 receptor antagonist and 
chemokines, but fail to produce pro-inflammatory mediators. Immunology 2006, 
119:317-327. 
 389.  Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M: 
Phagocytosing neutrophils produce and release high amounts of the neutrophil-
activating peptide 1/interleukin 8. J.Exp.Med. 1991, 173:771-774. 
 390.  Kasama T, Strieter RM, Standiford TJ, Burdick MD, Kunkel SL: Expression and 
regulation of human neutrophil-derived macrophage inflammatory protein 1 alpha. 
J.Exp.Med. 1993, 178:63-72. 
Page | 253  
 
 391.  Altstaedt J, Kirchner H, Rink L: Cytokine production of neutrophils is limited to 
interleukin-8. Immunology 1996, 89:563-568. 
 392.  Bliss SK, Marshall AJ, Zhang Y, Denkers EY: Human polymorphonuclear leukocytes 
produce IL-12, TNF-alpha, and the chemokines macrophage-inflammatory protein-1 
alpha and -1 beta in response to Toxoplasma gondii antigens. J.Immunol. 1999, 
162:7369-7375. 
 393.  Li L, Huang L, Vergis AL, Ye H, Bajwa A, Narayan V, Strieter RM, Rosin DL, 
Okusa MD: IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil 
migration in mouse kidney ischemia-reperfusion injury. J.Clin.Invest 2010, 120:331-
342. 
 394.  Tsuda Y, Takahashi H, Kobayashi M, Hanafusa T, Herndon DN, Suzuki F: Three 
different neutrophil subsets exhibited in mice with different susceptibilities to 
infection by methicillin-resistant Staphylococcus aureus. Immunity. 2004, 21:215-226. 
 395.  Bennouna S, Bliss SK, Curiel TJ, Denkers EY: Cross-talk in the innate immune 
system: neutrophils instruct recruitment and activation of dendritic cells during 
microbial infection. J.Immunol. 2003, 171:6052-6058. 
 396.  Abadie V, Badell E, Douillard P, Ensergueix D, Leenen PJ, Tanguy M, Fiette L, 
Saeland S, Gicquel B, Winter N: Neutrophils rapidly migrate via lymphatics after 
Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the 
draining lymph nodes. Blood 2005, 106:1843-1850. 
 397.  Maletto BA, Ropolo AS, Alignani DO, Liscovsky MV, Ranocchia RP, Moron VG, 
Pistoresi-Palencia MC: Presence of neutrophil-bearing antigen in lymphoid organs of 
immune mice. Blood 2006, 108:3094-3102. 
 398.  Abi Abdallah DS, Egan CE, Butcher BA, Denkers EY: Mouse neutrophils are 
professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell 
differentiation. Int.Immunol. 2011, 23:317-326. 
 399.  Beauvillain C, Delneste Y, Scotet M, Peres A, Gascan H, Guermonprez P, Barnaba V, 
Jeannin P: Neutrophils efficiently cross-prime naive T cells in vivo. Blood 2007, 
110:2965-2973. 
 400.  Tacchini-Cottier F, Zweifel C, Belkaid Y, Mukankundiye C, Vasei M, Launois P, 
Milon G, Louis JA: An immunomodulatory function for neutrophils during the 
induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major. 
J.Immunol. 2000, 165:2628-2636. 
 401.  Chatta GS, Andrews RG, Rodger E, Schrag M, Hammond WP, Dale DC: 
Hematopoietic progenitors and aging: alterations in granulocytic precursors and 
responsiveness to recombinant human G-CSF, GM-CSF, and IL-3. J.Gerontol. 1993, 
48:M207-M212. 
Page | 254  
 
 402.  Born J, Uthgenannt D, Dodt C, Nunninghoff D, Ringvolt E, Wagner T, Fehm HL: 
Cytokine production and lymphocyte subpopulations in aged humans. An assessment 
during nocturnal sleep. Mech.Ageing Dev. 1995, 84:113-126. 
 403.  Lord JM, Butcher S, Killampali V, Lascelles D, Salmon M: Neutrophil ageing and 
immunesenescence. Mech.Ageing Dev. 2001, 122:1521-1535. 
 404.  Walrand S, Guillet C, Boirie Y, Vasson MP: Insulin differentially regulates monocyte 
and polymorphonuclear neutrophil functions in healthy young and elderly humans. 
J.Clin.Endocrinol.Metab 2006, 91:2738-2748. 
 405.  Butcher SK, Chahal H, Nayak L, Sinclair A, Henriquez NV, Sapey E, O'Mahony D, 
Lord JM: Senescence in innate immune responses: reduced neutrophil phagocytic 
capacity and CD16 expression in elderly humans. J.Leukoc.Biol. 2001, 70:881-886. 
 406.  Esparza B, Sanchez H, Ruiz M, Barranquero M, Sabino E, Merino F: Neutrophil 
function in elderly persons assessed by flow cytometry. Immunol.Invest 1996, 25:185-
190. 
 407.  Damtew B, Spagnuolo PJ, Goldsmith GG, Marino JA: Neutrophil adhesion in the 
elderly: inhibitory effects of plasma from elderly patients. 
Clin.Immunol.Immunopathol. 1990, 54:247-255. 
 408.  Tortorella C, Piazzolla G, Spaccavento F, Vella F, Pace L, Antonaci S: Regulatory 
role of extracellular matrix proteins in neutrophil respiratory burst during aging. 
Mech.Ageing Dev. 2000, 119:69-82. 
 409.  Alonso-Fernandez P, Puerto M, Mate I, Ribera JM, De la Fuente M: Neutrophils of 
centenarians show function levels similar to those of young adults. J.Am.Geriatr.Soc. 
2008, 56:2244-2251. 
 410.  McLaughlin B, O'Malley K, Cotter TG: Age-related differences in granulocyte 
chemotaxis and degranulation. Clin.Sci.(Lond) 1986, 70:59-62. 
 411.  Niwa Y, Kasama T, Miyachi Y, Kanoh T: Neutrophil chemotaxis, phagocytosis and 
parameters of reactive oxygen species in human aging: cross-sectional and 
longitudinal studies. Life Sci. 1989, 44:1655-1664. 
 412.  Fulop T, Larbi A, Douziech N, Fortin C, Guerard KP, Lesur O, Khalil A, Dupuis G: 
Signal transduction and functional changes in neutrophils with aging. Aging Cell 
2004, 3:217-226. 
 413.  MacGregor RR, Shalit M: Neutrophil function in healthy elderly subjects. J.Gerontol. 
1990, 45:M55-M60. 
 414.  Nomellini V, Faunce DE, Gomez CR, Kovacs EJ: An age-associated increase in 
pulmonary inflammation after burn injury is abrogated by CXCR2 inhibition. 
J.Leukoc.Biol. 2008, 83:1493-1501. 
Page | 255  
 
 415.  Biasi D, Carletto A, Dell'Agnola C, Caramaschi P, Montesanti F, Zavateri G, 
Zeminian S, Bellavite P, Bambara LM: Neutrophil migration, oxidative metabolism, 
and adhesion in elderly and young subjects. Inflammation 1996, 20:673-681. 
 416.  Emanuelli G, Lanzio M, Anfossi T, Romano S, Anfossi G, Calcamuggi G: Influence 
of age on polymorphonuclear leukocytes in vitro: phagocytic activity in healthy 
human subjects. Gerontology 1986, 32:308-316. 
 417.  Mege JL, Capo C, Michel B, Gastaut JL, Bongrand P: Phagocytic cell function in 
aged subjects. Neurobiol.Aging 1988, 9:217-220. 
 418.  Wenisch C, Patruta S, Daxbock F, Krause R, Horl W: Effect of age on human 
neutrophil function. J.Leukoc.Biol. 2000, 67:40-45. 
 419.  Simell B, Vuorela A, Ekstrom N, Palmu A, Reunanen A, Meri S, Kayhty H, 
Vakevainen M: Aging reduces the functionality of anti-pneumococcal antibodies and 
the killing of Streptococcus pneumoniae by neutrophil phagocytosis. Vaccine 2011, 
29:1929-1934. 
 420.  Braga PC, Sala MT, Dal SM, Pecile A, Annoni G, Vergani C: Age-associated 
differences in neutrophil oxidative burst (chemiluminescence). Exp.Gerontol. 1998, 
33:477-484. 
 421.  Braga PC, Sala MT, Dal SM, Mancini L, Sandrini MC, Annoni G: Influence of age on 
oxidative bursts (chemiluminescence) of polymorphonuclear neutrophil leukocytes. 
Gerontology 1998, 44:192-197. 
 422.  Tortorella C, Simone O, Piazzolla G, Stella I, Cappiello V, Antonaci S: Role of 
phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways in 
granulocyte macrophage-colony-stimulating factor failure to delay fas-induced 
neutrophil apoptosis in elderly humans. J.Gerontol.A Biol.Sci.Med.Sci. 2006, 
61:1111-1118. 
 423.  Fortin CF, Larbi A, Dupuis G, Lesur O, Fulop T, Jr.: GM-CSF activates the 
Jak/STAT pathway to rescue polymorphonuclear neutrophils from spontaneous 
apoptosis in young but not elderly individuals. Biogerontology. 2007, 8:173-187. 
 424.  Lipschitz DA, Udupa KB, Indelicato SR, Das M: Effect of age on second messenger 
generation in neutrophils. Blood 1991, 78:1347-1354. 
 425.  Alvarez E, Ruiz-Gutierrez V, Sobrino F, Santa-Maria C: Age-related changes in 
membrane lipid composition, fluidity and respiratory burst in rat peritoneal 
neutrophils. Clin.Exp.Immunol. 2001, 124:95-102. 
 426.  Tortorella C, Ottolenghi A, Pugliese P, Jirillo E, Antonaci S: Relationship between 
respiratory burst and adhesiveness capacity in elderly polymorphonuclear cells. 
Mech.Ageing Dev. 1993, 69:53-63. 
 427.  Suzuki K, Swenson C, Sasagawa S, Sakatani T, Watanabe M, Kobayashi M, Fujikura 
T: Age-related decline in lysosomal enzyme release from polymorphonuclear 
Page | 256  
 
leukocytes after N-formyl-methionyl-leucyl-phenylalanine stimulation. Exp.Hematol. 
1983, 11:1005-1013. 
 428.  Fulop T, Jr., Larbi A, Linteau A, Desgeorges S, Douziech N: The role of Mcl-1 and 
Bax expression alteration in the decreased rescue of human neutrophils from 
apoptosis by GM-CSF with aging. Ann.N.Y.Acad.Sci. 2002, 973:305-308. 
 429.  Fortin CF, Larbi A, Lesur O, Douziech N, Fulop T, Jr.: Impairment of SHP-1 down-
regulation in the lipid rafts of human neutrophils under GM-CSF stimulation 
contributes to their age-related, altered functions. J.Leukoc.Biol. 2006, 79:1061-1072. 
 430.  Fulop T, Jr., Fouquet C, Allaire P, Perrin N, Lacombe G, Stankova J, Rola-
Pleszczynski M, Gagne D, Wagner JR, Khalil A, Dupuis G: Changes in apoptosis of 
human polymorphonuclear granulocytes with aging. Mech.Ageing Dev. 1997, 96:15-
34. 
 431.  Fortin CF, Lesur O, Fulop T, Jr.: Effects of aging on triggering receptor expressed on 
myeloid cells (TREM)-1-induced PMN functions. FEBS Lett. 2007, 581:1173-1178. 
 432.  Larbi A, Douziech N, Fortin C, Linteau A, Dupuis G, Fulop T, Jr.: The role of the 
MAPK pathway alterations in GM-CSF modulated human neutrophil apoptosis with 
aging. Immun.Ageing 2005, 2:6. 
 433.  Seres I, Csongor J, Mohacsi A, Leovey A, Fulop T: Age-dependent alterations of 
human recombinant GM-CSF effects on human granulocytes. Mech.Ageing Dev. 
1993, 71:143-154. 
 434.  Corberand J, Ngyen F, Laharrague P, Fontanilles AM, Gleyzes B, Gyrard E, Senegas 
C: Polymorphonuclear functions and aging in humans. J.Am.Geriatr.Soc. 1981, 
29:391-397. 
 435.  Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, 
Weinrauch Y, Zychlinsky A: Neutrophil extracellular traps kill bacteria. Science 
2004, 303:1532-1535. 
 436.  Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, Brinkmann 
V, Jungblut PR, Zychlinsky A: Neutrophil extracellular traps contain calprotectin, a 
cytosolic protein complex involved in host defense against Candida albicans. 
PLoS.Pathog. 2009, 5:e1000639. 
 437.  Young RL, Malcolm KC, Kret JE, Caceres SM, Poch KR, Nichols DP, Taylor-Cousar 
JL, Saavedra MT, Randell SH, Vasil ML, Burns JL, Moskowitz SM, Nick JA: 
Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: 
evidence of acquired resistance within the CF airway, independent of CFTR. 
PLoS.One. 2011, 6:e23637. 
 438.  Douda DN, Jackson R, Grasemann H, Palaniyar N: Innate immune collectin 
surfactant protein D simultaneously binds both neutrophil extracellular traps and 
carbohydrate ligands and promotes bacterial trapping. J.Immunol. 2011, 187:1856-
1865. 
Page | 257  
 
 439.  Urban CF, Reichard U, Brinkmann V, Zychlinsky A: Neutrophil extracellular traps 
capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol. 2006, 
8:668-676. 
 440.  Guimaraes-Costa AB, Nascimento MT, Froment GS, Soares RP, Morgado FN, 
Conceicao-Silva F, Saraiva EM: Leishmania amazonensis promastigotes induce and 
are killed by neutrophil extracellular traps. Proc.Natl.Acad.Sci.U.S.A 2009, 106:6748-
6753. 
 441.  Baker VS, Imade GE, Molta NB, Tawde P, Pam SD, Obadofin MO, Sagay SA, Egah 
DZ, Iya D, Afolabi BB, Baker M, Ford K, Ford R, Roux KH, Keller TC, III: 
Cytokine-associated neutrophil extracellular traps and antinuclear antibodies in 
Plasmodium falciparum infected children under six years of age. Malar.J. 2008, 7:41. 
 442.  Crotty Alexander LE, Maisey HC, Timmer AM, Rooijakkers SH, Gallo RL, von 
Kockritz-Blickwede M, Nizet V: M1T1 group A streptococcal pili promote epithelial 
colonization but diminish systemic virulence through neutrophil extracellular 
entrapment. J.Mol.Med.(Berl) 2010, 88:371-381. 
 443.  Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, Weinrauch Y, 
Brinkmann V, Zychlinsky A: Novel cell death program leads to neutrophil 
extracellular traps. J.Cell Biol. 2007, 176:231-241. 
 444.  Munafo DB, Johnson JL, Brzezinska AA, Ellis BA, Wood MR, Catz SD: DNase I 
inhibits a late phase of reactive oxygen species production in neutrophils. 
J.Innate.Immun. 2009, 1:527-542. 
 445.  Parker H, Albrett AM, Kettle AJ, Winterbourn CC: Myeloperoxidase associated with 
neutrophil extracellular traps is active and mediates bacterial killing in the presence of 
hydrogen peroxide. J.Leukoc.Biol. 2012, 91:369-376. 
 446.  Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, 
Lohmeyer J, Preissner KT: Neutrophil extracellular traps directly induce epithelial 
and endothelial cell death: a predominant role of histones. PLoS.One. 2012, 7:e32366. 
 447.  Menegazzi R, Decleva E, Dri P: Killing by neutrophil extracellular traps: fact or 
folklore? Blood 2012, 119:1214-1216. 
 448.  Nauseef WM: Editorial: Nyet to NETs? A pause for healthy skepticism. 
J.Leukoc.Biol. 2012, 91:353-355. 
 449.  Oehmcke S, Morgelin M, Herwald H: Activation of the human contact system on 
neutrophil extracellular traps. J.Innate.Immun. 2009, 1:225-230. 
 450.  Jaillon S, Peri G, Delneste Y, Fremaux I, Doni A, Moalli F, Garlanda C, Romani L, 
Gascan H, Bellocchio S, Bozza S, Cassatella MA, Jeannin P, Mantovani A: The 
humoral pattern recognition receptor PTX3 is stored in neutrophil granules and 
localizes in extracellular traps. J.Exp.Med. 2007, 204:793-804. 
Page | 258  
 
 451.  Tillack K, Breiden P, Martin R, Sospedra M: T lymphocyte priming by neutrophil 
extracellular traps links innate and adaptive immune responses. J.Immunol. 2012, 
188:3150-3159. 
 452.  Pilsczek FH, Salina D, Poon KK, Fahey C, Yipp BG, Sibley CD, Robbins SM, Green 
FH, Surette MG, Sugai M, Bowden MG, Hussain M, Zhang K, Kubes P: A novel 
mechanism of rapid nuclear neutrophil extracellular trap formation in response to 
Staphylococcus aureus. J.Immunol. 2010, 185:7413-7425. 
 453.  Yousefi S, Mihalache C, Kozlowski E, Schmid I, Simon HU: Viable neutrophils 
release mitochondrial DNA to form neutrophil extracellular traps. Cell Death.Differ. 
2009, 16:1438-1444. 
 454.  von Kockritz-Blickwede M, Nizet V: Innate immunity turned inside-out: 
antimicrobial defense by phagocyte extracellular traps. J.Mol.Med.(Berl) 2009, 
87:775-783. 
 455.  Neeli I, Dwivedi N, Khan S, Radic M: Regulation of extracellular chromatin release 
from neutrophils. J.Innate.Immun. 2009, 1:194-201. 
 456.  Wang Y, Wysocka J, Sayegh J, Lee YH, Perlin JR, Leonelli L, Sonbuchner LS, 
McDonald CH, Cook RG, Dou Y, Roeder RG, Clarke S, Stallcup MR, Allis CD, 
Coonrod SA: Human PAD4 regulates histone arginine methylation levels via 
demethylimination. Science 2004, 306:279-283. 
 457.  Saiki M, Watase M, Matsubayashi H, Hidaka Y: Recognition of the N-terminal 
histone H2A and H3 peptides by peptidylarginine deiminase IV. Protein Pept.Lett. 
2009, 16:1012-1016. 
 458.  Li P, Li M, Lindberg MR, Kennett MJ, Xiong N, Wang Y: PAD4 is essential for 
antibacterial innate immunity mediated by neutrophil extracellular traps. J.Exp.Med. 
2010, 207:1853-1862. 
 459.  Wang Y, Li M, Stadler S, Correll S, Li P, Wang D, Hayama R, Leonelli L, Han H, 
Grigoryev SA, Allis CD, Coonrod SA: Histone hypercitrullination mediates 
chromatin decondensation and neutrophil extracellular trap formation. J.Cell Biol. 
2009, 184:205-213. 
 460.  Kirchner T, Moller S, Klinger M, Solbach W, Laskay T, Behnen M: The impact of 
various reactive oxygen species on the formation of neutrophil extracellular traps. 
Mediators.Inflamm. 2012, 2012:849136. 
 461.  Seger RA: Modern management of chronic granulomatous disease. Br.J.Haematol. 
2008, 140:255-266. 
 462.  Nishinaka Y, Arai T, Adachi S, Takaori-Kondo A, Yamashita K: Singlet oxygen is 
essential for neutrophil extracellular trap formation. Biochem.Biophys.Res.Commun. 
2011, 413:75-79. 
Page | 259  
 
 463.  Bianchi M, Hakkim A, Brinkmann V, Siler U, Seger RA, Zychlinsky A, Reichenbach 
J: Restoration of NET formation by gene therapy in CGD controls aspergillosis. 
Blood 2009, 114:2619-2622. 
 464.  Palmer LJ, Cooper PR, Ling MR, Wright HJ, Huissoon A, Chapple IL: Hypochlorous 
acid regulates neutrophil extracellular trap release in humans. Clin.Exp.Immunol. 
2012, 167:261-268. 
 465.  Brinkmann V, Zychlinsky A: Neutrophil extracellular traps: Is immunity the second 
function of chromatin? J.Cell Biol. 2012, 198:773-783. 
 466.  Metzler KD, Fuchs TA, Nauseef WM, Reumaux D, Roesler J, Schulze I, Wahn V, 
Papayannopoulos V, Zychlinsky A: Myeloperoxidase is required for neutrophil 
extracellular trap formation: implications for innate immunity. Blood 2011, 117:953-
959. 
 467.  Gupta AK, Joshi MB, Philippova M, Erne P, Hasler P, Hahn S, Resink TJ: Activated 
endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-
mediated cell death. FEBS Lett. 2010, 584:3193-3197. 
 468.  Remijsen Q, Kuijpers TW, Wirawan E, Lippens S, Vandenabeele P, Vanden Berghe 
T: Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death 
modality. Cell Death.Differ. 2011, 18:581-588. 
 469.  Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A: Neutrophil elastase and 
myeloperoxidase regulate the formation of neutrophil extracellular traps. J.Cell Biol. 
2010, 191:677-691. 
 470.  Remijsen Q, Vanden Berghe T, Wirawan E, Asselbergh B, Parthoens E, De RR, 
Noppen S, Delforge M, Willems J, Vandenabeele P: Neutrophil extracellular trap cell 
death requires both autophagy and superoxide generation. Cell Res. 2011, 21:290-304. 
 471.  Yost CC, Cody MJ, Harris ES, Thornton NL, McInturff AM, Martinez ML, Chandler 
NB, Rodesch CK, Albertine KH, Petti CA, Weyrich AS, Zimmerman GA: Impaired 
neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of 
human neonates. Blood 2009, 113:6419-6427. 
 472.  Buchanan JT, Simpson AJ, Aziz RK, Liu GY, Kristian SA, Kotb M, Feramisco J, 
Nizet V: DNase expression allows the pathogen group A Streptococcus to escape 
killing in neutrophil extracellular traps. Curr.Biol. 2006, 16:396-400. 
 473.  Beiter K, Wartha F, Albiger B, Normark S, Zychlinsky A, Henriques-Normark B: An 
endonuclease allows Streptococcus pneumoniae to escape from neutrophil 
extracellular traps. Curr.Biol. 2006, 16:401-407. 
 474.  Narasaraju T, Yang E, Samy RP, Ng HH, Poh WP, Liew AA, Phoon MC, van RN, 
Chow VT: Excessive neutrophils and neutrophil extracellular traps contribute to acute 
lung injury of influenza pneumonitis. Am.J.Pathol. 2011, 179:199-210. 
 475.  Bruns S, Kniemeyer O, Hasenberg M, Aimanianda V, Nietzsche S, Thywissen A, 
Jeron A, Latge JP, Brakhage AA, Gunzer M: Production of extracellular traps against 
Page | 260  
 
Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading 
neutrophils and influenced by hydrophobin RodA. PLoS.Pathog. 2010, 6:e1000873. 
 476.  Hong W, Juneau RA, Pang B, Swords WE: Survival of bacterial biofilms within 
neutrophil extracellular traps promotes nontypeable Haemophilus influenzae 
persistence in the chinchilla model for otitis media. J.Innate.Immun. 2009, 1:215-224. 
 477.  Berends ET, Horswill AR, Haste NM, Monestier M, Nizet V, von Kockritz-
Blickwede M: Nuclease expression by Staphylococcus aureus facilitates escape from 
neutrophil extracellular traps. J.Innate.Immun. 2010, 2:576-586. 
 478.  Meng W, Paunel-Gorgulu A, Flohe S, Hoffmann A, Witte I, Mackenzie C, Baldus SE, 
Windolf J, Logters TT: Depletion of neutrophil extracellular traps in vivo results in 
hypersusceptibility to polymicrobial sepsis in mice. Crit Care 2012, 16:R137. 
 479.  Yipp BG, Petri B, Salina D, Jenne CN, Scott BN, Zbytnuik LD, Pittman K, 
Asaduzzaman M, Wu K, Meijndert HC, Malawista SE, de Boisfleury CA, Zhang K, 
Conly J, Kubes P: Infection-induced NETosis is a dynamic process involving 
neutrophil multitasking in vivo. Nat.Med. 2012. 
 480.  Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, Rubin CJ, 
Zhao W, Olsen SH, Klinker M, Shealy D, Denny MF, Plumas J, Chaperot L, Kretzler 
M, Bruce AT, Kaplan MJ: Netting neutrophils induce endothelial damage, infiltrate 
tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. 
J.Immunol. 2011, 187:538-552. 
 481.  Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, Grone 
HJ, Brinkmann V, Jenne DE: Netting neutrophils in autoimmune small-vessel 
vasculitis. Nat.Med. 2009, 15:623-625. 
 482.  Jennette JC, Falk RJ, Gasim AH: Pathogenesis of antineutrophil cytoplasmic 
autoantibody vasculitis. Curr.Opin.Nephrol.Hypertens. 2011, 20:263-270. 
 483.  Marcos V, Zhou Z, Yildirim AO, Bohla A, Hector A, Vitkov L, Wiedenbauer EM, 
Krautgartner WD, Stoiber W, Belohradsky BH, Rieber N, Kormann M, Koller B, 
Roscher A, Roos D, Griese M, Eickelberg O, Doring G, Mall MA, Hartl D: CXCR2 
mediates NADPH oxidase-independent neutrophil extracellular trap formation in 
cystic fibrosis airway inflammation. Nat.Med. 2010, 16:1018-1023. 
 484.  Papayannopoulos V, Staab D, Zychlinsky A: Neutrophil elastase enhances sputum 
solubilization in cystic fibrosis patients receiving DNase therapy. PLoS.One. 2011, 
6:e28526. 
 485.  Megens RT, Vijayan S, Lievens D, Doring Y, van Zandvoort MA, Grommes J, Weber 
C, Soehnlein O: Presence of luminal neutrophil extracellular traps in atherosclerosis. 
Thromb.Haemost. 2012, 107:597-598. 
 486.  Gupta AK, Hasler P, Holzgreve W, Gebhardt S, Hahn S: Induction of neutrophil 
extracellular DNA lattices by placental microparticles and IL-8 and their presence in 
preeclampsia. Hum.Immunol. 2005, 66:1146-1154. 
Page | 261  
 
 487.  Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, Meller S, 
Chamilos G, Sebasigari R, Riccieri V, Bassett R, Amuro H, Fukuhara S, Ito T, Liu 
YJ, Gilliet M: Neutrophils activate plasmacytoid dendritic cells by releasing self-
DNA-peptide complexes in systemic lupus erythematosus. Sci.Transl.Med. 2011, 
3:73ra19. 
 488.  Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch 
J, Guiducci C, Coffman RL, Barrat FJ, Banchereau J, Pascual V: Netting neutrophils 
are major inducers of type I IFN production in pediatric systemic lupus 
erythematosus. Sci.Transl.Med. 2011, 3:73ra20. 
 489.  Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, Herrmann M, 
Voll RE, Zychlinsky A: Impairment of neutrophil extracellular trap degradation is 
associated with lupus nephritis. Proc.Natl.Acad.Sci.U.S.A 2010, 107:9813-9818. 
 490.  Leffler J, Martin M, Gullstrand B, Tyden H, Lood C, Truedsson L, Bengtsson AA, 
Blom AM: Neutrophil extracellular traps that are not degraded in systemic lupus 
erythematosus activate complement exacerbating the disease. J.Immunol. 2012, 
188:3522-3531. 
 491.  Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, Chang B, Duramad 
O, Coffman RL: Nucleic acids of mammalian origin can act as endogenous ligands 
for Toll-like receptors and may promote systemic lupus erythematosus. J.Exp.Med. 
2005, 202:1131-1139. 
 492.  Means TK, Latz E, Hayashi F, Murali MR, Golenbock DT, Luster AD: Human lupus 
autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. 
J.Clin.Invest 2005, 115:407-417. 
 493.  Godoy-Ramirez K, Franck K, Gaines H: A novel method for the simultaneous 
assessment of natural killer cell conjugate formation and cytotoxicity at the single-cell 
level by multi-parameter flow cytometry. J.Immunol.Methods 2000, 239:35-44. 
 494.  Drose S, Bindseil KU, Bowman EJ, Siebers A, Zeeck A, Altendorf K: Inhibitory 
effect of modified bafilomycins and concanamycins on P- and V-type 
adenosinetriphosphatases. Biochemistry 1993, 32:3902-3906. 
 495.  Kataoka T, Takaku K, Magae J, Shinohara N, Takayama H, Kondo S, Nagai K: 
Acidification is essential for maintaining the structure and function of lytic granules 
of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on 
CTL-mediated cytotoxicity. J.Immunol. 1994, 153:3938-3947. 
 496.  Lehmann C, Zeis M, Schmitz N, Uharek L: Impaired binding of perforin on the 
surface of tumor cells is a cause of target cell resistance against cytotoxic effector 
cells. Blood 2000, 96:594-600. 
 497.  Lehmann C, Zeis M, Uharek L: Activation of natural killer cells with interleukin 2 
(IL-2) and IL-12 increases perforin binding and subsequent lysis of tumour cells. 
Br.J.Haematol. 2001, 114:660-665. 
Page | 262  
 
 498.  Al-Hubeshy ZB, Coleman A, Nelson M, Goodier MR: A rapid method for assessment 
of natural killer cell function after multiple receptor crosslinking. J.Immunol.Methods 
2011, 366:52-59. 
 499.  Freitas M, Lima JL, Fernandes E: Optical probes for detection and quantification of 
neutrophils' oxidative burst. A review. Anal.Chim.Acta 2009, 649:8-23. 
 500.  Hazeldine J, Hampson P, Lord JM: Reduced release and binding of perforin at the 
immunological synapse underlies the age-related decline in natural killer cell 
cytotoxicity. Aging Cell 2012, 11:751-759. 
 501.  Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, Fox B, Haldeman B, Ostrander CD, 
Kaifu T, Chabannon C, Moretta A, West R, Xu W, Vivier E, Levin SD: The B7 
family member B7-H6 is a tumor cell ligand for the activating natural killer cell 
receptor NKp30 in humans. J.Exp.Med. 2009, 206:1495-1503. 
 502.  Iwaszko M, Bogunia-Kubik K: Clinical significance of the HLA-E and CD94/NKG2 
interaction. Arch.Immunol.Ther.Exp.(Warsz.) 2011, 59:353-367. 
 503.  Winchester BG: Lysosomal membrane proteins. Eur.J.Paediatr.Neurol. 2001, 5 Suppl 
A:11-19. 
 504.  Alter G, Malenfant JM, Altfeld M: CD107a as a functional marker for the 
identification of natural killer cell activity. J.Immunol.Methods 2004, 294:15-22. 
 505.  Penack O, Gentilini C, Fischer L, Asemissen AM, Scheibenbogen C, Thiel E, Uharek 
L: CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor 
targets. Leukemia 2005, 19:835-840. 
 506.  Murugin VV, Zuikova IN, Murugina NE, Shulzhenko AE, Pinegin BV, Pashenkov 
MV: Reduced degranulation of NK cells in patients with frequently recurring herpes. 
Clin.Vaccine Immunol. 2011, 18:1410-1415. 
 507.  Bhat R, Watzl C: Serial killing of tumor cells by human natural killer cells--
enhancement by therapeutic antibodies. PLoS.One. 2007, 2:e326. 
 508.  Jewett A, Bonavida B: Target-induced anergy of natural killer cytotoxic function is 
restricted to the NK-target conjugate subset. Cell Immunol. 1995, 160:91-97. 
 509.  Jewett A, Bonavida B: Target-induced inactivation and cell death by apoptosis in a 
subset of human NK cells. J.Immunol. 1996, 156:907-915. 
 510.  Plett PA, Gardner EM, Murasko DM: Age-related changes in interferon-alpha/beta 
receptor expression, binding, and induction of apoptosis in natural killer cells from 
C57BL/6 mice. Mech.Ageing Dev. 2000, 118:129-144. 
 511.  Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, 
Green DR: Early redistribution of plasma membrane phosphatidylserine is a general 
feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression 
of Bcl-2 and Abl. J.Exp.Med. 1995, 182:1545-1556. 
Page | 263  
 
 512.  Bryceson YT, Rudd E, Zheng C, Edner J, Ma D, Wood SM, Bechensteen AG, 
Boelens JJ, Celkan T, Farah RA, Hultenby K, Winiarski J, Roche PA, Nordenskjold 
M, Henter JI, Long EO, Ljunggren HG: Defective cytotoxic lymphocyte 
degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 
(FHL4) patients. Blood 2007, 110:1906-1915. 
 513.  Orange JS, Ramesh N, Remold-O'Donnell E, Sasahara Y, Koopman L, Byrne M, 
Bonilla FA, Rosen FS, Geha RS, Strominger JL: Wiskott-Aldrich syndrome protein is 
required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating 
immunologic synapses. Proc.Natl.Acad.Sci.U.S.A 2002, 99:11351-11356. 
 514.  Topham NJ, Hewitt EW: Natural killer cell cytotoxicity: how do they pull the trigger? 
Immunology 2009, 128:7-15. 
 515.  Cargnello M, Roux PP: Activation and function of the MAPKs and their substrates, 
the MAPK-activated protein kinases. Microbiol.Mol.Biol.Rev. 2011, 75:50-83. 
 516.  Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK: Decreased natural 
killer cell activity is associated with atherosclerosis in elderly humans. Exp.Gerontol. 
2001, 37:127-136. 
 517.  Lopez-Verges S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, Norris 
PJ, Nixon DF, Lanier LL: CD57 defines a functionally distinct population of mature 
NK cells in the human CD56dimCD16+ NK-cell subset. Blood 2010, 116:3865-3874. 
 518.  Solana R, Tarazona R, Gayoso I, Lesur O, Dupuis G, Fulop T: Innate 
immunosenescence: Effect of aging on cells and receptors of the innate immune 
system in humans. Semin.Immunol. 2012. 
 519.  Chidrawar SM, Khan N, Chan YL, Nayak L, Moss PA: Ageing is associated with a 
decline in peripheral blood CD56bright NK cells. Immun.Ageing 2006, 3:10. 
 520.  Elpek KG, Rubinstein MP, Bellemare-Pelletier A, Goldrath AW, Turley SJ: Mature 
natural killer cells with phenotypic and functional alterations accumulate upon 
sustained stimulation with IL-15/IL-15Ralpha complexes. Proc.Natl.Acad.Sci.U.S.A 
2010, 107:21647-21652. 
 521.  Alter G, Teigen N, Davis BT, Addo MM, Suscovich TJ, Waring MT, Streeck H, 
Johnston MN, Staller KD, Zaman MT, Yu XG, Lichterfeld M, Basgoz N, Rosenberg 
ES, Altfeld M: Sequential deregulation of NK cell subset distribution and function 
starting in acute HIV-1 infection. Blood 2005, 106:3366-3369. 
 522.  Hu PF, Hultin LE, Hultin P, Hausner MA, Hirji K, Jewett A, Bonavida B, Detels R, 
Giorgi JV: Natural killer cell immunodeficiency in HIV disease is manifest by 
profoundly decreased numbers of CD16+CD56+ cells and expansion of a population 
of CD16dim. J.Acquir.Immune.Defic.Syndr.Hum.Retrovirol. 1995, 10:331-340. 
 523.  Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, Marcenaro E, O'Shea MA, 
Kinter A, Kovacs C, Moretta A, Fauci AS: Characterization of CD56-/CD16+ natural 
Page | 264  
 
killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic 
individuals. Proc.Natl.Acad.Sci.U.S.A 2005, 102:2886-2891. 
 524.  Eller MA, Eller LA, Ouma BJ, Thelian D, Gonzalez VD, Guwatudde D, McCutchan 
FE, Marovich MA, Michael NL, de Souza MS, Wabwire-Mangen F, Robb ML, 
Currier JR, Sandberg JK: Elevated natural killer cell activity despite altered functional 
and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection. 
J.Acquir.Immune.Defic.Syndr. 2009, 51:380-389. 
 525.  Gonzalez VD, Falconer K, Bjorkstrom NK, Blom KG, Weiland O, Ljunggren HG, 
Alaeus A, Sandberg JK: Expansion of functionally skewed CD56-negative NK cells 
in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-
alpha and ribavirin treatment. J.Immunol. 2009, 183:6612-6618. 
 526.  Dalbeth N, Gundle R, Davies RJ, Lee YC, McMichael AJ, Callan MF: CD56bright 
NK cells are enriched at inflammatory sites and can engage with monocytes in a 
reciprocal program of activation. J.Immunol. 2004, 173:6418-6426. 
 527.  Vitale M, Della CM, Carlomagno S, Romagnani C, Thiel A, Moretta L, Moretta A: 
The small subset of CD56bright. Eur.J.Immunol. 2004, 34:1715-1722. 
 528.  Nowbakht P, Ionescu MC, Rohner A, Kalberer CP, Rossy E, Mori L, Cosman D, De 
LG, Wodnar-Filipowicz A: Ligands for natural killer cell-activating receptors are 
expressed upon the maturation of normal myelomonocytic cells but at low levels in 
acute myeloid leukemias. Blood 2005, 105:3615-3622. 
 529.  Epling-Burnette PK, Bai F, Painter JS, Rollison DE, Salih HR, Krusch M, Zou J, Ku 
E, Zhong B, Boulware D, Moscinski L, Wei S, Djeu JY, List AF: Reduced natural 
killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and 
reduced expression of activating NK receptors. Blood 2007, 109:4816-4824. 
 530.  Ghiringhelli F, Menard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault 
S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, 
Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel 
L: CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a 
transforming growth factor-beta-dependent manner. J.Exp.Med. 2005, 202:1075-
1085. 
 531.  Draghi M, Pashine A, Sanjanwala B, Gendzekhadze K, Cantoni C, Cosman D, 
Moretta A, Valiante NM, Parham P: NKp46 and NKG2D recognition of infected 
dendritic cells is necessary for NK cell activation in the human response to influenza 
infection. J.Immunol. 2007, 178:2688-2698. 
 532.  Vankayalapati R, Wizel B, Weis SE, Safi H, Lakey DL, Mandelboim O, Samten B, 
Porgador A, Barnes PF: The NKp46 receptor contributes to NK cell lysis of 
mononuclear phagocytes infected with an intracellular bacterium. J.Immunol. 2002, 
168:3451-3457. 
 533.  Vankayalapati R, Garg A, Porgador A, Griffith DE, Klucar P, Safi H, Girard WM, 
Cosman D, Spies T, Barnes PF: Role of NK cell-activating receptors and their ligands 
Page | 265  
 
in the lysis of mononuclear phagocytes infected with an intracellular bacterium. 
J.Immunol. 2005, 175:4611-4617. 
 534.  Thoren FB, Riise RE, Ousback J, Della CM, Alsterholm M, Marcenaro E, Pesce S, 
Prato C, Cantoni C, Bylund J, Moretta L, Moretta A: Human NK Cells induce 
neutrophil apoptosis via an NKp46- and Fas-dependent mechanism. J.Immunol. 2012, 
188:1668-1674. 
 535.  Boyd AR, Orihuela CJ: Dysregulated inflammation as a risk factor for pneumonia in 
the elderly. Aging Dis. 2011, 2:487-500. 
 536.  Beziat V, Hervier B, Achour A, Boutolleau D, Marfain-Koka A, Vieillard V: Human 
NKG2A overrides NKG2C effector functions to prevent autoreactivity of NK cells. 
Blood 2011, 117:4394-4396. 
 537.  Vales-Gomez M, Reyburn HT, Erskine RA, Lopez-Botet M, Strominger JL: Kinetics 
and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A 
and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 1999, 18:4250-4260. 
 538.  Beli E, Clinthorne JF, Duriancik DM, Hwang I, Kim S, Gardner EM: Natural killer 
cell function is altered during the primary response of aged mice to influenza 
infection. Mech.Ageing Dev. 2011, 132:503-510. 
 539.  Podack ER, Young JD, Cohn ZA: Isolation and biochemical and functional 
characterization of perforin 1 from cytolytic T-cell granules. 
Proc.Natl.Acad.Sci.U.S.A 1985, 82:8629-8633. 
 540.  Jiang K, Zhong B, Gilvary DL, Corliss BC, Hong-Geller E, Wei S, Djeu JY: Pivotal 
role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. 
Nat.Immunol. 2000, 1:419-425. 
 541.  Herz J, Pardo J, Kashkar H, Schramm M, Kuzmenkina E, Bos E, Wiegmann K, 
Wallich R, Peters PJ, Herzig S, Schmelzer E, Kronke M, Simon MM, Utermohlen O: 
Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T 
lymphocytes. Nat.Immunol. 2009, 10:761-768. 
 542.  Chernomordik LV, Kozlov MM: Protein-lipid interplay in fusion and fission of 
biological membranes. Annu.Rev.Biochem. 2003, 72:175-207. 
 543.  Roozemond RC, Bonavida B: Effect of altered membrane fluidity on NK cell-
mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition 
events in the cytolytic pathway of NK cells. J.Immunol. 1985, 134:2209-2214. 
 544.  Laupland KB, Church DL, Mucenski M, Sutherland LR, Davies HD: Population-
based study of the epidemiology of and the risk factors for invasive Staphylococcus 
aureus infections. J.Infect.Dis. 2003, 187:1452-1459. 
 545.  Whitelaw DA, Rayner BL, Willcox PA: Community-acquired bacteremia in the 
elderly: a prospective study of 121 cases. J.Am.Geriatr.Soc. 1992, 40:996-1000. 
Page | 266  
 
 546.  Finkelstein MS, Petkun WM, Freedman ML, Antopol SC: Pneumococcal bacteremia 
in adults: age-dependent differences in presentation and in outcome. 
J.Am.Geriatr.Soc. 1983, 31:19-27. 
 547.  Kauffman CA: Fungal infections in older adults. Clin.Infect.Dis. 2001, 33:550-555. 
 548.  Carr R: Neutrophil production and function in newborn infants. Br.J.Haematol. 2000, 
110:18-28. 
 549.  Brinkmann V, Laube B, Abu AU, Goosmann C, Zychlinsky A: Neutrophil 
extracellular traps: how to generate and visualize them. J.Vis.Exp. 2010. 
 550.  Chow OA, von Kockritz-Blickwede M, Bright AT, Hensler ME, Zinkernagel AS, 
Cogen AL, Gallo RL, Monestier M, Wang Y, Glass CK, Nizet V: Statins enhance 
formation of phagocyte extracellular traps. Cell Host.Microbe 2010, 8:445-454. 
 551.  Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, Patel KD, 
Chakrabarti S, McAvoy E, Sinclair GD, Keys EM, Allen-Vercoe E, Devinney R, 
Doig CJ, Green FH, Kubes P: Platelet TLR4 activates neutrophil extracellular traps to 
ensnare bacteria in septic blood. Nat.Med. 2007, 13:463-469. 
 552.  Demers M, Krause DS, Schatzberg D, Martinod K, Voorhees JR, Fuchs TA, Scadden 
DT, Wagner DD: Cancers predispose neutrophils to release extracellular DNA traps 
that contribute to cancer-associated thrombosis. Proc.Natl.Acad.Sci.U.S.A 2012, 
109:13076-13081. 
 553.  Martinelli S, Urosevic M, Daryadel A, Oberholzer PA, Baumann C, Fey MF, 
Dummer R, Simon HU, Yousefi S: Induction of genes mediating interferon-dependent 
extracellular trap formation during neutrophil differentiation. J.Biol.Chem. 2004, 
279:44123-44132. 
 554.  El-Benna J, Dang PM, Gougerot-Pocidalo MA: Priming of the neutrophil NADPH 
oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the 
plasma membrane. Semin.Immunopathol. 2008, 30:279-289. 
 555.  Dewas C, Dang PM, Gougerot-Pocidalo MA, El-Benna J: TNF-alpha induces 
phosphorylation of p47(phox) in human neutrophils: partial phosphorylation of 
p47phox is a common event of priming of human neutrophils by TNF-alpha and 
granulocyte-macrophage colony-stimulating factor. J.Immunol. 2003, 171:4392-4398. 
 556.  Brown GE, Stewart MQ, Bissonnette SA, Elia AE, Wilker E, Yaffe MB: Distinct 
ligand-dependent roles for p38 MAPK in priming and activation of the neutrophil 
NADPH oxidase. J.Biol.Chem. 2004, 279:27059-27068. 
 557.  Ward RA, Nakamura M, McLeish KR: Priming of the neutrophil respiratory burst 
involves p38 mitogen-activated protein kinase-dependent exocytosis of 
flavocytochrome b558-containing granules. J.Biol.Chem. 2000, 275:36713-36719. 
 558.  Jones SA, Wolf M, Qin S, Mackay CR, Baggiolini M: Different functions for the 
interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and 
Page | 267  
 
phospholipase D are activated through IL-8R1 but not IL-8R2. 
Proc.Natl.Acad.Sci.U.S.A 1996, 93:6682-6686. 
 559.  Lu YC, Yeh WC, Ohashi PS: LPS/TLR4 signal transduction pathway. Cytokine 2008, 
42:145-151. 
 560.  Abi Abdallah DS, Lin C, Ball CJ, King MR, Duhamel GE, Denkers EY: Toxoplasma 
gondii triggers release of human and mouse neutrophil extracellular traps. 
Infect.Immun. 2012, 80:768-777. 
 561.  Mitroulis I, Kourtzelis I, Kambas K, Rafail S, Chrysanthopoulou A, Speletas M, Ritis 
K: Regulation of the autophagic machinery in human neutrophils. Eur.J.Immunol. 
2010, 40:1461-1472. 
 562.  Donati A, Cavallini G, Paradiso C, Vittorini S, Pollera M, Gori Z, Bergamini E: Age-
related changes in the autophagic proteolysis of rat isolated liver cells: effects of 
antiaging dietary restrictions. J.Gerontol.A Biol.Sci.Med.Sci. 2001, 56:B375-B383. 
 563.  Terman A: The effect of age on formation and elimination of autophagic vacuoles in 
mouse hepatocytes. Gerontology 1995, 41 Suppl 2:319-326. 
 564.  Tortorella C, Stella I, Piazzolla G, Simone O, Cappiello V, Antonaci S: Role of 
defective ERK phosphorylation in the impaired GM-CSF-induced oxidative response 
of neutrophils in elderly humans. Mech.Ageing Dev. 2004, 125:539-546. 
 565.  Lipschitz DA, Udupa KB, Boxer LA: The role of calcium in the age-related decline of 
neutrophil function. Blood 1988, 71:659-665. 
 566.  Pillay J, Ramakers BP, Kamp VM, Loi AL, Lam SW, Hietbrink F, Leenen LP, Tool 
AT, Pickkers P, Koenderman L: Functional heterogeneity and differential priming of 
circulating neutrophils in human experimental endotoxemia. J.Leukoc.Biol. 2010, 
88:211-220. 
 567.  Phillipson M, Kubes P: The neutrophil in vascular inflammation. Nat.Med. 2011, 
17:1381-1390. 
 568.  Liappis AP, Kan VL, Rochester CG, Simon GL: The effect of statins on mortality in 
patients with bacteremia. Clin.Infect.Dis. 2001, 33:1352-1357. 
 569.  Donnino MW, Cocchi MN, Howell M, Clardy P, Talmor D, Cataldo L, Chase M, Al-
Marshad A, Ngo L, Shapiro NI: Statin therapy is associated with decreased mortality 
in patients with infection. Acad.Emerg.Med. 2009, 16:230-234. 
 570.  Schlienger RG, Fedson DS, Jick SS, Jick H, Meier CR: Statins and the risk of 
pneumonia: a population-based, nested case-control study. Pharmacotherapy 2007, 
27:325-332. 
 571.  Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sorensen HT: 
Preadmission use of statins and outcomes after hospitalization with pneumonia: 
population-based cohort study of 29,900 patients. Arch.Intern.Med. 2008, 168:2081-
2087. 
Page | 268  
 
 572.  Vinogradova Y, Coupland C, Hippisley-Cox J: Risk of pneumonia in patients taking 
statins: population-based nested case-control study. Br.J.Gen.Pract. 2011, 61:e742-
e748. 
 573.  Raad H, Paclet MH, Boussetta T, Kroviarski Y, Morel F, Quinn MT, Gougerot-
Pocidalo MA, Dang PM, El-Benna J: Regulation of the phagocyte NADPH oxidase 
activity: phosphorylation of gp91phox/NOX2 by protein kinase C enhances its 
diaphorase activity and binding to Rac2, p67phox, and p47phox. FASEB J. 2009, 
23:1011-1022. 
 574.  Kim W, Yoon JH, Kim JR, Jang IJ, Bang YJ, Kim YJ, Lee HS: Synergistic anti-tumor 
efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma. 
Cancer Chemother.Pharmacol. 2009, 64:497-507. 
 575.  Spitaler M, Cantrell DA: Protein kinase C and beyond. Nat.Immunol. 2004, 5:785-
790. 
 576.  Steinberg SF: Structural basis of protein kinase C isoform function. Physiol Rev. 
2008, 88:1341-1378. 
 577.  Chow SC, NG J, Nordstedt C, Fredholm BB, Jondal M: Phosphoinositide breakdown 
and evidence for protein kinase C involvement during human NK killing. Cell 
Immunol. 1988, 114:96-103. 
 578.  Leibson PJ, Midthun DE, Windebank KP, Abraham RT: Transmembrane signaling 
during natural killer cell-mediated cytotoxicity. Regulation by protein kinase C 
activation. J.Immunol. 1990, 145:1498-1504. 
 579.  Steele TA, Brahmi Z: Phosphatidylinositol metabolism accompanies early activation 
events in tumor target cell-stimulated human natural killer cells. Cell Immunol. 1988, 
112:402-413. 
 580.  Windebank KP, Abraham RT, Powis G, Olsen RA, Barna TJ, Leibson PJ: Signal 
transduction during human natural killer cell activation: inositol phosphate generation 
and regulation by cyclic AMP. J.Immunol. 1988, 141:3951-3957. 
 581.  Bonnema JD, Karnitz LM, Schoon RA, Abraham RT, Leibson PJ: Fc receptor 
stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with 
protein kinase C-independent granule release and cell-mediated cytotoxicity. 
J.Exp.Med. 1994, 180:1427-1435. 
 582.  Ting AT, Schoon RA, Abraham RT, Leibson PJ: Interaction between protein kinase 
C-dependent and G protein-dependent pathways in the regulation of natural killer cell 
granule exocytosis. J.Biol.Chem. 1992, 267:23957-23962. 
 583.  Balogh G, de Boland AR, Boland R, Barja P: Effect of 1,25(OH)(2)-vitamin D(3) on 
the activation of natural killer cells: role of protein kinase C and extracellular calcium. 
Exp.Mol.Pathol. 1999, 67:63-74. 
 584.  Garcia-Lora A, Martinez M, Pedrinaci S, Garrido F: Different regulation of PKC 
isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities 
Page | 269  
 
of the NKL human natural killer cell line. Cancer Immunol.Immunother. 2003, 52:59-
64. 
 585.  Solerte SB, Fioravanti M, Pascale A, Ferrari E, Govoni S, Battaini F: Increased 
natural killer cell cytotoxicity in Alzheimer's disease may involve protein kinase C 
dysregulation. Neurobiol.Aging 1998, 19:191-199. 
 586.  Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, Ohno S: Protein kinase C activates 
the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. 
J.Biol.Chem. 1996, 271:23512-23519. 
 587.  Zeidan YH, Hannun YA: Activation of acid sphingomyelinase by protein kinase 
Cdelta-mediated phosphorylation. J.Biol.Chem. 2007, 282:11549-11561. 
 588.  Zeidan YH, Wu BX, Jenkins RW, Obeid LM, Hannun YA: A novel role for protein 
kinase Cdelta-mediated phosphorylation of acid sphingomyelinase in UV light-
induced mitochondrial injury. FASEB J. 2008, 22:183-193. 
 589.  Ghoneum M, Suzuki K, Gollapudi S: Phorbol myristate acetate corrects impaired NK 
function of old mice. Scand.J.Immunol. 1991, 34:391-397. 
 590.  Borrego F, Pena J, Solana R: Regulation of CD69 expression on human natural killer 
cells: differential involvement of protein kinase C and protein tyrosine kinases. 
Eur.J.Immunol. 1993, 23:1039-1043. 
 591.  Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens 
M, Rubelj I, Pereira-Smith O, .: A biomarker that identifies senescent human cells in 
culture and in aging skin in vivo. Proc.Natl.Acad.Sci.U.S.A 1995, 92:9363-9367. 
 592.  Price JS, Waters JG, Darrah C, Pennington C, Edwards DR, Donell ST, Clark IM: 
The role of chondrocyte senescence in osteoarthritis. Aging Cell 2002, 1:57-65. 
 593.  Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I: Endothelial 
cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. 
Circulation 2002, 105:1541-1544. 
 594.  Jeyapalan JC, Sedivy JM: Cellular senescence and organismal aging. Mech.Ageing 
Dev. 2008, 129:467-474. 
 595.  Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, 
Kirkland JL, van Deursen JM: Clearance of p16Ink4a-positive senescent cells delays 
ageing-associated disorders. Nature 2011, 479:232-236. 
 596.  Sagiv A, Biran A, Yon M, Simon J, Lowe SW, Krizhanovsky V: Granule exocytosis 
mediates immune surveillance of senescent cells. Oncogene 2012. 
 597.  Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender 
L, Lowe SW: Senescence of activated stellate cells limits liver fibrosis. Cell 2008, 
134:657-667. 
Page | 270  
 
 598.  Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, Gazit R, Gonen-Gross T, 
Hanna J, Nahari E, Porgador A, Honigman A, Plachter B, Mevorach D, Wolf DG, 
Mandelboim O: Inhibition of the NKp30 activating receptor by pp65 of human 
cytomegalovirus. Nat.Immunol. 2005, 6:515-523. 
 599.  Cederarv M, Soderberg-Naucler C, Odeberg J: HCMV infection of PDCs deviates the 
NK cell response into cytokine-producing cells unable to perform cytotoxicity. 
Immunobiology 2009, 214:331-341. 
 600.  Lang PA, Lang KS, Xu HC, Grusdat M, Parish IA, Recher M, Elford AR, Dhanji S, 
Shaabani N, Tran CW, Dissanayake D, Rahbar R, Ghazarian M, Brustle A, Fine J, 
Chen P, Weaver CT, Klose C, Diefenbach A, Haussinger D, Carlyle JR, Kaech SM, 
Mak TW, Ohashi PS: Natural killer cell activation enhances immune pathology and 
promotes chronic infection by limiting CD8+ T-cell immunity. 
Proc.Natl.Acad.Sci.U.S.A 2012, 109:1210-1215. 
 601.  Waggoner SN, Cornberg M, Selin LK, Welsh RM: Natural killer cells act as rheostats 
modulating antiviral T cells. Nature 2012, 481:394-398. 
 602.  Andrews DM, Estcourt MJ, Andoniou CE, Wikstrom ME, Khong A, Voigt V, 
Fleming P, Tabarias H, Hill GR, van der Most RG, Scalzo AA, Smyth MJ, Degli-
Esposti MA: Innate immunity defines the capacity of antiviral T cells to limit 
persistent infection. J.Exp.Med. 2010, 207:1333-1343. 
 603.  Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, 
Ahmed R: Restoring function in exhausted CD8 T cells during chronic viral infection. 
Nature 2006, 439:682-687. 
 604.  Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, Long BR, Wong JC, 
Satkunarajah M, Schweneker M, Chapman JM, Gyenes G, Vali B, Hyrcza MD, Yue 
FY, Kovacs C, Sassi A, Loutfy M, Halpenny R, Persad D, Spotts G, Hecht FM, Chun 
TW, McCune JM, Kaul R, Rini JM, Nixon DF, Ostrowski MA: Tim-3 expression 
defines a novel population of dysfunctional T cells with highly elevated frequencies in 
progressive HIV-1 infection. J.Exp.Med. 2008, 205:2763-2779. 
 605.  Yamashita Y, Shimokata K, Mizuno S, Yamaguchi H, Nishiyama Y: Down-
regulation of the surface expression of class I MHC antigens by human 
cytomegalovirus. Virology 1993, 193:727-736. 
 606.  Beersma MF, Bijlmakers MJ, Ploegh HL: Human cytomegalovirus down-regulates 
HLA class I expression by reducing the stability of class I H chains. J.Immunol. 1993, 
151:4455-4464. 
 607.  Abendroth A, Lin I, Slobedman B, Ploegh H, Arvin AM: Varicella-zoster virus 
retains major histocompatibility complex class I proteins in the Golgi compartment of 
infected cells. J.Virol. 2001, 75:4878-4888. 
 608.  Zuo J, Quinn LL, Tamblyn J, Thomas WA, Feederle R, Delecluse HJ, Hislop AD, 
Rowe M: The Epstein-Barr virus-encoded BILF1 protein modulates immune 
recognition of endogenously processed antigen by targeting major histocompatibility 
Page | 271  
 
complex class I molecules trafficking on both the exocytic and endocytic pathways. 
J.Virol. 2011, 85:1604-1614. 
 609.  Tseng CW, Kyme PA, Arruda A, Ramanujan VK, Tawackoli W, Liu GY: Innate 
immune dysfunctions in aged mice facilitate the systemic dissemination of 
methicillin-resistant S. aureus. PLoS.One. 2012, 7:e41454. 
 610.  Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD, Jr., 
Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD: Extracellular DNA traps 
promote thrombosis. Proc.Natl.Acad.Sci.U.S.A 2010, 107:15880-15885. 
 611.  Dworski R, Simon HU, Hoskins A, Yousefi S: Eosinophil and neutrophil extracellular 
DNA traps in human allergic asthmatic airways. J.Allergy Clin.Immunol. 2011, 
127:1260-1266. 
 612.  Astaldi Ricotti GC, Pazzaglia M, Martelli AM, Cerino A, Bestagno M, Caprelli A, 
Riva S, Pedrini MA, Facchini A: Autoantibodies to purified nuclear proteins related to 
DNA metabolism during ageing and in SLE patients. Immunology 1987, 61:375-381. 
 613.  Xavier RM, Yamauchi Y, Nakamura M, Tanigawa Y, Ishikura H, Tsunematsu T, 
Kobayashi S: Antinuclear antibodies in healthy aging people: a prospective study. 
Mech.Ageing Dev. 1995, 78:145-154. 
 614.  Kasjanov A, Cebecauer L, Balaz V: Antibodies against ss-DNA in persons of various 
age. Mech.Ageing Dev. 1984, 28:289-295. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page | 272  
 
Appendix I – Primary papers and review articles published during the  
completion of this PhD 
1. Hazeldine J, Hampson P and Lord JM. Reduced release and binding of perforin at the 
immunological synapse underlies the age-related decline in natural killer cell 
cytotoxicity. Aging Cell, 2012. October; 11(5) 751-759. 
 
2. Wang K*, Hampson P*, Hazeldine J, Krystof V, Strnad M, Pechan P and Lord JM. 
Cyclin-dependent kinase 9 activity regulates neutrophil spontaneous apoptosis.                    
PLoS One. 2012;7(1):e30128. Epub 2012 Jan 19. 
 
*Joint first authorship 
 
3. Hampson P*, Hazeldine J* and Lord JM. Neutrophil apoptosis and its induction as a 
potential treatment for chronic inflammatory disease. Curr.Opin.Heam. (In press) 
 
*Joint first authorship 
 
4. Hazeldine J, Arlt W and Lord JM. Dehydroepiandrosterone as a regulator of immune 
cell function. J.Steroid.Biochem.Mol.Biol. 2010 May 31;120(2-3):127-36. 
 
 
 
